{
  "accuracy": 0.7,
  "correct": 35,
  "total": 50,
  "parameters": {
    "max_results": 10,
    "hybrid_search": true,
    "neural_ratio": 0.3,
    "gemini_model": "gemini/gemini-2.0-flash-exp"
  },
  "detailed_results": [
    {
      "question": "Has anyone shown a gene therapy that is delivered via an aerosol?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Inhalation delivery technology for genome-editing of respiratory diseases",
          "author": "Michael Y T Chow, Rachel Yoon Kyung Chang, Hak-Kim  Chan",
          "published_date": "2023-11-09T20:29:42.827000+00:00",
          "summary": "This review article discusses the potential of aerosol delivery for CRISPR/Cas9 gene therapy targeting respiratory diseases.  While no specific examples of successful aerosol-delivered gene therapies are presented, the authors highlight the need for improved inhalation formulations to facilitate clinical translation of this approach.  They suggest that adapting existing gene and protein delivery methods could accelerate development of inhalable CRISPR/Cas9 therapies.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0169409X20300478"
        },
        {
          "title": "Inhalation delivery technology for genome-editing of respiratory diseases",
          "author": "M. Y. Chow,R. Chang,H. Chan",
          "published_date": "2023-10-26T19:28:51+00:00",
          "summary": "This review article discusses the potential of using aerosol delivery for CRISPR/Cas9-based gene therapy for respiratory diseases.  While the CRISPR/Cas9 system shows promise, the authors highlight the lack of progress in developing effective inhalable formulations for genes and proteins.  The article focuses on strategies and methods for formulating inhalable biologics (genes and proteins), suggesting that adapting these methods could accelerate the development of inhalable CRISPR/Cas9 therapies.  The review doesn't present examples of *completed* aerosol gene therapies, but rather discusses the *potential* and necessary steps for their development.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32512029"
        },
        {
          "title": "Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes - PubMed",
          "author": "Tony Le Gall 1 ,",
          "published_date": "2021-12-23T00:00:00+00:00",
          "summary": "Yes.  The provided PubMed article discusses aerosol-mediated non-viral lung gene therapy, citing progress in cystic fibrosis treatment using the lipidic formulation GL67A as evidence of the viability of this approach.  The research highlights the need for more effective gene transfer agents, but confirms that aerosol delivery of gene therapy has been demonstrated.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35056921/"
        },
        {
          "title": "Aerosol Inhalation of Gene Delivery Therapy for Pulmonary ...",
          "author": "Yiheng Huang 1 ,",
          "published_date": "2024-07-25T00:00:00+00:00",
          "summary": "Yes, this PubMed review article discusses aerosol gene delivery therapy for pulmonary diseases.  The authors review various gene carriers (viral and non-viral vectors) and types of genes (DNA, mRNA, siRNA, CRISPR/Cas9) delivered via aerosol, citing examples of successful applications in treating diseases like SARS-CoV-2, cystic fibrosis, and lung cancer.  The review also highlights challenges, such as overcoming physiological barriers to ensure effective lung accumulation and minimize off-target effects.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39199292/"
        },
        {
          "title": "Aerosol Inhalation of Gene Delivery Therapy for Pulmonary ...",
          "author": "Hecheng Li",
          "published_date": "2024-07-25T00:00:00+00:00",
          "summary": "Yes, this review article discusses aerosol gene delivery therapy for pulmonary diseases.  Various gene types (DNA, mRNA, siRNA, CRISPR/Cas9) and carriers (viral and non-viral vectors) are being studied.  The method shows promise for treating diseases like SARS-CoV-2, cystic fibrosis, and lung cancer due to high lung accumulation and reduced systemic side effects.\n",
          "url": "https://www.mdpi.com/2218-273X/14/8/904"
        },
        {
          "title": "Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa ...",
          "author": "",
          "published_date": "2020-01-10T00:00:00+00:00",
          "summary": "Yes. This study demonstrates aerosol delivery of synthetic mRNA encoding a broadly neutralizing antibody against HIV to the vaginal mucosa of sheep and rhesus macaques.  The mRNA, delivered in water without formulation, resulted in high levels of antibody expression for over 28 days in sheep and prevented SHIV infection in *ex vivo* macaque explants.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7054722/"
        },
        {
          "title": "Effective pulmonary delivery of an aerosolized plasmid DNA ...",
          "author": "Anushi E Rajapaksa, Monash University, Wellington Road, 3800, Clayton, Australia, Jenny J Ho, Monash University, Wellington Road, 3800, Clayton, Australia, Aisha  Qi, RMIT University, 124 La Trobe Street, 3000, Melbourne, Australia, Rob  Bischof, Monash University, Wellington Road, 3800, Clayton, Australia, Tri-Hung  Nguyen, Monash University, 3800, Monash, Parkville, Australia, Michelle  Tate, Monash Institute of Medical Research, 3800, Clayton, Australia, David  Piedrafita, Monash University, Wellington Road, 3800, Clayton, Australia, Michelle P Mcintosh, Monash University, 3800, Monash, Parkville, Australia, Leslie Y Yeo, RMIT University, 124 La Trobe Street, 3000, Melbourne, Australia, Els  Meeusen, Ross L Coppel, Nursing and Health Sciences, Wellington Road, 3800, Clayton, Australia, James R Friend, RMIT University, 124 La Trobe Street, 3000, Melbourne, Australia, james.friend@rmit.edu.au",
          "published_date": "2023-11-09T20:03:59.707000+00:00",
          "summary": "Yes. This research demonstrates successful aerosolized delivery of a plasmid DNA (pDNA) vaccine encoding an influenza A virus surface glycoprotein to sheep using a novel surface acoustic wave (SAW) nebulizer.  The SAW nebulizer generated pDNA aerosols suitable for deep lung delivery, resulting in effective systemic and mucosal antibody responses in rats and successful gene expression in mice.  This is the first reported instance of successful aerosolized pDNA vaccine delivery in a large animal model.\n",
          "url": "https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-15-60"
        },
        {
          "title": "EFFICIENT GENE DELIVERY TO PIGLET LUNGS ...",
          "author": "Parton, Lance A",
          "published_date": "1996-04-01T00:00:00+00:00",
          "summary": "Yes, this 1996 study demonstrated aerosol delivery of gene therapy using cationic liposomes and a novel cationic peptide to piglet lungs.  The method showed high levels of \u03b2-galactosidase expression in airway epithelial cells without inflammation, suggesting a potentially safe and effective approach for lung-specific gene therapy.  A novel aerosol device was used for nebulization.\n",
          "url": "https://www.nature.com/articles/pr19961553"
        },
        {
          "title": "The expanding role of aerosols in systemic drug delivery ...",
          "author": "Beth L Laube, The Johns Hopkins Medical Institutions, Suite 3015, 200 North Wolfe Street, 21287, Baltimore, MD, USA, blaube@jhmi.edu",
          "published_date": "2023-11-09T20:01:48.304000+00:00",
          "summary": "Yes, this review article discusses the development of aerosolized gene therapy, highlighting the challenges in efficiently delivering gene vectors that can penetrate mucus barriers, cell membranes, and ultimately transfer DNA to the cell nucleus.  However, the article does not cite specific examples of successful clinical trials or commercially available aerosolized gene therapies.  The focus is on the ongoing research and development in this area.\n",
          "url": "https://transrespmed.springeropen.com/articles/10.1186/2213-0802-2-3"
        },
        {
          "title": "Pediatric Aerosol Therapy: New Devices and New Drugs",
          "author": "Bruce K Rubin, brubin@vcu.edu",
          "published_date": "2023-11-09T20:08:35.726000+00:00",
          "summary": "This article on pediatric aerosol therapy discusses advancements in aerosol drug delivery devices and formulations,  but it does *not* mention gene therapy delivered via aerosol.  The text focuses on traditional drug delivery methods for airway diseases.\n",
          "url": "https://rc.rcjournal.com/content/56/9/1411"
        }
      ],
      "full_explanation": "Several papers demonstrate that the proposed research question has been addressed. Specifically, the paper titled \"Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes\" (URL: https://pubmed.ncbi.nlm.nih.gov/35056921/) confirms aerosol-mediated non-viral lung gene therapy has been demonstrated, citing progress using the lipidic formulation GL67A in cystic fibrosis treatment as an example. Furthermore, the paper \"Aerosol Inhalation of Gene Delivery Therapy for Pulmonary...\" (URL: https://pubmed.ncbi.nlm.nih.gov/39199292/) and a similarly titled paper (URL: https://www.mdpi.com/2218-273X/14/8/904) review aerosol gene delivery therapy for pulmonary diseases, noting various gene types and carriers and citing successes in diseases like SARS-CoV-2, cystic fibrosis, and lung cancer. Additionally, the paper \"Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7054722/) shows successful aerosol delivery of mRNA to the vaginal mucosa. \"Effective pulmonary delivery of an aerosolized plasmid DNA...\" (URL: https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-15-60) provides evidence of successful aerosolized delivery of plasmid DNA to the lungs. Finally, the 1996 study \"EFFICIENT GENE DELIVERY TO PIGLET LUNGS...\" (URL: https://www.nature.com/articles/pr19961553) demonstrates aerosol delivery of gene therapy using cationic liposomes and a novel cationic peptide to piglet lungs. While the review \"Inhalation delivery technology for genome-editing of respiratory diseases\" (URL: https://www.sciencedirect.com/science/article/pii/S0169409X20300478 and https://pubmed.ncbi.nlm.nih.gov/32512029) discusses the potential of aerosol-delivered gene therapy, these do not provide examples of successful therapies, but rather focus on the need for future development. The review, \"The expanding role of aerosols in systemic drug delivery...\" (URL: https://transrespmed.springeropen.com/articles/10.1186/2213-0802-2-3) discusses the challenges of gene therapy delivered via aerosol, but does not deny that such work exists. Therefore, there is ample evidence to confirm that the research question has been addressed."
    },
    {
      "question": "Has anyone identified all the potential functions of intrinsically disordered proteins (IDPs)?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Intrinsically disordered regions that drive phase separation form a robustly distinct protein class",
          "author": "Ayyam Y. Ibrahim,Nathan Khaodeuanepheng,Dhanush L. Amarasekara,J. Correia,Karen A. Lewis,Nicholas C. Fitzkee,L. Hough,S. Whitten",
          "published_date": "2023-10-26T19:30:38.732000+00:00",
          "summary": "No, this research paper does not identify all potential functions of intrinsically disordered proteins (IDPs).  Instead, it focuses on a subset of IDPs: those intrinsically disordered regions (IDRs) that drive protein phase separation, a process crucial for membrane-less organelle formation involved in various biological functions like stress response and ribosome biogenesis. The study develops a method to improve the prediction of these phase-separating IDRs, highlighting the mechanisms involved, but does not attempt a comprehensive catalog of all IDP functions.\n",
          "url": "http://www.jbc.org/article/S0021925822012443/pdf"
        },
        {
          "title": "Intrinsically Disordered Proteins: An Overview",
          "author": "Rakesh Trivedi,H. Nagarajaram",
          "published_date": "2023-10-26T19:30:59.305000+00:00",
          "summary": "No, a complete catalog of all potential functions of intrinsically disordered proteins (IDPs) has not been identified.  Research indicates that IDPs often lack a stable three-dimensional structure under physiological conditions, yet perform various cellular functions, sometimes exhibiting \"functional promiscuity\". While significant progress has been made in understanding IDPs, their diverse roles and the full extent of their functionalities remain an area of ongoing investigation.\n",
          "url": "https://www.mdpi.com/1422-0067/23/22/14050/pdf?version=1668429018"
        },
        {
          "title": "Crowder-directed interactions and conformational dynamics in multistimuli-responsive intrinsically disordered protein",
          "author": "Rajkamal Balu; Nisal Wanasingha; Jitendra P Mata; Agata Rekas; Susan Barrett; Geoff Dumsday; Aaron W Thornton; Anita J Hill; Namita Roy Choudhury; Naba K Dutta",
          "published_date": "2023-04-13T16:58:57.212000+00:00",
          "summary": "No, the provided text does not claim that all functions of intrinsically disordered proteins (IDPs) have been identified.  It mentions that IDPs are involved in a wide range of biological processes, including cell signaling, regulation, transcription elongation, membrane-less organelles, and homeostasis, but this is not an exhaustive list.  The research focuses on the effects of macromolecular crowding on the structure and dynamics of one specific IDP (Rec1-resilin), not on a complete functional catalog of all IDPs.\n",
          "url": "https://www.science.org/doi/10.1126/sciadv.abq2202"
        },
        {
          "title": "Intrinsically Disordered Proteins: An Overview - PMC",
          "author": "",
          "published_date": "2022-11-14T00:00:00+00:00",
          "summary": "No, a complete understanding of all potential functions of intrinsically disordered proteins (IDPs) has not yet been achieved.  The review article states that IDPs are involved in various cellular functions and exhibit \"functional promiscuity,\" meaning they can interact with multiple partners. However, the article focuses on the concept of IDPs and methods for identifying them, rather than providing an exhaustive list of all their known functions.  Further research is needed to fully elucidate the diverse roles of IDPs.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9693201/"
        },
        {
          "title": "Intrinsically Disordered Proteins: Insights from Poincar\u00e9, ...",
          "author": "Prakash Kulkarni",
          "published_date": "2023-02-06T10:59:39.487000+00:00",
          "summary": "No, the provided text does not claim that all functions of intrinsically disordered proteins (IDPs) have been identified.  The article focuses on the history of IDP research, highlighting the authors' contributions and future research directions, including their role in phenotypic switching and multicellularity.  While it mentions several key functions, it emphasizes that the field is still actively exploring the diverse roles of IDPs.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692701/"
        },
        {
          "title": "Identification of a Drug Targeting an Intrinsically ...",
          "author": "Abi\u00e1n, Olga",
          "published_date": "2017-01-05T00:00:00+00:00",
          "summary": "No, the exact functions of intrinsically disordered proteins (IDPs) are not fully understood.  The provided research focuses on NUPR1, an IDP implicated in pancreatic adenocarcinoma. While NUPR1's involvement in cell migration, invasion, adhesion, apoptosis, and chemoresistance is known, its complete functional role remains partially determined.  The article highlights the challenges in studying IDPs due to their dynamic nature and lack of well-defined structure, making comprehensive functional identification difficult.\n",
          "url": "https://www.nature.com/articles/srep39732"
        },
        {
          "title": "Intrinsically Disordered Proteins - Science topic",
          "author": "",
          "published_date": "2023-04-17T00:00:00+00:00",
          "summary": "No, a complete catalog of all potential functions of intrinsically disordered proteins (IDPs) has not been identified.  ResearchGate discussions show ongoing investigations into IDP behavior, including questions about their anomalous behavior in SDS-PAGE gels and the prediction of their interactions with other proteins using tools like ANCHOR2 and molecular dynamics simulations.  The provided text highlights the complexity of IDPs and the challenges in fully understanding their diverse functions.\n",
          "url": "https://www.researchgate.net/topic/Intrinsically-Disordered-Proteins"
        },
        {
          "title": "The function of the intrinsically disordered proteins.",
          "author": "Maqueda",
          "published_date": "2024-09-25T00:00:00+00:00",
          "summary": "No, a complete catalog of intrinsically disordered protein (IDP) functions is not available.  While over 70,000 pure IDPs and 40 million proteins with varying degrees of disorder exist, research is hampered by the complexity of IDP interactions.  These interactions involve three partners (IDP, its protein partner, and water) and are governed by a complex energy balance, making simple classification schemes inadequate.  Furthermore, post-translational modifications create numerous chemically distinct forms of IDPs, each with its own dynamics and function, further complicating functional assignment.  Therefore, identifying all potential IDP functions remains a significant challenge.\n",
          "url": "https://www.researchgate.net/post/The_function_of_the_intrinsically_disordered_proteins"
        },
        {
          "title": "On the roles of intrinsically disordered proteins and regions in ...",
          "author": "Uversky, Vladimir N.",
          "published_date": "2021-08-30T00:00:00+00:00",
          "summary": "No, a complete identification of all potential functions of intrinsically disordered proteins (IDPs) has not been achieved.  The article highlights that while the function of many structured proteins follows a sequence \u2192 structure \u2192 function paradigm, IDPs instead follow a sequence \u2192 IDP/IDR ensemble \u2192 function paradigm, often interacting with structured proteins or other IDPs to perform their roles in signaling and regulation.  Thirteen articles in this collection explore IDP roles in diverse organisms, demonstrating their wide-ranging contributions to cellular processes, but this does not represent an exhaustive catalog of all their functions.\n",
          "url": "https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00774-3"
        },
        {
          "title": "PSB 2020: Intrinsically disordered proteins and their functions",
          "author": "",
          "published_date": "2019-11-15T00:00:00+00:00",
          "summary": "No, a complete catalog of intrinsically disordered protein (IDP) functions has not been identified.  While IDPs play crucial roles in numerous biological processes (e.g., gene regulation, embryonic development, prion disease, stem cell generation, autophagy, circadian rhythms, and phage display \u2013 processes recognized by several Nobel Prizes),  research is ongoing, and many functions likely remain undiscovered.  The text highlights the significant but still incomplete understanding of IDPs and their roles in various diseases.\n",
          "url": "http://biomine.cs.vcu.edu/PSB2020/"
        }
      ],
      "full_explanation": "The provided papers consistently indicate that a comprehensive identification of all potential functions of intrinsically disordered proteins (IDPs) has not been achieved. Several papers explicitly state this. For instance, the paper titled \"Intrinsically Disordered Proteins: An Overview\" (URL: https://www.mdpi.com/1422-0067/23/22/14050/pdf?version=1668429018) states that \"the full extent of their functionalities remain an area of ongoing investigation.\" Similarly, the review article \"Intrinsically Disordered Proteins: An Overview - PMC\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC9693201/) also notes that \"further research is needed to fully elucidate the diverse roles of IDPs.\" The paper by Maqueda \"The function of the intrinsically disordered proteins.\" (URL: https://www.researchgate.net/post/The_function_of_the_intrinsically_disordered_proteins) explicitly mentions that a complete catalog is unavailable due to the complexity of IDP interactions and post-translational modifications. It states that, \"identifying all potential IDP functions remains a significant challenge.\" Other papers highlight that while many functions are known, the field is still actively exploring their diverse roles (e.g., \"Intrinsically Disordered Proteins: Insights from Poincar\u00e9, ...\" (URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692701/)). The paper \"PSB 2020: Intrinsically disordered proteins and their functions\" (URL: http://biomine.cs.vcu.edu/PSB2020/) also notes that while IDPs have crucial roles, \"research is ongoing, and many functions likely remain undiscovered.\" While research papers have found multiple functions of IDPs (as seen in the paper \"Crowder-directed interactions and conformational dynamics in multistimuli-responsive intrinsically disordered protein\" (URL: https://www.science.org/doi/10.1126/sciadv.abq2202)), no study has identified ALL potential functions of IDPs."
    },
    {
      "question": "Has anyone developed a means to model multiple length scales in biological simulations?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "A Multi-Scale Approach to Modeling E. coli Chemotaxis",
          "author": "Eran  Agmon, Stanford University, 94305, Stanford, CA, USA, eagmon@stanford.edu, Ryan K Spangler, Stanford University, 94305, Stanford, CA, USA, spanglry@stanford.edu",
          "published_date": "2023-11-09T20:31:34.917000+00:00",
          "summary": "Yes.  This paper describes a multi-scale model of *E. coli* chemotaxis using Vivarium, a computational biology engine.  The model integrates sub-models of metabolism/transport, gene expression (transcription, translation, etc.), and flagella/chemoreceptor activity to simulate processes across multiple length scales, from molecular interactions to cellular behavior.\n",
          "url": "https://www.mdpi.com/1099-4300/22/10/1101"
        },
        {
          "title": "The scaling of goals from cellular to anatomical homeostasis: an evolutionary simulation, experiment and analysis",
          "author": "L. Pio-Lopez,J. Bischof,Jennifer V. LaPalme,M. Levin",
          "published_date": "2023-10-26T19:28:53.608000+00:00",
          "summary": "Yes, this research uses a two-dimensional neural cellular automata simulation (TAME framework) to model the scaling of homeostatic goals from individual cells to tissue-level behavior in morphogenesis.  The model successfully evolved complex tissue-level setpoints that solved a morphogenetic problem (French flag problem), demonstrating the emergence of higher-level behavior from lower-level cellular interactions.  The simulation predicted and the researchers observed in planaria a phenomenon of sudden remodeling, highlighting the model's capacity to capture multi-scale biological processes.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37065270"
        },
        {
          "title": "Capturing the mechanosensitivity of cell proliferation in models of epithelium",
          "author": "View ORCID ProfileKevin H\u00f6llring",
          "published_date": "2023-02-03T00:00:00+00:00",
          "summary": "Yes, this bioRxiv preprint describes a model of cell proliferation in 2D epithelia that captures both short and long time- and length-scales.  The model incorporates cell-cell and cell-matrix interactions and separates cell populations into growing and dividing cells.  The researchers validated the model using in vitro and in silico experiments, demonstrating its ability to predict large-scale density structures within the tissue using nonlinear delayed Fisher-Kolmogorov-like equations.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.01.31.526438v1"
        },
        {
          "title": "Multi-scale Modeling in Biology: How to Bridge the Gaps ...",
          "author": "",
          "published_date": "2011-06-23T00:00:00+00:00",
          "summary": "Yes, the paper reviews multi-scale modeling methodologies used in computational and systems biology to address the challenge of simulating biological systems across vastly different spatial and temporal scales (from molecules to organisms).  A key challenge is representing the dynamics of a high-dimensional lower-scale model within a lower-dimensional higher-scale model.  The paper discusses various modeling approaches and methods for bridging the gaps between scales, highlighting the hierarchical structure and feedback loops inherent in biological systems.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3190585/"
        },
        {
          "title": "How computational models can help unlock biological ...",
          "author": "Author links open overlay panel G Wayne Brodland",
          "published_date": "2023-12-04T03:09:35.364000+00:00",
          "summary": "Yes, the article discusses computational models capable of spanning multiple length scales in biological simulations, citing multi-scale, multifaceted embryogenesis as an example.  These models integrate information from different sources and scales to replicate system behavior based on known component properties.  The authors argue that such models complement experimental and theoretical studies, providing valuable insights.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S1084952115001287"
        },
        {
          "title": "Modeling Biology Spanning Different Scales: An Open ...",
          "author": "",
          "published_date": "2014-07-17T00:00:00+00:00",
          "summary": "Yes, this research paper discusses the challenges and importance of multiscale modeling in biology, particularly within the immune system.  The authors highlight the need for computational and mathematical models spanning different space and time scales to achieve a unified description of biological systems.  They argue that this is crucial given the vast amount of high-throughput data now available.\n",
          "url": "https://www.researchgate.net/publication/263809652_Modeling_Biology_Spanning_Different_Scales_An_Open_Challenge"
        },
        {
          "title": "Mathematical and computational modeling in biology at ...",
          "author": "El-Magd, Rabab M Abou",
          "published_date": "2014-12-27T00:00:00+00:00",
          "summary": "Yes, this 2014 review article discusses mathematical and computational modeling in biology across multiple scales, from populations of organisms down to the atomic level.  It covers methods like differential equations for large-scale systems and molecular dynamics for biomolecules, highlighting the challenge of bridging these different scales.  The article specifically mentions the use of maximum entropy as an inference tool applicable across scales, from gene evolution to protein-drug interactions.\n",
          "url": "https://tbiomed.biomedcentral.com/articles/10.1186/1742-4682-11-52"
        },
        {
          "title": "Multiscale Modeling and Numerical Simulations",
          "author": "Guoqing Hu, Dongqing Li",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "Yes, multiscale modeling is used to simulate biological processes across multiple length scales, from the molecular level to the continuum level.  This approach addresses the hierarchical nature of microfluidic and nanofluidic phenomena in Lab-on-a-Chip devices.  Several cited papers detail methods for molecular dynamics-continuum hybrid computations and heterogeneous atomistic-continuum representations to achieve this.\n",
          "url": "https://link.springer.com/doi/10.1007/978-0-387-48998-8_1075"
        },
        {
          "title": "Multi-scale Modeling in Biology: How to Bridge the Gaps ...",
          "author": "",
          "published_date": "2011-06-22T00:00:00+00:00",
          "summary": "Yes, multi-scale modeling is a computational approach widely used in systems biology to address the challenge of integrating information across different spatial and temporal scales in biological systems.  The paper reviews various modeling methodologies and their applications at different scales (molecular, cellular, tissue/organ), highlighting the need to bridge the gaps between these scales to understand complex dynamical behaviors.  A systems biology approach, using multiscale computational models, is presented as a way to connect in-vitro single-scale models with in-vivo whole-system models, enabling investigation of complex interactions and feedback mechanisms across scales.  This is particularly relevant in fields like cardiovascular disease research.\n",
          "url": "https://www.researchgate.net/publication/51248697_Multi-scale_Modeling_in_Biology_How_to_Bridge_the_Gaps_between_Scales"
        },
        {
          "title": "Interlink among different length scales of simulation and ...",
          "author": "user366312user366312 2,54633 silver badges1616 bronze badges",
          "published_date": "2023-02-07T02:38:07+00:00",
          "summary": "This StackExchange post discusses a figure from a non-peer-reviewed paper depicting different simulation techniques across length scales (e.g., molecular, sub-molecular).  The author questions the figure's accuracy and proposes corrections to the categorization of techniques like Molecular Dynamics (MD), Monte Carlo (MC), Density Functional Theory (DFT), and Quantum Mechanics Molecular Dynamics (QMMD).  The post's primary goal is to find references (books or articles) that clarify the relationships between various simulation techniques and their corresponding length scales, not specifically biological simulations.  Therefore, it does not directly address the user's query regarding multi-scale modeling in biological systems.\n",
          "url": "https://mattermodeling.stackexchange.com/questions/9118/interlink-among-different-length-scales-of-simulation-and-modelling-techniques"
        }
      ],
      "full_explanation": "Multiple papers demonstrate that the research question, \"Has anyone developed a means to model multiple length scales in biological simulations?\" has been addressed. Specifically, several papers describe models and methodologies for simulating biological systems across multiple scales. For example, the paper \"A Multi-Scale Approach to Modeling E. coli Chemotaxis\" (https://www.mdpi.com/1099-4300/22/10/1101) details a model of *E. coli* chemotaxis that integrates molecular, cellular, and behavioral processes. Similarly, \"The scaling of goals from cellular to anatomical homeostasis: an evolutionary simulation, experiment and analysis\" (https://pubmed.ncbi.nlm.nih.gov/37065270) uses a neural cellular automata simulation to model how homeostatic goals scale from cells to tissues. \"Capturing the mechanosensitivity of cell proliferation in models of epithelium\" (https://www.biorxiv.org/content/10.1101/2023.01.31.526438v1) models cell proliferation, capturing short and long time and length scales. Several review articles also confirm that multiscale modeling is an active area of research in biology. The paper \"Multi-scale Modeling in Biology: How to Bridge the Gaps ...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC3190585/) reviews methods for simulating biological systems across scales, while the article \"How computational models can help unlock biological ...\" (https://www.sciencedirect.com/science/article/pii/S1084952115001287) cites multiscale embryogenesis as an example of such a model. In addition, \"Modeling Biology Spanning Different Scales: An Open ...\" (https://www.researchgate.net/publication/263809652_Modeling_Biology_Spanning_Different_Scales_An_Open_Challenge) and \"Mathematical and computational modeling in biology at ...\" (https://tbiomed.biomedcentral.com/articles/10.1186/1742-4682-11-52) discuss the challenges and importance of multiscale modeling and provide methods used to model across scales. Finally, \"Multiscale Modeling and Numerical Simulations\" (https://link.springer.com/doi/10.1007/978-0-387-48998-8_1075) and \"Multi-scale Modeling in Biology: How to Bridge the Gaps ...\" (https://www.researchgate.net/publication/51248697_Multi-scale_Modeling_in_Biology_How_to_Bridge_the_Gaps_between_Scales) describe multiscale modelling and its applications in different biological fields."
    },
    {
      "question": "Has anyone Measured how well different people use search engines?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Measuring the Utility of Search Engine Result Pages | The 41st International ACM SIGIR Conference on Research & Development in Information Retrieval",
          "author": "View Profile",
          "published_date": "2018-06-27T00:00:00+00:00",
          "summary": "This paper introduces a new measure for evaluating the utility of Search Engine Result Pages (SERPs), based on information foraging theory.  The authors address the challenge of measuring SERP quality, given their heterogeneity (web results, ads, specialized answers), using the Cost-Worth-Loss (CWL) framework.  Their proposed measure accounts for the varying costs of different elements and incorporates a user stopping model that adapts to the rate of information gain.  The study analyzes data from ~1000 popular queries on a major search engine, comparing the new foraging-based measure to existing ones.  Results show it better reflects both utility and observed user behavior (stopping rank and time spent).  The research directly connects models of how people search with how we measure search effectiveness, offering new insights into user behavior and performance.\n",
          "url": "https://dl.acm.org/doi/10.1145/3209978.3210027"
        },
        {
          "title": "Measuring personalization of web search",
          "author": "Anik\u00f3 Hann\u00e1k,Piotr Sapiezynski,A. M. Kakhki,B. Krishnamurthy,D. Lazer,A. Mislove,Christo Wilson",
          "published_date": "2023-10-26T19:30:31.092000+00:00",
          "summary": "This paper measures personalization in Google and Bing web search, not user proficiency.  The authors developed a methodology to quantify how often different users receive different results for the same query.  They found that 11.7% of Google results and 15.8% of Bing results varied due to personalization, primarily based on logged-in account and IP address.  Other user attributes showed no significant impact on personalization beyond baseline noise.  The study is considered a first step in understanding the extent of personalization in web search.\n",
          "url": "https://arxiv.org/pdf/1706.05011.pdf"
        },
        {
          "title": "Large Language Models vs. Search Engines: Evaluating User Preferences Across Varied Information Retrieval Scenarios",
          "author": "[Submitted on 11 Jan 2024]",
          "published_date": "2024-01-11T00:00:00+00:00",
          "summary": "A study (N=100 US participants) compared user preferences between search engines and LLMs across 20 diverse information retrieval scenarios.  Results showed a preference for search engines for factual queries, while LLMs were favored for tasks needing nuanced understanding and language processing.  This research directly addresses user performance with search engines in different contexts.\n",
          "url": "http://arxiv.org/abs/2401.05761"
        },
        {
          "title": "Main findings",
          "author": "By , Joanna Brenner and Lee Rainie",
          "published_date": "2012-03-09T00:00:00+00:00",
          "summary": "A 2012 Pew Research Center study found that search engine use varies significantly across demographics.  Younger adults, college-educated individuals, and those with higher incomes use search engines more frequently.  While white and black online adults use search engines more than Hispanics, white adults use them more often on a given day.  Additionally, younger users express more confidence in search engine results' fairness and accuracy than older users.  Women also report slightly higher trust in accuracy than men, and higher-income individuals show more confidence as well.\n",
          "url": "https://www.pewresearch.org/internet/2012/03/09/main-findings-11/"
        },
        {
          "title": "A study of results overlap and uniqueness among major ...",
          "author": "K. Bharat",
          "published_date": "2006-09-01T00:00:00+00:00",
          "summary": "This study focuses on the overlap in search results across different search engines (Google, MSN, Yahoo!, Ask Jeeves) rather than on how well different *people* use search engines.  The research analyzed tens of thousands of queries and found significant differences in results, with 84.9% of results unique to a single engine.  The study concludes that metasearch engines are valuable due to the biases of individual search engines, but it does not address user performance.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0306457305001500"
        },
        {
          "title": "Evaluation of Search Engines: A Conceptual Model and ...",
          "author": "",
          "published_date": "2013-02-21T00:00:00+00:00",
          "summary": "This 2013 paper develops a conceptual model to evaluate search engines, focusing on user satisfaction and usage as key success metrics.  It investigates factors influencing user evaluation, including why users choose specific engines and switch between them. While the paper doesn't directly measure how *different* people use search engines, it examines the user-centric aspects of search engine success, which is relevant to understanding user behavior and performance variation.\n",
          "url": "https://www.researchgate.net/publication/315446518_Evaluation_of_Search_Engines_A_Conceptual_Model_and_Research_Issues"
        },
        {
          "title": "The Impact of Search Engine Selection and Sorting Criteria ...",
          "author": "",
          "published_date": "2014-04-02T00:00:00+00:00",
          "summary": "This study investigated how search engine results influence users' views on vaccination.  Two experiments manipulated search results to show either mostly pro-vaccine, mostly anti-vaccine, or a mix of both.  Results showed that seeing mostly pro-vaccine sites increased participants' knowledge of and positive attitudes toward vaccines, while mostly anti-vaccine sites increased concerns about side effects.  Users using a standard search engine showed some negative effects on beliefs and attitudes.  The study highlights how search engine algorithms significantly impact health information seeking, even unconsciously influencing users regardless of their ability to judge website credibility.  While the study doesn't directly measure *how well* different people use search engines, it demonstrates how search engine results themselves significantly shape users' understanding and opinions, indirectly addressing the query's underlying concern about the impact of search engine use.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4004139/"
        },
        {
          "title": "A Study On Online Search By People Using Search Engine",
          "author": "",
          "published_date": "2017-05-26T00:00:00+00:00",
          "summary": "This study qualitatively investigated how people use search engines to find online information.  Eleven participants were interviewed using fifteen open-ended questions. The researchers aimed to understand user search behavior and  gain insights into how people utilize the internet to find information.  The study doesn't directly measure how *well* different people use search engines, but rather explores their search behaviors.\n",
          "url": "https://www.researchgate.net/publication/328527875_A_Study_On_Online_Search_By_People_Using_Search_Engine"
        },
        {
          "title": "Research about search vs navigation",
          "author": "BoatBoat 65744 silver badges1616 bronze badges",
          "published_date": "2018-01-10T09:46:00+00:00",
          "summary": "Studies show varying preferences in website navigation:  while some users (a small percentage) consistently prioritize search, most prefer browsing.  However, the effectiveness of search versus browsing is heavily influenced by website design;  sites with well-organized navigation see significantly less search usage.  One study found that users searched less than 10% of the time with broad, well-organized menus, but nearly 40% of the time with poorly structured ones.  Another study indicated that 11-21% of users begin with site search, though this varies considerably depending on the website's design.  No study has shown any users who *always* use search first.\n",
          "url": "https://ux.stackexchange.com/questions/114862/research-about-search-vs-navigation"
        },
        {
          "title": "You are how (and where) you search? Comparative ...",
          "author": "Makhortykh, Mykola",
          "published_date": "2023-05-03T00:00:00+00:00",
          "summary": "This research paper investigates how different demographic and socioeconomic characteristics affect web search engine usage.  Using web tracking data from Germany and Switzerland, the study overcomes limitations of previous research (eye-tracking studies with small samples and log-based studies lacking individual-level detail).  It examines search frequency, temporal patterns, and the relationship between search result ranking and user clicks across a large user sample, providing a comparative perspective beyond the commonly studied US population.  The study directly addresses the question of how different people use search engines.\n",
          "url": "https://link.springer.com/article/10.1007/s42001-023-00208-9"
        }
      ],
      "full_explanation": "Several papers touch upon aspects of how different people use search engines, indicating that this research question has been explored.  Specifically, the paper titled \"You are how (and where) you search? Comparative...\" directly investigates how demographic and socioeconomic factors affect web search engine usage, examining search frequency and patterns across a large user sample, and is highly relevant to the research question (URL: https://link.springer.com/article/10.1007/s42001-023-00208-9). Additionally, the Pew Research Center study, \"Main findings,\" reveals differences in search engine use based on age, education, income, and race, as well as varying levels of trust in search accuracy across demographics (URL: https://www.pewresearch.org/internet/2012/03/09/main-findings-11/). Furthermore, the paper \"Large Language Models vs. Search Engines: Evaluating User Preferences Across Varied Information Retrieval Scenarios\" directly looks at user preference and performance with search engines, specifically in contrast to other methods (URL: http://arxiv.org/abs/2401.05761). While some papers focus on search engine performance or user behavior more broadly, these three papers specifically address the core of the research question by examining differences in how various groups of people interact with and use search engines."
    },
    {
      "question": "Has anyone built a high throughput measurement technique for electrochemical measurements to evolve enzymes?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics",
          "author": "View ORCID ProfileC.J. Markin",
          "published_date": "2020-11-25T00:00:00+00:00",
          "summary": "This bioRxiv preprint describes HT-MEK, a high-throughput microfluidic platform for enzyme characterization.  While not directly focused on electrochemical measurements, it performs >670,000 kinetic reactions on >1500 enzyme variants to determine kinetic and physical constants.  This allows researchers to map functional regions of enzymes, including those outside the active site.  The technique uses fluorescent assays, not electrochemical ones.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2020.11.24.383182v1.full"
        },
        {
          "title": "What can electrochemistry tell us about individual enzymes?",
          "author": "Connor  Davis, University of California at Santa, 93106, Barbara, Santa Barbara, CA, United States, Stephanie X Wang, University of California at Santa Barbara, 93106, Santa Barbara, CA, United States, Lior  Sepunaru, University of California at Santa Barbara, 93106, Santa Barbara, CA, United States",
          "published_date": "2023-11-09T20:31:14.449000+00:00",
          "summary": "This article reviews electrochemical techniques for studying single enzyme activity, focusing on nano-impact electrochemistry (NIE) and electrochemical scanning tunneling microscopy (ECSTM).  While NIE can measure single-enzyme activity, its high-throughput application for freely diffusing enzymes is uncertain. ECSTM offers an alternative, measuring an enzyme's electronic conductivity, which is linked to substrate binding, oxidation state, and structural fluctuations.  The article does *not* discuss high-throughput methods for *evolving* enzymes via electrochemical measurements.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2451910320301848"
        },
        {
          "title": "Measurements drive progress in directed evolution for precise engineering of biological systems.",
          "author": "Drew S Tack, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Eugenia F Romantseva, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Peter D Tonner, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Abe  Pressman, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Jayan  Rammohan, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Elizabeth A Strychalski, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, elizabeth.strychalski@nist.gov",
          "published_date": "2023-11-09T20:31:00.743000+00:00",
          "summary": "The provided text focuses on the general use of high-throughput measurement techniques in directed evolution to engineer biological systems,  but doesn't specifically address electrochemical measurements for enzyme evolution.  Therefore, the answer to the query is not directly provided in this abstract.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2452310020300366"
        },
        {
          "title": "High Throughput Screening and Selection Methods for ...",
          "author": "",
          "published_date": "2014-10-03T00:00:00+00:00",
          "summary": "This article reviews high-throughput screening and selection methods for directed enzyme evolution, focusing on coupling phenotypic analysis with compatible methods.  While it details various high-throughput screening methods (e.g., using microtiter plates, fluorescence-activated cell sorting (FACS)), it does *not* discuss high-throughput electrochemical measurement techniques for enzyme evolution.  Therefore, the answer to your query is no, based on the information presented in this paper.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4461044/"
        },
        {
          "title": "High-Throughput Screening Technology in Industrial ...",
          "author": "M. Wehrs",
          "published_date": "2020-08-01T00:00:00+00:00",
          "summary": "This article focuses on high-throughput screening (HTS) in industrial biotechnology, primarily using spectroscopy (UV/Vis) to identify microorganisms with improved phenotypes for producing various products (chemicals, fuels, etc.).  While it details various HTS methods and their applications, it does *not* discuss high-throughput electrochemical measurement techniques for enzyme evolution.  Therefore, the answer to your query is no, at least not according to this article.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0167779920300019"
        },
        {
          "title": "High Throughput Screening and Selection Methods for ...",
          "author": "Han  Xiao, Zehua  Bao, Huimin  Zhao, zhao5@illinois.edu",
          "published_date": "2023-11-09T20:05:22.195000+00:00",
          "summary": "This review article discusses high-throughput screening and selection methods for directed enzyme evolution, but it does *not* specifically address the development of high-throughput electrochemical measurement techniques for enzyme evolution.  While it covers various high-throughput methods,  it doesn't mention any focused on electrochemical properties.\n",
          "url": "https://pubs.acs.org/doi/10.1021/ie503060a"
        },
        {
          "title": "Ultrahigh-throughput screening-assisted in vivo directed ...",
          "author": "Zhang, Guoqiang",
          "published_date": "2024-01-22T00:00:00+00:00",
          "summary": "This research describes a high-throughput *in vivo* directed evolution system for enzyme engineering.  While not directly electrochemical, it uses ultrahigh-throughput screening (microfluidic droplet screening and fluorescence-activated cell sorting) coupled with a novel thermal-responsive mutagenesis system in *E. coli* to evolve enzymes (\u03b2-lactamase, \u03b1-amylase) and biosynthetic pathways (resveratrol).  The system achieved a 600-fold increase in targeted mutation rate and yielded improved enzyme activity (48.3% for \u03b1-amylase) and pathway output (1.7-fold for resveratrol).  The study does not utilize electrochemical measurements for screening, however.\n",
          "url": "https://biotechnologyforbiofuels.biomedcentral.com/articles/10.1186/s13068-024-02457-w"
        },
        {
          "title": "High-Throughput Steady-State Enzyme Kinetics Measured ...",
          "author": "",
          "published_date": "2022-11-23T00:00:00+00:00",
          "summary": "This paper describes a high-throughput method for measuring enzyme kinetics using a microfluidic droplet system.  While not electrochemical, it achieves a 10-fold improvement over previous methods, processing 8640 data points per hour.  The system measures absorbance to analyze enzyme activity across concentration gradients, enabling the characterization of Michaelis-Menten kinetics for many enzymes simultaneously.  The authors suggest its potential use in analyzing clones from large-scale combinatorial experiments, which could be relevant to directed enzyme evolution, though it doesn't directly address electrochemical measurements.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9730296/"
        },
        {
          "title": "Minireactor-based high-throughput temperature profiling for ...",
          "author": "B\u00fcchs, Jochen",
          "published_date": "2014-08-04T00:00:00+00:00",
          "summary": "This paper describes a high-throughput system for temperature profiling of microbial and enzymatic processes using 96-well microtiter plates and fluorescence thermometry.  While it focuses on temperature optimization, not electrochemical measurements, the high-throughput approach using microplates could be relevant to the development of similar systems for electrochemical enzyme evolution.  The system's ability to rapidly assess numerous conditions (microorganisms, enzymes, media) in a small volume suggests its underlying principles might be adaptable to electrochemical applications.\n",
          "url": "https://jbioleng.biomedcentral.com/articles/10.1186/1754-1611-8-22"
        },
        {
          "title": "Directed evolution of diacetylchitobiose deacetylase via ...",
          "author": "A. Baraket",
          "published_date": "2023-01-01T00:00:00+00:00",
          "summary": "This paper describes a high-throughput droplet sorting system for directed enzyme evolution, but it uses a bacteria-based biosensor and fluorescence, not electrochemical measurements.  The researchers evolved diacetylchitobiose deacetylase (Dac) by measuring glucosamine (GlcN) production via a fluorescence signal.  While not directly addressing electrochemical methods, the work demonstrates a successful high-throughput approach for enzyme evolution using a novel biosensor.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0956566322008582"
        }
      ],
      "full_explanation": "Based on the provided papers, no one has specifically built a high-throughput measurement technique for *electrochemical* measurements to evolve enzymes. While several papers discuss high-throughput methods for enzyme characterization and evolution, they utilize other techniques like fluorescence, absorbance, or biosensors, not electrochemical methods.\n\nFor example:\n\n*   **Paper: Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics** ([https://www.biorxiv.org/content/10.1101/2020.11.24.383182v1.full](https://www.biorxiv.org/content/10.1101/2020.11.24.383182v1.full)) describes a high-throughput microfluidic platform (HT-MEK) that uses *fluorescent assays* to characterize enzyme kinetics of over 1500 enzyme variants. It does not use electrochemical methods.\n*   **Paper: What can electrochemistry tell us about individual enzymes?** ([https://www.sciencedirect.com/science/article/pii/S2451910320301848](https://www.sciencedirect.com/science/article/pii/S2451910320301848)) reviews electrochemical techniques for studying single-enzyme activity, such as nano-impact electrochemistry (NIE) and electrochemical scanning tunneling microscopy (ECSTM). It specifically states that while NIE can measure single-enzyme activity, its high-throughput application is uncertain, and the article does *not* discuss high-throughput methods for *evolving* enzymes using electrochemical techniques.\n*   **Paper: High Throughput Screening and Selection Methods for ...** ([https://pmc.ncbi.nlm.nih.gov/articles/PMC4461044/](https://pmc.ncbi.nlm.nih.gov/articles/PMC4461044/)) reviews high-throughput screening methods, mentioning microtiter plates and fluorescence-activated cell sorting (FACS), but *does not* discuss high-throughput *electrochemical* methods for enzyme evolution.\n*   **Paper: High Throughput Screening Technology in Industrial ...** ([https://www.sciencedirect.com/science/article/abs/pii/S0167779920300019](https://www.sciencedirect.com/science/article/abs/pii/S0167779920300019)) and **Paper: High Throughput Screening and Selection Methods for ...** ([https://pubs.acs.org/doi/10.1021/ie503060a](https://pubs.acs.org/doi/10.1021/ie503060a)) focus on high-throughput screening methods, mainly using spectroscopy, and *do not* discuss electrochemical measurements for enzyme evolution.\n*   **Paper: Ultrahigh-throughput screening-assisted in vivo directed ...** ([https://biotechnologyforbiofuels.biomedcentral.com/articles/10.1186/s13068-024-02457-w](https://biotechnologyforbiofuels.biomedcentral.com/articles/10.1186/s13068-024-02457-w)) describes a high-throughput *in vivo* system for enzyme evolution, but it uses microfluidic droplet screening and fluorescence-activated cell sorting.  It does not utilize electrochemical measurements.\n*  **Paper: High-Throughput Steady-State Enzyme Kinetics Measured ...** ([https://pmc.ncbi.nlm.nih.gov/articles/PMC9730296/](https://pmc.ncbi.nlm.nih.gov/articles/PMC9730296/)) describes a high-throughput method for measuring enzyme kinetics using a microfluidic droplet system, measuring absorbance instead of electrochemical methods.\n* **Paper: Directed evolution of diacetylchitobiose deacetylase via ...** ([https://www.sciencedirect.com/science/article/abs/pii/S0956566322008582](https://www.sciencedirect.com/science/article/abs/pii/S0956566322008582)) uses a"
    },
    {
      "question": "Has anyone shown saunas can improve human health in anyway in an RCT?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study",
          "author": "Laukkanen, Jari",
          "published_date": "2018-12-07T16:15:11+00:00",
          "summary": "This prospective cohort study (not an RCT) of 1688 participants (mean age 63) found a correlation between sauna bathing frequency and reduced cardiovascular mortality in both men and women over a 15-year period.  The risk decreased linearly with more frequent sauna use.  While the study shows an association, it doesn't establish a causal link proven through a randomized controlled trial (RCT).\n",
          "url": "https://jyx.jyu.fi/handle/123456789/60594"
        },
        {
          "title": "Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study - BMC Medicine",
          "author": "Laukkanen; Tanjaniina; Kunutsor; Setor K; Khan; Hassan; Willeit; Peter; Zaccardi; Francesco; Jari A",
          "published_date": "2023-02-07T05:46:00.626000+00:00",
          "summary": "This prospective cohort study (not an RCT) of 1688 participants (mean age 63) followed for a median of 15 years found that higher frequency and duration of sauna bathing were associated with a reduced risk of cardiovascular mortality in both men and women.  The study suggests that adding sauna bathing frequency to existing cardiovascular risk prediction models improves accuracy.  However, it's crucial to note that this was not a randomized controlled trial.\n",
          "url": "https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1198-0"
        },
        {
          "title": "Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study - PubMed",
          "author": "Tanjaniina Laukkanen 1 2 ,",
          "published_date": "2018-11-29T00:00:00+00:00",
          "summary": "This study, a prospective cohort study (not a randomized controlled trial, RCT), found a strong inverse association between sauna bathing frequency and duration, and cardiovascular mortality in middle-aged and elderly men and women.  More frequent and longer sauna sessions were linked to a reduced risk of fatal cardiovascular events.  Adding sauna frequency to existing cardiovascular risk prediction models improved their accuracy.  While not an RCT, the results suggest a potential health benefit.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30486813/"
        },
        {
          "title": "Effects of regular sauna bathing in conjunction with exercise on ...",
          "author": "Earric Lee 1 ,",
          "published_date": "2022-01-09T00:00:00+00:00",
          "summary": "Yes, a randomized controlled trial (RCT) found that regular sauna bathing, combined with exercise, improved cardiovascular function in sedentary adults with cardiovascular disease risk factors.  Compared to exercise alone, the combined sauna and exercise group showed significantly better improvements in cardiorespiratory fitness, lower systolic blood pressure, and lower total cholesterol.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35785965/"
        },
        {
          "title": "Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review",
          "author": "",
          "published_date": "2018-04-24T00:00:00+00:00",
          "summary": "A systematic review of 40 studies (including 13 randomized controlled trials) on the effects of regular dry sauna bathing found potential health benefits.  However, most studies were small, and only one small RCT (n=10) reported a negative effect (reversible male spermatogenesis disruption).  More high-quality research is needed to confirm benefits and determine optimal frequency and duration for specific health outcomes and populations.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/"
        },
        {
          "title": "Sauna bathing is associated with reduced cardiovascular mortality ...",
          "author": "Laukkanen; Tanjaniina; Kunutsor; Setor K; Khan; Hassan; Willeit; Peter; Zaccardi; Francesco; Jari A",
          "published_date": "2023-02-07T05:46:00.626000+00:00",
          "summary": "This prospective cohort study (not a randomized controlled trial) of 1688 participants (mean age 63) found a strong inverse association between sauna bathing frequency and duration, and cardiovascular mortality in both men and women over a median 15-year follow-up.  Increased sauna use (sessions per week and minutes per week) was associated with reduced risk of death from cardiovascular disease, even after adjusting for other risk factors.  Adding sauna frequency to existing cardiovascular risk prediction models improved their accuracy.  However, it is important to note that this was a cohort study, not an RCT.\n",
          "url": "https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1198-0"
        },
        {
          "title": "How regular sauna sessions affect the body's health - ResearchGate",
          "author": "Authors:",
          "published_date": "2024-12-08T00:00:00+00:00",
          "summary": "This research review article discusses the health benefits of regular sauna use, focusing on cardiovascular, respiratory, and urinary systems.  While it cites research showing positive effects like reduced blood pressure and improved lung function,  it does *not* specify whether these findings are based on randomized controlled trials (RCTs).  The abstract only mentions that research confirms the benefits, without detailing the methodology of those studies.  Therefore, the question of whether RCTs support the claimed health improvements from sauna use remains unanswered by this article.\n",
          "url": "https://www.researchgate.net/publication/386587070_Sauna_and_health_How_regular_sauna_sessions_affect_the_body's_health"
        },
        {
          "title": "Are There Benefits from Using Saunas? - Healthline",
          "author": "How we reviewed this article:",
          "published_date": "2016-05-23T07:00:00+00:00",
          "summary": "A 2008 study on people with chronic musculoskeletal diseases (including rheumatoid and ankylosing spondylitis) found that sauna sessions improved pain, stiffness, and fatigue over four weeks.  However, the improvements weren't statistically significant, and the authors recommended trial sessions before incorporating sauna use into treatment routines.  The text does not cite any other randomized controlled trials (RCTs) demonstrating health improvements from sauna use.\n",
          "url": "https://www.healthline.com/health/fitness-exercise/are-saunas-good-for-you"
        },
        {
          "title": "[PDF] Sauna Bathing as an Alternative Adjunct Therapy in the",
          "author": "",
          "published_date": null,
          "summary": "This review article examines the benefits of sauna bathing for various chronic health conditions, but it does not focus on RCTs (Randomized Controlled Trials).  While it cites numerous studies showing correlations between frequent sauna use (4-7 times/week) and reduced risks of cardiovascular mortality, hypertension, dementia, and psychosis, and improved metabolic markers and depression scores,  the article does not specify whether these studies were RCTs or observational studies.  Therefore, the question of whether sauna's health benefits have been proven via RCTs remains unanswered by this paper.\n",
          "url": "https://esmed.org/MRA/mra/article/download/3965/99193546945/"
        }
      ],
      "full_explanation": "The research question asks if anyone has shown that saunas can improve human health in any way using a randomized controlled trial (RCT). The paper titled \"Effects of regular sauna bathing in conjunction with exercise on ...\" (URL: https://pubmed.ncbi.nlm.nih.gov/35785965/) provides evidence that this research has been done. This paper's summary states: \"Yes, a randomized controlled trial (RCT) found that regular sauna bathing, combined with exercise, improved cardiovascular function in sedentary adults with cardiovascular disease risk factors. Compared to exercise alone, the combined sauna and exercise group showed significantly better improvements in cardiorespiratory fitness, lower systolic blood pressure, and lower total cholesterol.\" This directly answers the research question, confirming that an RCT has shown sauna use can improve human health. Additionally, the paper \"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/) states that it included 13 randomized controlled trials in its review of the effects of sauna use, indicating that multiple RCTs on this topic exist, although only one of them was noted to have a negative effect."
    },
    {
      "question": "Has anyone studied how concordant family members' perceptions of patient's goals of care/code status/decisions around CPR intubation are with patient's goals of cares? ",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Goal-concordant care in the ICU: a conceptual framework for future research",
          "author": "A. Turnbull,C. Hartog",
          "published_date": "2023-10-26T19:30:46.871000+00:00",
          "summary": "Yes, the authors discuss challenges in determining patient goals of care, particularly when patients lack decision-making capacity and family members act as surrogates.  They cite studies showing family members are often unprepared to act as surrogates and may be uncertain or incorrect about patient goals and treatment limitations, including code status and decisions around CPR and intubation.  The paper highlights the need for research to address this issue, advocating for standardized methods of collecting this data longitudinally or retrospectively via standardized questionnaires, acknowledging potential biases in retrospective data collection.\n",
          "url": "https://link.springer.com/content/pdf/10.1007/s00134-017-4873-2.pdf"
        },
        {
          "title": "Patient-reported receipt of goal-concordant care among seriously ill outpatients - prevalence and associated factors.",
          "author": "Matthew E Modes, modes@uw.edu, Susan R Heckbert, Ruth A Engelberg, Elizabeth L Nielsen, J Randall Curtis, Erin K Kross",
          "published_date": "2023-11-09T20:29:40.032000+00:00",
          "summary": "This study examined patient-reported receipt of goal-concordant care among seriously ill outpatients, but did *not* investigate concordance between patients' goals and those of their family members.  The study found that only 58% of patients reported receiving care aligned with their prioritized goals.  Those prioritizing pain relief were significantly less likely to report goal-concordant care (51%) compared to those prioritizing life extension (86%).  The research focused solely on patient self-report and did not include family member perspectives.\n",
          "url": "http://jpsmjournal.com/retrieve/pii/S0885392420302463"
        },
        {
          "title": "Goal-Concordant Care After Severe Acute Brain Injury",
          "author": "Rutz Voumard; Rachel; Dugger; Kaley M; Kiker; Whitney A; Barber; Jason; Borasio; Gian Domenico; Curtis; J Randall; Jox; Ralf J; Creutzfeldt; Claire J",
          "published_date": "2023-02-06T12:32:54.802000+00:00",
          "summary": "This study assessed whether family members' perceptions of a patient's goals of care align with the patient's actual goals, specifically focusing on severe acute brain injury (SABI) patients lacking decision-making capacity.  Researchers examined family-assessed goals of care in the acute setting, the frequency of concordant care, associated patient/family characteristics, and how these goals changed six months later.  The study design involved a prospective, observational cohort of SABI patients (stroke, TBI, HIE) and their families, assessing concordance around high-stakes decisions such as life-sustaining treatment (LST) including intubation and CPR.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fneur.2021.710783/full"
        },
        {
          "title": "Resuscitation team perceptions of family presence during ...",
          "author": "Kathleen Evanovich Zavotsky 1 ,",
          "published_date": "2014-11-01T00:00:00+00:00",
          "summary": "This study examines resuscitation team perceptions of family presence during CPR, not the concordance between family members' and patients' goals of care regarding CPR or intubation.  While the study mentions perceived benefits of family presence and identifies educational needs for healthcare providers, it does not address the alignment of family and patient wishes concerning end-of-life care decisions.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/25356893/"
        },
        {
          "title": "Code Status Orders and Goals of Care in the Medical ICU",
          "author": "",
          "published_date": "2011-02-01T00:00:00+00:00",
          "summary": "A study of 100 MICU patients and their surrogates found inconsistencies between patient/surrogate preferences for code status and actual medical orders.  While 83% preferred full code status, only 4% understood the components of CPR.  Significant disagreement (67.7%) also existed between patients/surrogates and physicians regarding the most important goals of care.  The study highlights a need for improved communication and understanding regarding patient preferences and goals of care surrounding CPR and end-of-life decisions.  It directly addresses the user's query by showing that discrepancies exist between patient/surrogate perceptions and medical orders related to code status and goals of care.\n",
          "url": "https://www.researchgate.net/publication/49809238_Code_Status_Orders_and_Goals_of_Care_in_the_Medical_ICU"
        },
        {
          "title": "Code status discussions in medical inpatients: Results of a ...",
          "author": "Authors:",
          "published_date": "2020-03-23T00:00:00+00:00",
          "summary": "This study surveyed 145 patients and 258 physicians in a Swiss hospital to assess code status discussions.  It found that 61.4% of patients didn't recall such a discussion.  Of those who did, 23.7% showed discrepancies between their stated preferences and documented code status.  Further, 72.4% of physicians reported deciding on DNR status without prior patient discussion, leading to increased conflict with patients and families.  While the study doesn't directly address family member concordance with patient goals, the high rate of physician-initiated DNR orders and patient-physician disagreement highlights a significant gap in aligning medical decisions with patient preferences, which may indirectly relate to family perceptions.\n",
          "url": "https://www.researchgate.net/publication/340408424_Code_status_discussions_in_medical_inpatients_Results_of_a_survey_of_patients_and_physicians"
        },
        {
          "title": "Strategies for Collaborative Consideration of Patients ...",
          "author": "Kimberly Kopecky; Pete Pelletier; Pringl Miller",
          "published_date": "2023-02-07T20:30:58.006000+00:00",
          "summary": "This article focuses on the process of \"required reconsideration\" discussions between medical professionals and patients (or surrogates) regarding Do-Not-Resuscitate (DNR) orders during perioperative periods.  While the article doesn't directly address the concordance between family members' and patients' goals of care regarding CPR or intubation, it highlights the importance of respecting patient autonomy and engaging in discussions to ensure treatment aligns with their wishes.  The slow implementation of required reconsideration discussions suggests a need for further research into effective communication strategies and understanding patient preferences in these situations.  The study's focus is on ensuring patient preferences are respected, which implicitly relates to your query about alignment between patient and family views, though it doesn't provide data on the concordance itself.\n",
          "url": "https://journalofethics.ama-assn.org/article/strategies-collaborative-consideration-patients-resuscitation-preferences/2020-04"
        },
        {
          "title": "Discordance Between Surrogate Care Goals and Medical ...",
          "author": "Amber R Comer, Susan E Hickman, James E Slaven, Patrick O Monahan, Greg A Sachs, Lucia D Wocial, Emily S Burke, Alexia M Torke",
          "published_date": "2023-11-09T20:30:05.393000+00:00",
          "summary": "This JAMA Network Open cohort study investigated the discordance between surrogate decision-makers' goals of care and the actual medical treatment received by hospitalized, incapacitated older adults.  The study directly addresses your question regarding the concordance between family members' perceptions of a patient's wishes (regarding code status, CPR, and intubation) and the medical care provided.  While the abstract doesn't detail specific findings on concordance rates, the study design suggests it directly measured the alignment (or lack thereof) between surrogate goals and provided treatment.\n",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2766000"
        },
        {
          "title": "Obstacles to patient inclusion in CPR/DNAR decisions and ...",
          "author": "Michele Bedulli,",
          "published_date": "2023-03-22T00:00:00+00:00",
          "summary": "This qualitative study of physicians in Southern Switzerland did not directly assess the concordance between family members' and patients' goals of care regarding CPR or intubation.  While the study explored obstacles to patient inclusion in CPR/DNAR decisions, focusing on physician perspectives and perceived challenges in communicating with patients and families, it did not investigate the agreement between these two groups on end-of-life care preferences.\n",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0282270"
        },
        {
          "title": "Failure to Engage Hospitalized Elderly Patients and Their ...",
          "author": "",
          "published_date": "2013-04-23T00:00:00+00:00",
          "summary": "Yes, the ACCEPT study (cited in the provided text) investigated concordance between elderly patients' preferences for end-of-life (EOL) care and those of their family members, as well as how well these preferences were documented in medical records.  The study found only 30.2% agreement between patients' expressed EOL care preferences and the medical record.  While the study didn't specifically focus on CPR or intubation, the low concordance rate suggests a potential disconnect between patient wishes and both family perceptions and medical documentation of those wishes for various aspects of EOL care.\n",
          "url": "https://www.thecarenet.ca/docs/Failure%20to%20engage%20JAMA%20Intern%20Med%202013.pdf"
        }
      ],
      "full_explanation": "Several studies have directly investigated the concordance between family members' perceptions of a patient's goals of care and the patient's actual goals, specifically regarding code status, CPR, and intubation decisions. \n\n*   The paper titled \"Goal-Concordant Care After Severe Acute Brain Injury\" directly addresses this question by examining family-assessed goals of care for patients with severe acute brain injuries and comparing them to the patient\u2019s actual goals of care. This study looked at concordance around high-stakes decisions such as life-sustaining treatment including intubation and CPR (URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.710783/full).\n*   The study \"Code Status Orders and Goals of Care in the Medical ICU\" found inconsistencies between patient/surrogate preferences for code status and actual medical orders and also identified a significant disagreement between patient/surrogates and physicians regarding the most important goals of care (URL: https://www.researchgate.net/publication/49809238_Code_Status_Orders_and_Goals_of_Care_in_the_Medical_ICU). Although this study looked at physician goals, it still shows that there is a disconnect between patient/surrogate preferences and actual medical orders which is relevant to the question.\n*   The research paper \"Discordance Between Surrogate Care Goals and Medical Treatment Received Among Hospitalized Incapacitated Older Adults\" specifically investigates the disagreement between surrogate decision-makers' goals of care and the actual medical treatment provided to hospitalized, incapacitated older adults. This is directly related to the question of whether family member (surrogate) understanding of patient wishes matches the care they receive (URL: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2766000).\n*  The \"Failure to Engage Hospitalized Elderly Patients and Their Families in End-of-Life Care Planning: The ACCEPT Study\" investigated concordance between patients' preferences and their family members, finding only 30.2% agreement for all EOL preferences which indicates a disconnect between patients' goals and family perceptions of these goals (URL: https://www.thecarenet.ca/docs/Failure%20to%20engage%20JAMA%20Intern%20Med%202013.pdf).\n\nThese studies collectively demonstrate that research has been conducted exploring the concordance between family members' perceptions of patient goals and the patient's actual wishes regarding code status, CPR, intubation, and overall goals of care."
    },
    {
      "question": "Has anyone detected dyson sphere signatures?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Project Hephaistos \u2013 II. Dyson sphere candidates from Gaia DR3, 2MASS, and WISE",
          "author": "Suazo; Mat\u00edas; Zackrisson; Erik; Mahto; Priyatam K; Lundell; Fabian; Nettelblad; Carl; Korn; Andreas J; Wright; Jason T; Majumdar; Suman",
          "published_date": "2024-05-13T00:00:00+00:00",
          "summary": "No conclusive detection of Dyson sphere signatures has been made.  This paper describes a search using data from Gaia, 2MASS, and WISE, identifying seven potential candidates around M-dwarf stars that warrant further investigation.  However, these are not confirmed Dyson spheres; further analysis is needed to rule out natural explanations for the observed infrared excess.\n",
          "url": "https://academic.oup.com/mnras/article/531/1/695/7665761"
        },
        {
          "title": "Project Hephaistos - II. Dyson sphere candidates from Gaia DR3, 2MASS, and WISE",
          "author": "Suazo; Mat\u00edas; Zackrisson; Erik; Mahto; Priyatam K; Lundell; Fabian; Nettelblad; Carl; Korn; Andreas J; Wright; Jason T; Majumdar; Suman",
          "published_date": "2024-05-05T00:00:00+00:00",
          "summary": "A new study (Project Hephaistos) searched for partial Dyson sphere signatures in data from Gaia, 2MASS, and WISE.  Using a pipeline with a convolutional neural network to filter out false positives, the researchers identified 7 potential candidates, all M-dwarf stars exhibiting unexplained infrared excess emission.  While not definitive proof of Dyson spheres, these candidates warrant further investigation.\n",
          "url": "https://arxiv.org/abs/2405.02927"
        },
        {
          "title": "Anomalous Variability of Dyson Megastructures",
          "author": null,
          "published_date": "2023-01-06T18:01:03.444000+00:00",
          "summary": "No definitive detection of Dyson sphere signatures has been confirmed.  While studies have explored potential candidates based on anomalous light curves (like Tabby's Star) and infrared observations, these have alternative explanations (e.g., exocomets).  Research continues to investigate potential observational signatures, such as anomalous variability from oscillating ring-like megastructures, but no conclusive evidence currently exists.\n",
          "url": "https://arxiv.org/pdf/arxiv.org/ftp/arxiv/papers/1909/1909.08851.pdf"
        },
        {
          "title": "Dyson spheres: astronomers report potential candidates for ...",
          "author": "Simon Goodwin",
          "published_date": "2024-05-22T00:00:00+00:00",
          "summary": "A team of astronomers has identified seven potential candidates for Dyson spheres, alien megastructures designed to harness a star's energy, based on their excess infrared radiation.  While these candidates don't fit typical models for gas and dust clouds,  the infrared signature could also have natural explanations.  Further investigation is needed, including searching for another potential Dyson sphere signature: dips in the star's visible light as the megastructure transits.  The article notes that while Dyson spheres are theoretically possible, a civilization capable of building them might not need to, given alternative energy solutions.\n",
          "url": "https://theconversation.com/dyson-spheres-astronomers-report-potential-candidates-for-alien-megastructures-heres-what-to-make-of-it-230364"
        },
        {
          "title": "II. Dyson sphere candidates from Gaia DR3, 2MASS, and ...",
          "author": "Suazo; Mat\u00edas; Zackrisson; Erik; Mahto; Priyatam K; Lundell; Fabian; Nettelblad; Carl; Korn; Andreas J; Wright; Jason T; Majumdar; Suman",
          "published_date": "2024-05-13T00:00:00+00:00",
          "summary": "No strong candidates for Dyson spheres (megastructures built by advanced civilizations to harness stellar energy) have been detected in previous searches.  This study analyzed data from Gaia, 2MASS, and WISE to identify potential partial Dyson spheres, resulting in seven candidates around M-dwarf stars which warrant further investigation.  These candidates exhibit infrared excess emission not easily explained by known astrophysical phenomena.\n",
          "url": "https://academic.oup.com/mnras/article/531/1/695/7665761"
        },
        {
          "title": "Did a NASA telescope detect cosmic 'hot dogs' or Dyson ...",
          "author": "Robert Lea",
          "published_date": "2024-10-02T13:00:01+00:00",
          "summary": "A recent paper by Project Hephaistos suggests the detection of seven unusual objects that *might* be Dyson spheres.  These potential megastructures, designed to harvest stellar energy, were identified using data from the WISE and Gaia spacecraft. However, a NASA scientist counters this interpretation, arguing that the signals are more likely from \"Hot DOGs\"\u2014dusty galaxies with obscured black holes.  The debate continues over whether these signals are evidence of advanced alien civilizations.\n",
          "url": "https://www.space.com/hot-dogs-wise-nasa-dyson-spheres"
        },
        {
          "title": "New Study Suggests of Dyson Spheres, Possible Alien ...",
          "author": "Darren Orf",
          "published_date": "2024-05-14T00:00:00+00:00",
          "summary": "Two recent studies analyzing data from Gaia, WISE, and 2MASS satellites have found evidence suggesting potential Dyson sphere signatures.  These studies developed methods to filter out natural explanations for excess infrared radiation from stars, identifying several candidates that cannot be readily explained by known natural phenomena.  While not definitive proof of alien megastructures, the findings present intriguing possibilities.\n",
          "url": "https://www.popularmechanics.com/space/deep-space/a60780331/dyson-sphere-evidence-alien-civilizations/"
        },
        {
          "title": "Astronomers Are on the Hunt for Dyson Spheres",
          "author": "Evan Gough; Universe Today",
          "published_date": "2024-05-13T00:00:00+00:00",
          "summary": "The provided text contains only HTML markup and lacks the actual article content about the search for Dyson spheres.  Therefore, I cannot answer whether anyone has detected Dyson sphere signatures based on this input.  The article's title suggests that astronomers are *searching* for them, but no results are presented.\n",
          "url": "https://astrobiology.arizona.edu/news/astronomers-are-hunt-dyson-spheres"
        },
        {
          "title": "Have Scientists Found 'Potential Evidence' of Dyson ...",
          "author": "EditorDavid hypothetical-megastructures dept",
          "published_date": "2024-06-15T00:00:00+00:00",
          "summary": "Two recent studies analyzing infrared data from 5 million Milky Way stars have identified potential Dyson sphere candidates. One study found seven stars with unexplained infrared emissions, while another found 53 potential anomalies, though neither study definitively attributes these to Dyson spheres.  Further research, potentially using the James Webb Space Telescope, is needed to rule out alternative explanations like dust clouds or planetary collisions.  Even the researchers involved emphasize the need for more data before concluding these are signs of alien megastructures. A subsequent paper suggests that several of the candidates are likely misidentified galaxies.\n",
          "url": "https://science.slashdot.org/story/24/06/15/1855235/have-scientists-found-potential-evidence-of-dyson-spheres?utm_source=rss1.0mainlinkanon&utm_medium=feed"
        },
        {
          "title": "Astronomers find 60 Dyson sphere candidates, among ...",
          "author": "Paul Scott Anderson",
          "published_date": "2024-05-15T00:00:00+00:00",
          "summary": "Yes.  Two teams of astronomers have identified 60 stars exhibiting an excess of infrared radiation, a potential signature of Dyson spheres (megastructures built by extraterrestrial civilizations to harness stellar energy).  While other explanations are possible, the researchers currently lack a natural explanation for this phenomenon.  The findings are based on analysis of data from the Gaia satellite, 2MASS, and WISE.  The candidate stars range from red dwarfs to sun-like stars, located up to 6,500 light-years away.\n",
          "url": "https://earthsky.org/space/dyson-sphere-alien-megastructures-infrared-heat-stars/"
        }
      ],
      "full_explanation": "Multiple research papers have investigated the possibility of detecting Dyson sphere signatures. Project Hephaistos has been a key effort in this area, with multiple publications describing the search for Dyson sphere candidates using data from Gaia, 2MASS, and WISE. Several papers highlight the identification of potential candidates, mainly around M-dwarf stars, that exhibit unexplained infrared excess, a key signature of a Dyson sphere. For example, the paper \"Project Hephaistos \u2013 II. Dyson sphere candidates from Gaia DR3, 2MASS, and WISE\" (https://academic.oup.com/mnras/article/531/1/695/7665761 and https://arxiv.org/abs/2405.02927) details the methods used to find these candidates and identifies seven of them. Another article titled \"Dyson spheres: astronomers report potential candidates for ...\" (https://theconversation.com/dyson-spheres-astronomers-report-potential-candidates-for-alien-megastructures-heres-what-to-make-of-it-230364) also discusses these findings and their implications. A paper by \"Paul Scott Anderson\" titled \"Astronomers find 60 Dyson sphere candidates, among ...\" (https://earthsky.org/space/dyson-sphere-alien-megastructures-infrared-heat-stars/) indicates that two teams of astronomers have identified 60 stars exhibiting excess infrared radiation. However, it is important to note that while these studies have found potential candidates, they have not found definitive proof of Dyson spheres. A paper by \"EditorDavid hypothetical-megastructures dept\" titled \"Have Scientists Found 'Potential Evidence' of Dyson ...\" (https://science.slashdot.org/story/24/06/15/1855235/have-scientists-found-potential-evidence-of-dyson-spheres?utm_source=rss1.0mainlinkanon&utm_medium=feed) highlights that some findings have been refuted, further underscoring the challenges in confirming such a detection. While one article notes an alternate explanation for these signals coming from \"hot dogs\" rather than Dyson Spheres (https://www.space.com/hot-dogs-wise-nasa-dyson-spheres), this does not negate the fact the search has been done before. Finally, the paper \"Anomalous Variability of Dyson Megastructures\" (https://arxiv.org/pdf/arxiv.org/ftp/arxiv/papers/1909/1909.08851.pdf) specifically addresses that no definitive detection has been made, but explores the search space of unusual light curves. The overall theme of these papers is the active search for and identification of candidates, but the lack of conclusive evidence."
    },
    {
      "question": "Has anyone done a practical engineering analysis of starting a dyson sphere?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Stellar engines: Design considerations for maximizing acceleration",
          "author": "Matthew E Caplan, Illinois State University, 61761, Normal, IL, USA, Acta  Astronautica, Illinois State University, 61761, Normal, IL, USA",
          "published_date": "2023-11-09T20:26:49.925000+00:00",
          "summary": "This scientific article analyzes two designs for stellar engines, large-scale structures capable of moving stars.  While not directly addressing Dyson sphere construction, the analysis of an \"active\" stellar engine, which uses thermonuclear fusion of matter collected from a star's solar wind,  is relevant.  The study provides calculations of achievable acceleration (up to 10\u207b\u2079 m/s\u00b2) for such an engine, offering insights into the engineering challenges involved in moving a star\u2014a necessary prerequisite to building a Dyson sphere around it, although it does not address the construction of the sphere itself.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0094576519312457"
        },
        {
          "title": "Review and viability of a Dyson Swarm as a form of Dyson Sphere",
          "author": "Jack Smith",
          "published_date": "2023-10-26T19:30:27.197000+00:00",
          "summary": "This paper analyzes the viability of a Dyson swarm, a collection of smaller objects orbiting a star to collect solar energy, as a more practical alternative to a solid Dyson sphere.  The author argues that a swarm avoids the engineering challenges of building and maintaining a massive, fragile shell, citing issues like asteroid impacts and structural instability.  The paper compares the Sun's energy output to current global energy consumption to demonstrate the scale involved, concluding that a Dyson swarm is a more efficient and feasible approach to harnessing stellar energy.  However, the paper does not present a detailed engineering analysis of the *construction* of a Dyson sphere (or swarm), focusing instead on a comparison of the theoretical feasibility of the two concepts.\n",
          "url": "https://arxiv.org/pdf/2109.11443.pdf"
        },
        {
          "title": "A Dyson Sphere around a black hole",
          "author": "Yu-Yang  Hsiao, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Tomotsugu  Goto, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Tetsuya  Hashimoto, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Daryl Joe D Santos, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Alvina Y L On, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Ece  Kilerci-Eser, Sabanc\u0131 University, 34956, Istanbul, Turkey, Yi  Hang, Valerie  Wong, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Seong Jin Kim, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, -W  Wu, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, -C  Ho, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Ting-Yi  Lu, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan",
          "published_date": "2023-11-16T01:35:15.834000+00:00",
          "summary": "This paper does not perform a practical engineering analysis of building a Dyson sphere, but rather explores the feasibility of constructing one around a black hole as a method for an advanced civilization to harness energy.  It examines six potential energy sources (cosmic microwave background, Hawking radiation, accretion disk, Bondi accretion, corona, and relativistic jets), concluding that an accretion disk offers the most promising energy yield, potentially sufficient to support a Type II civilization.  The paper also discusses the detectability of such a structure through its waste heat radiation.\n",
          "url": "https://arxiv.org/pdf/2106.15181.pdf"
        },
        {
          "title": "(PDF) DYSON SPHERE RESEARCH PAPER - ResearchGate",
          "author": "",
          "published_date": "2019-06-04T00:00:00+00:00",
          "summary": "This research paper from Antalya Bilim University discusses the Dyson sphere concept, noting its theoretical nature and the significant technological challenges to its construction.  The paper does not present a practical engineering analysis of building a Dyson sphere, but rather focuses on the sphere's potential as a solution to increasing energy demands for advanced civilizations (Type 1, 2, and 3).\n",
          "url": "https://www.researchgate.net/publication/333603778_DYSON_SPHERE_RESEARCH_PAPER"
        },
        {
          "title": "Dyson sphere - Wikipedia",
          "author": null,
          "published_date": "2023-02-06T22:31:11.519000+00:00",
          "summary": "No practical engineering analysis of building a Dyson sphere exists.  While the concept, initially proposed by Freeman Dyson, focuses on energy collection from a star,  no detailed plans for construction have been developed.  The Wikipedia article notes that Dyson himself considered a solid shell enclosing a star to be the least plausible variant of the idea.  The focus has been more on the theoretical implications of such a structure for advanced civilizations rather than on the feasibility of its construction.\n",
          "url": "https://en.wikipedia.org/wiki/Dyson_sphere"
        },
        {
          "title": "Would building a Dyson sphere be worth it? We ran the numbers.",
          "author": "Paul Sutter - Mar 27, 2023 11:40 am UTC",
          "published_date": "2023-03-27T11:40:34+00:00",
          "summary": "No, the article states that a practical engineering analysis of building a Dyson sphere is currently impossible.  The author, a theoretical cosmologist, acknowledges the lack of knowledge regarding the necessary technological advancements and focuses instead on a theoretical physics-based analysis to estimate the energy cost and feasibility, making simplifying assumptions due to the inherent complexities.\n",
          "url": "https://arstechnica.com/science/2023/03/building-a-dyson-sphere-whats-the-payback-time-of-disassembling-a-planet/"
        },
        {
          "title": "Have Scientists Found 'Potential Evidence' of Dyson Spheres?",
          "author": "EditorDavid hypothetical-megastructures dept",
          "published_date": "2024-06-15T00:00:00+00:00",
          "summary": "This article discusses recent studies identifying infrared anomalies around several stars, raising the possibility of Dyson spheres.  However, the article emphasizes that these are potential candidates only, with natural explanations like dust clouds and galactic alignment still under consideration.  No practical engineering analysis of Dyson sphere construction is mentioned.  While researchers are exploring further investigation using the James Webb Space Telescope, the article focuses on the astronomical detection of potential candidates, not on the feasibility of building one.\n",
          "url": "https://science.slashdot.org/story/24/06/15/1855235/have-scientists-found-potential-evidence-of-dyson-spheres?utm_source=rss1.0mainlinkanon&utm_medium=feed"
        },
        {
          "title": "(PDF) Dyson spheres - ResearchGate",
          "author": "Authors:",
          "published_date": "2020-01-01T00:00:00+00:00",
          "summary": "This paper reviews the concept of Dyson spheres, addressing their purpose, engineering challenges, and detectability.  The author highlights the instability of monolithic Dyson sphere designs due to gravity and radiation pressure, proposing a model for radiative coupling between a star and orbiting material. While the paper explores optimal sizes based on different purposes (low-entropy emission, dissipative work, or computation), it doesn't delve into the practical engineering analysis of *initiating* a Dyson sphere construction.  Therefore, the question of practical engineering analysis for starting a Dyson sphere is not directly addressed.\n",
          "url": "https://www.researchgate.net/publication/342632672_Dyson_spheres"
        },
        {
          "title": "What is a realistic based Situation in which a Dyson Sphere could ...",
          "author": "Mister SirCodeMister SirCode 18577 bronze badges",
          "published_date": "2019-11-14T21:23:00+00:00",
          "summary": "The provided text focuses on a fictional scenario for creating a Dyson swarm, not a practical engineering analysis.  It suggests a gradual, unplanned evolution from individual solar-powered spacecraft to a massive swarm over centuries, bypassing the need for a large-scale, coordinated project.  No actual engineering analysis of the feasibility or challenges is presented.\n",
          "url": "https://worldbuilding.stackexchange.com/questions/160880/what-is-a-realistic-based-situation-in-which-a-dyson-sphere-could-be-created"
        },
        {
          "title": "Review and viability of a Dyson Swarm as a form of Dyson Sphere",
          "author": "",
          "published_date": "2022-11-11T00:00:00+00:00",
          "summary": "Yes, this paper presents an engineering analysis of a Dyson Swarm, a type of Dyson sphere composed of many individual satellites orbiting a star.  It concludes that a Martian-based Dyson Swarm is feasible, potentially generating Earth's 2019 energy consumption (18.35 TW) within 50 years of commencing construction (starting as early as 2040).  The analysis details construction using electromagnetic launchers and includes estimates of efficiency (0.74\u20132.77% of solar output) and the number of satellites required (over 5.5 billion).\n",
          "url": "https://www.research.ed.ac.uk/en/publications/review-and-viability-of-a-dyson-swarm-as-a-form-of-dyson-sphere"
        }
      ],
      "full_explanation": "While several papers discuss Dyson spheres and related concepts, none of them provide a practical engineering analysis of *starting* the construction of a Dyson sphere.\n\nSeveral papers discuss the theoretical implications and challenges of Dyson spheres, including:\n*  The Wikipedia article on Dyson spheres ([https://en.wikipedia.org/wiki/Dyson_sphere](https://en.wikipedia.org/wiki/Dyson_sphere)) states that no detailed plans for construction have been developed and that Dyson considered a solid shell to be the least plausible.\n* The paper from ResearchGate ([https://www.researchgate.net/publication/333603778_DYSON_SPHERE_RESEARCH_PAPER](https://www.researchgate.net/publication/333603778_DYSON_SPHERE_RESEARCH_PAPER)) notes that the Dyson sphere concept is theoretical with significant technological challenges.\n* The ResearchGate paper ([https://www.researchgate.net/publication/342632672_Dyson_spheres](https://www.researchgate.net/publication/342632672_Dyson_spheres)) reviews Dyson spheres and their purpose but doesn't delve into the practical engineering of initiation.\n* Paul Sutter's article ([https://arstechnica.com/science/2023/03/building-a-dyson-sphere-whats-the-payback-time-of-disassembling-a-planet/](https://arstechnica.com/science/2023/03/building-a-dyson-sphere-whats-the-payback-time-of-disassembling-a-planet/)) states that a practical engineering analysis is impossible given current knowledge.\n* The paper from Antalya Bilim University  ([https://www.researchgate.net/publication/333603778_DYSON_SPHERE_RESEARCH_PAPER](https://www.researchgate.net/publication/333603778_DYSON_SPHERE_RESEARCH_PAPER)) discusses the Dyson sphere concept but does not present a practical engineering analysis of construction.\n\nSome papers focus on variations of the Dyson sphere, such as swarms, which are more practical:\n* The paper \"Review and viability of a Dyson Swarm as a form of Dyson Sphere\" ([https://arxiv.org/pdf/2109.11443.pdf](https://arxiv.org/pdf/2109.11443.pdf)) discusses the viability of a Dyson swarm compared to a solid Dyson sphere, but doesn't focus on the engineering of initiating construction of a swarm.\n\n* A paper with the same name ([https://www.research.ed.ac.uk/en/publications/review-and-viability-of-a-dyson-swarm-as-a-form-of-dyson-sphere](https://www.research.ed.ac.uk/en/publications/review-and-viability-of-a-dyson-swarm-as-a-form-of-dyson-sphere)) does provide an engineering analysis of a Dyson *swarm*, concluding that it is feasible from a Martian base. While this paper analyzes the feasibility of construction of the *swarm* it doesn't touch on the issue of the broader *sphere* construction.\n\n* The article about a fictional scenario for creating a Dyson swarm ([https://worldbuilding.stackexchange.com/questions/160880/what-is-a-realistic-based-situation-in-which-a-dyson-sphere-could-be-created](https://worldbuilding.stackexchange.com/questions/160880/what-is-a-realistic-based-situation-in-which-a-dyson-sphere-could-be-created)) suggests a gradual approach, rather than a coordinated project.\n\nThe paper on stellar engines ([https://www.sciencedirect.com/science/article/pii/S0094576519312457](https://www.sciencedirect.com/science/article/pii/S0094576519312457)) analyzes the movement of a star, which is a potential prerequisite but does not look at the construction of the sphere itself.\n\nThe research question specifically asks for a practical engineering analysis of *starting* a Dyson sphere, which means how the first stages of construction would be achieved, not just the general idea or the"
    },
    {
      "question": "Has anyone tried betaine as a treatment for Alzheimer's disease",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Reversal of cognitive decline: A novel therapeutic program",
          "author": "Bredesen, Dale E.",
          "published_date": "2014-09-27T00:00:00+00:00",
          "summary": "This research article describes a novel therapeutic program for Alzheimer's disease and other cognitive impairments.  The program, involving multiple modalities designed to achieve metabolic enhancement, showed positive results in 9 out of 10 patients within 3-6 months, with sustained improvement in some cases for up to two and a half years.  The study does not mention the use of betaine as a treatment.\n",
          "url": "https://www.aging-us.com/article/100690/text"
        },
        {
          "title": "Reversal of cognitive decline: A novel therapeutic program",
          "author": "Dale E Bredesen",
          "published_date": "2023-02-27T02:47:00.276000+00:00",
          "summary": "This research article describes a novel therapeutic program for Alzheimer's disease and related cognitive decline, showing positive results in 9 out of 10 patients.  The program uses multiple modalities to improve metabolic function related to neurodegeneration.  The study does *not* mention the use of betaine as a treatment.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221920/"
        },
        {
          "title": "A unique and promising combination of medications for the treatment of Alzheimer's disease.",
          "author": "James D Weinstein, Marshall University School of Medicine, 1600 Medical Center Dr, 25701, Huntington, WV, United States, jweinstein3438@gmail.com",
          "published_date": "2023-11-09T20:21:11.893000+00:00",
          "summary": "This research article proposes a new combination therapy for Alzheimer's disease using Trental, Nicergoline, Nilotinib, Methylene blue, and vitamin B6.  The study focuses on addressing four major pathological processes of Alzheimer's, and  does not mention betaine as a treatment.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0306987717309787"
        },
        {
          "title": "Betaine attenuates Alzheimer-like pathological changes ...",
          "author": "Gao-Shang Chai 1 ,",
          "published_date": "2014-11-01T00:00:00+00:00",
          "summary": "A 2013 study in hyperhomocysteinemic rats found that betaine supplementation ameliorated memory deficits, improved synaptic function (LTP, dendritic branching, spine density), and reduced Alzheimer's-like pathology (tau hyperphosphorylation and A\u03b2 production) induced by homocysteine.  The researchers suggest betaine as a potential treatment for Alzheimer's-related conditions.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23157378/"
        },
        {
          "title": "Making the case for prophylactic use of betaine to promote ...",
          "author": "Leena S. KnightThomas A. Knight*",
          "published_date": "2023-09-22T00:00:00+00:00",
          "summary": "This review article discusses betaine's potential neuroprotective effects, including its role in mitigating concussion damage.  While the article focuses on prophylactic use in young athletes, it cites betaine's benefits in improving cognitive function (observed in elderly populations) and its anti-convulsant properties, suggesting potential relevance to neurodegenerative diseases like Alzheimer's.  However, the article does *not* present evidence of betaine being used as a treatment for Alzheimer's disease, only suggesting further research into its potential.\n",
          "url": "https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1214976/full"
        },
        {
          "title": "Betaine Mitigates Amyloid-\u03b2-Associated ...",
          "author": "",
          "published_date": "2023-07-25T00:00:00+00:00",
          "summary": "This study investigated betaine's effect on amyloid-\u03b2 (A\u03b2)-induced neuroinflammation in microglial cells (BV2 cells), a key factor in Alzheimer's disease (AD).  Researchers found that betaine effectively reduced levels of inflammatory factors (IL-1\u03b2, IL-18, TNF-\u03b1) induced by A\u03b2, by suppressing the NLRP3 inflammasome and NF-\u03baB signaling pathways.  While this is an in vitro study, the results suggest betaine may be a potential therapeutic modulator for AD, warranting further investigation.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10473109/"
        },
        {
          "title": "Betaine reduces \u03b2-amyloid-induced paralysis through ...",
          "author": "Anne Leiteritz,Benjamin Dilberger,U. Wenzel,Elena Fitzenberger",
          "published_date": "2023-10-26T19:30:50.811000+00:00",
          "summary": "Studies in *C. elegans* (a roundworm used as an Alzheimer's disease model) show that betaine reduces \u03b2-amyloid-induced paralysis.  This effect isn't through the expected remethylation pathway, but rather via the transsulfuration pathway involving cystathionine-\u03b2-synthase. While promising in this model,  it's crucial to note that this research is pre-clinical and in a simple organism, not humans.  Therefore, no clinical trials have yet tested betaine as a treatment for Alzheimer's disease in humans.\n",
          "url": "https://genesandnutrition.biomedcentral.com/articles/10.1186/s12263-018-0611-9"
        },
        {
          "title": "Betaine alleviates cognitive impairment induced by ...",
          "author": "Z. Yang, D.D. Zhou, S.Y. Huang, A.P. Fang, H.B. Li, H.L. Zhu",
          "published_date": "2024-02-01T00:00:00+00:00",
          "summary": "This research study investigated whether betaine could alleviate cognitive impairment caused by high homocysteine levels, a potential risk factor for dementia, including Alzheimer's disease.  The study found that betaine did mitigate cognitive impairment in a model, by reducing microglial pyroptosis (a type of inflammatory cell death) through an m6A-YTHDF2-dependent mechanism.  While not directly a treatment for Alzheimer's, the results suggest betaine's potential as a therapeutic agent targeting a specific mechanism contributing to cognitive decline associated with conditions like Alzheimer's.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2213231724000028"
        },
        {
          "title": "Effects of betaine on lipopolysaccharide-induced memory ...",
          "author": "Masaya  Miwa, Laboratory of Neuropsychopharmacology, Meijo University, 150 Yagotoyama, Tenpaku-ku, 468-8503, Nagoya, Japan, Mizuki  Tsuboi, Laboratory of Neuropsychopharmacology, Meijo University, 150 Yagotoyama, Tenpaku-ku, 468-8503, Nagoya, Japan, Yumiko  Noguchi, Laboratory of Neuropsychopharmacology, Meijo University, 150 Yagotoyama, Tenpaku-ku, 468-8503, Nagoya, Japan, Aoi  Enokishima, Laboratory of Neuropsychopharmacology, Meijo University, 150 Yagotoyama, Tenpaku-ku, 468-8503, Nagoya, Japan, Toshitaka  Nabeshima, Laboratory of Neuropsychopharmacology, Meijo University, 150 Yagotoyama, Tenpaku-ku, 468-8503, Nagoya, Japan, Masayuki  Hiramatsu, Laboratory of Neuropsychopharmacology, Meijo University, 150 Yagotoyama, Tenpaku-ku, 468-8503, Nagoya, Japan",
          "published_date": "2023-11-09T19:16:00.670000+00:00",
          "summary": "This study in mice found that betaine prevented memory impairment caused by lipopolysaccharide (LPS), a bacterial toxin that induces inflammation.  While not directly testing Alzheimer's disease, the results suggest betaine may have neuroprotective effects by modulating GABA transporter 2 (GAT2) expression in the hippocampus.  The study did not examine the effects of betaine on Alzheimer's disease specifically.\n",
          "url": "https://jneuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-8-153"
        },
        {
          "title": "Betaine as a Functional Ingredient: Metabolism, Health- ...",
          "author": "Jovana Koji\u0107",
          "published_date": "2023-06-17T00:00:00+00:00",
          "summary": "This review article on betaine discusses its metabolism, health benefits, sources, applications, and analysis methods.  However, it does *not* mention any research or trials on betaine's use as a treatment for Alzheimer's disease.\n",
          "url": "https://www.mdpi.com/1420-3049/28/12/4824"
        }
      ],
      "full_explanation": "Although many papers discuss the potential of betaine in relation to Alzheimer's and cognitive decline, only one directly addresses the use of betaine as a treatment. The paper \"Betaine attenuates Alzheimer-like pathological changes...\" (URL: https://pubmed.ncbi.nlm.nih.gov/23157378/) describes a study in hyperhomocysteinemic rats where betaine supplementation reduced Alzheimer's-like pathology. This study is not a clinical trial in humans with Alzheimer's, but it does investigate betaine as a *treatment* in an Alzheimer's relevant model and suggests it as a potential therapeutic. Several other papers also suggest a potential for betaine to be used as a treatment, but do not describe experiments where betaine is used to treat a model of Alzheimer's directly. These include: \"Betaine Mitigates Amyloid-\u03b2-Associated...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10473109/), which found betaine reduces inflammation in microglial cells treated with amyloid-beta, and \"Betaine alleviates cognitive impairment induced by...\" (URL: https://www.sciencedirect.com/science/article/pii/S2213231724000028), which found betaine mitigates cognitive impairment caused by high homocysteine levels in a model. These studies support the potential for betaine as a treatment, but do not directly test it as a treatment for the disease.\nTherefore, while the majority of the papers focus on preventative or mechanistic effects, the study by Chai et al. (https://pubmed.ncbi.nlm.nih.gov/23157378/) does investigate betaine as a treatment for Alzheimer's-like conditions in a rat model, thereby confirming that this research has been undertaken before."
    },
    {
      "question": "Has anyone investigated the mechanism of increased cardiac output in patients treated with both milrinone and a beta blocker?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Systemic Hemodynamic and Myocardial Metabolic Effects of Isoproterenol and Angiotensin After Open\u2010Heart Surgery",
          "author": "Hiltrud S Mueller, New York University School of Medicine, New York, New York, John J Gregory, New York University School of Medicine, New York, New York, Stanley  Giannelli, New York University School of Medicine, New York, New York, Stephen M Ayres, New York University School of Medicine, New York, New York",
          "published_date": "2023-11-09T20:08:37.636000+00:00",
          "summary": "This study investigated the hemodynamic and metabolic effects of isoproterenol (a beta-agonist) and angiotensin in patients after open-heart surgery, not the combination of milrinone and a beta-blocker.  The study found isoproterenol increased cardiac index (a measure of cardiac output) while angiotensin decreased it.  The study does not address the user's specific query regarding the mechanism of increased cardiac output with the combination of milrinone and a beta-blocker.\n",
          "url": "https://www.ahajournals.org/doi/10.1161/01.CIR.42.3.491"
        },
        {
          "title": "Isoproterenol for the treatment of circulatory shock.",
          "author": "",
          "published_date": "2023-11-09T20:25:04.026000+00:00",
          "summary": "This article focuses on isoproterenol's use in treating circulatory shock and doesn't address the combined use of milrinone and beta-blockers to increase cardiac output.  Therefore, it does not contain information relevant to your query.\n",
          "url": "https://annals.org/article.aspx?doi=10.7326/0003-4819-70-3-638"
        },
        {
          "title": "Intravenous inotropic agents in heart failure.",
          "author": "",
          "published_date": "2023-11-09T20:14:24.768000+00:00",
          "summary": "This article discusses the use of inotropic agents in heart failure, noting their limited long-term value and increased mortality risk with prolonged use.  While it mentions that inotropes increase cardiac contractility and improve cardiac output, it does *not* address the specific mechanism of this improvement when using a combination of milrinone and a beta-blocker.  Therefore, the provided text offers no answer to your query regarding the combined effects of milrinone and a beta-blocker on cardiac output.\n",
          "url": "https://www.magonlinelibrary.com/doi/10.12968/hmed.2008.69.1.28037"
        },
        {
          "title": "Combined milrinone and enteral metoprolol therapy in ...",
          "author": "",
          "published_date": "2008-08-04T00:00:00+00:00",
          "summary": "This study investigated the effects of combined milrinone and enteral metoprolol in septic shock patients with cardiac depression.  While heart rate was controlled, and stroke volume index increased,  the cardiac index and cardiac power index remained unchanged.  The study did not investigate the mechanism behind any increase in cardiac output, only observing hemodynamic changes.  Further research is needed to understand the mechanisms involved.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2575588/"
        },
        {
          "title": "Intravenous Milrinone in Treatment of Advanced ...",
          "author": "",
          "published_date": "2003-01-01T00:00:00+00:00",
          "summary": "This study investigated the combination of intravenous milrinone and oral beta-blockers in patients with severe congestive heart failure.  While the study shows improved functional status and reduced hospital days with this combination therapy, it doesn't delve into the specific mechanism of increased cardiac output resulting from their interaction.  The focus is on the overall clinical outcomes of the combined treatment, not the underlying physiological mechanisms.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC161895/"
        },
        {
          "title": "A pragmatic approach to the use of inotropes ...",
          "author": "D. Farmakis, J. Parissis, A. Karavidas, et al.",
          "published_date": "2019-12-15T00:00:00+00:00",
          "summary": "This article focuses on the use of inotropes in acute and advanced heart failure, not on the combined use of milrinone and beta-blockers.  Therefore, it does not offer information regarding the mechanism of increased cardiac output in patients treated with this specific combination.  The article discusses the use of inotropes like milrinone to increase cardiac output by enhancing contractility, but it does not address the interaction with beta-blockers.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0167527319325021"
        },
        {
          "title": "Milrinone - an overview",
          "author": "Info icon",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "The provided text focuses on milrinone's mechanism of action as a phosphodiesterase (PDE) inhibitor, increasing cAMP and thus intracellular calcium, leading to improved myocardial contractility and vasodilation.  While it mentions that milrinone may be preferred over dobutamine in patients taking beta-blockers because it doesn't rely on beta-adrenergic receptors for contractility, it does *not* discuss studies investigating the combined effect of milrinone and beta-blockers on cardiac output.  Therefore, the answer to your query is that the provided text does not contain information on such investigations.\n",
          "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/milrinone"
        },
        {
          "title": "Inotropes in Acute Heart Failure: From Guidelines to ...",
          "author": "Vasiliki Bistola ,",
          "published_date": "2019-09-11T00:00:00+00:00",
          "summary": "This article focuses on the use of inotropes in acute heart failure (AHF), not the combined mechanism of milrinone and beta-blockers.  While it mentions milrinone (a phosphodiesterase III inhibitor) as one class of inotropes used to improve cardiac output, it does not address the specific interaction with beta-blockers.  The article emphasizes the short-term use of inotropes to stabilize patients with AHF and hypoperfusion, highlighting potential adverse effects and the need for careful patient selection.  It does not delve into the combined effects of different drug classes on cardiac output mechanisms.\n",
          "url": "https://www.cfrjournal.com/articles/inotropes-acute-heart-failure-guidelines-practical-use-therapeutic-options-and-clinical"
        },
        {
          "title": "\u03b2-Adrenergic Receptor Blockade in Chronic Heart Failure",
          "author": "Michael R Bristow",
          "published_date": "2023-12-04T04:02:18.951000+00:00",
          "summary": "This article focuses on the role of beta-blockers in treating chronic heart failure, not the combination of milrinone and beta-blockers.  Therefore, it does not address the mechanism of increased cardiac output in patients treated with both medications.  The article details the maladaptive adrenergic signaling in heart failure and how beta-blockade, initially considered a contraindication, has become a standard treatment by addressing the harmful effects of excessive norepinephrine on the heart.\n",
          "url": "https://www.ahajournals.org/doi/10.1161/01.CIR.101.5.558"
        }
      ],
      "full_explanation": "While several papers discuss the use of milrinone and beta-blockers in heart failure, none of them specifically investigate the *mechanism* of increased cardiac output when these two drugs are used in combination. The paper \"Combined milrinone and enteral metoprolol therapy in ...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2575588/) notes that although heart rate was controlled and stroke volume increased, the cardiac index did not change significantly, so the mechanism of any increase in cardiac output is not investigated. Similarly, the study \"Intravenous Milrinone in Treatment of Advanced ...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC161895/) demonstrates improved clinical outcomes with the combination but does not explore the underlying physiological mechanisms. Other papers, like \u201cMilrinone - an overview\u201d (URL: https://www.sciencedirect.com/topics/medicine-and-dentistry/milrinone) describe the mechanisms of action for milrinone and beta-blockers separately but does not delve into the mechanism of their combined effect. The papers generally focus on individual drug mechanisms or overall clinical benefits and do not address the specific research question regarding the mechanism of increased cardiac output from the combination of milrinone and a beta-blocker. Thus, based on the provided papers, this specific research question has not been investigated before."
    },
    {
      "question": "Has anyone found a small molecule to increase ovarian reserve?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation.",
          "author": "Venkataraman  Sriraman, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, venkat.sriraman@emdserono.com, Deborah  Denis, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, Daniel  De Matos, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, Henry  Yu, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, Stephen  Palmer, TocopheRx, Suite 1077, 15 New England Executive Park, 01803, Burlington, MA, United States, Selva  Nataraja, TocopheRx, Suite 1077, 15 New England Executive Park, 01803, Burlington, MA, United States",
          "published_date": "2023-11-09T20:02:09.316000+00:00",
          "summary": "A thiazolidinone derivative (Compound 5) has shown promise in stimulating follicular development and ovulation in animal models.  It activates the follicle-stimulating hormone receptor (FSHR), increasing estradiol production and supporting follicle growth to the preovulatory stage. However, its poor oral bioavailability and genotoxicity prevent its clinical development as an oral FSHR modulator for increasing ovarian reserve.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0006295214001385"
        },
        {
          "title": "Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging",
          "author": "Zhang; Yu; Bai; Jie; Cui; Zhaokang; Li; Gao; Qian; Miao; Yilong; Xiong; Bo",
          "published_date": "2023-10-16T00:00:00+00:00",
          "summary": "This research shows that the polyamine metabolite spermidine improves oocyte quality in aged females by enhancing mitophagy (a process of removing damaged mitochondria).  While the study doesn't directly address increasing ovarian reserve,  the improvement in oocyte quality suggests a potential avenue for future research exploring whether spermidine or similar molecules could impact ovarian reserve.  The study focuses on the mechanism of action of spermidine, not on directly increasing the number of oocytes.\n",
          "url": "https://www.nature.com/articles/s43587-023-00498-8"
        },
        {
          "title": "mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy",
          "author": "Robert J. Schneider",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "This study found that inhibiting mTOR, a kinase, with the small molecule inhibitors everolimus (mTORC1 inhibitor) or INK128 (mTORC1/2 inhibitor) prevented the loss of ovarian reserve and preserved fertility in mice undergoing chemotherapy.  While the study focused on *preserving* ovarian reserve during chemotherapy, the successful use of small molecule inhibitors suggests a potential avenue for future research into *increasing* ovarian reserve.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.1617233114"
        },
        {
          "title": "Can ovarian aging be delayed by pharmacological ...",
          "author": "",
          "published_date": "2019-01-23T00:00:00+00:00",
          "summary": "This article reviews pharmacological strategies to delay ovarian aging, a process characterized by declining follicle quantity and quality.  While it discusses potential approaches like calorie restriction mimetics and antioxidants, it does not identify any specific small molecules proven to increase ovarian reserve.  The focus is on the mechanisms of ovarian aging and potential avenues for intervention, rather than reporting on the success of specific small molecule treatments.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6366956/"
        },
        {
          "title": "Recent progress in the treatment of women with diminished ...",
          "author": "J. Cohen, N. Chabbert-Buffet, E. Darai",
          "published_date": "2021-12-01T00:00:00+00:00",
          "summary": "This article reviews treatments for diminished ovarian reserve (DOR), but doesn't report the discovery of a small molecule specifically to increase ovarian reserve.  While research into stem cell therapy for improving ovarian function is mentioned, the focus is on broader treatment strategies and improved IVF techniques to increase pregnancy outcomes in women with DOR.  No specific small molecule drug is highlighted as successfully increasing ovarian reserve.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S266716462100052X"
        },
        {
          "title": "Examining Use of Small-molecule Inhibitors in Preserving ...",
          "author": "medweb",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "A Northwestern Medicine study found that a clinically available small-molecule mTOR inhibitor, when used alongside chemotherapy in mice, preserved ovarian function and fertility.  While total follicle counts were still lower than in untreated mice, the inhibitor prevented premature activation of immature follicles and maintained normal birth rates.  The researchers suggest this combination may be an effective treatment to preserve fertility during chemotherapy, although further studies are needed to optimize dosage and assess effects on tumor growth.  The study does not demonstrate an increase in ovarian reserve in the absence of chemotherapy.\n",
          "url": "https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/"
        },
        {
          "title": "Poor ovarian reserve - PMC",
          "author": "",
          "published_date": "2015-11-01T00:00:00+00:00",
          "summary": "This research review on poor ovarian reserve (POR) focuses on diagnosis and management, not on treatments using small molecules to increase ovarian reserve.  The article discusses the challenges of POR, including low pregnancy rates and high pregnancy loss, and the use of *in vitro* fertilization (IVF) as a common treatment.  It does not mention any small molecule interventions to improve ovarian reserve.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4915288/"
        },
        {
          "title": "NADase CD38 is a key determinant of ovarian aging",
          "author": "Yang; Qingling; Chen; Wenhui; Cong; Luping; Wang; Mengchen; Li; Hui; Huan; Luo; Xiaoyan; Zhu; Jing; Zeng; Xinxin; Zhenye; Xu; Yining; Lei; Min; Zhao; Yanqing; Wei; Sun; Yingpu",
          "published_date": "2023-12-21T00:00:00+00:00",
          "summary": "This research article focuses on the mechanisms of ovarian aging, identifying NADase CD38 as a key factor.  While it explores the role of oxidative stress and inflammation in ovarian decline and mentions the impact of follicle dysfunction on premature ovarian insufficiency, it does *not* discuss the discovery of any small molecules to increase ovarian reserve.  The study focuses on understanding the underlying biological processes, not on therapeutic interventions.\n",
          "url": "https://www.nature.com/articles/s43587-023-00532-9"
        },
        {
          "title": "Effect of resveratrol and metformin on ovarian reserve and ...",
          "author": "Guzel, Elif",
          "published_date": "2018-06-29T00:00:00+00:00",
          "summary": "This study investigated the effects of resveratrol and metformin, small molecules, on ovarian reserve in a rat model of PCOS.  Both individually and in combination, these treatments improved several markers of ovarian health, including reducing ovarian weight, improving hormone levels (testosterone, LH, FSH), and increasing the number of Graafian follicles while decreasing atretic follicles.  The improvements were linked to the activation of SIRT1 and AMPK pathways. While not directly stating an increase in *ovarian reserve*, the results suggest these small molecules positively impact follicle development and potentially ovarian reserve in this PCOS model.\n",
          "url": "https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-018-0427-7"
        },
        {
          "title": "Kinase-independent inhibition of cyclophosphamide ...",
          "author": "Gonfloni, Stefania",
          "published_date": "2019-09-27T00:00:00+00:00",
          "summary": "This research investigated whether inhibiting pathways triggered by the chemotherapy drug cyclophosphamide could protect ovarian reserve and fertility.  While the study doesn't identify a small molecule *increasing* ovarian reserve, it shows that inhibiting kinase activity, specifically targeting pathways involving CHK2 and CK1,  protected oocytes from damage in a mouse model.  The findings suggest that kinase inhibitors might be a potential avenue for preserving ovarian reserve during chemotherapy, but further research is needed to develop and test such molecules in humans.  The study focused on *protecting* existing reserve, not increasing it.\n",
          "url": "https://www.nature.com/articles/s41419-019-1961-y"
        }
      ],
      "full_explanation": "While several studies investigate the preservation of ovarian reserve or the improvement of oocyte quality, none definitively demonstrate a small molecule that increases ovarian reserve in the sense of increasing the number of follicles or oocytes.\n\nThe paper titled \"Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation\" (URL: https://www.sciencedirect.com/science/article/pii/S0006295214001385) describes a small molecule that stimulates follicular development, but this molecule's poor bioavailability and genotoxicity prevent it from being considered a clinical treatment to increase ovarian reserve.\n\nThe study \"mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy\" (URL: https://www.pnas.org/doi/full/10.1073/pnas.1617233114), and the article \u201cExamining Use of Small-molecule Inhibitors in Preserving ...\u201d (URL: https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/) both demonstrate that mTOR inhibitors, small molecules, can protect ovarian reserve during chemotherapy. This is *preservation* rather than an increase of ovarian reserve.\n\nThe paper \"Effect of resveratrol and metformin on ovarian reserve and ...\" (URL: https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-018-0427-7) shows that resveratrol and metformin improved markers of ovarian health and increased the number of Graafian follicles, in a rat model of PCOS. While this suggests a potential positive impact on ovarian reserve, it is in the context of a disease model, and therefore the paper does not definitively demonstrate that these small molecules can *increase* ovarian reserve in a healthy context.\n\nThe remaining papers, while relevant to the general topic of ovarian function and aging, either focus on the mechanisms of ovarian aging, or review treatments for diminished ovarian reserve. They do not identify any small molecules that have been shown to directly and successfully increase ovarian reserve. For example, the paper \"Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging\" (URL: https://www.nature.com/articles/s43587-023-00498-8) improves oocyte *quality* but does not address ovarian reserve. The papers \u201cKinase-independent inhibition of cyclophosphamide ...\u201d (URL: https://www.nature.com/articles/s41419-019-1961-y) focuses on *protecting* oocytes. The papers \u201cCan ovarian aging be delayed by pharmacological ...\u201d (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6366956/), \u201cRecent progress in the treatment of women with diminished ...\u201d (URL: https://www.sciencedirect.com/science/article/pii/S266716462100052X), \"Poor ovarian reserve - PMC\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC4915288/) and \"NADase CD38 is a key determinant of ovarian aging\" (URL: https://www.nature.com/articles/s43587-023-00532-9) do not mention any small molecules that have been shown to increase ovarian reserve."
    },
    {
      "question": "Has anyone shown that quantum computing can be used for trainable ML models?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Arbitrary Polynomial Separations in Trainable Quantum Machine Learning",
          "author": "[Submitted on 13 Feb 2024 (v1), last revised 23 Dec 2024 (this version, v3)]",
          "published_date": "2024-02-13T00:00:00+00:00",
          "summary": "Yes. This arXiv paper presents a hierarchy of efficiently trainable quantum neural networks (QNNs) that demonstrate provably better performance than classical neural networks (including Transformers) on a classical sequence modeling task.  The improvement is polynomial in the model size, and the QNNs achieve this with constant gate complexity per unit cell. The authors attribute this advantage to contextuality in the task.\n",
          "url": "https://arxiv.org/abs/2402.08606"
        },
        {
          "title": "Training Classical Neural Networks by Quantum Machine Learning",
          "author": "[Submitted on 26 Feb 2024]",
          "published_date": "2024-02-26T00:00:00+00:00",
          "summary": "Yes.  This arXiv preprint demonstrates a method for training classical neural networks using a quantum approach.  The authors map a classical neural network with *M* parameters to a quantum neural network with significantly fewer parameters (O(polylog(M))).  The quantum neural network's parameters are then updated to train the classical network.  Importantly, the results obtained from the quantum computation are directly usable on classical computers.  The method's effectiveness is shown through numerical results on MNIST and Iris datasets.\n",
          "url": "https://arxiv.org/abs/2402.16465"
        },
        {
          "title": "A quantum algorithm for training wide and deep classical neural networks",
          "author": "Alexander  Zlokapa, Massachusetts Institute of Technology, 02139, Cambridge, Massachusetts, azlokapa@mit.edu, Hartmut  Neven, Google Quantum AI, 90291, Venice, California, Seth  Lloyd, Massachusetts Institute of Technology, 02139, Cambridge, Massachusetts",
          "published_date": "2023-11-16T01:35:17.737000+00:00",
          "summary": "Yes, this paper proposes a quantum algorithm for training wide and deep classical neural networks.  The authors show that conditions allowing for efficient classical training via gradient descent also enable efficient quantum linear system solving.  Their algorithm achieves O(1/n) error for a training set of size n in O(log n) time.  While requiring efficient state preparation and readout, they demonstrate its efficacy on the MNIST dataset, achieving accuracy comparable to a classical fully-connected network.  Empirical evidence also suggests O(log n) training for convolutional neural networks with pooling.  This represents a potential quantum speedup for training machine learning models, though it depends on the data distribution.\n",
          "url": "https://arxiv.org/pdf/2107.09200.pdf"
        },
        {
          "title": "Systematic literature review: Quantum machine learning and its ...",
          "author": "",
          "published_date": "2024-02-01T00:00:00+00:00",
          "summary": "Yes, this systematic literature review (2017-2023) of 94 articles shows that quantum computing is being used to develop trainable machine learning models.  The review identifies quantum implementations of classical algorithms (like support vector machines and k-nearest neighbor) and classical deep learning algorithms (like quantum neural networks).  Image classification is highlighted as a key application area.  While promising, the review notes that current quantum hardware limitations restrict the full potential of quantum machine learning.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S1574013724000030"
        },
        {
          "title": "Power of data in quantum machine learning | Nature Communications",
          "author": "Huang; Hsin-Yuan; Broughton; Michael; Mohseni; Masoud; Babbush; Ryan; Boixo; Sergio; Neven; Hartmut; McClean; Jarrod R",
          "published_date": "2023-02-07T20:10:03.666000+00:00",
          "summary": "Yes, this Nature Communications article explores the use of quantum neural networks (QNNs) as trainable machine learning models.  The authors investigate how the availability of data impacts the ability of classical models to learn functions generated by QNNs.  They show that while computing the function of a QNN may be classically hard without training data,  training a classical model on data to learn this function is not necessarily hard.  The paper uses amplitude encoding to represent data in a quantum state and analyzes the complexity of learning the resulting function.\n",
          "url": "https://www.nature.com/articles/s41467-021-22539-9"
        },
        {
          "title": "Better Machine-Learning Models With Quantum Computers",
          "author": "Tammy Xu",
          "published_date": "2023-11-15T13:00:04+00:00",
          "summary": "Yes. Researchers at Terra Quantum have demonstrated improved training of machine learning models using a hybrid classical-quantum approach.  Their parallel hybrid networks leverage the strengths of both classical (handling jagged data) and quantum (handling smooth, curved data) computation. While current quantum hardware limitations are addressed by using specialized classical computers to emulate quantum behavior, the results show that combining classical and quantum methods leads to better model performance than using either alone, as demonstrated in a real-world application modeling gas emissions from a waste-burning power plant.\n",
          "url": "https://spectrum.ieee.org/quantum-machine-learning-terra-quanta"
        },
        {
          "title": "Can Quantum Computing accelerate Generative AI? - Medium",
          "author": "Alexander Del Toro Barba (PhD)",
          "published_date": "2024-08-10T07:41:51+00:00",
          "summary": "The article discusses whether quantum computing can accelerate generative AI, focusing on Quantum Machine Learning (QML).  While it mentions various QML applications like Quantum Support Vector Machines and Variational Quantum Eigensolvers, it doesn't directly address whether quantum computing has been proven to train *classical* machine learning models.  The article categorizes QML research into four areas, one of which explores using quantum computers to improve classical machine learning, but doesn't offer conclusive evidence of success in training classical ML models with quantum computers.\n",
          "url": "https://medium.com/@deltorobarba/can-quantum-computing-accelerate-generative-ai-b1df36398ac5"
        },
        {
          "title": "Quantum Machine Learning and the Power of Data - Google Research",
          "author": "",
          "published_date": "2021-06-22T00:00:00+00:00",
          "summary": "Yes, research shows quantum computers can potentially create more powerful machine learning models.  A Google study published in Nature Communications investigates when quantum computers offer an advantage in machine learning, showing that the availability of data significantly impacts the potential quantum advantage.  While quantum algorithms may excel in specific tasks,  the study also demonstrates that sufficient data can allow classical models to compete with quantum approaches.  The research introduces a method to leverage both quantum and classical strengths for improved machine learning.\n",
          "url": "https://research.google/blog/quantum-machine-learning-and-the-power-of-data/"
        },
        {
          "title": "Shadows of quantum machine learning | Nature Communications",
          "author": "Dunjko, Vedran",
          "published_date": "2024-07-06T00:00:00+00:00",
          "summary": "Yes, the paper demonstrates that standard quantum machine learning models for supervised learning can be expressed as linear models.  These models use parametrized quantum circuits to encode classical data and learn from it,  performing regression or classification tasks.  The authors show that even more complex models, like data re-uploading models, can be mapped to these linear models.  Therefore, the research confirms the use of quantum computing for creating trainable machine learning models.\n",
          "url": "https://www.nature.com/articles/s41467-024-49877-8"
        },
        {
          "title": "Quantum Computing-Enabled Machine Learning for an Enhanced ...",
          "author": "",
          "published_date": "2023-03-30T00:00:00+00:00",
          "summary": "Yes, this research paper explores using quantum computing to enhance machine learning model training.  Specifically, it examines Quantum Support Vector Machines (QSVMs) applied to a malignant breast cancer classification problem.  The authors compare the performance and time complexity of QSVMs (run on IBM's quantum computer using Qiskit) against classical SVMs (using Scikit-learn).  The paper details the implementation and evaluation using metrics like accuracy, precision, recall, and F1-score.\n",
          "url": "https://www.researchgate.net/publication/369636217_Quantum_Computing-Enabled_Machine_Learning_for_an_Enhanced_Model_Training_Approach"
        }
      ],
      "full_explanation": "The provided papers clearly demonstrate that the use of quantum computing for training machine learning models, both quantum and classical, has been extensively researched. Several papers provide direct evidence for this:\n\n*   **\"Arbitrary Polynomial Separations in Trainable Quantum Machine Learning\"** (URL: https://arxiv.org/abs/2402.08606) explicitly shows that trainable *quantum* neural networks (QNNs) can achieve better performance than classical neural networks, demonstrating the capacity to train machine learning models using quantum techniques.\n*   **\"Training Classical Neural Networks by Quantum Machine Learning\"** (URL: https://arxiv.org/abs/2402.16465) demonstrates a specific method to train *classical* neural networks using a quantum approach, proving the ability of quantum computers to train classical machine learning models.\n*   **\"A quantum algorithm for training wide and deep classical neural networks\"** (URL: https://arxiv.org/pdf/2107.09200.pdf) proposes a quantum algorithm to train *classical* wide and deep neural networks, showing a potential speedup using quantum computing for training purposes.\n*   **\"Systematic literature review: Quantum machine learning and its ...\"** (URL: https://www.sciencedirect.com/science/article/pii/S1574013724000030) is a review article (2017-2023) summarizing 94 articles, confirming the use of quantum computing to develop trainable machine learning models. It includes both quantum implementations of classical algorithms and quantum neural networks.\n*  **\"Power of data in quantum machine learning\"** (URL: https://www.nature.com/articles/s41467-021-22539-9) explores the use of quantum neural networks (QNNs) as trainable machine learning models and how data availability affects their training.\n*   **\"Better Machine-Learning Models With Quantum Computers\"** (URL: https://spectrum.ieee.org/quantum-machine-learning-terra-quanta) reports that researchers have improved the training of machine learning models using a hybrid approach, combining classical and quantum computation.\n*   **\"Shadows of quantum machine learning\"** (URL: https://www.nature.com/articles/s41467-024-49877-8) demonstrates that quantum machine learning models for supervised learning are also trainable and can be expressed as linear models.\n*   **\"Quantum Computing-Enabled Machine Learning for an Enhanced ...\"** (URL: https://www.researchgate.net/publication/369636217_Quantum_Computing-Enabled_Machine_Learning_for_an_Enhanced_Model_Training_Approach) examines the use of quantum support vector machines for a classification task and demonstrates the ability to use quantum computers for training these models.\n*   **\"Quantum Machine Learning and the Power of Data\"** (URL: https://research.google/blog/quantum-machine-learning-and-the-power-of-data/) demonstrates a method to leverage both quantum and classical strengths for improved machine learning. This suggests quantum can be used to help train models.\n\nThese papers collectively provide substantial evidence that the research question has been addressed, with multiple approaches and algorithms investigated using quantum computing to train both quantum and classical machine learning models."
    },
    {
      "question": "Has anyone written a paper containing a differential equation for the rate at which ice might spread over a surface area ",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Ice wicking",
          "author": "Katherine E Witt, Virginia Tech, 24061, Blacksburg, Virginia, USA, S Farzad Ahmadi, Virginia Tech, 24061, Blacksburg, Virginia, USA, Jonathan B Boreyko, Virginia Tech, 24061, Blacksburg, Virginia, USA, boreyko@vt.edu",
          "published_date": "2023-11-09T20:33:27.253000+00:00",
          "summary": "This research paper investigates liquid wicking across ice surfaces, focusing on silicone oil's behavior on frost-covered aluminum.  While it doesn't present a differential equation for ice spreading, it does find that the rate of oil wicking (and thus implicitly, ice displacement) follows a power law dependent on surface wettability and orientation.  On superhydrophilic surfaces, a 1/3 power law is observed, contrasting with the 1/2 power law of Washburn's equation for porous media.  This difference is attributed to the dendritic frost structure.  Hydrophobic surfaces exhibit slower wicking, and the authors note that oil cannot wick within a bulk ice volume due to the ice's structure.\n",
          "url": "https://journals.aps.org/prfluids/abstract/10.1103/PhysRevFluids.4.024002"
        },
        {
          "title": "How ice grows from premelting films and water droplets",
          "author": "D. Sibley,Pablo Llombart,E. Noya,A. Archer,L. G. Macdowell",
          "published_date": "2023-10-26T19:30:34.045000+00:00",
          "summary": "Yes, this Nature Communications paper develops a mesoscopic model of ice growth from supersaturated vapor, incorporating a system of two non-conservative phase-field differential equations.  These equations govern the dynamics of ice growth, considering factors like premelted layer thickness and interface energies.  The model uses molecular dynamics simulations to parameterize an interface potential and predicts different kinetic regimes of ice growth depending on temperature and vapor pressure, visualized in a kinetic phase diagram.  While not explicitly stating \"rate of ice spread,\" the model implicitly describes this through its dynamic equations and resulting phase diagram.\n",
          "url": "https://www.nature.com/articles/s41467-020-20318-6.pdf"
        },
        {
          "title": "The unsteady plane flow of ice-sheets: A parabolic problem with two moving boundaries",
          "author": "R C A Hindmarsh, University of Edinburgh, EH9 3JW, Edinburgh, UK, L W Morland, University of East Anglia, Norwich, UK, G S Boulton, University of Edinburgh, EH9 3JW, Edinburgh, UK, K  Hutter",
          "published_date": "2023-11-09T20:07:25.211000+00:00",
          "summary": "Yes, this paper presents a one-dimensional nonlinear parabolic partial differential equation modeling unsteady plane flow of ice sheets.  The equation is used to simulate ice-sheet response to climate change and reconstruct past climates.  Two numerical algorithms (fixed domain and moving mesh) are described for solving the equation, which incorporates moving boundaries representing the ice sheet's extent.\n",
          "url": "https://www.tandfonline.com/doi/abs/10.1080/03091928708208812"
        },
        {
          "title": "Universal differential equations for glacier ice flow modelling",
          "author": "",
          "published_date": "2023-11-16T00:00:00+00:00",
          "summary": "This paper reviews existing methods for glacier ice flow modeling, citing several relevant publications.  While it doesn't present a new differential equation for ice spread specifically, it does discuss the use of differential equations within ice flow models and cites related work.  The paper focuses on computational methods and large-scale data analysis more broadly.  To find a paper with a specific differential equation for ice spread rate, a more targeted literature search using keywords like \"ice sheet growth,\" \"glacier advance model,\" or \"ice spreading dynamics\" would be needed.\n",
          "url": "https://gmd.copernicus.org/articles/16/6671/2023/"
        },
        {
          "title": "High speed computing of ice thickness equation for ...",
          "author": "",
          "published_date": "2016-08-04T00:00:00+00:00",
          "summary": "This research paper uses a finite difference method on a GPU to improve the speed of calculating ice thickness in a 2D ice flow thermodynamics model.  While it doesn't directly present a differential equation for the *rate* of ice spread over a surface area, the paper does discuss the application of parallelization techniques to differential equations for ice thickness prediction.  The authors mention related work using parallelization in differential equation fields, including ice thickness prediction, but the specifics of those equations are not detailed in this paper.\n",
          "url": "https://www.researchgate.net/publication/308626724_High_speed_computing_of_ice_thickness_equation_for_ice_sheet_model"
        },
        {
          "title": "Climate Modeling in Differential Equations",
          "author": "",
          "published_date": "2016-02-20T00:00:00+00:00",
          "summary": "This UMAP module on climate modeling uses differential equations to model global average temperature and includes a project focusing on a surface temperature\u2013ice sheet coupled model.  The project details a latitude-dependent model considering glaciers, insolation distribution, meridional heat transport, and Legendre polynomials.  While it doesn't explicitly present a single differential equation solely for ice spread rate, the project's model incorporates ice sheet dynamics within a broader climate system differential equation framework.\n",
          "url": "https://www2.oberlin.edu/math/faculty/walsh/UMAPclimate.pdf"
        },
        {
          "title": "Immersion mode heterogeneous ice nucleation by an illite rich ...",
          "author": "",
          "published_date": "2011-08-12T00:00:00+00:00",
          "summary": "This paper investigates ice nucleation in water droplets containing illite, a mineral dust component.  While it doesn't contain a differential equation explicitly describing the rate of ice spread across a surface, it does present a multiple component stochastic model to describe ice nucleation, incorporating temperature-dependent nucleation rate coefficients.  The model accounts for observations where ice nucleation continues at constant temperature, a phenomenon inconsistent with simpler, time-independent models.  The authors found that  the bulk of atmospheric mineral dust particles are less efficient at nucleating ice than previously assumed in models.\n",
          "url": "https://acp.copernicus.org/preprints/11/22801/2011/acpd-11-22801-2011-print.pdf"
        },
        {
          "title": "Partial Differential Equation Models in Biology",
          "author": "",
          "published_date": "2010-09-29T00:00:00+00:00",
          "summary": "This document discusses partial differential equation (PDE) models in biology, focusing on population spread and movement.  It traces the historical development of such models, from early work by Pearson and Blakeman to later contributions by Fisher, Turing, and Skellam.  The text details various applications, including modeling the spread of genes and diseases, the collective motion of microorganisms, and density-dependent dispersal. While it covers diverse biological examples using PDEs (e.g., Fisher's equation for gene spread), it does *not* contain any discussion of ice spreading.\n",
          "url": "http://mitran-lab.amath.unc.edu/courses/MATH564/biblio/text/10.pdf"
        },
        {
          "title": "Thermodynamics",
          "author": "D Garanin",
          "published_date": "2023-01-06T08:55:48.288000+00:00",
          "summary": "This document is a general introduction to thermodynamics and does not contain information about differential equations modeling ice spread.  The text focuses on the definitions of systems (open, closed, adiabatic, isolated), types of thermodynamic quantities (intensive, extensive, specific), and the distinction between quasi-static, reversible, and irreversible processes.  Therefore, the query regarding a paper with a specific differential equation for ice spread cannot be answered based on this content.\n",
          "url": "https://www.lehman.edu/faculty/dgaranin/Statistical_Thermodynamics/Thermodynamics.pdf"
        },
        {
          "title": "Calculus: Related Rates [Melting Ice Cube]",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "The provided text only gives YouTube video metadata (view count, likes, subscribers) and does not contain the video's content.  Therefore, I cannot determine whether the video discusses a differential equation for ice spreading.  To answer your query,  more information (e.g., the video transcript or description) is needed.\n",
          "url": "https://www.youtube.com/watch?v=ekf6uqiyDew"
        }
      ],
      "full_explanation": "Several papers address aspects of ice spreading or growth using differential equations, although not always in the precise context of a rate of spread over a surface area in all cases. \n\n*   **The paper \"How ice grows from premelting films and water droplets\"** presents a mesoscopic model of ice growth using two non-conservative phase-field differential equations. These equations describe the *dynamics* of ice growth, implicitly encompassing the rate of ice spread through parameters like premelted layer thickness and interface energies. This paper clearly contains a system of differential equations that model ice growth, a process closely related to the spreading of ice. [https://www.nature.com/articles/s41467-020-20318-6.pdf]\n\n*   **The paper \"The unsteady plane flow of ice-sheets: A parabolic problem with two moving boundaries\"** provides a one-dimensional nonlinear parabolic partial differential equation to model unsteady plane flow of ice sheets. This is a more macroscopic model focused on large-scale ice sheet movement and changes, directly addressing the spreading of ice over an area (albeit a 1D plane). While not exactly describing the rate of ice spread over a *general* surface, it very much captures the concept in the context of ice sheets and presents a relevant differential equation. [https://www.tandfonline.com/doi/abs/10.1080/03091928708208812]\n\n*   The paper **\"Climate Modeling in Differential Equations\"** describes a project using a surface temperature\u2013ice sheet coupled model that incorporates ice sheet dynamics within a broader climate system differential equation framework. This model, while not a single equation for ice spread rate, models the dynamic movement of glaciers using a system of differential equations. The use of differential equations to model ice sheet dynamics is a clear link to the research question. [https://www2.oberlin.edu/math/faculty/walsh/UMAPclimate.pdf]\n\nThe other papers, while related to ice, don't directly present differential equations for the *rate* of ice spread: \"Ice wicking\" focuses on the wicking of liquids across ice, rather than ice spreading; \"Universal differential equations for glacier ice flow modelling\" reviews existing methods and does not present a new equation; \"High speed computing of ice thickness equation for ...\" discusses computation of ice thickness not the rate of spread; \"Immersion mode heterogeneous ice nucleation by an illite rich ...\" focuses on ice nucleation using a stochastic model not a rate of spread via a differential equation; \"Partial Differential Equation Models in Biology\" uses PDEs but not on ice; \"Thermodynamics\" is an introduction to thermodynamics not modelling of ice spread; and \"Calculus: Related Rates [Melting Ice Cube]\" is not available."
    },
    {
      "question": "Has anyone shown Cholecystokinin to increase or decrease weight loss directly? ",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Satiety effects of a physiological dose of cholecystokinin in humans.",
          "author": "R J Lieverse; J B Jansen; A A Masclee; C B Lamers",
          "published_date": "2023-02-07T21:00:55.949000+00:00",
          "summary": "A study showed that administering a physiological dose of cholecystokinin (CCK) to obese and lean women significantly reduced food intake compared to a saline control.  The study did not, however, directly measure weight loss; it only measured the effect on food intake.  Therefore, while CCK decreased food consumption in this study, it's not possible to definitively conclude whether this translates to weight loss based solely on this research.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382399/"
        },
        {
          "title": "Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight",
          "author": "Robert C Ritter, Washington State University, Pullman, WA, USA, britter@vetmed.wsu.edu, M  Covasa, Washington State University, Pullman, WA, USA, C A Matson, Washington State University, Pullman, WA, USA",
          "published_date": "2023-11-09T19:56:36.210000+00:00",
          "summary": "Studies show cholecystokinin (CCK) influences meal size, but its direct effect on overall weight loss remains unclear. While CCK's role in regulating food intake via vagal sensory neurons and CCK-A receptors is documented, research reveals inconsistencies suggesting other mechanisms and locations of action beyond the endocrine system may be involved in its influence on daily food intake and body weight.  The article doesn't definitively state whether CCK increases or decreases weight loss directly.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0143417999900513"
        },
        {
          "title": "Role of cholecystokinin in appetite control and body weight regulation",
          "author": "T J Little, M  Horowitz, C  Feinle-Bisset",
          "published_date": "2023-11-09T19:25:47.304000+00:00",
          "summary": "Studies show CCK acutely suppresses energy intake, impacting appetite. However, research indicates that using CCK agonists or dietary manipulation to modulate CCK doesn't lead to sustained weight loss, making it an unlikely long-term obesity treatment strategy.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2005.00212.x"
        },
        {
          "title": "Long-acting CCK analogue NN9056 lowers food intake ...",
          "author": "Berit \u00d8 Christoffersen, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Rikke Bjerring Skyggebjerg, Anne  Bugge, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Rikke Kaae Kirk, Bill  Vestergaard, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Henriette Kold Uldam, Johannes Josef Fels, Global Research Technologies, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Charles  Pyke, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Ulrich  Sensfuss, Global Research Technologies, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Annika  Sanfridson, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Trine Ryberg Clausen, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark",
          "published_date": "2023-11-09T20:26:13.419000+00:00",
          "summary": "Yes.  A study using obese G\u00f6ttingen Minipigs showed that NN9056, a long-acting cholecystokinin (CCK) analogue, significantly reduced food intake and body weight over 13 weeks.  Both low and high doses of NN9056 resulted in weight loss compared to a control group which experienced weight gain.\n",
          "url": "https://www.nature.com/articles/s41366-019-0386-0"
        },
        {
          "title": "Effect of weight loss and ketosis on postprandial ...",
          "author": "Supornpim  Chearskul, Elizabeth  Delbridge, Arthur  Shulkes, Joseph  Proietto, Adamandia  Kriketos, a.kriketos@unimelb.edu.au.",
          "published_date": "2023-11-09T20:23:10.447000+00:00",
          "summary": "This study on obese men found that rapid weight loss (approximately 10% of initial body weight) reduced postprandial cholecystokinin (CCK) concentrations. However, when participants were in ketosis (elevated beta-hydroxybutyrate), CCK levels remained similar to those before weight loss.  The study doesn't directly show CCK *causing* weight loss or gain, but it demonstrates a correlation: reduced CCK levels are associated with weight loss, suggesting a potential indirect relationship.  Ketosis appears to mitigate this reduction in CCK.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0002916523236175"
        },
        {
          "title": "Roles of Cholecystokinin in the Nutritional Continuum ...",
          "author": "",
          "published_date": "2021-06-02T00:00:00+00:00",
          "summary": "Studies on cholecystokinin (CCK), a gastrointestinal hormone, and its role in weight management have yielded mixed results.  While CCK affects appetite regulation, full agonist CCK1 receptor drugs designed to promote weight loss have failed in clinical trials.  The review discusses potential reasons for this failure and explores alternative pharmacological strategies like biased agonists and allosteric modulators as ways to potentially improve weight management outcomes.  Direct evidence supporting CCK's ability to increase or decrease weight loss independently is inconclusive based on the provided text.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8206557/"
        },
        {
          "title": "Cholecystokinin - an overview | ScienceDirect Topics",
          "author": null,
          "published_date": "2023-02-22T12:38:55.270000+00:00",
          "summary": "Studies have shown CCK to induce satiety (a feeling of fullness), suggesting a potential role in weight management.  However, the provided text does not directly address whether CCK increases or decreases weight loss. While low CCK levels are associated with bulimia nervosa (an eating disorder involving weight fluctuations), and elevated levels are seen in some chronic pancreatitis cases,  no definitive conclusions on CCK's direct impact on weight loss can be drawn from this information.  More research is needed to establish a direct causal link.\n",
          "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/cholecystokinin"
        },
        {
          "title": "Intracellular interplay between cholecystokinin and leptin ...",
          "author": "Hayato  Koizumi, Shahid  Mohammad, Tomoya  Ozaki, Kiyokazu  Muto, Nanami  Matsuba, Juhyon  Kim, Weihong  Pan, Eri  Morioka, Takatoshi  Mochizuki, Masayuki  Ikeda, msikeda@sci.u-toyama.ac.jp",
          "published_date": "2023-11-09T20:30:25.037000+00:00",
          "summary": "This study in rats examined the interaction between cholecystokinin (CCK) and leptin in satiety.  While the study doesn't directly assess CCK's impact on weight loss, it shows CCK enhances leptin's satiety effects.  Blocking CCK receptors increased food intake in rats.  This suggests CCK contributes to short-term satiety, implying a potential indirect role in weight management by influencing appetite, but the study doesn't directly measure weight change.\n",
          "url": "https://www.nature.com/articles/s41598-020-69035-6"
        },
        {
          "title": "CCK-8 in mouse models of obesity/diabetes | Diabetologia",
          "author": "N  Irwin, SAAD Centre for Pharmacy and Diabetes, University of Ulster, BT52 1SA, Coleraine, Northern Ireland, UK, n.irwin@ulster.ac.uk, P  Frizelle, SAAD Centre for Pharmacy and Diabetes, University of Ulster, BT52 1SA, Coleraine, Northern Ireland, UK, I A Montgomery, SAAD Centre for Pharmacy and Diabetes, University of Ulster, BT52 1SA, Coleraine, Northern Ireland, UK, R C Moffett, SAAD Centre for Pharmacy and Diabetes, University of Ulster, BT52 1SA, Coleraine, Northern Ireland, UK, F P M O\u2019harte, P R Flatt, SAAD Centre for Pharmacy and Diabetes, University of Ulster, BT52 1SA, Coleraine, Northern Ireland, UK",
          "published_date": "2023-11-09T20:01:02.965000+00:00",
          "summary": "Studies in high-fat-fed and obese mice show that the modified cholecystokinin analogue (pGlu-Gln)-CCK-8 significantly reduces body weight (p<0.001) and food intake (p<0.001) over 28 days.  This weight loss was not due to changes in energy expenditure or simple dietary restriction, suggesting a direct effect on weight management.  The study demonstrates (pGlu-Gln)-CCK-8's potential for treating obesity.\n",
          "url": "https://link.springer.com/article/10.1007/s00125-012-2654-6"
        },
        {
          "title": "Cholecystokinin and stomach distension combine to reduce ...",
          "author": "Harry R Kissileff; Julie C Carretta; Allan Geliebter; F Xavier Pi-Sunyer",
          "published_date": "2023-12-04T03:00:08.677000+00:00",
          "summary": "Studies show cholecystokinin (CCK) reduces food intake in humans, but its direct effect on weight loss isn't explicitly addressed in this research.  The study focuses on how CCK interacts with gastric distension to reduce food intake, showing a combined effect is more potent than either alone.  While this suggests a potential indirect role in weight management through appetite suppression,  the research doesn't directly measure or conclude on weight loss itself.\n",
          "url": "https://journals.physiology.org/doi/full/10.1152/ajpregu.00272.2003"
        }
      ],
      "full_explanation": "Several studies have investigated the effect of cholecystokinin (CCK) on weight loss, though the results are not always consistent. Some studies suggest that CCK, or its analogues, can directly induce weight loss, while others demonstrate its role in appetite suppression without directly measuring weight loss.\n\nSpecifically, the paper \"Long-acting CCK analogue NN9056 lowers food intake ...\" (URL: https://www.nature.com/articles/s41366-019-0386-0) demonstrates that a long-acting CCK analogue, NN9056, significantly reduced both food intake and body weight in obese minipigs over 13 weeks. Both low and high doses led to weight loss compared to a control group that gained weight, indicating a direct effect of CCK on weight loss, at least in this animal model.\n\nSimilarly, the paper \"CCK-8 in mouse models of obesity/diabetes | Diabetologia\" (URL: https://link.springer.com/article/10.1007/s00125-012-2654-6) showed that a modified CCK analogue, (pGlu-Gln)-CCK-8, significantly reduced body weight and food intake in high-fat-fed and obese mice. This study directly demonstrates that a CCK analogue can induce weight loss.\n\nHowever, other studies indicate that while CCK reduces food intake, it doesn\u2019t always translate to sustained weight loss in humans. For example, \"Satiety effects of a physiological dose of cholecystokinin in humans\" (URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382399/) found that CCK reduced food intake in both obese and lean women, but did not measure weight loss directly, so the effect on long term weight management is unclear. Further supporting this, \"Role of cholecystokinin in appetite control and body weight regulation\" (URL: https://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2005.00212.x) notes that while CCK acutely suppresses energy intake, treatments designed to modulate CCK have not resulted in sustained weight loss in humans. Furthermore, the paper \"Roles of Cholecystokinin in the Nutritional Continuum ...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8206557/) notes that CCK1 receptor drugs designed to promote weight loss failed in clinical trials. The review further suggests that while CCK affects appetite regulation, direct evidence supporting its ability to independently cause weight loss is inconclusive.\n\nThe study \"Effect of weight loss and ketosis on postprandial ...\" (URL: https://www.sciencedirect.com/science/article/pii/S0002916523236175) revealed a correlation between reduced CCK levels and weight loss in obese men, although the study examines the effect of weight loss on CCK rather than CCK's direct effect on weight loss. This correlation suggests a complex relationship between CCK and weight management.\n\nIn conclusion, while some studies, particularly those using CCK analogues in animal models, have shown CCK can directly decrease weight, the evidence for a direct and consistent effect on weight loss in humans is less clear and requires further research."
    },
    {
      "question": "Has anyone found good small molecule drug target sites on beta-arrestin 2?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Therapeutic Potential of Targeting \u00df-Arrestin",
          "author": "Richard A Bond; Emilio Y Lucero Garcia-Rojas; Akhil Hegde; Julia K L Walker",
          "published_date": "2023-02-06T10:52:54.139000+00:00",
          "summary": "This review article on the therapeutic potential of targeting \u03b2-arrestins does not identify specific small molecule drug target sites on \u03b2-arrestin 2.  While it details \u03b2-arrestin's role in regulating G protein-coupled receptors (GPCRs) and its involvement in various diseases, making it a prime therapeutic target, it focuses on the broader mechanisms of \u03b2-arrestin modulation of GPCR signaling and the potential for therapeutic intervention by targeting these pathways, rather than specific small molecule binding sites on \u03b2-arrestin 2.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414794/"
        },
        {
          "title": "Arresting the Development of Addiction: The Role of \u03b2-Arrestin 2 in Drug Abuse",
          "author": "Kirsten A Porter-Stransky; David Weinshenker",
          "published_date": "2023-02-27T06:29:26.972000+00:00",
          "summary": "This research article explores the role of \u03b2-arrestin 2 (\u03b2arr2) in mediating the effects of addictive drugs.  While the paper details \u03b2arr2's involvement in various drug-induced behaviors and its interaction with numerous signaling pathways, it does *not* identify specific small molecule drug target sites on \u03b2arr2 itself.  The authors highlight the need for further research to elucidate the neurobiological mechanisms of \u03b2arr2 and its potential as a therapeutic target, suggesting this is an area for future investigation.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443318/"
        },
        {
          "title": "A non\u2013GPCR-binding partner interacts with a novel surface on \u03b2-arrestin1 to mediate GPCR signaling",
          "author": "Y. Zhuo,V. Gurevich,S. Vishnivetskiy,C. Klug,A. Marchese",
          "published_date": "2023-10-26T19:31:57.431000+00:00",
          "summary": "This research article focuses on \u03b2-arrestin1, not \u03b2-arrestin2.  Therefore, it does not provide information about potential small molecule drug target sites on \u03b2-arrestin2.  The study investigates how \u03b2-arrestin1 interacts with other proteins (STAM1) to mediate GPCR signaling, particularly in the context of the CXCR4 receptor.  While it details conformational changes in \u03b2-arrestin1 upon receptor binding, it doesn't identify druggable sites.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549033/pdf/"
        },
        {
          "title": "A new inhibitor of the \u03b2-arrestin/AP2 endocytic complex reveals ...",
          "author": "Alexandre  Beautrait, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Justine S Paradis, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Brandon  Zimmerman, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Jenna  Giubilaro, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Ljiljana  Nikolajev, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Sylvain  Armando, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Hiroyuki  Kobayashi, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Lama  Yamani, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Yoon  Namkung, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Franziska M Heydenreich, Laboratory of Biomolecular Research, Paul Scherrer Institut, 5232, Villigen PSI, Switzerland, Switzerland, Etienne  Khoury, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Martin  Audet, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Philippe P Roux, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Dmitry B Veprintsev, Laboratory of Biomolecular Research, Paul Scherrer Institut, 5232, Villigen PSI, Switzerland, Switzerland, St\u00e9phane A Laporte, Michel  Bouvier, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, michel.bouvier@umontreal.ca",
          "published_date": "2023-11-09T20:20:30.770000+00:00",
          "summary": "Research has identified Barbadin, a small molecule inhibitor, that selectively targets the interaction between \u03b2-arrestin and the AP2 complex, a key component of receptor endocytosis.  While not directly targeting \u03b2-arrestin2 itself, this interaction is crucial for \u03b2-arrestin-mediated signaling and receptor internalization.  Barbadin's effect on blocking signaling pathways downstream of \u03b2-arrestin suggests that this interaction site could be a viable drug target.\n",
          "url": "https://www.nature.com/articles/ncomms15054"
        },
        {
          "title": "Targeted Disruption of \u03b2-Arrestin 2-Mediated Signaling Pathways by ...",
          "author": "",
          "published_date": "2014-04-15T00:00:00+00:00",
          "summary": "This research article focuses on using RNA aptamers, not small molecule drugs, to target \u03b2-arrestin 2.  While it highlights the challenges of targeting \u03b2-arrestin 2 with traditional small molecule drugs, it doesn't identify specific small molecule drug target sites on the protein.  The study shows that inhibiting \u03b2-arrestin 2 activity, using aptamers,  impedes multiple oncogenic signaling pathways, suggesting its therapeutic potential but not through the mechanism the query seeks.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3988186/"
        },
        {
          "title": "The multifaceted functions of \u03b2-arrestins and their therapeutic ...",
          "author": "Woo, Jung-A A.",
          "published_date": "2024-01-11T00:00:00+00:00",
          "summary": "This review article discusses the roles of \u03b2-arrestin1 and \u03b2-arrestin2 in neurodegenerative diseases like Alzheimer's, frontotemporal dementia, and Parkinson's disease.  While it highlights the involvement of \u03b2-arrestins in disease pathogenesis (e.g.,  \u03b2-arrestin oligomers inhibiting autophagy and increased amyloid-beta production), it does *not* identify specific small molecule drug target sites on \u03b2-arrestin 2.  The paper focuses on the multifaceted functions of \u03b2-arrestins and their potential as therapeutic targets, but doesn't delve into specific druggable sites.\n",
          "url": "https://www.nature.com/articles/s12276-023-01144-4"
        },
        {
          "title": "Targeting G protein-coupled receptor signalling by blocking G ...",
          "author": "",
          "published_date": "2018-09-28T00:00:00+00:00",
          "summary": "This article focuses on targeting G proteins, not \u03b2-arrestin 2, to modulate G protein-coupled receptor (GPCR) signaling. While it mentions \u03b2-arrestins' role in GPCR desensitization and internalization,  it does not discuss small molecule drug target sites on \u03b2-arrestin 2 or any findings related to that specific question.  The review primarily details the development of G protein \u03b1 and \u03b2\u03b3-subunit ligands as therapeutic approaches.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6409483/"
        },
        {
          "title": "Implications of \u03b2-Arrestin biased signaling by angiotensin II type 1 ...",
          "author": "R.E. Schmieder, K.F. Hilgers, M.P. Schlaich, B.M. Schmidt",
          "published_date": "2024-12-01T00:00:00+00:00",
          "summary": "This research paper discusses biased signaling by the angiotensin II type 1 receptor (AT1R), focusing on the role of \u03b2-arrestin.  While the paper details various AngII analogs and their effects on AT1R, including some that bias signaling towards \u03b2-arrestin, it does *not* identify specific small molecule drug target sites on \u03b2-arrestin 2 itself.  The research centers on modulating AT1R signaling, not directly targeting \u03b2-arrestin 2.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0898656824003784"
        },
        {
          "title": "Target identification of small molecules: an overview of the current ...",
          "author": "Barakat, Khaled",
          "published_date": "2023-10-10T00:00:00+00:00",
          "summary": "This article reviews small molecule target identification methods in drug discovery, focusing on affinity-based pull-down and label-free approaches.  While it doesn't specifically address beta-arrestin 2 as a target, it describes the general strategies used to identify small molecule targets for drugs, which could be applied to beta-arrestin 2.  The article does not present any findings regarding specific targets on beta-arrestin 2.\n",
          "url": "https://bmcbiotechnol.biomedcentral.com/articles/10.1186/s12896-023-00815-4"
        },
        {
          "title": "Small Molecule Modulators of Beta-arrestins - bioRxiv",
          "author": "View ORCID ProfileAlem W. Kahsai",
          "published_date": "2024-12-27T00:00:00+00:00",
          "summary": "This study identifies novel small molecule allosteric inhibitors of beta-arrestins (including, implicitly, beta-arrestin 2) that disrupt their interaction with activated GPCRs.  Cryo-EM structural analysis of beta-arrestin1 (closely related to beta-arrestin2) bound to one such inhibitor (Cmpd-5) reveals a binding site within a cryptic cleft.  While the research focuses on beta-arrestin1, the findings suggest potential drug target sites on beta-arrestin 2 as well, given the high degree of homology.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2024.12.27.630464v1"
        }
      ],
      "full_explanation": "Based on the provided papers, it appears that the research question of identifying small molecule drug target sites on beta-arrestin 2 *has* been explored. Specifically, the paper \"Small Molecule Modulators of Beta-arrestins - bioRxiv\" (URL: https://www.biorxiv.org/content/10.1101/2024.12.27.630464v1) directly addresses this. This study identifies novel small molecule allosteric inhibitors of beta-arrestins, including implicitly beta-arrestin 2, that disrupt their interaction with activated GPCRs. Moreover, cryo-EM analysis of beta-arrestin1 (which has high homology to beta-arrestin 2), bound to a specific inhibitor (Cmpd-5) reveals a binding site within a cryptic cleft, suggesting a possible druggable site which might translate to beta-arrestin2.\n\nAdditionally, while not directly identifying a site on beta-arrestin 2, the paper \"A new inhibitor of the \u03b2-arrestin/AP2 endocytic complex reveals ...\" (URL: https://www.nature.com/articles/ncomms15054) identifies a small molecule inhibitor, Barbadin, that targets the interaction of beta-arrestin with AP2. This interaction is crucial for beta-arrestin function and, therefore, could be considered a viable drug target relating to beta-arrestin.\n\nWhile several other papers detail beta-arrestin 2's role in various cellular processes and diseases, and discuss the potential for it as a therapeutic target, they do not specifically identify small molecule binding sites on the protein itself, such as \"Therapeutic Potential of Targeting \u00df-Arrestin\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414794/), \"Arresting the Development of Addiction: The Role of \u03b2-Arrestin 2 in Drug Abuse\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443318/), \"Targeted Disruption of \u03b2-Arrestin 2-Mediated Signaling Pathways by ...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC3988186/), and \"The multifaceted functions of \u03b2-arrestins and their therapeutic ...\" (https://www.nature.com/articles/s12276-023-01144-4)."
    },
    {
      "question": "Has anyone investigated if there are benefits or risks related to Alzheimers disease in patients who take statins? E.g. do they increase or decrease AD risk?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease - Alzheimer's Research & Therapy",
          "author": "Geifman; Nophar; Brinton; Roberta Diaz; Kennedy; Richard E; Schneider; Lon S; Butte; Atul J",
          "published_date": "2023-02-07T20:01:21.200000+00:00",
          "summary": "This research investigated the potential benefits of statins in Alzheimer's disease (AD).  Analysis of clinical trial data suggested that simvastatin may slow cognitive decline, particularly in patients with two copies of the ApoE4 gene.  Observational studies also showed better cognitive performance and a lower incidence of AD in statin users compared to non-users.  The study concludes that statins may benefit AD patients, potentially more so in those with the ApoE4/ApoE4 genotype.\n",
          "url": "https://alzres.biomedcentral.com/articles/10.1186/s13195-017-0237-y"
        },
        {
          "title": "Statin therapy and risk of Alzheimer's and age\u2010related neurodegenerative diseases",
          "author": "Georgina Torrandell\u2010Haro; Gregory L Branigan; Francesca Vitali; Nophar Geifman; Julie M Zissimopoulos; Roberta Diaz Brinton",
          "published_date": "2023-02-06T13:54:31.539000+00:00",
          "summary": "A retrospective cohort study of 288,515 US patients aged 45+ found that statin use was associated with a lower incidence of Alzheimer's disease (AD) (relative risk [RR] 0.46, 95% CI 0.44-0.49, p<0.001).  Statins were also associated with reduced risk of other neurodegenerative diseases like dementia, multiple sclerosis, Parkinson's disease, and amyotrophic lateral sclerosis.  However, the effect varied slightly between individual statins, with fluvastatin showing no significant effect.  The study suggests statin-activated pathways may offer targets for AD prevention.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687291/"
        },
        {
          "title": "Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in \u03b54 carriers",
          "author": "Donald R Royall",
          "published_date": "2023-12-06T00:00:00+00:00",
          "summary": "This study investigated the relationship between statin use and Alzheimer's disease (AD) risk and severity, focusing on the interaction with APOE \u03b54 and C-reactive protein (CRP).  Results suggest that statin use may moderate the association between APOE \u03b54 and CRP with dementia, potentially leading to less severe dementia in individuals carrying the APOE \u03b54 allele.  While statins are not typically considered to have adverse cognitive effects, this research indicates a potential benefit in mitigating AD risk and severity, particularly for those with genetic risk factors.\n",
          "url": "https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13543"
        },
        {
          "title": "Statins and risks of dementia among patients with heart failure",
          "author": "Qing-wen Ren; Tiew-Hwa Katherine Teng; Yi-Kei Tse; Christopher Tze Wei Tsang; Si-Yeung Yu; Mei-Zhen Wu; Xin-li Li; Denise Hung; Hung-Fat Tse; Carolyn S P Lam; Kai-Hang Yiu",
          "published_date": "2024-01-16T00:00:00+00:00",
          "summary": "A Hong Kong study of over 100,000 heart failure patients found that statin use was associated with a 28% lower risk of Alzheimer's disease.  The study used inverse probability of treatment weighting to compare statin users and non-users, controlling for baseline factors.  While further research (randomized trials) is recommended, the findings suggest a potential neuroprotective effect of statins against Alzheimer's in heart failure patients.\n",
          "url": "https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(23)00324-3/fulltext"
        },
        {
          "title": "Association between statin use and Alzheimer's disease ...",
          "author": "",
          "published_date": "2021-07-27T00:00:00+00:00",
          "summary": "Studies on statin use and Alzheimer's Disease (AD) risk have yielded mixed results.  A recent study of 119,013 Korean adults found that short-term statin use was associated with a higher risk of AD. However, consistent, long-term statin use (\u2265540 days or cumulative defined daily dose \u2265540) was associated with a decreased risk of AD.  The overall effect of statin use on AD risk was not significant.  Previous research has shown inconsistent findings, with some studies showing reduced AD risk and others showing no effect or even increased risk.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8316580/"
        },
        {
          "title": "Statins and cognitive decline in patients with Alzheimer's and ...",
          "author": "Garcia-Ptacek, Sara",
          "published_date": "2023-12-20T00:00:00+00:00",
          "summary": "A recent longitudinal study (n=15,586) investigated the association between statin use and cognitive decline in Alzheimer's and mixed dementia patients.  Results showed a dose-response effect: taking one defined daily dose of statins was associated with 0.63 more points on the MMSE (a cognitive test) after 3 years compared to non-users.  Simvastatin users showed even greater improvement compared to atorvastatin users, particularly in younger patients.  The study did not directly assess increased or decreased *risk* of developing Alzheimer's Disease, but rather focused on cognitive decline *after* diagnosis in patients already prescribed statins.  Therefore, it suggests a potential benefit of statins in slowing cognitive decline in those already diagnosed with AD or mixed dementia, but more research is needed to determine if this translates to a reduced risk of developing the disease.\n",
          "url": "https://alzres.biomedcentral.com/articles/10.1186/s13195-023-01360-0"
        },
        {
          "title": "Statin therapy and risk of Alzheimer's and age\u2010related ...",
          "author": "",
          "published_date": "2020-11-25T00:00:00+00:00",
          "summary": "This retrospective cohort study of 288,515 US patients aged 45+ investigated the association between statin use and the incidence of Alzheimer's disease (AD) and other neurodegenerative diseases.  Statin use was associated with a significantly lower incidence of AD (relative risk [RR] 0.46, 95% CI 0.44-0.49, P<0.001), suggesting that statins may decrease AD risk.  Similar reductions were observed for other neurodegenerative diseases like dementia, multiple sclerosis, Parkinson's disease, and amyotrophic lateral sclerosis.  However, the study notes that the benefits and risks of statins regarding neurological outcomes should be considered when prescribing to at-risk populations.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7687291/"
        },
        {
          "title": "Do Statins Increase or Decrease Alzheimer's Risk?",
          "author": "James M. Ellison, MD, MPH",
          "published_date": "2021-07-07T00:00:00+00:00",
          "summary": "Studies show mixed results on statins' impact on Alzheimer's risk.  Some large studies find statin use modestly reduces Alzheimer's risk, particularly in those under 65. However, other research shows a potential for increased risk, especially in those over 80, and some reports link statins to cognitive impairment, though this is often reversible upon discontinuation.  The overall consensus leans towards the benefits outweighing the risks,  but the effect is not consistent across all age groups and studies.\n",
          "url": "https://www.brightfocus.org/alzheimers/article/do-statins-increase-or-decrease-alzheimers-risk"
        },
        {
          "title": "Do statins increase the risk of dementia and Alzheimer's ...",
          "author": "Prof. Maja-Lisa L\u00f8chen",
          "published_date": "2022-01-18T00:00:00+00:00",
          "summary": "A recent meta-analysis of 36 observational studies found that statin use was associated with a *decreased* risk of dementia (OR 0.80) and Alzheimer's disease (OR 0.68).  While this suggests a potential protective effect, the authors acknowledge the limitations of observational studies and call for high-quality randomized clinical trials to confirm these findings.  The analysis included many older patients and showed no significant difference in effect between sexes or statin types.  However, the benefit in dementia prevention shouldn't be considered a recommendation at this time.\n",
          "url": "https://www.escardio.org/Sub-specialty-communities/European-Association-of-Preventive-Cardiology-(EAPC)/News/do-statins-increase-the-risk-of-dementia-and-alzheimer-s-disease"
        },
        {
          "title": "Evidence for benefit of statins to modify cognitive decline and ...",
          "author": "Geifman; Nophar; Brinton; Roberta Diaz; Kennedy; Richard E; Schneider; Lon S; Butte; Atul J",
          "published_date": "2023-02-07T20:01:21.200000+00:00",
          "summary": "This 2017 study investigated the effects of statins on Alzheimer's Disease (AD).  Analysis of clinical trial data suggested that simvastatin may slow cognitive decline, particularly in individuals homozygous for ApoE4.  Further analysis of observational studies showed better cognitive performance in long-term statin users and a lower incidence of AD among statin users.  The study concludes that statins may benefit all AD patients, potentially more so for those with ApoE4 homozygosity.\n",
          "url": "https://alzres.biomedcentral.com/articles/10.1186/s13195-017-0237-y"
        }
      ],
      "full_explanation": "The provided papers clearly demonstrate that the research question regarding the benefits and risks of statins related to Alzheimer's disease (AD) has been investigated extensively. Several studies have explored whether statins increase or decrease the risk of developing AD, as well as their impact on cognitive decline in those already diagnosed.\n\nSpecifically, multiple papers indicate that statin use is associated with a *decreased* risk of developing AD. The paper titled \"Statin therapy and risk of Alzheimer's and age\u2010related neurodegenerative diseases\" (URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687291/) reports a significant reduction in AD incidence among statin users (RR 0.46). A similar finding is reported in \"Statin therapy and risk of Alzheimer's and age\u2010related...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7687291/), which is the same study as mentioned in the previous sentence but with a duplicated citation. This is also supported by the paper from \"Do statins increase the risk of dementia and Alzheimer's...\" which presents a meta-analysis indicating decreased risk of both dementia and AD in statin users (URL: https://www.escardio.org/Sub-specialty-communities/European-Association-of-Preventive-Cardiology-(EAPC)/News/do-statins-increase-the-risk-of-dementia-and-alzheimer-s-disease). Additionally, the paper titled \"Statins and risks of dementia among patients with heart failure\" (URL: https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(23)00324-3/fulltext) found a lower risk of AD in heart failure patients taking statins.\n\nHowever, not all research points to a clear benefit. The paper with title \"Association between statin use and Alzheimer's disease...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8316580/) reports mixed results with short-term use of statins being associated with increased AD risk and long-term use associated with decreased risk. Furthermore, the article \"Do Statins Increase or Decrease Alzheimer's Risk?\" (URL: https://www.brightfocus.org/alzheimers/article/do-statins-increase-or-decrease-alzheimers-risk) explicitly states that studies show mixed results with some finding a reduced risk and some a potential for an increased risk. This shows a clear investigation into the risks as well as benefits.\n\nFurthermore, some papers explore the benefits of statins in slowing cognitive decline *after* an AD diagnosis, which although is not a direct answer to if the risk changes, does explore the impacts of statins on people with Alzheimers which is related. For example \"Statins and cognitive decline in patients with Alzheimer's and...\" (URL: https://alzres.biomedcentral.com/articles/10.1186/s13195-023-01360-0) demonstrates that statin use is associated with less cognitive decline in AD patients. The paper \"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease - Alzheimer's Research & Therapy\" (URL: https://alzres.biomedcentral.com/articles/10.1186/s13195-017-0237-y) (and its duplicate) reports similar findings, with simvastatin potentially slowing cognitive decline, specifically in those with ApoE4/ApoE4 genotype. Additionally, \"Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in \u03b54 carriers\" (URL: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13543) indicates statins may mitigate AD risk and severity, particularly in those with APOE \u03b54.\n\nIn summary, the existing literature clearly addresses the research question of whether statins are beneficial or harmful in relation to Alzheimer's disease, and if they modify the risk of developing it. While there are inconsistencies in the findings, the research question has been actively pursued."
    },
    {
      "question": "Has anyone ever made a split GFP?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Imaging with Split Fluorescent Proteins Based on the Reconstruction of Separated Asymmetric Protein Fragments",
          "author": "Minato  Watanabe, Tokyo University of Science, 2641, 278-8510, Yamazaki, Noda, Chiba, Japan, Yuki  Sakamoto, Tokyo University of Science, 2641, 278-8510, Yamazaki, Noda, Chiba, Japan, Sachihiro  Matsunaga, Tokyo University of Science, 2641, 278-8510, Yamazaki, Noda, Chiba, Japan",
          "published_date": "2023-11-09T20:31:06.966000+00:00",
          "summary": "Yes, split GFP has been developed.  The technique divides GFP between its 10th and 11th beta sheets, creating two fragments (GFP1-10 and GFP11).  Neither fragment alone fluoresces, but fluorescence is restored upon their reassociation.  This allows researchers to study protein localization, interactions, and membrane protein topology.\n",
          "url": "https://www.jstage.jst.go.jp/article/cytologia/83/4/83_830401/_article"
        },
        {
          "title": "Interaction of Haloarchaeal Gas Vesicle Proteins Determined by Split-GFP",
          "author": "K. Winter,J. Born,F. Pfeifer",
          "published_date": "2023-10-26T19:27:47.130000+00:00",
          "summary": "Yes, this research used a split GFP method to investigate protein interactions in haloarchaea.  They adapted a salt-stable mGFP2 for use in high-salt environments, creating four vectors for N- or C-terminal fusions to proteins of interest.  The study successfully used this split-GFP system to identify interactions between various gas vesicle proteins (GvpM, GvpH, GvpJ, GvpL, and GvpF).\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fmicb.2018.01897/pdf"
        },
        {
          "title": "Protease Activation of Split Green Fluorescent Protein",
          "author": "Brian P Callahan, Matthew J Stanger, Marlene  Belfort, belfort@wadsworth.org",
          "published_date": "2023-11-09T19:08:33.390000+00:00",
          "summary": "Yes, this article describes a protease-activatable switch based on split green fluorescent protein (GFP).  The authors engineered a system where two GFP fragments are prevented from reassembling (and thus producing fluorescence) until a protease cleaves a connecting tether, restoring their interaction and fluorescence.\n",
          "url": "https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.201000453"
        },
        {
          "title": "Split Green Fluorescent Proteins: Scope, Limitations, and ...",
          "author": "",
          "published_date": "2019-02-20T00:00:00+00:00",
          "summary": "Yes, split green fluorescent proteins (GFPs) exist.  The paper reviews their use in investigating protein-protein interactions, as versatile sensors, molecular glues, optogenetic tools, and platforms for photophysical studies.  The earliest example of a split protein, however, was ribonuclease S.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6537611/"
        },
        {
          "title": "FAST, a method based on split-GFP for the detection in ...",
          "author": "Giuliodori, Anna Maria",
          "published_date": "2024-04-05T00:00:00+00:00",
          "summary": "Yes, the paper describes a method (FAST) using split GFP for detecting proteins synthesized in cell-free expression systems.  The method leverages the superfolder GFP (sfGFP) variant, which has optimized folding kinetics, making it suitable for this application.  While the paper doesn't detail the creation of *a* split GFP,  it utilizes a pre-existing split GFP variant within its methodology.\n",
          "url": "https://www.nature.com/articles/s41598-024-58588-5"
        },
        {
          "title": "Split-GFP Reassembly Assay: Strengths and Caveats from ...",
          "author": "",
          "published_date": "2022-10-29T00:00:00+00:00",
          "summary": "Yes, the split-GFP reassembly assay was first developed in the early 2000s by Regan's lab and is used to study protein-protein interactions.  The assay involves splitting GFP into two parts, fusing them to proteins of interest, and observing fluorescence reconstitution as an indicator of interaction.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9658207/"
        },
        {
          "title": "Engineering an efficient and bright split Corynactis ...",
          "author": "Waldo, Geoffrey S.",
          "published_date": "2021-09-16T00:00:00+00:00",
          "summary": "Yes, split GFPs have been developed.  The first efficient, self-assembling two-part split GFP was created from *Aequorea victoria* GFP.  This system uses strand 11 as a fusion tag and the remaining strands as a detector.  Further, three-part split GFP systems also exist and have been widely used in various biological applications.\n",
          "url": "https://www.nature.com/articles/s41598-021-98149-8"
        },
        {
          "title": "How to reduce background in split-GFP experiments?",
          "author": "Guor Mour Her",
          "published_date": "2024-06-18T00:00:00+00:00",
          "summary": "The provided text describes a bacterial transformation experiment using DH10Bac competent cells and a pFastBac\u2122 construct, but it does not mention split GFP or its creation.  The experiment failed, possibly due to primer self-annealing.  Therefore, the answer to the search query \"Has anyone ever made a split GFP?\" cannot be answered from this document.\n",
          "url": "https://www.researchgate.net/post/How-to-reduce-background-in-split-GFP-experiments"
        },
        {
          "title": "Split GFP | The Royal (Dick) School of Veterinary Studies",
          "author": "",
          "published_date": "2024-09-02T00:00:00+00:00",
          "summary": "Yes, a split GFP system was developed by Cabantous et al. (2005).  The Roslin Institute created a transgenic line where the large subunit (GFP1-10) fluoresces only when the complementary small subunit (GFP-11) is delivered.  This can be achieved via viral delivery or expression of a second protein tagged with GFP-11.  The system is being further developed for research into infection and neuromuscular junctions.\n",
          "url": "https://vet.ed.ac.uk/roslin/engagement/facilities/national-avian-research-facility/avian-resources/genetically-altered-lines/split-gfp"
        },
        {
          "title": "Green fluorescent protein",
          "author": "Contributors to Wikimedia projects",
          "published_date": "2024-05-12T04:32:27+00:00",
          "summary": "The provided text focuses on the discovery and properties of Green Fluorescent Protein (GFP) from *Aequorea victoria*, and doesn't mention split GFP.  Therefore, I cannot answer your query using this text.\n",
          "url": "https://en.wikipedia.org/wiki/Green_fluorescent_protein"
        }
      ],
      "full_explanation": "The provided papers overwhelmingly demonstrate that split GFP has been successfully created and used in various research contexts. Several papers explicitly mention the development of split GFP systems and their applications. For example, Watanabe et al. (2023) describe dividing GFP between its 10th and 11th beta sheets to create two fragments that reconstitute fluorescence upon interaction, noting this technique is useful for studying protein localization and interactions (https://www.jstage.jst.go.jp/article/cytologia/83/4/83_830401/_article). Similarly, Winter et al. (2023) used a split-GFP system to investigate protein interactions in haloarchaea, further indicating the existence and use of this technology (https://www.frontiersin.org/articles/10.3389/fmicb.2018.01897/pdf). Callahan et al. (2010) detail a protease-activatable switch based on split GFP where reassembly is controlled by a protease, also indicating its prior creation (https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.201000453). The review article, \"Split Green Fluorescent Proteins: Scope, Limitations, and...\" (2019) confirms the existence of split GFPs and their versatility as sensors and tools for studying protein-protein interactions (https://pmc.ncbi.nlm.nih.gov/articles/PMC6537611/). Giuliodori (2024) also uses a pre-existing split GFP variant in her described methodology (https://www.nature.com/articles/s41598-024-58588-5). Further proof is provided in the articles that describe the history of split GFP, such as the article \"Split-GFP Reassembly Assay: Strengths and Caveats from...\" (2022) which credits Regan's lab with its initial development in the early 2000s (https://pmc.ncbi.nlm.nih.gov/articles/PMC9658207/), and Waldo (2021) who credits the creation of the first efficient, self-assembling two-part split GFP to *Aequorea victoria* GFP (https://www.nature.com/articles/s41598-021-98149-8). Finally, a split GFP system was developed by Cabantous et al (2005), which is referenced by the Royal (Dick) School of Veterinary Studies (https://vet.ed.ac.uk/roslin/engagement/facilities/national-avian-research-facility/avian-resources/genetically-altered-lines/split-gfp)."
    },
    {
      "question": "Has anyone made a database of all the CRISPR-associated proteins and engineering Cas proteins that are used in CRISPR genome engineering? ",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "A catalogue of biochemically diverse CRISPR-Cas9 orthologs",
          "author": "Giedrius  Gasiunas, CasZyme, LT-10257, Vilnius, Lithuania, Joshua K Young, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, josh.young@corteva.com, Tautvydas  Karvelis, Vilnius University, LT-10257, Vilnius, Lithuania, Darius  Kazlauskas, Vilnius University, LT-10257, Vilnius, Lithuania, Tomas  Urbaitis, CasZyme, LT-10257, Vilnius, Lithuania, Monika  Jasnauskaite, CasZyme, LT-10257, Vilnius, Lithuania, Mantvyda M Grusyte, CasZyme, LT-10257, Vilnius, Lithuania, Sushmitha  Paulraj, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Po-Hao  Wang, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Zhenglin  Hou, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Shane K Dooley, Iowa State University, 50011, Ames, IA, USA, Mark  Cigan, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Clara  Alarcon, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, N Doane Chilcoat, Greta  Bigelyte, Vilnius University, LT-10257, Vilnius, Lithuania, Jennifer L Curcuru, New England Biolabs, 01938, Ipswich, MA, USA, Megumu  Mabuchi, New England Biolabs, 01938, Ipswich, MA, USA, Zhiyi  Sun, New England Biolabs, 01938, Ipswich, MA, USA, Ryan T Fuchs, New England Biolabs, 01938, Ipswich, MA, USA, Ezra  Schildkraut, New England Biolabs, 01938, Ipswich, MA, USA, Peter R Weigele, New England Biolabs, 01938, Ipswich, MA, USA, William E Jack, New England Biolabs, 01938, Ipswich, MA, USA, G Brett Robb, New England Biolabs, 01938, Ipswich, MA, USA, robb@neb.com, \u010ceslovas  Venclovas, Vilnius University, LT-10257, Vilnius, Lithuania, Virginijus  Siksnys, CasZyme, LT-10257, Vilnius, Lithuania, siksnys@ibt.lt",
          "published_date": "2023-11-09T20:31:30.506000+00:00",
          "summary": "This Nature article describes a bioinformatic and biochemical analysis of 79 Cas9 proteins, identifying at least 7 distinct guide RNA classes and 50 different PAM sequence requirements.  While not a comprehensive database of *all* CRISPR-associated proteins used in genome engineering, the research significantly expands the known diversity of Cas9 orthologs and their functional parameters, which is relevant to the development and improvement of CRISPR-Cas genome engineering tools.  The study itself doesn't create a database, but characterizes a large number of Cas9 variants to potentially inform the creation of one.\n",
          "url": "https://www.nature.com/articles/s41467-020-19344-1"
        },
        {
          "title": "Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability",
          "author": "Lisa M Alexander; Daniela S Aliaga Goltsman; Jason Liu; Jyun-Liang Lin; Morayma M Temoche-Diaz; Sarah M Laperriere; Andreas Neerincx; Christien Bednarski; Philipp Knyphausen; Andre Cohnen; Justine Albers; Liliana Gonzalez-Osorio; Rodrigo Fregoso Ocampo; Jennifer Oki; Audra E Devoto; Cindy J Castelle; Rebecca C Lamothe; Gregory J Cost; Cristina N Butterfield; Brian C Thomas; Christopher T Brown",
          "published_date": "2023-12-04T04:12:50.156000+00:00",
          "summary": "This research article focuses on discovering and engineering new Type II CRISPR systems from uncultivated microbes to improve genome editing capabilities.  While it doesn't create a database of all CRISPR-associated proteins, the study does identify novel Cas9 enzymes with diverse PAM specificities, expanding the possibilities for targeted gene editing.  The researchers mined metagenomic databases for these novel systems and tested their activity *in vitro*, in *E. coli*, and mammalian cells.  They also demonstrate successful PAM swapping in one of the most efficient enzymes, suggesting a method for engineering PAM compatibility in distantly related orthologs.  Therefore, this work contributes to the development of new tools for CRISPR genome engineering, but it does not itself present a comprehensive database as requested.\n",
          "url": "https://www.liebertpub.com/doi/10.1089/crispr.2022.0090"
        },
        {
          "title": "CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering - Nature Biotechnology",
          "author": "Vo; Phuc Leo H; Ronda; Carlotta; Klompe; Sanne E; Chen; Ethan E; Acree; Christopher; Wang; Harris H; Sternberg; Samuel H",
          "published_date": "2023-02-27T03:51:57.749000+00:00",
          "summary": "This Nature Biotechnology article describes CRISPR RNA-guided integrases for highly efficient, multiplexed bacterial genome engineering.  It does *not* focus on a database of CRISPR-associated proteins or engineered Cas proteins.  The article's subject matter is a novel method for genome editing, and therefore does not address your specific query about existing databases.\n",
          "url": "https://www.nature.com/articles/s41587-020-00745-y"
        },
        {
          "title": "WGE: a CRISPR database for genome engineering",
          "author": "Hodgkins; Alex; Farne; Anna; Perera; Sajith; Grego; Tiago; Parry-Smith; David J; Skarnes; William C; Iyer; Vivek",
          "published_date": "2023-02-23T13:02:33.610000+00:00",
          "summary": "This article describes the Wellcome Trust Sanger Institute Genome Editing (WGE) database, a genome browser that identifies optimal CRISPR sites in mouse and human exomes.  WGE displays single and paired CRISPR sites, pre-calculated off-target information, and allows users to design and visualize gene targeting vectors. While it doesn't contain *all* CRISPR-associated proteins or engineered Cas proteins,  WGE focuses on providing tools to find and evaluate CRISPR sites for genome engineering.  The database is freely available at www.sanger.ac.uk/htgt/wge.\n",
          "url": "https://academic.oup.com/bioinformatics/article/31/18/3078/240857"
        },
        {
          "title": "CRISPR-Cas systems: Overview, innovations and ...",
          "author": "",
          "published_date": "2020-09-08T00:00:00+00:00",
          "summary": "This article reviews CRISPR-Cas systems, their innovations, and applications in human disease research and gene therapy.  While it details the mechanisms of CRISPR-Cas systems, including the roles of CRISPR RNA (crRNA), trans-activating CRISPR RNA (tracrRNA), and Cas proteins, it does not mention the existence of a database compiling all CRISPR-associated proteins and engineered Cas proteins used in genome engineering.  The review focuses on the broader applications and mechanisms of CRISPR technology rather than a specific catalog of Cas proteins.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7508700/"
        },
        {
          "title": "The CRISPR tool kit for genome editing and beyond",
          "author": "Adli; Mazhar",
          "published_date": "2023-02-06T07:49:39.887000+00:00",
          "summary": "This Nature Communications article does not describe a database of CRISPR-associated proteins or engineered Cas proteins used in genome engineering.  The provided text is a list of citations related to early work on restriction enzymes, which predate CRISPR technology.  Therefore, the answer to your query is no, based on the content of this specific article.\n",
          "url": "https://www.nature.com/articles/s41467-018-04252-2"
        },
        {
          "title": "CasPDB: an integrated and annotated database for Cas ...",
          "author": "",
          "published_date": "2019-08-14T00:00:00+00:00",
          "summary": "Yes, the Cas Protein Data Bank (CasPDB) is an online database containing 287 reviewed and 257,745 putative Cas proteins, along with 3593 Cas operons from various bacteria and archaea species.  It's designed to aid in the exploration and characterization of CRISPR-Cas systems for genome editing applications.  The database includes information on CRISPR-associated proteins used in CRISPR genome engineering.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6693189/"
        },
        {
          "title": "Recent advances in CRISPR-based genome editing ...",
          "author": "Yang, Xiao",
          "published_date": "2023-03-10T00:00:00+00:00",
          "summary": "This review article on CRISPR-based genome editing in cardiovascular research does not describe a database of CRISPR-associated proteins (Cas) or engineered Cas proteins.  While it discusses the expansion of the CRISPR toolbox, including newly identified Cas orthologs and engineered variants, it does not mention the existence of a compiled database of these proteins.\n",
          "url": "https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00447-x"
        },
        {
          "title": "CRISPR Clinical Trials: A 2024 Update",
          "author": "By Hope Henderson",
          "published_date": "2024-03-14T16:58:56+00:00",
          "summary": "This article focuses on the recent approval of Casgevy, the first CRISPR-based therapy for sickle cell disease and beta-thalassemia, and the current landscape of CRISPR clinical trials.  It does not contain information about a database of CRISPR-associated proteins or engineered Cas proteins used in genome engineering.\n",
          "url": "https://innovativegenomics.org/news/crispr-clinical-trials-2024/"
        },
        {
          "title": "CRISPR/Cas9 therapeutics: progress and prospects",
          "author": "Li; Tianxiang; Yang; Yanyan; Qi; Hongzhao; Cui; Weigang; Zhang; Fu; Xiuxiu; He; Xiangqin; Meixin; Pei-feng; Yu; Tao",
          "published_date": "2023-01-16T00:00:00+00:00",
          "summary": "This article focuses on the CRISPR/Cas9 system's mechanism and applications in treating diseases like cancer, cardiovascular disease, sickle cell anemia, and neurodegenerative disorders.  It doesn't address the existence of a database compiling all CRISPR-associated proteins and engineered Cas proteins used in genome engineering.  The text describes CRISPR's function, highlighting its advantages over earlier gene-editing technologies like ZFNs and TALENs due to its ease of targeting via guide RNA modification.  While the article mentions the importance of  protospacer-adjacent motifs (PAMs) in targeting, it does not discuss a comprehensive database of Cas proteins.\n",
          "url": "https://www.nature.com/articles/s41392-023-01309-7"
        }
      ],
      "full_explanation": "Based on the provided papers, the research question \"Has anyone made a database of all the CRISPR-associated proteins and engineering Cas proteins that are used in CRISPR genome engineering?\" has been addressed, though not exhaustively. Specifically, the paper \"CasPDB: an integrated and annotated database for Cas...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6693189/) explicitly states that it is \"an online database containing 287 reviewed and 257,745 putative Cas proteins, along with 3593 Cas operons from various bacteria and archaea species.\" This clearly indicates the existence of a database compiling a large number of Cas proteins, including those used in CRISPR genome engineering. Additionally, while not a complete database of *all* proteins, the paper \"A catalogue of biochemically diverse CRISPR-Cas9 orthologs\" (URL: https://www.nature.com/articles/s41467-020-19344-1) describes an analysis of 79 Cas9 proteins which expands the known diversity of Cas9 orthologs and their functional parameters, and \"Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability\" (URL: https://www.liebertpub.com/doi/10.1089/crispr.2022.0090) identifies novel Cas9 enzymes with diverse PAM specificities, which could inform databases of these types of proteins. These papers contribute to the resources available, showing that the general topic has been addressed although \"all\" is likely an unachievable goal due to the rate of discovery in the field."
    },
    {
      "question": "Has anyone done research into the impact of microRNA dysregulation on protein-protein interactions in cancer cells?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors",
          "author": "Andrew  Dhawan, University of Oxford, OX3 7DQ, Oxford, UK, Jacob G Scott, Translational Hematology and Radiology, Cleveland Clinic, 44195, Cleveland, USA, Adrian L Harris, University of Oxford, OX3 7DQ, Oxford, UK, Francesca M Buffa, University of Oxford, OX3 7DQ, Oxford, UK, francesca.buffa@oncology.ox.ac.uk",
          "published_date": "2023-11-09T20:24:25.701000+00:00",
          "summary": "This research investigated the association between microRNA expression and cancer hallmarks across 15 epithelial cancer types.  While it doesn't directly address microRNA dysregulation's impact on protein-protein interactions, the study does identify extensive microRNA regulation of tumor suppressor genes (e.g., PTEN, FAT4, CDK12), suggesting an alternative mechanism of cancer development beyond mutation or methylation.  This indirect finding may be relevant to exploring the downstream effects of microRNA dysregulation on protein function and interactions.\n",
          "url": "https://www.nature.com/articles/s41467-018-07657-1"
        },
        {
          "title": "A Survey of Regulatory Interactions Among RNA Binding Proteins and MicroRNAs in Cancer",
          "author": "Ying  Liu, Hunan University, Changsha, China, Chu  Pan, Hunan University, Changsha, China, Dehan  Kong, University of Toronto, Toronto, ON, Canada, Jiawei  Luo, Hunan University, Changsha, China, luojiawei@hnu.edu.cn, Zhaolei  Zhang, University of Toronto, Toronto, ON, Canada, zhaolei.zhang@utoronto.ca",
          "published_date": "2023-11-09T20:31:08.804000+00:00",
          "summary": "This research investigated the interplay between RNA-binding proteins (RBPs) and microRNAs (miRNAs) in cancer, analyzing their binding sites on mRNA transcripts.  While it doesn't directly address miRNA dysregulation's impact on *protein-protein* interactions, the study *does* show widespread interaction effects between RBPs and miRNAs in cancer, suggesting indirect influence on protein expression levels.  The researchers categorized RBP/miRNA interactions as overlapping, neighboring, or independent target sites on mRNA, observing interaction effects across multiple cancer datasets.  This indirectly supports the possibility that miRNA dysregulation could affect protein levels via its interaction with RBPs, impacting downstream protein-protein interactions.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fgene.2020.515094/full"
        },
        {
          "title": "Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors",
          "author": "Andrew Dhawan; Jacob G Scott; Adrian L Harris; Francesca M Buffa",
          "published_date": "2023-02-26T08:28:27.850000+00:00",
          "summary": "This study analyzed microRNA expression across 15 epithelial cancer types and its association with cancer hallmarks.  While it doesn't directly address microRNA dysregulation's impact on protein-protein interactions, it does reveal extensive miRNA regulation of tumor suppressor genes (like PTEN, FAT4, and CDK12), suggesting an alternative mechanism of repression independent of mutation, methylation, or copy number changes.  The research focuses on miRNA's role in regulating gene expression,  a process that indirectly influences protein-protein interactions, but doesn't directly investigate the stated interaction.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286392/"
        },
        {
          "title": "Causes and consequences of microRNA dysregulation in ...",
          "author": "",
          "published_date": "2009-10-01T00:00:00+00:00",
          "summary": "This research article focuses on microRNA dysregulation in cancer, highlighting its role in oncogene and tumor suppressor gene expression. While it doesn't directly address the impact of microRNA dysregulation on protein-protein interactions, it emphasizes that microRNAs control or are controlled by dysregulation of multiple protein-coding oncogenes or tumor suppressor genes.  This strongly suggests that microRNA dysregulation indirectly affects protein-protein interactions, as these genes' altered expression would lead to changes in protein levels and activity, thus impacting interactions. The article's focus is on the broader consequences of microRNA dysregulation in cancer development and potential therapeutic targets, rather than a detailed examination of specific protein-protein interactions.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3467096/"
        },
        {
          "title": "miRNA: A Promising Therapeutic Target in Cancer - PMC",
          "author": "",
          "published_date": "2022-09-29T00:00:00+00:00",
          "summary": "This review article focuses on microRNAs (miRNAs) in cancer, their therapeutic potential, and delivery methods. While it details miRNA's role in gene regulation (including post-transcriptional gene silencing via mRNA cleavage, translational repression, or DNA methylation), and their function as tumor suppressors or oncogenes, it does *not* specifically address the impact of miRNA dysregulation on protein-protein interactions in cancer cells.  The article mentions miRNAs' involvement in various cellular processes, including those related to cancer development and metastasis, but doesn't delve into the protein-protein interaction aspect.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9569513/"
        },
        {
          "title": "RNA-binding proteins and exoribonucleases modulating ...",
          "author": "Kim, Jong Heon",
          "published_date": "2024-05-01T00:00:00+00:00",
          "summary": "This review focuses on how RNA-binding proteins (RBPs) and exoribonucleases regulate microRNA (miRNA) biogenesis and turnover in cancer, including the impact on Hepatitis C virus-related hepatocellular carcinoma. While the review extensively covers miRNA dysregulation in cancer and the role of RBPs, it does *not* directly address the impact of miRNA dysregulation on protein-protein interactions in cancer cells.  The research described centers on how RBPs affect miRNA *expression*, not how altered miRNA levels subsequently affect protein interactions.\n",
          "url": "https://www.nature.com/articles/s12276-024-01224-z"
        },
        {
          "title": "Dysregulation of microRNAs in breast cancer and their ...",
          "author": "Eleni  Van Schooneveld, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium, eleni.vanschooneveld@gmail.com, Hans  Wildiers, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium, Ignace  Vergote, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium, Peter B Vermeulen, CORE, University of Antwerp, Universiteitsplein 1, B-2016, Antwerp, Belgium, Luc Y Dirix, CORE, University of Antwerp, Universiteitsplein 1, B-2016, Antwerp, Belgium, Steven J Van Laere, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium",
          "published_date": "2023-11-09T20:08:10.463000+00:00",
          "summary": "This review article on microRNAs (miRNAs) in breast cancer focuses primarily on their prognostic and predictive biomarker potential. While it details miRNA dysregulation's role in breast cancer pathogenesis, including its influence on cell processes like apoptosis and cell cycle regulation,  it does *not* directly address the impact of miRNA dysregulation on protein-protein interactions in cancer cells.  The article concentrates on miRNA detection methods and their clinical applications in patient management, not the mechanistic details of miRNA effects on protein interactions.\n",
          "url": "https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-015-0526-y"
        },
        {
          "title": "Dynamic and Modularized MicroRNA Regulation and Its ...",
          "author": "Jiang  Shu, Systems Biology and Biomedical Informatics (SBBI) Laboratory, 68588, Lincoln, NE, USA, Bruno Vieira Resende E Silva, Tian  Gao, Systems Biology and Biomedical Informatics (SBBI) Laboratory, 68588, Lincoln, NE, USA, Zheng  Xu, University of Nebraska-Lincoln, 68588, Lincoln, NE, USA, Juan  Cui, Systems Biology and Biomedical Informatics (SBBI) Laboratory, 68588, Lincoln, NE, USA, jcui@unl.edu",
          "published_date": "2023-11-09T20:21:11.110000+00:00",
          "summary": "This study investigated the dynamic regulation of microRNAs in nine cancer types using a large-scale genomic dataset (~4200 patients).  While the research focuses on microRNA-mRNA interactions and identifies regulatory modules involved in processes like glycolysis and focal adhesion, it does *not* directly address the impact of microRNA dysregulation on protein-protein interactions in cancer cells.  The study's methodology centers on identifying microRNA-mediated gene regulation through a meta-Lasso regression model, analyzing the interplay of competing and cooperative mechanisms.\n",
          "url": "https://www.nature.com/articles/s41598-017-13470-5"
        },
        {
          "title": "Exosomal miRNAs and miRNA dysregulation in cancer ...",
          "author": "Yang; Fengming; Ning; Zhiqiang; Ma; Ling; Liu; Weitao; Shao; Chuchu; Shu; Yongqian; Shen; Hua",
          "published_date": "2023-12-04T02:12:09.514000+00:00",
          "summary": "This 2017 review focuses on exosomal microRNAs (miRNAs) and their dysregulation in cancer-associated fibroblasts (CAFs), not directly on the impact of miRNA dysregulation on protein-protein interactions within cancer cells themselves.  While the review discusses miRNA dysregulation's role in CAF formation, activation, tumor invasion, metastasis, and drug resistance,  it doesn't address the specific question of protein-protein interaction changes resulting from miRNA dysregulation in cancer cells.  Therefore, the provided text does not offer an answer to your query.\n",
          "url": "https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-017-0718-4"
        },
        {
          "title": "MicroRNA dysregulation in cancer: diagnostics, monitoring ...",
          "author": "Carlo M. Croce",
          "published_date": "2012-02-20T00:00:00+00:00",
          "summary": "This review article focuses on microRNA's role in cancer diagnostics, prognostics, and therapeutics, but does not directly address the impact of microRNA dysregulation on protein-protein interactions in cancer cells.  While the article details microRNA biogenesis and mechanisms of action (including their impact on gene regulation and ultimately, protein expression), it doesn't delve into the specific effects on protein-protein interactions.  Therefore, based on this text alone, the answer to your question is not directly available.\n",
          "url": "https://www.embopress.org/doi/full/10.1002/emmm.201100209"
        }
      ],
      "full_explanation": "While many of the provided papers discuss microRNA dysregulation in cancer and its impact on gene expression, none of them directly investigate the impact of microRNA dysregulation on **protein-protein interactions** in cancer cells. Several papers discuss related concepts, which are close but not quite the same. For example:\n\n*   The paper by Dhawan et al., titled \"Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors,\" (https://www.nature.com/articles/s41467-018-07657-1 and https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286392/) investigates the downregulation of tumor suppressor genes by microRNAs. This suggests a potential indirect effect on protein interactions because changing the levels of those proteins will naturally affect any protein interaction those proteins are involved in. This study does not, however, directly assess the actual protein-protein interactions themselves.\n\n*   Liu et al., in their study \"A Survey of Regulatory Interactions Among RNA Binding Proteins and MicroRNAs in Cancer,\" (https://www.frontiersin.org/articles/10.3389/fgene.2020.515094/full) explore the interplay between RNA-binding proteins (RBPs) and microRNAs, showing how miRNAs might influence protein expression. This, again, suggests an indirect influence on protein-protein interactions by altering the protein levels. However, it does not examine the actual changes in protein interactions themselves.\n\n*   The \"Causes and consequences of microRNA dysregulation in...\" article (https://pmc.ncbi.nlm.nih.gov/articles/PMC3467096/) acknowledges that microRNA dysregulation controls protein coding genes, suggesting that the subsequent changes in protein levels could impact protein-protein interactions. But it also does not investigate those interactions explicitly.\n\nIn conclusion, while these papers provide evidence of the role of miRNA dysregulation in altering protein levels, and thus indirectly affecting protein-protein interactions, none of them directly address the specific research question of the direct impact of miRNA dysregulation on protein-protein interactions in cancer cells. Thus, the research question is not covered by the provided literature."
    },
    {
      "question": "Has anyone ever experimented with giving animals money?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Evolutionary origins of money categorization and exchange: an experimental investigation in tufted capuchin monkeys (Sapajus spp.) - Animal Cognition",
          "author": "De Petrillo; Francesca; Caroli; Martina; Gori; Emanuele; Micucci; Antonia; Gastaldi; Serena; Bourgeois-Gironde; Sacha; Addessi; Elsa",
          "published_date": "2023-02-06T19:51:15.040000+00:00",
          "summary": "Yes, researchers experimented with giving capuchin monkeys tokens that functioned similarly to money.  Two experiments showed the monkeys could recognize valid tokens, exchange them for food, and even participate in chained exchanges (trading food for a token, then the token for different food).  The monkeys' success varied based on the value of the exchange.  While not a fully developed monetary system, the study suggests some aspects of human money use may have evolutionary roots in animal exchange behaviors.\n",
          "url": "https://link.springer.com/article/10.1007/s10071-018-01233-2"
        },
        {
          "title": "Non-human primate token use shows possibilities but also limitations for establishing a form of currency | Philosophical Transactions of the Royal Society B: Biological Sciences",
          "author": "Michael J Beran; Audrey E Parrish",
          "published_date": "2023-02-27T16:57:10.984000+00:00",
          "summary": "Yes, researchers have experimented with giving non-human primates tokens to investigate whether they can understand and use them as a form of currency.  Studies have explored whether primates can grasp concepts like value (understanding that quantity and size are not always correlated with worth), delayed gratification, and exchanging tokens for desired goods. While primates show some capacity for these behaviors, the experiments reveal limitations in their ability to fully utilize tokens as a currency system comparable to humans. The limitations are still being investigated, and it's unclear whether they stem primarily from cognitive differences or environmental factors that haven't necessitated the development of such complex economic systems in other species.\n",
          "url": "https://royalsocietypublishing.org/doi/full/10.1098/rstb.2019.0675"
        },
        {
          "title": "Give a dog a bone: Spending money on pets promotes happiness",
          "author": "Michael W White; Nazia Khan; Jennifer S Deren; Jessica J Sim; Elizabeth A Majka",
          "published_date": "2023-02-06T12:30:10.219000+00:00",
          "summary": "This research paper doesn't directly address giving animals money.  It explores the link between pet ownership and human happiness, suggesting that spending money on pets can boost well-being.  No experiments involving giving animals money are described.\n",
          "url": "https://www.tandfonline.com/doi/abs/10.1080/17439760.2021.1897871"
        },
        {
          "title": "Non-human primate token use shows possibilities but also ...",
          "author": "",
          "published_date": "2021-01-11T00:00:00+00:00",
          "summary": "Yes, researchers have experimented with giving non-human primates tokens that function similarly to currency.  These primates learned to associate tokens with rewards (like food), accumulating them and exchanging them for rewards, showing some understanding of their value. However, studies reveal limitations in their ability to consistently use tokens in complex economic decision-making like humans do.  These limitations highlight the cognitive prerequisites for the development and use of currency systems, offering insights into the evolution of human economic behavior.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7815425/"
        },
        {
          "title": "Monkey Business",
          "author": "Stephen J. Dubner, Steven D. Levitt",
          "published_date": "2005-06-05T00:00:00+00:00",
          "summary": "Yes, Keith Chen and Laurie Santos at Yale have conducted experiments where capuchin monkeys were taught to use tokens to buy food like grapes, apples, and Jell-O.  The research explores how monkeys respond to economic incentives, comparing their behavior to that of humans.  The experiments were designed to study whether monetary exchange is unique to humans.\n",
          "url": "https://www.nytimes.com/2005/06/05/magazine/monkey-business.html"
        },
        {
          "title": "How scientists taught monkeys the concept of money. Not ...",
          "author": "Tibi Puiu",
          "published_date": "2023-12-15T14:16:30+00:00",
          "summary": "Yes.  Yale researchers Keith Chen and Laurie Santos taught capuchin monkeys to use tokens as currency to purchase treats like grapes and Jell-O.  The experiment explored the monkeys' economic behavior and motivations, revealing insights into their decision-making processes and responses to incentives.  While the study initially focused on simple exchange, it unintentionally led to observations of unexpected social behaviors among the monkeys.\n",
          "url": "https://www.zmescience.com/research/how-scientists-tught-monkeys-the-concept-of-money-not-long-after-the-first-prostitute-monkey-appeared/"
        },
        {
          "title": "The Experiment That Taught Monkeys How to Use Money",
          "author": "Freakonomics Radio Network",
          "published_date": "2011-10-11T18:58:57+00:00",
          "summary": "Yes.  This Freakonomics Radio episode discusses research by Keith Chen who experimented with giving monkeys \"money\" to see how they would use it to purchase different goods.  The experiment explored the monkeys' economic behavior.\n",
          "url": "https://www.youtube.com/watch?v=J8449HgS3FM"
        },
        {
          "title": "The Experiment That Taught Monkeys How to Use Money",
          "author": "",
          "published_date": "2024-01-17T00:00:00+00:00",
          "summary": "Yes.  Yale economist Keith Chen conducted an experiment where capuchin monkeys were taught to use coins as currency to purchase treats.  The monkeys demonstrated an understanding of value,  responded rationally to price changes, and even engaged in transactional sex for a coin, showcasing a sophisticated grasp of monetary incentives.\n",
          "url": "https://econ.sites.northeastern.edu/wiki/microeconomics/introduction-to-economics/the-experiment-that-taught-monkeys-how-to-use-money-freakonomics/"
        },
        {
          "title": "That Time Scientists Gave Monkeys Money",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "The provided text only gives YouTube video metadata (view count, likes, subscribers) and doesn't contain any information about the video's content.  Therefore, it's impossible to determine whether the video explores the topic of giving animals money.  More information is needed to answer the search query.\n",
          "url": "https://www.youtube.com/watch?v=y2M0fzcYlgI"
        },
        {
          "title": "Facts and Statistics About Animal Testing",
          "author": "",
          "published_date": "2024-05-29T12:21:26+00:00",
          "summary": "This article from PETA discusses the ethics and effectiveness of animal testing, focusing on the large number of animals used and the questionable reliability of results when extrapolated to humans.  It does not contain any information about experiments involving animals and money.\n",
          "url": "https://www.peta.org/issues/animals-used-for-experimentation/animals-used-experimentation-factsheets/animal-experiments-overview/"
        }
      ],
      "full_explanation": "Multiple research papers and articles confirm that experiments have been conducted where animals, particularly monkeys, have been given tokens or objects that function as a form of money.\n\nThe paper \"Evolutionary origins of money categorization and exchange: an experimental investigation in tufted capuchin monkeys (Sapajus spp.)\" (URL: https://link.springer.com/article/10.1007/s10071-018-01233-2) details experiments where capuchin monkeys were given tokens that they could exchange for food, indicating an understanding of token value.\n\nSimilarly, \"Non-human primate token use shows possibilities but also limitations for establishing a form of currency\" (URL: https://royalsocietypublishing.org/doi/full/10.1098/rstb.2019.0675) and another paper with the same title (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7815425/) discuss experiments where non-human primates used tokens as currency and how they understood concepts like delayed gratification and value.\n\nSeveral sources mention the work of Keith Chen and Laurie Santos at Yale where they taught capuchin monkeys to use tokens as money. This is summarized in \"Monkey Business\" (URL: https://www.nytimes.com/2005/06/05/magazine/monkey-business.html), \"How scientists taught monkeys the concept of money. Not ...\" (URL: https://www.zmescience.com/research/how-scientists-tught-monkeys-the-concept-of-money-not-long-after-the-first-prostitute-monkey-appeared/), \"The Experiment That Taught Monkeys How to Use Money\" (URL: https://www.youtube.com/watch?v=J8449HgS3FM), and \"The Experiment That Taught Monkeys How to Use Money\" (URL: https://econ.sites.northeastern.edu/wiki/microeconomics/introduction-to-economics/the-experiment-that-taught-monkeys-how-to-use-money-freakonomics/). These studies detail how monkeys learned to exchange tokens for food and displayed behaviors related to price changes and even unexpected transactional behavior."
    },
    {
      "question": "Has anyone created a system or pipeline for automatic metareview of literature?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Prompting LLMs to Compose Meta-Review Drafts from Peer-Review Narratives of Scholarly Manuscripts",
          "author": "Santu; Shubhra Kanti Karmaker; Sinha; Sanjeev Kumar; Bansal; Naman; Knipper; Alex; Sarkar; Souvika; Salvador; John; Mahajan; Yash; Guttikonda; Sri; Akter; Mousumi; Freestone; Matthew; Williams Jr",
          "published_date": "2024-02-23T00:00:00+00:00",
          "summary": "Yes, this arXiv paper describes a case study using GPT-3.5, LLaMA2, and PaLM2 to automatically generate meta-reviews of scholarly manuscripts.  The system prompts the LLMs with different prompt types based on the TELeR taxonomy, then qualitatively analyzes the generated meta-reviews.  The paper details findings and recommendations for prompting LLMs for this task.\n",
          "url": "https://arxiv.org/abs/2402.15589"
        },
        {
          "title": "Reviewer2: Optimizing Review Generation Through Prompt Generation",
          "author": "Gao; Zhaolin; Brantley; Kiant\u00e9; Joachims; Thorsten",
          "published_date": "2024-02-16T00:00:00+00:00",
          "summary": "This paper introduces Reviewer2, a two-stage framework for generating detailed automated reviews of research papers.  Unlike previous methods, Reviewer2 explicitly models the distribution of potential review aspects, resulting in more comprehensive reviews that better reflect the variety of feedback provided by human reviewers.  The authors created a large dataset (27k papers, 99k reviews) annotated with aspect prompts to support this research and made it publicly available. While not explicitly a \"meta-review\" system in the sense of reviewing multiple existing reviews, Reviewer2 addresses a related problem by improving the quality and comprehensiveness of individual automated reviews, which could be a component of a future meta-review system.\n",
          "url": "https://arxiv.org/abs/2402.10886"
        },
        {
          "title": "Can We Automate Scientific Reviewing?",
          "author": "Weizhe  Yuan, weizhey@cs.cmu.edu, Pengfei  Liu, Graham  Neubig, gneubig@cs.cmu.edu",
          "published_date": "2023-11-16T01:35:01.879000+00:00",
          "summary": "This paper explores automating scientific peer review using NLP models.  While not directly addressing meta-review of literature, the authors investigate using NLP to generate first-pass reviews of individual papers.  They train models on a dataset of machine learning papers and evaluate the generated reviews. The results show that the system generates more comprehensive reviews covering more aspects than human reviews, but the quality and constructiveness are lower, except for explanations of core ideas.  The authors also discuss challenges and potential solutions for future research in this area, but don't specifically address automated meta-review pipelines.\n",
          "url": "https://arxiv.org/pdf/2102.00176.pdf"
        },
        {
          "title": "Utilizing ChatGPT to select literature for meta-analysis shows ...",
          "author": "",
          "published_date": null,
          "summary": "The provided text is largely unintelligible, containing a significant amount of non-textual characters and seemingly random strings.  Therefore, it's impossible to determine whether it describes a system or pipeline for automatic meta-review of literature.  No information relevant to the search query can be extracted from this text.\n",
          "url": "https://www.medrxiv.org/content/10.1101/2023.09.06.23295072v1.full-text"
        },
        {
          "title": "Automation of literature screening using machine learning in ...",
          "author": "Pan, Hui",
          "published_date": "2022-01-15T00:00:00+00:00",
          "summary": "This systematic review protocol investigates the use of AI algorithms to automate literature screening in medical systematic reviews.  While not directly addressing automated *meta-review*, the research focuses on automating the initial screening process, a crucial step in meta-analysis.  The study will analyze the effectiveness of various AI methods used for this screening, potentially informing the development of future automated meta-review systems.  The researchers will assess the performance of different algorithms and identify potential biases.\n",
          "url": "https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-021-01881-5"
        },
        {
          "title": "An open source machine learning framework for efficient and ...",
          "author": "Van De Schoot; Rens; De Bruin; Jonathan; Schram; Raoul; Zahedi; Parisa; De Boer; Jan; Weijdema; Felix; Kramer; Bianca; Huijts; Martijn; Hoogerwerf; Maarten; Ferdinands; Gerbrich; Harkema; Albert; Willemsen; Joukje; Ma; Yongchao; Fang; Qixiang; Hindriks; Sybren; Tummers; Lars; Oberski; Daniel L",
          "published_date": "2023-02-23T00:48:34.763000+00:00",
          "summary": "This Nature Machine Intelligence article introduces an open-source machine learning framework designed to improve the efficiency and transparency of systematic reviews (and by implication, meta-analyses).  The framework uses active learning to prioritize relevant studies, minimizing the manual effort required to screen large numbers of publications.  While not explicitly called an \"automatic meta-review system,\" the described framework directly addresses the challenges of efficiently processing the vast amounts of literature involved in meta-analysis by automating significant portions of the review process.\n",
          "url": "https://www.nature.com/articles/s42256-020-00287-7"
        },
        {
          "title": "Rayyan: AI-Powered Systematic Review Management Platform",
          "author": "",
          "published_date": "2021-11-08T19:01:59+00:00",
          "summary": "Rayyan is a collaborative systematic review platform used by over 500,000 researchers.  While it doesn't offer fully automated meta-review, its AI-powered features (like advanced filtration and 5-star relevance ranking) assist in streamlining the literature review process, potentially accelerating manual meta-review.  It offers various membership plans, including free options, for individuals, teams, and organizations, with features such as  de-duplication,  PICO highlighting and filters, and mobile app access.\n",
          "url": "https://www.rayyan.ai/"
        },
        {
          "title": "Toward systematic review automation: a practical guide to using ...",
          "author": "Wallace, Byron C.",
          "published_date": "2019-07-11T00:00:00+00:00",
          "summary": "This article reviews machine learning applications for automating systematic reviews, addressing the time-consuming nature of manually synthesizing evidence.  While it doesn't focus on fully automated *meta-reviews* specifically, it details methods used to automate various stages of systematic review creation, including search, screening, and data extraction.  The authors offer guidance on which machine learning techniques are currently suitable for practical use in systematic reviews, highlighting their strengths and weaknesses.  The article suggests that automation can help address the scalability issues inherent in current evidence-based medicine practices.\n",
          "url": "https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1074-9"
        },
        {
          "title": "Technological advances in preclinical meta-research - PMC",
          "author": "",
          "published_date": "2021-07-25T00:00:00+00:00",
          "summary": "This article discusses the application of systematic reviews (a core meta-research tool) to preclinical studies.  While it details the process of conducting these reviews, including challenges like the large volume of preclinical studies and variations in reporting, it does *not* describe any automated systems or pipelines for conducting meta-reviews.  The paper focuses on the manual process and its inherent difficulties.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8647618/"
        },
        {
          "title": "How To Automate Your Literature Review ETHICALLY ... - YouTube",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "The provided text gives YouTube video statistics (326K views, 10K likes, 46.9K subscribers) but no information about the video's content.  Therefore, I cannot determine whether the video discusses automated meta-review systems for literature.  To answer your query, more information about the video's content is needed.\n",
          "url": "https://www.youtube.com/watch?v=elLdVHALZ88"
        }
      ],
      "full_explanation": "Yes, the research question has been addressed by at least one paper. The paper \"Prompting LLMs to Compose Meta-Review Drafts from Peer-Review Narratives of Scholarly Manuscripts\" (URL: https://arxiv.org/abs/2402.15589) directly describes a system using Large Language Models (LLMs) to automatically generate meta-reviews from peer review narratives. This system takes the outputs of individual peer reviews as inputs and generates a meta-review, therefore, it fits the criteria of an automated meta-review pipeline or system.\n\nWhile other papers discuss automation in literature review, they do not focus specifically on meta-review generation. For example:\n* \"Reviewer2: Optimizing Review Generation Through Prompt Generation\" (URL: https://arxiv.org/abs/2402.10886) focuses on generating individual paper reviews, not meta-reviews of existing reviews.\n* \"Can We Automate Scientific Reviewing?\" (URL: https://arxiv.org/pdf/2102.00176.pdf) also addresses the generation of first-pass reviews, not meta-reviews.\n* \"Automation of literature screening using machine learning in...\" (URL: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-021-01881-5)  and \"An open source machine learning framework for efficient and...\" (URL: https://www.nature.com/articles/s42256-020-00287-7) focus on automating steps in literature screening or systematic review processes, not the generation of meta-reviews.\n* \"Rayyan: AI-Powered Systematic Review Management Platform\" (URL: https://www.rayyan.ai/) is a platform that assists in literature review but does not fully automate meta-review.\n* \"Toward systematic review automation: a practical guide to using...\" (URL: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1074-9) outlines methods to automate aspects of systematic reviews, it does not describe the construction of an automated metareview system."
    },
    {
      "question": "Has anyone mapped the entire microbiome of the human body and its full impact on health and disease?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species - Nature Communications",
          "author": "Leviatan; Sigal; Shoer; Saar; Rothschild; Daphna; Gorodetski; Maria; Segal; Eran",
          "published_date": "2023-04-13T10:23:28.575000+00:00",
          "summary": "No, a complete map of the entire human microbiome and its full impact on health and disease has not yet been achieved.  However, a recent study in *Nature Communications* created an expanded reference map of the human gut microbiome, identifying 3594 species, including 310 previously unknown ones.  This research significantly improves our understanding of the gut microbiome, a key component of the human microbiome, and its link to health and disease, but the entire human microbiome remains incompletely mapped.\n",
          "url": "https://www.nature.com/articles/s41467-022-31502-1"
        },
        {
          "title": "Microbiome-associated human genetic variants impact phenome-wide disease risk",
          "author": "Seth R.  Bordenstein",
          "published_date": "2022-06-24T00:00:00+00:00",
          "summary": "No, a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.  However, research is ongoing. This study analyzed nearly 1,000 microbiome-associated variants (MAVs) and their link to various diseases (neurological, metabolic, digestive, circulatory) in tens of thousands of individuals.  While the study reveals associations between MAVs, specific microbes, and diseases,  it doesn't represent a complete map of the entire human microbiome and its effects.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.2200551119"
        },
        {
          "title": "Organization of the human intestine at single-cell resolution - Nature",
          "author": "Hickey; John W; Becker; Winston R; Nevins; Stephanie A; Horning; Aaron; Perez; Almudena Espin; Zhu; Chenchen; Bokai; Wei; Bei; Chiu; Roxanne; Chen; Derek C; Cotter; Daniel L; Esplin; Edward D; Annika K; Caraccio; Chiara; Venkataraaman; Vishal; Sch\u00fcrch; Christian M; Black; Sarah; Brbi\u0107; Maria; Cao; Kaidi; Shuxiao; Zhang; Monte; Emma; Nancy R; Ma; Zongming; Leskovec; Jure; Zhengyan; Lin; Shin; Longacre; Teri; Plevritis; Sylvia K; Yiing; Nolan; Garry P; Greenleaf; William J; Snyder; Michael",
          "published_date": "2023-07-19T00:00:00+00:00",
          "summary": "This Nature article focuses on mapping the human intestine's cell types at a single-cell level, not the entire human microbiome.  While it mentions the gut microbiome's role in nutrient absorption and its interaction with the immune system,  it doesn't address a complete map of the entire human microbiome or its full impact on health and disease.  The study uses single-cell RNA sequencing, spatial proteomics, and other techniques to analyze the spatial organization and molecular phenotypes of intestinal cells across different regions (duodenum, jejunum, ileum, etc.).\n",
          "url": "https://www.nature.com/articles/s41586-023-05915-x"
        },
        {
          "title": "NIH Human Microbiome Project defines normal bacterial ...",
          "author": "",
          "published_date": "2015-08-31T18:39:53+00:00",
          "summary": "The NIH Human Microbiome Project (HMP) has mapped the normal microbial makeup of healthy humans, creating a reference database of microbes from various body sites.  While not a completely exhaustive map of *every* microbe in every individual,  the HMP\u2019s findings represent a significant advance, revealing that healthy individuals carry pathogens that coexist without causing disease.  The research provides insights into how microorganisms contribute to health and disease, though further research is needed to fully understand the complex interplay between the microbiome and human health.  The study involved genome sequencing of samples from 242 healthy volunteers across multiple body sites.\n",
          "url": "https://www.nih.gov/news-events/news-releases/nih-human-microbiome-project-defines-normal-bacterial-makeup-body"
        },
        {
          "title": "Current understanding of the human microbiome - PMC",
          "author": "",
          "published_date": "2018-04-10T00:00:00+00:00",
          "summary": "No, a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.  While research shows a strong correlation between microbiome composition and various diseases (including obesity, inflammatory bowel disease, arthritis, autism, cancer, and depression),  many challenges remain in understanding the complexities of this relationship.  Current research focuses on moving beyond correlation to establish causation and ultimately, develop effective treatments.  The sheer diversity of microbial species and genes, along with individual variation in microbiome composition, makes this a complex undertaking.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7043356/"
        },
        {
          "title": "An expanded reference map of the human gut microbiome ...",
          "author": "Leviatan; Sigal; Shoer; Saar; Rothschild; Daphna; Gorodetski; Maria; Segal; Eran",
          "published_date": "2023-04-13T10:23:28.575000+00:00",
          "summary": "No, a complete map of the entire human microbiome and its full impact on health and disease has not yet been achieved.  However, a new study has expanded the reference map of the gut microbiome (the body's richest microbial ecosystem), identifying 310 previously unknown species. This research used 51,052 metagenomic samples to create a high-quality reference set of 3,594 gut microbial species, significantly improving upon previous efforts. While this advances our understanding, mapping the entire human microbiome and fully understanding its health implications remains an ongoing area of research.\n",
          "url": "https://www.nature.com/articles/s41467-022-31502-1"
        },
        {
          "title": "A systematic framework for understanding the microbiome ...",
          "author": "Ma; Ziqi; Zuo; Tao; Frey; Norbert; Rangrez; Ashraf Yusuf",
          "published_date": "2024-09-23T00:00:00+00:00",
          "summary": "No, a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.  While significant progress has been made through projects like the Human Microbiome Project and others mentioned in the article (MetaHIT, AGP, DMP),  research is ongoing.  The article highlights advancements in sequencing and AI that are improving understanding, but a comprehensive map remains elusive.  The complexity of the microbiome and its interaction with the human genome makes this a challenging undertaking.\n",
          "url": "https://www.nature.com/articles/s41392-024-01946-6"
        },
        {
          "title": "Human Microbiome Project",
          "author": "Credit",
          "published_date": "2024-06-01T00:00:00+00:00",
          "summary": "No, the entire human microbiome has not been fully mapped, nor has its complete impact on health and disease been determined.  The Human Microbiome Project aims to characterize the microbiome and its role in health and disease. While significant progress has been made using metagenomics (analyzing genetic material without culturing microbes),  a large percentage of microorganisms remain unidentified and uncultivated.  The project has revealed the vast diversity and importance of the microbiome, but comprehensive mapping and understanding of its full impact are ongoing research areas.\n",
          "url": "https://www.bcm.edu/departments/molecular-virology-and-microbiology/research/human-microbiome-project"
        },
        {
          "title": "Unraveling the Microbiome\u2013Human Body Axis",
          "author": "Stelu\u021ba Constan\u021ba Boroghin\u0103",
          "published_date": "2024-05-20T00:00:00+00:00",
          "summary": "This review article examines the human microbiome and its therapeutic implications, but it does not claim to have mapped the *entire* human microbiome or its complete impact on health and disease.  The authors discuss therapeutic strategies and interactions related to the microbiome, indicating that research in this area is ongoing and comprehensive mapping remains a future goal.\n",
          "url": "https://www.mdpi.com/1422-0067/25/10/5561"
        },
        {
          "title": "How the microbiome affects human health, explained",
          "author": "mheslinga",
          "published_date": "2023-06-21T21:24:10+00:00",
          "summary": "No, a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.  While research, such as that at the University of Chicago, is significantly advancing our understanding of the microbiome (the bacteria, viruses, and fungi inhabiting our bodies),  it remains largely unexplored.  Scientists are cataloging the microbiome and investigating its role in various aspects of health, including metabolism, disease susceptibility, and treatment response, but a comprehensive understanding is still developing.\n",
          "url": "https://news.uchicago.edu/explainer/how-microbiome-affects-human-health-explained"
        }
      ],
      "full_explanation": "Based on the provided papers, a complete map of the entire human microbiome and its full impact on health and disease has not yet been achieved. While significant progress has been made in understanding the microbiome, particularly the gut microbiome, a comprehensive mapping remains a goal for future research. Several papers explicitly state this:\n\n*   The *Nature Communications* paper titled \"An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species\" (URL: https://www.nature.com/articles/s41467-022-31502-1) explicitly states that while their research \"significantly improves our understanding of the gut microbiome\u2026 the entire human microbiome remains incompletely mapped.\" This is repeated in another paper of the same name, with the same authors, and with the same URL.\n*   The *PNAS* paper \"Microbiome-associated human genetic variants impact phenome-wide disease risk\" (URL: https://www.pnas.org/doi/full/10.1073/pnas.2200551119) indicates that while associations between microbiome variants and disease are being uncovered, \"it doesn't represent a complete map of the entire human microbiome and its effects.\"\n*   The paper titled \"Current understanding of the human microbiome\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7043356/) clearly states, \"a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.\" It also mentions the challenge of understanding \"the complexities of this relationship\" due to the diversity of species and individual variations.\n*   The article \"A systematic framework for understanding the microbiome\" (URL: https://www.nature.com/articles/s41392-024-01946-6) notes \"a complete map remains elusive\", despite advancements from projects like the Human Microbiome Project.\n*   The \"Human Microbiome Project\" summary (URL: https://www.bcm.edu/departments/molecular-virology-and-microbiology/research/human-microbiome-project) also states that \"the entire human microbiome has not been fully mapped, nor has its complete impact on health and disease been determined.\" It further explains that while metagenomics has helped, many microorganisms are still unidentified.\n*   The \"How the microbiome affects human health, explained\" article (URL: https://news.uchicago.edu/explainer/how-microbiome-affects-human-health-explained) reinforces the idea that the microbiome \"remains largely unexplored\" and that while researchers are cataloging it, \"a comprehensive understanding is still developing\".\n*   The review article \"Unraveling the Microbiome\u2013Human Body Axis\" (URL: https://www.mdpi.com/1422-0067/25/10/5561) discusses ongoing research into therapeutic strategies but doesn't claim a complete mapping has been achieved.\n\nWhile the NIH Human Microbiome Project (URL: https://www.nih.gov/news-events/news-releases/nih-human-microbiome-project-defines-normal-bacterial-makeup-body) did create a reference database, it acknowledges the need for further research to fully understand the microbiome's complexity. The other research papers similarly indicate that while significant advancements are being made, no complete map of the microbiome and its full impact on health exists."
    },
    {
      "question": "Has anyone used language models, agents, or RL to automate coffee production?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Towards autonomous system: flexible modular production system enhanced with large language model agents",
          "author": "[Submitted on 28 Apr 2023 (v1), last revised 24 Jul 2023 (this version, v4)]",
          "published_date": "2023-04-28T00:00:00+00:00",
          "summary": "This research paper explores using large language models (LLMs) and agents to automate a modular production system.  While it doesn't focus on coffee production, it demonstrates a framework where LLMs interpret information from a digital twin of a production system and control it via service interfaces to execute tasks. The system can handle unplanned tasks and orchestrate sequences of actions to complete them.  The authors present a prototype and discuss its potential for agile and flexible production processes in smart factories.  The research is relevant to your query as it shows the application of LLMs and agents in automating industrial processes, suggesting the potential for similar approaches in automating coffee production.  A GitHub link to a demo is provided.\n",
          "url": "https://arxiv.org/abs/2304.14721"
        },
        {
          "title": "Economical-Epidemiological Analysis of the Coffee Trees Rust Pandemic",
          "author": "T. Lazebnik,A. Rosenfeld,A. Alexi,Labib Shami",
          "published_date": "2023-10-26T19:30:23.489000+00:00",
          "summary": "This paper models the economic and epidemiological effects of coffee leaf rust in Colombia using agent-based simulation and a deep reinforcement learning agent to find near-optimal pandemic intervention policies.  While it focuses on managing the disease, not automating production itself, the use of reinforcement learning to optimize pandemic response strategies represents a related application of AI to coffee farming.  The study does *not* directly address automation of coffee production.\n",
          "url": "https://arxiv.org/pdf/2304.14515.pdf"
        },
        {
          "title": "Computer Vision-Aided Intelligent Monitoring of Coffee: Towards Sustainable Coffee Production",
          "author": "F. Eron,M. Noman,Raphael Ricon de Oliveira,Deigo de Souza Marques,R. Durelli,Andre Pimenta Freire,A. C. Junior",
          "published_date": "2023-10-26T19:31:20.662000+00:00",
          "summary": "This research uses the YOLOv7 machine learning algorithm (a convolutional neural network) to analyze images of coffee plants to predict harvest time, estimate yield and quality, and assess plant health.  While it doesn't employ language models, agents, or reinforcement learning (RL), it does represent an AI-driven approach to automating aspects of coffee production monitoring through image processing and a mobile application (\"CoffeApp\").  The study focuses on improving the efficiency and accuracy of data annotation using a semi-supervised method and achieves a high mean average precision (mAP@.5) of 0.89.\n",
          "url": "https://arxiv.org/pdf/2304.04966.pdf"
        },
        {
          "title": "tmgthb/Autonomous-Agents - GitHub",
          "author": "tmgthb",
          "published_date": "2023-09-16T15:09:48+00:00",
          "summary": "This GitHub repository collects research papers on autonomous agents and LLMs, but doesn't contain information about using language models, agents, or reinforcement learning to automate coffee production.  The papers focus on areas such as LLM safety (GuardAgent), multi-agent software development, benchmarking LLM performance, jailbreaking attacks, and the security and privacy of LLMs.\n",
          "url": "https://github.com/tmgthb/Autonomous-Agents"
        },
        {
          "title": "Autonomous Evaluation and Refinement of Digital Agents - arXiv",
          "author": "",
          "published_date": "2022-02-15T00:00:00+00:00",
          "summary": "This arXiv paper does not discuss the use of language models, agents, or reinforcement learning in automating coffee production.  The provided text is primarily metadata and acknowledgments, lacking any substantive content related to the search query.\n",
          "url": "https://arxiv.org/html/2404.06474v2"
        },
        {
          "title": "(PDF) Machine Learning Techniques for Coffee Classification",
          "author": "",
          "published_date": "2024-06-18T00:00:00+00:00",
          "summary": "This research paper reviews the application of machine learning (ML) techniques for coffee classification, covering aspects like maturity, roast intensity, disease identification, and flavor profiles.  While it focuses on classification rather than automation of production, the use of ML suggests a potential pathway towards automating certain aspects of coffee production in the future.  The paper does not directly address the use of language models, agents, or reinforcement learning (RL) for automating coffee production.\n",
          "url": "https://www.researchgate.net/publication/381632661_Machine_Learning_Techniques_for_Coffee_Classification_A_Comprehensive_Review_of_Scientific_Research"
        },
        {
          "title": "Better language models and their implications - OpenAI",
          "author": "",
          "published_date": "2024-04-24T00:00:00+00:00",
          "summary": "This webpage discusses OpenAI's GPT-2 language model and its advancements, including its performance on various language modeling tasks.  It does not contain information about the use of language models, agents, or reinforcement learning (RL) to automate coffee production.\n",
          "url": "https://openai.com/index/better-language-models"
        },
        {
          "title": "Game On: Towards Language Models as RL Experimenters - arXiv",
          "author": "Zhang; Jingwei; Lampe; Thomas; Abdolmaleki; Abbas; Springenberg; Jost Tobias; Riedmiller; Martin",
          "published_date": "2024-09-05T00:00:00+00:00",
          "summary": "This research paper explores using a Vision-Language Model (VLM) and reinforcement learning (RL) to automate the *experimentation process* in embodied agent control, not the production of coffee.  The system uses a VLM to monitor experiments, propose new tasks, decompose complex tasks into subtasks, and retrieve relevant skills, effectively creating an automated curriculum for the RL agent.  The paper demonstrates the feasibility of this approach in a robotics domain, but does not address the automation of coffee production.\n",
          "url": "https://arxiv.org/abs/2409.03402"
        },
        {
          "title": "Do Large Language Models Understand Us? | Daedalus | MIT Press",
          "author": "y Arcas, Blaise Ag\u00fcera",
          "published_date": "2022-05-01T00:00:00+00:00",
          "summary": "This article discusses the capabilities of large language models (LLMs) and their potential for understanding and consciousness, not the automation of coffee production.  The query is unrelated to the article's content.\n",
          "url": "https://direct.mit.edu/daed/article/151/2/183/110604/Do-Large-Language-Models-Understand-Us"
        },
        {
          "title": "Artificial Intelligence to Automate Network Meta-Analyses - PubMed",
          "author": "Tim Reason 1 ,",
          "published_date": "2024-01-05T00:00:00+00:00",
          "summary": "This research does not pertain to automating coffee production.  It focuses on using large language models (LLMs) to automate network meta-analyses (NMAs) in medical research.  The study used GPT-4 to automate data extraction, R script generation for NMAs, and result interpretation across four case studies, achieving over 99% accuracy in data extraction.  While the study explores AI automation in a healthcare setting, it is unrelated to the application of language models, agents, or reinforcement learning in the context of coffee production.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38340277/"
        }
      ],
      "full_explanation": "While some papers explore the application of AI in coffee-related areas, none directly address the use of language models, agents, or reinforcement learning (RL) to automate the *entire process* of coffee production.\n\nThe most relevant paper is \"Towards autonomous system: flexible modular production system enhanced with large language model agents\" (https://arxiv.org/abs/2304.14721). This paper demonstrates how LLMs and agents can be used to control a modular production system, handling unplanned tasks and orchestrating sequences of actions. Though not specifically about coffee, it shows the *potential* for such an approach to be applied to coffee production. However, it doesn't state that this has been done.\n\nOther papers use AI in coffee-related fields, but they do not use language models, agents, or RL to automate production. \"Economical-Epidemiological Analysis of the Coffee Trees Rust Pandemic\" (https://arxiv.org/pdf/2304.14515.pdf) uses reinforcement learning, but to optimize pandemic response, not to automate coffee production itself. Similarly, \"Computer Vision-Aided Intelligent Monitoring of Coffee: Towards Sustainable Coffee Production\" (https://arxiv.org/pdf/2304.04966.pdf) uses machine learning (computer vision) to improve monitoring and data collection but does not automate the actual production. \"Machine Learning Techniques for Coffee Classification\" (https://www.researchgate.net/publication/381632661_Machine_Learning_Techniques_for_Coffee_Classification_A_Comprehensive_Review_of_Scientific_Research) focuses on classification tasks, not automation of production.\n\nFinally, \"Game On: Towards Language Models as RL Experimenters\" (https://arxiv.org/abs/2409.03402) explores the use of VLM and RL to automate the *experimentation process* in embodied agent control. It is not focused on coffee production. The remaining papers are not relevant as they are about either: a collection of papers related to agents and LLMs, but not applied to coffee production (https://github.com/tmgthb/Autonomous-Agents), autonomous evaluation of digital agents (https://arxiv.org/html/2404.06474v2), language model development (https://openai.com/index/better-language-models), the understanding capabilities of LLMs (https://direct.mit.edu/daed/article/151/2/183/110604/Do-Large-Language-Models-Understand-Us) and LLMs used for meta-analysis in a medical context (https://pubmed.ncbi.nlm.nih.gov/38340277/).\n\nTherefore, based on the provided papers, no research has been done that directly uses language models, agents, or RL to automate coffee production."
    },
    {
      "question": "Has anyone ever created a bacteria composed entirely of non-natural stereoisomers? \"Mirror life\" as some call it?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Tempo-spatial chirogenesis. Limonene-induced mirror symmetry breaking of SiSi bond polymers during aggregation in chiral fluidic media",
          "author": "Michiya  Fujiki, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan, fujikim@ms.naist.jp, Keisuke  Yoshida, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan, Nozomu  Suzuki, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan, Nor Azura Abdul Rahim, Jalilah Abd Jalil, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan",
          "published_date": "2023-11-09T20:15:46.405000+00:00",
          "summary": "This research does not involve creating bacteria or \"mirror life\" composed entirely of non-natural stereoisomers.  Instead, the study investigates how the chirality of limonene and \u03b1-pinene affects the formation of chiral polymer aggregates.  The researchers induced chirality in achiral polysilane polymers through aggregation in a chiral fluidic medium, demonstrating that the chirality of the surrounding environment influences the resulting polymer structure.  This work explores chirality at the molecular level in synthetic polymers, not the creation of living organisms with inverted chirality.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S101060301600023X"
        },
        {
          "title": "Resonance in Chirogenesis and Photochirogenesis: Colloidal Polymers Meet Chiral Optofluidics",
          "author": "Michiya  Fujiki, fujikim@ms.naist.jp, Rui  Tamura, Ivan  Fernandez-Corbaton",
          "published_date": "2023-11-09T20:33:41.663000+00:00",
          "summary": "This research paper does not discuss the creation of bacteria composed entirely of non-natural stereoisomers (\"mirror life\").  The study focuses on using colloidal polymers in an optofluidic medium to achieve controlled chirality (handedness) through resonance effects, manipulating circular dichroism and other chiroptical properties. While relevant to the broader concept of chirality and its importance in biological systems, it does not address the creation of artificial life forms with inverted chirality.\n",
          "url": "https://www.mdpi.com/2073-8994/13/2/199"
        },
        {
          "title": "Spontaneous mirror symmetry breaking in heterocatalytically coupled enantioselective replicators\u2020 \u2020Electronic supplementary information (ESI) available: Methods and text on stability analysis. Five figures showing simulation examples. See DOI: 10.1039/c6sc02446g Click here for additional data file.",
          "author": "J. Rib\u00f3,J. Crusats,Z. El-Hachemi,A. Moyano,D. Hochberg",
          "published_date": "2023-10-26T19:31:58.697000+00:00",
          "summary": "This research paper does not discuss the creation of bacteria composed entirely of non-natural stereoisomers.  The study focuses on computational simulations of spontaneous mirror symmetry breaking in chemical systems, exploring conditions under which a racemic mixture of chiral molecules transitions to a homochiral state.  While relevant to the concept of \"mirror life,\" the research is theoretical and does not involve the creation of any biological organisms.\n",
          "url": "https://pubs.rsc.org/en/content/articlepdf/2017/sc/c6sc02446g"
        },
        {
          "title": "Leading Scientists Urge Ban On Developing 'Mirror-Image' ...",
          "author": "BeauHD; Desist Dept",
          "published_date": "2024-12-12T00:00:00+00:00",
          "summary": "No, no one has yet created bacteria composed entirely of non-natural stereoisomers (\"mirror life\").  However, a group of leading scientists published a commentary in *Science* urging a ban on research aimed at creating such bacteria due to the potentially catastrophic consequences of a global pandemic that would be impossible to defend against. While mirror-image amino acids and peptides have been used in some drugs, creating a self-replicating organism remains a distant prospect (at least a decade away, according to the authors), but they still advocate for a preemptive ban.\n",
          "url": "https://science.slashdot.org/story/24/12/13/0014232/leading-scientists-urge-ban-on-developing-mirror-image-bacteria?utm_source=rss1.0mainlinkanon&utm_medium=feed"
        },
        {
          "title": "Biomolecular Significance of Homochirality: The Origin ...",
          "author": "",
          "published_date": "2012-09-01T00:00:00+00:00",
          "summary": "This research paper discusses the homochirality of life (the preference for L-amino acids and D-sugars), exploring its origin and potential influences like circularly polarized radiation and parity violation.  It does *not* address the creation of bacteria using non-natural stereoisomers (\"mirror life\").  The paper focuses on the naturally occurring chirality of life and the theoretical exploration of its origins, not on artificial creation of mirror-image life forms.\n",
          "url": "https://www.researchgate.net/publication/286221247_82_Perspective_and_Concepts_Biomolecular_Significance_of_Homochirality_The_Origin_of_the_Homochiral_Signature_of_Life"
        },
        {
          "title": "Mirror image proteins",
          "author": "",
          "published_date": "2014-10-01T00:00:00+00:00",
          "summary": "Research has explored creating mirror-image proteins using unnatural D-amino acids and glycine.  This includes attempts to synthesize mirror-image bacteria, such as a D-form of *E. coli*, although the text doesn't confirm complete success.  The goal is to create \"mirror life\" for therapeutic applications and studying pathogens without harming humans.  While the paper details advances in techniques like chiral synthesis, the creation of a fully non-natural stereoisomer bacteria isn't explicitly stated as achieved.\n",
          "url": "https://www.researchgate.net/publication/266397602_Mirror_image_proteins"
        },
        {
          "title": "Young Academy of India",
          "author": "",
          "published_date": null,
          "summary": "The provided text is unintelligible and does not contain information relevant to the user's query about the creation of bacteria composed entirely of non-natural stereoisomers (\"mirror life\").  Therefore, no summary can be provided that answers the user's question.\n",
          "url": "https://www.facebook.com/groups/youngacademyofindia/"
        }
      ],
      "full_explanation": "While research is being conducted on aspects related to chirality and the potential for \"mirror life,\" no one has yet successfully created a bacteria composed entirely of non-natural stereoisomers. The provided papers, while interesting, do not describe this achievement. Specifically:\n\n*   The papers \"Tempo-spatial chirogenesis. Limonene-induced mirror symmetry breaking of SiSi bond polymers during aggregation in chiral fluidic media\" (https://www.sciencedirect.com/science/article/pii/S101060301600023X) and \"Resonance in Chirogenesis and Photochirogenesis: Colloidal Polymers Meet Chiral Optofluidics\" (https://www.mdpi.com/2073-8994/13/2/199) focus on the manipulation of chirality in synthetic polymers using chiral environments and optofluidic mediums. These studies are about inducing or observing chirality in non-biological molecules, not creating life with inverted chirality.\n*   The paper \"Spontaneous mirror symmetry breaking in heterocatalytically coupled enantioselective replicators\" (https://pubs.rsc.org/en/content/articlepdf/2017/sc/c6sc02446g) explores the theoretical basis for homochirality through simulations, but it does not involve creating any living organisms.\n*   The paper \"Leading Scientists Urge Ban On Developing 'Mirror-Image'...\" (https://science.slashdot.org/story/24/12/13/0014232/leading-scientists-urge-ban-on-developing-mirror-image-bacteria?utm_source=rss1.0mainlinkanon&utm_medium=feed) explicitly states that while \"mirror-image\" amino acids and peptides exist, the creation of a self-replicating mirror-image organism has not been achieved and is a subject of concern and discussion amongst scientists.\n*   The paper \"Mirror image proteins\" (https://www.researchgate.net/publication/266397602_Mirror_image_proteins) does mention that research has explored creating mirror-image proteins and attempts to create a D-form of *E. coli*, but it does *not* confirm the full and successful creation of a bacteria composed entirely of non-natural stereoisomers, only that it is an area of research. It states the goal is to create 'mirror life' without stating that it has been achieved.\n\nIn summary, although there is significant theoretical and experimental work related to chirality and the manipulation of molecular handedness, the creation of a self-replicating bacteria composed entirely of non-natural stereoisomers remains an unrealized goal."
    },
    {
      "question": "Has anyone made an effective HIV vaccine?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Triggering rare HIV antibodies by vaccination",
          "author": "Penny L Moore",
          "published_date": "2023-02-27T23:21:54.662000+00:00",
          "summary": "No effective HIV vaccine currently exists.  While a recent clinical trial showed that a germline-targeting vaccine elicited rare, broadly neutralizing antibodies (bnAbs) \u2014 a key step towards an effective vaccine \u2014  much more research is needed.  The trial provides a proof of concept, offering valuable insights for designing future vaccine trials.  The urgency is highlighted by the high rate of new HIV infections, especially among young women in sub-Saharan Africa.\n",
          "url": "https://www.science.org/doi/10.1126/science.adf3722?cookieSet=1"
        },
        {
          "title": "A multiclade env\u2013gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques - Nature Medicine",
          "author": "Zhang; Peng; Narayanan; Elisabeth; Liu; Qingbo; Tsybovsky; Yaroslav; Boswell; Kristin; Ding; Shilei; Hu; Zonghui; Follmann; Dean; Lin; Yin; Miao; Schmeisser; Hana; Rogers; Denise; Falcone; Samantha; Elbashir; Sayda M; Presnyak; Vladimir; Bahl; Kapil; Prabhakaran; Madhu; Chen; Xuejun; Sarfo; Edward K; Ambrozak; David R; Gautam; Rajeev; Martin; Malcom A; Swerczek; Joanna; Herbert; Richard; Weiss; Deborah; Misamore; Johnathan; Ciaramella; Giuseppe; Himansu; Sunny; Stewart-Jones; Guillaume; McDermott; Adrian; Koup; Mascola; John R; Finzi; Andr\u00e9s; Carfi; Andrea; Fauci; Anthony S; Lusso; Paolo",
          "published_date": "2023-02-07T21:14:57.779000+00:00",
          "summary": "No effective HIV vaccine has yet been developed despite over four decades of research.  While some preclinical studies show promise, including one that elicited tier-2 HIV-1-neutralizing antibodies and reduced SHIV infection risk in macaques,  no vaccine has achieved significant protection in humans.  The RV144 trial in Thailand showed only ~30% efficacy, and this result hasn't been replicated.  The challenges remain substantial, including HIV's high antigenic variability and the difficulty in eliciting broadly neutralizing antibodies.\n",
          "url": "https://www.nature.com/articles/s41591-021-01574-5"
        },
        {
          "title": "Progress in HIV-1 vaccine development.",
          "author": "Barton F Haynes, hayne002@mc.duke.edu, M Anthony Moody, Munir  Alam, Mattia  Bonsignori, Laurent  Verkoczy, Guido  Ferrari, Feng  Gao, Georgia D Tomaras, Hua-Xin  Liao, Garnett  Kelsoe",
          "published_date": "2023-11-09T20:07:47.988000+00:00",
          "summary": "No, an effective HIV-1 vaccine has not yet been developed.  While significant progress has been made in understanding HIV-1 and identifying potential vaccine targets (e.g., envelope targets, CD8+ T cells), a 2013 efficacy trial failed to prevent infection.  The development of an effective vaccine remains years away.\n",
          "url": "https://jacionline.org/retrieve/pii/S0091674914006009"
        },
        {
          "title": "HIV vaccine: Can it be developed in the 21st century? - PMC",
          "author": "",
          "published_date": "2015-07-25T00:00:00+00:00",
          "summary": "No, there is currently no effective HIV vaccine.  While research is ongoing and there is hope for future development,  no vaccine has yet been proven to protect against HIV infection.  Antiretroviral drugs are available to treat HIV, enabling those infected to live long and healthy lives.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4962743/#:~:text=This%20US.,HIV%2Dinfected%20were%20placebo%20recipients."
        },
        {
          "title": "NIH research identifies opportunities to improve future HIV ...",
          "author": "",
          "published_date": "2023-12-15T17:24:37+00:00",
          "summary": "No, an effective HIV vaccine has not yet been developed.  While research has identified that strong CD8+ T-cell responses are crucial for HIV immunity, previous vaccine candidates, despite generating CD8+ T cells, failed to adequately stimulate these cells to destroy HIV-infected cells.  This suggests that future vaccine development needs to focus on enhancing CD8+ T-cell function and sensitivity, not just quantity.\n",
          "url": "https://www.nih.gov/news-events/news-releases/nih-research-identifies-opportunities-improve-future-hiv-vaccine-candidates"
        },
        {
          "title": "Encouraging First-in-Human Results for a Promising HIV ...",
          "author": "",
          "published_date": "2023-06-08T00:00:00+00:00",
          "summary": "No, there is not yet an FDA-approved HIV vaccine.  However, encouraging early results from a first-in-human trial of an experimental HIV nanoparticle vaccine show it to be safe and capable of eliciting a robust immune response in nearly all participants.  While this vaccine alone won't offer complete protection and is intended as part of a larger regimen, the results are promising in the ongoing search for an effective HIV vaccine.\n",
          "url": "https://www.hiv.gov/blog/encouraging-first-in-human-results-for-a-promising-hiv-vaccine"
        },
        {
          "title": "HIV Vaccines",
          "author": "",
          "published_date": "2024-03-04T18:06:01+00:00",
          "summary": "No effective HIV vaccine currently exists.  While research has made significant progress, including the discovery of broadly neutralizing antibodies (bnAbs) that can block HIV infection in some cases (even showing promise in clinical trials),  no vaccine has yet been developed that provides widespread protection against HIV infection.  Many scientific challenges remain, including HIV's ability to evade the immune system and its high genetic variability.  Scientists are actively pursuing new approaches, focusing on eliciting bnAbs through vaccination, but an effective vaccine remains elusive.\n",
          "url": "https://www.iavi.org/our-work/hiv-vaccines/"
        },
        {
          "title": "A brief history of the global effort to develop a preventive ...",
          "author": "Author links open overlay panel Jos\u00e9 Esparza",
          "published_date": "2023-02-23T05:43:24.073000+00:00",
          "summary": "No effective preventive HIV vaccine currently exists.  While significant global efforts have been underway since the 1980s, exploring different approaches like inducing neutralizing antibodies and cell-mediated immunity,  efficacy trials have consistently failed to demonstrate protection.  The RV144 trial in Thailand showed some modest success, offering hope for new research paradigms, but no fully effective vaccine has resulted.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0264410X13005963"
        },
        {
          "title": "Why Don't We Have an HIV Vaccine? | Johns Hopkins",
          "author": "",
          "published_date": "2022-11-30T15:35:09+00:00",
          "summary": "No, there is not yet an effective HIV vaccine.  The virus's ability to constantly change its shape makes it difficult for vaccines to work.  Additionally, the virus integrates into the host's DNA, limiting the types of vaccines that can be safely used.  While research continues,  a vaccine is not expected by 2030.  Currently, PrEP and new monoclonal antibody therapies offer some protection.\n",
          "url": "https://publichealth.jhu.edu/2022/why-dont-we-have-an-hiv-vaccine"
        },
        {
          "title": "40 years of AIDS vaccine research",
          "author": "",
          "published_date": "2024-01-08T20:55:53+00:00",
          "summary": "No effective HIV vaccine currently exists.  While significant progress has been made in HIV/AIDS treatment and prevention (including antiretroviral therapy and pre-exposure prophylaxis),  40 years of research has yet to yield a successful vaccine.  The text highlights the ongoing challenges in inducing effective immunity against the virus, although research continues and offers hope for future breakthroughs.\n",
          "url": "https://www.iavi.org/iavi-report/40-years-of-aids-vaccine-research/"
        }
      ],
      "full_explanation": "All the provided papers consistently state that an effective HIV vaccine has not yet been developed. While significant research and progress have been made, no vaccine has been proven to provide widespread protection against HIV infection. Several papers explicitly state that \"no effective HIV vaccine currently exists\" ([https://www.science.org/doi/10.1126/science.adf3722?cookieSet=1](https://www.science.org/doi/10.1126/science.adf3722?cookieSet=1), [https://www.iavi.org/our-work/hiv-vaccines/](https://www.iavi.org/our-work/hiv-vaccines/), [https://www.iavi.org/iavi-report/40-years-of-aids-vaccine-research/](https://www.iavi.org/iavi-report/40-years-of-aids-vaccine-research/)). Papers also note the challenges, including HIV's high variability, its ability to evade the immune system and the difficulty in inducing broadly neutralizing antibodies ([https://www.nature.com/articles/s41591-021-01574-5](https://www.nature.com/articles/s41591-021-01574-5), [https://www.iavi.org/our-work/hiv-vaccines/](https://www.iavi.org/our-work/hiv-vaccines/), [https://publichealth.jhu.edu/2022/why-dont-we-have-an-hiv-vaccine](https://publichealth.jhu.edu/2022/why-dont-we-have-an-hiv-vaccine)). Furthermore, the provided papers state that trials, while showing some promise in certain cases, have not resulted in a broadly effective vaccine ([https://www.nature.com/articles/s41591-021-01574-5](https://www.nature.com/articles/s41591-021-01574-5), [https://www.sciencedirect.com/science/article/pii/S0264410X13005963](https://www.sciencedirect.com/science/article/pii/S0264410X13005963)). One paper notes that an experimental vaccine showed promising early results but it is not yet an FDA-approved and effective vaccine, and is only intended as a part of a larger treatment regimen ([https://www.hiv.gov/blog/encouraging-first-in-human-results-for-a-promising-hiv-vaccine](https://www.hiv.gov/blog/encouraging-first-in-human-results-for-a-promising-hiv-vaccine)). Another paper highlights that despite promising CD8+ T cell responses, previous vaccines have not been effective, implying the need to focus on improving function rather than just quantity ([https://www.nih.gov/news-events/news-releases/nih-research-identifies-opportunities-improve-future-hiv-vaccine-candidates](https://www.nih.gov/news-events/news-releases/nih-research-identifies-opportunities-improve-future-hiv-vaccine-candidates)). The cumulative evidence from the papers strongly indicates that no effective HIV vaccine has been developed thus far."
    },
    {
      "question": "Has anyone showed an effective nootropic in an RCT?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Acute effects of a chewable beetroot-based supplement on cognitive performance: a double-blind randomized placebo-controlled crossover clinical trial",
          "author": "Vaccaro; Maria Grazia; Innocenti; Bernardo; Cione; Erika; Gallelli; Luca; De Sarro; Giovambattista; Bonilla; Diego A; Cannataro; Roberto",
          "published_date": "2023-10-24T00:00:00+00:00",
          "summary": "A double-blind, placebo-controlled crossover trial (RCT) showed that a chewable beetroot-based supplement significantly improved memory consolidation (short and long-term) and aspects of frontal lobe function and cognitive flexibility in healthy adults.  The improvement was observed 90 minutes after ingestion.  While other cognitive functions were not significantly impacted, this study demonstrates a positive effect of a beetroot supplement on certain cognitive abilities in an RCT setting.\n",
          "url": "https://link.springer.com/article/10.1007/s00394-023-03265-y"
        },
        {
          "title": "Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers",
          "author": "Hartmann; Helena; Forkmann; Katarina; Schmidt; Katharina; Kleine-Borgmann; Julian; Albers; Johanna; Wiech; Katja; Bingel; Ulrike",
          "published_date": "2023-11-09T00:00:00+00:00",
          "summary": "This study investigated whether open-label placebo treatment, where participants are aware the treatment is inert, could enhance cognitive abilities.  The results showed no improvement in objective cognitive performance measures, despite previous research suggesting that positive expectations (often involving deception) *might* improve subjective performance.  Therefore, this RCT provides no evidence supporting the effectiveness of this type of placebo as a nootropic.  The study does not address the effectiveness of other nootropics.\n",
          "url": "https://www.nature.com/articles/s41598-023-45979-3"
        },
        {
          "title": "Efficacy of a nootropic spearmint extract on reactive agility: a randomized, double-blind, placebo-controlled, parallel trial - PubMed",
          "author": "Paul H Falcone 1 ,",
          "published_date": "2018-12-12T00:00:00+00:00",
          "summary": "Yes, a randomized, double-blind, placebo-controlled trial (RCT) showed a proprietary spearmint extract (containing at least 14.5% rosmarinic acid and 24% total phenolic content) improved reactive agility.  While the study focused on reactive agility, not general cognitive function, it suggests a positive nootropic effect from this specific spearmint extract.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30541572/?dopt=Abstract"
        },
        {
          "title": "Effectiveness of Nootropics in Combination with ...",
          "author": "",
          "published_date": "2022-08-09T00:00:00+00:00",
          "summary": "This study using real-world data (not a randomized controlled trial, RCT) investigated the combined effectiveness of cholinesterase inhibitors (ChEIs) and nootropics in treating mild-to-moderate dementia.  While overall cognitive function (measured by MMSE) didn't significantly improve with the combination compared to ChEIs alone,  in patients with Alzheimer's disease, the combination group showed less deterioration in language skills.  Specifically, choline alfoscerate and ginkgo biloba showed the most significant improvement in language scores within this subgroup.  The authors emphasize the need for well-controlled studies (like RCTs) to confirm these findings.  Therefore, the study does not definitively demonstrate an effective nootropic in an RCT setting.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9409895/"
        },
        {
          "title": "The effectiveness of Bacopa monnieri (Linn.) Wettst. as a ...",
          "author": "James M Brimson, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, Sirikalaya  Brimson, Chulalongkorn University, 10330, Bangkok, Thailand, Mani Iyer Prasanth, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, Premrutai  Thitilertdecha, Siriraj Research Group in Immunobiology and Therapeutic Sciences, Mahidol University, Bangkok, Thailand, Dicson Sheeja Malar, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, Tewin  Tencomnao, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, tewin.t@chula.ac.th",
          "published_date": "2023-11-09T20:32:26.308000+00:00",
          "summary": "A meta-analysis of studies on *Bacopa monnieri* found limited evidence of its effectiveness as a nootropic.  While some studies showed modest improvements in memory tasks in healthy subjects and those with memory loss, few reached statistical significance, and no two studies showed significant effects on the same tests.  The review concludes that more research, including randomized controlled trials (RCTs) comparing *B. monnieri* to standard drugs, is needed to confirm its nootropic effects.  Therefore, based on this meta-analysis, no definitively effective nootropic has been conclusively demonstrated in an RCT.\n",
          "url": "https://www.nature.com/articles/s41598-020-80045-2"
        },
        {
          "title": "Nootropics as Cognitive Enhancers: Types, Dosage and ...",
          "author": "",
          "published_date": "2022-08-17T00:00:00+00:00",
          "summary": "This review article on nootropics (smart drugs) discusses various types, dosages, and side effects but doesn't cite any randomized controlled trials (RCTs) demonstrating the *effectiveness* of a specific nootropic.  While it mentions that nootropics are often well-tolerated and have low side effect incidence, particularly in those with cognitive impairment,  the long-term effects on healthy individuals remain unknown, and the review focuses on providing an overview of available substances rather than definitive proof of efficacy from RCTs.  Therefore, the answer to your query is no, based on this particular review.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9415189/"
        },
        {
          "title": "The Efficacy of A Nootropic Supplement on Information ...",
          "author": "",
          "published_date": "2023-03-07T00:00:00+00:00",
          "summary": "Yes, a double-blind, placebo-controlled study (RCT) showed that the nootropic supplement Mind Lab Pro significantly improved simple reaction time, choice reaction time, and anticipation in healthy adults compared to a placebo group.  The improvements were statistically significant (p<0.001 for SRT and CRT; p=0.001 for anticipation).\n",
          "url": "https://biomedres.us/pdfs/BJSTR.MS.ID.007746.pdf"
        },
        {
          "title": "A Combination of Nootropic Ingredients (CAF+) Is Not ...",
          "author": "Caldenhove; S; A; Woo; G; Blokland",
          "published_date": "2023-02-06T09:26:20.201000+00:00",
          "summary": "A randomized, double-blind, placebo-controlled crossover study (RCT) found that caffeine improved memory performance and sensorimotor speed in healthy young adults, but a combination nootropic supplement (CAF+), containing caffeine, l-theanine, vinpocetine, l-tyrosine, and B vitamins, did not show a significant cognitive benefit compared to placebo.\n",
          "url": "https://link.springer.com/article/10.1007/s41465-017-0061-0"
        },
        {
          "title": "Nootropics: Types, safety, and risks of smart drugs",
          "author": "How we reviewed this article:",
          "published_date": "2019-09-19T02:00:00+00:00",
          "summary": "The provided text focuses on the types and safety of nootropics, including prescription drugs like Modafinil, Adderall, Ritalin, and Memantine, and non-prescription options such as caffeine and creatine.  It details their uses (e.g., treating ADHD, narcolepsy, Alzheimer's) and potential side effects (high blood pressure, insomnia, addiction). However, the article does *not* discuss the results of any randomized controlled trials (RCTs) demonstrating the effectiveness of any specific nootropic.  Therefore, the answer to your question is not found in this article.\n",
          "url": "https://www.medicalnewstoday.com/articles/326379"
        },
        {
          "title": "Cognitive impairment in opioid use disorders",
          "author": "R.A. Alsulaimani",
          "published_date": "2023-08-01T00:00:00+00:00",
          "summary": "This review article discusses cognitive impairment in opioid use disorder (OUD) and the potential of nootropics to treat it.  While the article details the cognitive deficits associated with OUD (affecting areas like working memory, attention, and decision-making), it does *not* present data from any randomized controlled trials (RCTs) demonstrating the effectiveness of any specific nootropic in treating these cognitive impairments.  Therefore, the answer to your question is no, the article does not cite any RCTs showing an effective nootropic.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178123002858"
        }
      ],
      "full_explanation": "Several studies have shown an effective nootropic in an RCT. \n\nThe paper \"Acute effects of a chewable beetroot-based supplement on cognitive performance: a double-blind randomized placebo-controlled crossover clinical trial\" (URL: https://link.springer.com/article/10.1007/s00394-023-03265-y) demonstrates in a double-blind, placebo-controlled crossover trial (RCT) that a beetroot-based supplement significantly improved memory consolidation and aspects of frontal lobe function and cognitive flexibility in healthy adults.\n\nThe paper \"Efficacy of a nootropic spearmint extract on reactive agility: a randomized, double-blind, placebo-controlled, parallel trial - PubMed\" (URL: https://pubmed.ncbi.nlm.nih.gov/30541572/?dopt=Abstract) also shows that a proprietary spearmint extract improved reactive agility in an RCT setting, which is considered a nootropic effect.\n\nAdditionally, \"The Efficacy of A Nootropic Supplement on Information ...\" (URL: https://biomedres.us/pdfs/BJSTR.MS.ID.007746.pdf) reported in a double-blind, placebo-controlled study (RCT) that the nootropic supplement Mind Lab Pro significantly improved simple reaction time, choice reaction time, and anticipation in healthy adults compared to a placebo group."
    },
    {
      "question": "Has anyone found experimental or observational evidence that explicitly contradicts the dark matter hypothesis?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "A possible tension between galaxy rotational velocity and observed physical properties",
          "author": "L. Shamir,Darius Mcadam",
          "published_date": "2023-10-26T19:31:31.955000+00:00",
          "summary": "This paper presents an observation that may challenge the standard dark matter explanation for galaxy rotation curves.  The authors found a significant brightness difference between galaxies rotating in the same direction as the Milky Way versus those rotating in the opposite direction. This difference is larger than expected from Doppler shifts alone and implies galaxies have far greater rotational velocities than predicted.  The consistency of this observation across multiple telescopes and annotation methods strengthens the finding. While not directly contradicting dark matter, the paper suggests an alternative explanation involving parity violation in the early universe, and notes a correlation with the H\u2080 tension.  The authors acknowledge that this observation requires further investigation and is not definitive proof against dark matter.\n",
          "url": "https://arxiv.org/pdf/2212.04044.pdf"
        },
        {
          "title": "Distinguishing Dark Matter, Modified Gravity, and Modified Inertia with the Inner and Outer Parts of Galactic Rotation Curves",
          "author": "Kyu-Hyun Chae",
          "published_date": "2023-04-13T16:48:35.134000+00:00",
          "summary": "This paper analyzes galaxy rotation curves to compare predictions of cold dark matter (CDM), modified gravity, and modified inertia.  The study finds that modified gravity best fits the observed data, particularly in the inner and outer regions of galaxies.  The results show a discrepancy between CDM predictions and observations, suggesting potential challenges for the CDM hypothesis.  While not explicitly contradictory, the strong agreement of modified gravity with observations could be interpreted as weakening the need for dark matter.\n",
          "url": "https://iopscience.iop.org/article/10.3847/1538-4357/ac93fc"
        },
        {
          "title": "A Candid Assessment of Standard Cosmology",
          "author": "Fulvio Melia",
          "published_date": "2022-12-19T00:00:00+00:00",
          "summary": "This paper argues that the standard cosmological model (\u039bCDM), which incorporates dark matter, is incomplete and possibly wrong.  While \u039bCDM successfully explains some observations, the authors highlight eight major inconsistencies between the model and observations.  These inconsistencies, described in detail in the paper, challenge the viability of \u039bCDM and, by extension, the dark matter hypothesis.  The paper does not present direct experimental contradiction of dark matter, but rather presents a collection of observational discrepancies that collectively cast significant doubt on the model's completeness and accuracy.\n",
          "url": "https://iopscience.iop.org/article/10.1088/1538-3873/aca51f"
        },
        {
          "title": "The Scientific Evidence Against the Big Bang",
          "author": "Ivana Karamitsos",
          "published_date": "2022-06-16T03:33:50+00:00",
          "summary": "This article focuses on evidence contradicting the Big Bang theory, not the dark matter hypothesis.  Therefore, it does not provide an answer to your query.\n",
          "url": "https://www.lppfusion.com/science/cosmic-connection/plasma-cosmology/the-growing-case-against-the-big-bang/"
        },
        {
          "title": "Has a new study disproven dark matter and dark energy?",
          "author": "Ethan Siegel",
          "published_date": "2024-03-29T03:20:06+00:00",
          "summary": "No, a recent study claiming to debunk dark matter hasn't presented experimental or observational evidence that explicitly contradicts the hypothesis.  The author argues that the current cosmological model, incorporating dark matter and dark energy, is strongly supported by numerous independent lines of evidence from various sources. While alternative theories exist, they haven't yet provided a compelling explanation for the observed phenomena as well as the current model.\n",
          "url": "https://bigthink.com/starts-with-a-bang/new-study-disprove-dark-matter-dark-energy/"
        },
        {
          "title": "Study: Dark matter doesn't exist, the universe is 27B years old",
          "author": "",
          "published_date": "2024-10-15T12:04:30+00:00",
          "summary": "A recent study proposes a cosmological model that eliminates the need for dark matter while remaining consistent with key observations.  However, the discussion on Hacker News highlights that this model, while interesting, hasn't yet been experimentally verified.  The post also emphasizes that the absence of evidence for dark matter doesn't equate to evidence of its absence.  While some dark matter candidates have been ruled out through testing, the overall consensus remains that dark matter is the best-fitting model for current observations, despite its limitations.  The study itself doesn't present direct experimental or observational evidence contradicting dark matter; rather, it offers an alternative model.\n",
          "url": "https://news.ycombinator.com/item?id=41847656"
        },
        {
          "title": "Has Dark Matter Finally Been Detected? | Not Even Wrong",
          "author": "Posted on",
          "published_date": "2009-12-18T03:09:54+00:00",
          "summary": "No experimental evidence explicitly contradicts the dark matter hypothesis, but the results from the CDMS experiment, showing two events where 0.8 were expected, are not considered strong evidence for dark matter.  While some initially interpreted the results as potentially exciting, further analysis revealed that they are statistically insignificant (1.5 sigma) and can be explained by background noise.  Furthermore, the lack of a dark matter signal continues to constrain certain supersymmetry models that predict the existence of WIMPs.\n",
          "url": "https://www.math.columbia.edu/~woit/wordpress/?p=2597"
        },
        {
          "title": "Have there been any physics experiments or searches to ...",
          "author": "user129079user129079",
          "published_date": "2016-09-03T05:24:00+00:00",
          "summary": "No experimental or observational evidence explicitly contradicts the dark matter hypothesis. While the nature of dark matter remains unknown, numerous observations (e.g., galactic rotation curves, gravitational lensing) consistently support its existence.  Alternative explanations, such as modified gravity, are considered less likely.  Research continues to investigate dark matter's properties and potential candidates.\n",
          "url": "https://physics.stackexchange.com/questions/277912/have-there-been-any-physics-experiments-or-searches-to-try-to-disprove-the-hypot"
        },
        {
          "title": "What if Dark Matter Doesn't Exist? Unique Prediction ...",
          "author": "Mike O'Neill",
          "published_date": "2023-02-06T17:10:23.957000+00:00",
          "summary": "Yes.  A recent study published in *The Astrophysical Journal* claims to have detected the \"external field effect\" (EFE) in over 150 galaxies.  EFE is a unique prediction of Modified Newtonian Dynamics (MOND), a theory that challenges the dark matter hypothesis by suggesting gravity behaves differently at low accelerations, rather than requiring unseen dark matter.  Researchers found that the observed galactic rotation curves align better with MOND's predictions, including the EFE, which has no equivalent in standard dark matter models.  One researcher stated that this could be \"the smoking gun proving that galaxies are governed by modified dynamics.\"  While the findings are considered surprising and initially met with reluctance, they are presented as strong evidence contradicting the dark matter hypothesis.\n",
          "url": "https://scitechdaily.com/what-if-dark-matter-doesnt-exist-unique-prediction-of-modified-gravity-challenges-dark-matter-hypothesis/"
        },
        {
          "title": "Dark energy might not exist after all",
          "author": "",
          "published_date": "2019-11-30T11:44:00+00:00",
          "summary": "This article discusses a recent paper challenging the existence of dark energy, not dark matter.  The paper questions the analysis of supernova data used to support dark energy, suggesting that corrections applied to the data may lead to inaccurate conclusions about the accelerating expansion of the universe.  The article does not present evidence contradicting the dark matter hypothesis.\n",
          "url": "http://backreaction.blogspot.com/2019/11/dark-energy-might-not-exist-after-all.html"
        }
      ],
      "full_explanation": "Several papers discuss evidence that challenges or contradicts the dark matter hypothesis. \n\n*   **Shamir & Mcadam (2023)** present an observational finding of brightness differences in galaxies rotating in different directions that cannot be explained by Doppler shifts alone. This observation, they argue, implies unexpected rotational velocities that are difficult to reconcile with the standard dark matter model, and they suggest parity violation as a possible alternative. While they do not directly claim to disprove dark matter, this observation is presented as a challenge to the theory, and is suggested as an alternative to dark matter. [https://arxiv.org/pdf/2212.04044.pdf]\n*   **Chae (2023)** analyzes galaxy rotation curves and finds that modified gravity provides a better fit to the data than cold dark matter, particularly in the inner and outer regions of galaxies. The discrepancy between CDM predictions and observations suggests challenges for the CDM model and, whilst not explicitly contradicting the existence of dark matter, it suggests there are viable and potentially more accurate alternatives. [https://iopscience.iop.org/article/10.3847/1538-4357/ac93fc]\n*   **Melia (2022)** highlights inconsistencies between the standard cosmological model (\u039bCDM), which includes dark matter, and observational data. These discrepancies, while not direct experimental contradictions, collectively cast doubt on the completeness and accuracy of the \u039bCDM model and by extension, the dark matter hypothesis. [https://iopscience.iop.org/article/10.1088/1538-3873/aca51f]\n*  **O'Neill (2023)** discusses a study claiming the detection of the \"external field effect\" (EFE) which is a prediction of Modified Newtonian Dynamics (MOND). The researchers found that galactic rotation curves align better with MOND's predictions, including EFE, which has no explanation in dark matter models. This study is presented as potentially contradictory evidence, or a \"smoking gun,\" against the dark matter hypothesis. [https://scitechdaily.com/what-if-dark-matter-doesnt-exist-unique-prediction-of-modified-gravity-challenges-dark-matter-hypothesis/]\n\nIt is also important to note that while some papers, such as those by Siegel (2024), the unknown author of \"Study: Dark matter doesn't exist, the universe is 27B years old\" (2024), and user129079user129079 (2016), argue that there is no experimental or observational evidence that explicitly contradicts the dark matter hypothesis, these papers are responding to existing claims that challenge the theory, which implies that the research question has been addressed. Furthermore, the paper \"Has Dark Matter Finally Been Detected? | Not Even Wrong\" (2009) discusses a failed detection attempt, which whilst not a contradiction, does indicate that the concept of disproving dark matter has been considered."
    },
    {
      "question": "Has anyone had an AI-generated paper accepted at a major journal? ",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Real or Fake Text?: Investigating Human Ability to Detect Boundaries Between Human-Written and Machine-Generated Text",
          "author": "Liam Dugan,Daphne Ippolito,Arun Kirubarajan,Sherry Shi,Chris Callison-Burch",
          "published_date": "2023-10-26T19:32:09.031000+00:00",
          "summary": "This paper does not address whether AI-generated papers have been accepted by major journals.  It focuses on human ability to detect the transition point between human-written and AI-generated text within a document, finding significant variation in human skill at this task.  The researchers created a dataset (RoFT) from a game where participants identify the boundary between human and AI text, analyzing factors like model size and decoding strategy that influence detection accuracy.  While relevant to the broader issue of AI-generated text, the study doesn't directly address journal acceptance of AI-authored papers.\n",
          "url": "https://arxiv.org/pdf/2212.12672.pdf"
        },
        {
          "title": "The death of the short-form physics essay in the coming AI revolution",
          "author": "W. Yeadon,Oto-Obong Inyang,Arin Mizouri,Alex Peach,Craig P. Testrow",
          "published_date": "2023-10-26T19:31:18.436000+00:00",
          "summary": "This paper does not address the acceptance of AI-generated papers in major journals.  Instead, it focuses on the impact of AI on university assessments, specifically showing that AI can generate high-quality, first-class short-form physics essays that bypass plagiarism detection software.  The study found AI-generated essays scored similarly to human-written essays on a university assignment.  The authors conclude that this renders short-form essays an unreliable assessment method.\n",
          "url": "https://arxiv.org/pdf/2212.11661.pdf"
        },
        {
          "title": "Comparing scientific abstracts generated by ChatGPT to original abstracts using an artificial intelligence output detector, plagiarism detector, and blinded human reviewers",
          "author": "View ORCID ProfileCatherine A. Gao",
          "published_date": "2022-12-27T00:00:00+00:00",
          "summary": "This study did not find any AI-generated papers accepted in major journals.  Researchers used ChatGPT to generate scientific abstracts and found that while the AI produced believable text,  it fabricated data and was often detectable by AI output detectors and human reviewers.  The study suggests that journals should incorporate AI detection tools into their editorial processes.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2022.12.23.521610v1.full"
        },
        {
          "title": "What should I do if I suspect one of the journal reviews I got ...",
          "author": "pintorpintor 82311 gold badge22 silver badges88 bronze badges",
          "published_date": "2023-11-30T07:12:00+00:00",
          "summary": "This question asks whether to inform a journal editor about a suspected AI-generated review.  The user suspects AI authorship due to oddly-phrased, abstract-repetitive questions, irrelevant suggested readings, and positive AI detection tool results.  An answer suggests contacting the editor, explaining the suspicions (and their limitations), emphasizing concerns about peer review integrity and intellectual property, and expressing willingness to revise.  The editor will then decide how to proceed.  The original question does *not* address AI-generated *papers* being accepted, only AI-generated *reviews*.\n",
          "url": "https://academia.stackexchange.com/questions/204370/what-should-i-do-if-i-suspect-one-of-the-journal-reviews-i-got-is-ai-generated"
        },
        {
          "title": "Science journals set new authorship guidelines for AI- ...",
          "author": "By Jennifer Harker",
          "published_date": "2023-03-01T00:00:00+00:00",
          "summary": "No, the article states that Science journals have explicitly banned the use of AI-generated text in their publications and prohibit AI as an author.  While some journals are developing policies regarding AI use, none are reported to have accepted a paper with AI-generated text as of the publication date of this article.\n",
          "url": "https://factor.niehs.nih.gov/2023/3/feature/2-artificial-intelligence-ethics"
        },
        {
          "title": "Use of AI Is Seeping Into Academic Journals\u2014and It's ...",
          "author": "Amanda Hoover",
          "published_date": "2023-08-17T11:00:00+00:00",
          "summary": "A peer-reviewed study in *Resources Policy* contained a sentence revealing the authors used an AI language model, though it's unclear if the entire paper was AI-generated.  The journal's publisher, Elsevier, is investigating.  While Elsevier's policies don't prohibit AI use for writing assistance, disclosure is required.  This incident highlights the challenges academic journals face in detecting and managing AI-generated content, with various journals adopting different approaches, ranging from requiring disclosure to prohibiting AI-generated content altogether.  The incident with *Resources Policy* is the closest example found to an AI-generated paper being accepted, but the full extent of AI involvement is still under investigation.\n",
          "url": "https://www.wired.com/story/use-of-ai-is-seeping-into-academic-journals-and-its-proving-difficult-to-detect/"
        },
        {
          "title": "Using Peer Review to Detect AI-Generated Scientific Papers",
          "author": "",
          "published_date": "2023-01-12T00:00:00+00:00",
          "summary": "This article discusses the challenges of AI-generated scientific papers and the potential of peer review to detect them, but it does not address whether any AI-generated papers have been accepted by major journals.  The article highlights concerns about plagiarism, lack of originality, and inconsistencies in AI-written text, suggesting that current peer review processes may need improvement to catch such submissions.  However, it doesn't offer any examples of successful AI-generated paper submissions.\n",
          "url": "http://www.morressier.com/post/using-peer-review-to-detect-ai-generated-scientific-papers"
        },
        {
          "title": "Will Scientific Journals Accept Papers Containing AI ...",
          "author": "Scientific Writing with Karen L. McKee",
          "published_date": "2023-04-27T16:00:31+00:00",
          "summary": "This YouTube video discusses how scientific journals are handling AI-generated text in submitted papers.  While it doesn't report on any AI-generated papers being *accepted*, it reviews the policies of Nature, Elsevier, and Wiley, highlighting that most journals currently disapprove of listing AI as an author.  The video cites articles detailing this disapproval from *Nature* and *Science*.\n",
          "url": "https://www.youtube.com/watch?v=2Ddlzh4IGzU"
        },
        {
          "title": "Scientific Journal Publishes Paper With AI-Generated ...",
          "author": "Molly Campbell",
          "published_date": "2024-03-21T10:58:06+00:00",
          "summary": "Yes.  A scientific paper published in Elsevier's *Surfaces and Interfaces* journal was found to have an AI-generated introduction (\"Certainly, here is a possible introduction for your topic\").  The authors failed to disclose the use of AI, violating Elsevier's policies.  Elsevier is investigating the incident, and the incident has sparked debate on the use of AI in scientific publishing.  The article notes other instances of AI-generated text appearing in peer-reviewed journals.\n",
          "url": "https://www.technologynetworks.com/informatics/news/scientific-journal-publishes-paper-with-ai-generated-introduction-384837"
        },
        {
          "title": "Researchers submitted an academic paper written by ...",
          "author": "Mihai Andrei",
          "published_date": "2023-03-22T12:31:09+00:00",
          "summary": "Yes.  Researchers submitted a ChatGPT-generated paper to *Innovations in Education and Teaching International*, and it passed peer review without detection.  The paper, titled \"Chatting and Cheating,\" addressed the use of AI in academia.  While the journal was eventually informed, the incident highlights the difficulty of detecting AI-generated academic work.\n",
          "url": "https://www.zmescience.com/science/researchers-submitted-an-academic-paper-written-by-chatgpt-to-see-if-it-gets-accepted-it-did/"
        }
      ],
      "full_explanation": "Several papers and news articles indicate that AI-generated papers have been accepted, or at least have slipped through the review process, at major journals. The article \"Use of AI Is Seeping Into Academic Journals\u2014and It's...\" (https://www.wired.com/story/use-of-ai-is-seeping-into-academic-journals-and-its-proving-difficult-to-detect/) details that a paper published in *Resources Policy* contained a sentence revealing the authors used an AI language model, and that Elsevier is investigating the extent of AI use in the paper. While this instance doesn't confirm a fully AI-generated paper, it does suggest that at least parts of papers are being accepted that contain AI-generated text. Moreover, the article \"Scientific Journal Publishes Paper With AI-Generated...\" (https://www.technologynetworks.com/informatics/news/scientific-journal-publishes-paper-with-ai-generated-introduction-384837) reports that a paper in Elsevier's *Surfaces and Interfaces* journal contained an AI-generated introduction that went undetected. Critically, the article \"Researchers submitted an academic paper written by...\" (https://www.zmescience.com/science/researchers-submitted-an-academic-paper-written-by-chatgpt-to-see-if-it-gets-accepted-it-did/) states that a fully AI-generated paper was submitted to *Innovations in Education and Teaching International*, and passed peer review. Therefore, multiple instances confirm that AI-generated papers have indeed been accepted at journals, meeting the terms of the research question."
    },
    {
      "question": "Has anyone shown that eating oreos is good for your health?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover Experiment",
          "author": "William C. Cromwell",
          "published_date": "2024-01-22T00:00:00+00:00",
          "summary": "A case study showed that eating Oreos lowered LDL cholesterol in one individual on a ketogenic diet who had high LDL cholesterol.  This reduction was comparable to, or greater than, that achieved with high-intensity statin therapy.  However, this is a single case study and does not prove that Oreos are generally good for health.  The study participant had a specific condition (lean mass hyper-responder phenotype) characterized by high LDL cholesterol on a ketogenic diet.\n",
          "url": "https://www.mdpi.com/2218-1989/14/1/73"
        },
        {
          "title": "Positive Effects of a Healthy Snack (Fruit) Versus an Unhealthy Snack (Chocolate/Crisps) on Subjective Reports of Mental and Physical Health: A Preliminary Intervention Study",
          "author": "Andrew Paul Smith* Rosannagh Rogers",
          "published_date": "2014-07-16T00:00:00+00:00",
          "summary": "No, this study does not show that Oreos or similar unhealthy snacks are good for health.  In fact, it found that snacking on crisps, chocolate, and biscuits was associated with higher stress, more cognitive failures, and more injuries.  The research focuses on the contrast between healthy snacks (fruit) and unhealthy snacks (chocolate/crisps) and their impact on mental and physical well-being, concluding that unhealthy snacking has negative effects.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fnut.2014.00010/full"
        },
        {
          "title": "Patterned Feeding of a Hyper-Palatable Food (Oreo Cookies) Reduces Alcohol Drinking in Rats - PubMed",
          "author": "Zoela Leon 1 ,",
          "published_date": "2021-10-20T00:00:00+00:00",
          "summary": "A study on rats found that intermittent access to Oreo cookies reduced their alcohol consumption.  However, this effect disappeared when the patterned Oreo feeding stopped.  The study does *not* conclude that Oreos are good for health, but rather explores the complex relationship between highly palatable food and alcohol intake.  The observed effect is likely linked to changes in dopamine levels in the brain.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34744651/"
        },
        {
          "title": "Oreo Cookie Treatment Lowers LDL Cholesterol More ...",
          "author": "",
          "published_date": "2024-01-22T00:00:00+00:00",
          "summary": "A single case study showed that eating Oreos (100g of carbs daily) lowered LDL cholesterol by 71% in a person on a ketogenic diet, more than a high-dose statin.  However, this was a single subject and does not constitute evidence that Oreos are generally good for health.  The study suggests a complex interaction between carbohydrate intake, ketogenic diets, and cholesterol levels in a specific subgroup of individuals.  Further research is needed.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10818743/"
        },
        {
          "title": "The Truth About Oreos & Lowering Your Cholesterol",
          "author": "By Elizabeth Klodas, MD",
          "published_date": "2024-08-08T19:37:32+00:00",
          "summary": "No, a study showing that Oreos lowered one person's cholesterol while on a ketogenic diet is not evidence that Oreos are healthy.  The study subject had extremely high cholesterol levels, and the reduction was likely due to the addition of carbohydrates to his high-saturated-fat keto diet, not the Oreos themselves.  The article concludes that a whole-food, plant-based diet is superior for overall health and longevity compared to a diet including highly processed foods like Oreos.\n",
          "url": "https://www.steponefoods.com/blogs/news/why-you-shouldn-t-lower-your-cholesterol-with-oreos?srsltid=AfmBOoq_B4WLc0i8n1N4kpBLNgAE0ENpzbM9V-qnw_XIVW0YvGJPcZsi"
        },
        {
          "title": "Harvard Med Student & Scientist Lowers Cholesterol with ...",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "This YouTube video (38K views) doesn't provide evidence that eating Oreos is good for your health.  The summary does not contain information about the video's content.  Therefore, I cannot answer your question based on the provided data.\n",
          "url": "https://www.youtube.com/watch?v=qk2htmeR6e4"
        },
        {
          "title": "Debunking Health Myths: Truth About Oreos, Heart Disease ...",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "This YouTube video (11K views) does not discuss the health benefits of eating Oreos.  The provided text only gives viewership and like counts; it offers no information about the video's content.\n",
          "url": "https://www.youtube.com/watch?v=UtLNuezKxD8"
        },
        {
          "title": "Eating more during the holidays? Don't mistake Oreo ...",
          "author": "Alvin Powell",
          "published_date": "2023-04-13T10:13:53.503000+00:00",
          "summary": "No, this Harvard Gazette article discusses obesity and weight loss, mentioning that 100 calories of Oreos affect the body differently than 100 calories of olives due to differing metabolic effects.  It does not suggest that Oreos are healthy.  The article focuses on the flaws of the \"calories in, calories out\" model and proposes an alternative approach to understanding obesity.\n",
          "url": "https://news.harvard.edu/gazette/story/2022/12/eating-more-during-the-holidays-dont-mistake-oreo-calories-for-olive-calories/?utm_source=twitter&utm_campaign=general&utm_medium=social"
        },
        {
          "title": "Oreos and obesity: Probing the phenomenon of impulse",
          "author": "",
          "published_date": "2015-10-14T00:00:00+00:00",
          "summary": "This article does not discuss the health benefits of eating Oreos.  Instead, it describes a UAA research study using rats to investigate the relationship between impulsivity, binge eating, and obesity.  The study uses a \"choice-delay task\" similar to offering a child a small cookie immediately or a larger cookie after a delay, to measure impulsivity in rats and its correlation with their eating habits and weight gain.\n",
          "url": "https://www.uaa.alaska.edu/news/archive/2015/10/oreos-and-obesity-probing-the-phenomenon-of-impulse.cshtml"
        },
        {
          "title": "Oreos or Cocaine? | SiOWfa16: Science in Our World",
          "author": "by Margaret Marchok",
          "published_date": "2016-09-27T00:00:00+00:00",
          "summary": "No, this article does not show that eating Oreos is good for your health.  Instead, it discusses a study suggesting that Oreos may be as addictive as cocaine because they stimulate the brain's pleasure center.  The author questions the methodology of the rat study cited, noting that preference doesn't equal addiction.  While acknowledging a preference for Oreos over rice cakes, the article ultimately highlights concerns about the potentially negative health consequences of overconsumption of sugary foods like Oreos.\n",
          "url": "https://sites.psu.edu/siowfa16/2016/09/27/oreos-or-cocaine/"
        }
      ],
      "full_explanation": "While several papers discuss the effects of Oreos on the body, none of them conclude that eating Oreos is generally good for your health. The majority of the papers indicate either negative or complex effects, rather than positive ones.\nSpecifically, the paper \"Positive Effects of a Healthy Snack (Fruit) Versus an Unhealthy Snack (Chocolate/Crisps) on Subjective Reports of Mental and Physical Health: A Preliminary Intervention Study\" (https://www.frontiersin.org/articles/10.3389/fnut.2014.00010/full) showed that unhealthy snacks like chocolate and biscuits (which could include Oreos) are associated with negative effects, such as increased stress and cognitive failures.\nThe paper \"Patterned Feeding of a Hyper-Palatable Food (Oreo Cookies) Reduces Alcohol Drinking in Rats\" (https://pubmed.ncbi.nlm.nih.gov/34744651/) explored the effect of Oreos on alcohol intake in rats, but it did not conclude that Oreos are good for health.\nThe case studies \"Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover Experiment\" (https://www.mdpi.com/2218-1989/14/1/73) and \"Oreo Cookie Treatment Lowers LDL Cholesterol More ...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC10818743/) demonstrate a *single case* where Oreo consumption resulted in reduced LDL cholesterol in a subject on a ketogenic diet. However, they are clear that the effect was highly specific to the unique individual and is not evidence that Oreos are generally healthy. Further, the blog post \"The Truth About Oreos & Lowering Your Cholesterol\" (https://www.steponefoods.com/blogs/news/why-you-shouldn-t-lower-your-cholesterol-with-oreos?srsltid=AfmBOoq_B4WLc0i8n1N4kpBLNgAE0ENpzbM9V-qnw_XIVW0YvGJPcZsi) directly refutes the idea that the effect in those case studies makes Oreos healthy, and that the reduced cholesterol was more likely caused by the introduction of carbs into a ketogenic diet, not a direct beneficial effect of Oreos.\nFinally, the article \"Oreos or Cocaine? | SiOWfa16: Science in Our World\" (https://sites.psu.edu/siowfa16/2016/09/27/oreos-or-cocaine/) suggests that Oreos may be addictive, further reinforcing that they are likely unhealthy.\nTherefore, while specific studies show some complex effects of Oreos, nobody has shown that eating Oreos is generally good for health. The studies either show negative effects, or specific effects in particular individuals or non-human models, and these effects are then often refuted as being generally applicable to health."
    },
    {
      "question": "Has anyone shown that Amylin increases weight loss?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression",
          "author": "Jonathan D Roth, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Heather  Hughes, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Eric  Kendall, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Alain D Baron, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Christen M Anderson, Amylin Pharmaceuticals, Inc, 92121, San Diego, California",
          "published_date": "2023-11-09T20:13:16.011000+00:00",
          "summary": "Yes, studies in diet-induced obese rats show that amylin (300 \u00b5g/kg per day for 22 days) reduces food intake and weight gain, similar to pair-feeding.  Amylin treatment resulted in a three-fold greater fat loss compared to pair-feeding, while preserving lean tissue mass.  Increased energy expenditure was observed in amylin-treated rats after three weeks,  though this wasn't attributed to thermogenesis.  The study suggests amylin promotes weight loss through anorexigenic and metabolic effects.\n",
          "url": "https://academic.oup.com/endo/article/147/12/5855/2501043"
        },
        {
          "title": "Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies | Proceedings of the National Academy of Sciences",
          "author": "Jonathan D Roth; Barbara L Roland; Rebecca L Cole; James L Trevaskis; Christian Weyer; Joy E Koda; Christen M Anderson; David G Parkes; Alain D Baron; Roth; Jonathan D; Roland; Barbara L; Cole; Rebecca L; Trevaskis; James L; Weyer; Christian; Koda; Joy E; Anderson; Christen M; Parkes; David G; Baron; Alain D",
          "published_date": "2023-02-22T20:44:40.478000+00:00",
          "summary": "Yes, studies in both rats and humans show that amylin increases weight loss.  In diet-induced obese rats, amylin administration, particularly when combined with leptin, resulted in synergistic weight loss, exceeding the effects of either treatment alone.  A 24-week human clinical trial confirmed this, showing that co-administration of pramlintide (an amylin analog) and leptin led to a significantly greater weight loss (12.7%) compared to either treatment alone.  The mechanism appears to involve restoring leptin responsiveness in the obese state.\n",
          "url": "https://www.pnas.org/doi/10.1073/pnas.0706473105"
        },
        {
          "title": "Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies",
          "author": "Jonathan D Roth; Barbara L Roland; Rebecca L Cole; James L Trevaskis; Christian Weyer; Joy E Koda; Christen M Anderson; David G Parkes; Alain D Baron; Roth; Jonathan D; Roland; Barbara L; Cole; Rebecca L; Trevaskis; James L; Weyer; Christian; Koda; Joy E; Anderson; Christen M; Parkes; David G; Baron; Alain D",
          "published_date": "2023-12-04T02:39:38.899000+00:00",
          "summary": "Yes.  Studies in both obese rats and overweight/obese humans showed that amylin (specifically, the amylin analog pramlintide) significantly increased weight loss.  In rats, combining amylin with leptin led to synergistic weight loss, exceeding the effect of either treatment alone.  A 24-week human clinical trial demonstrated a 12.7% mean weight loss with combined amylin and leptin treatment, significantly more than with either treatment individually.  The mechanism appears to involve restoring leptin responsiveness in diet-induced obesity.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.0706473105"
        },
        {
          "title": "Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce ...",
          "author": "",
          "published_date": "2021-01-08T00:00:00+00:00",
          "summary": "Preclinical studies in rats using dual amylin and calcitonin receptor agonists (DACRAs) have shown significant weight loss.  While the clinical translation of these findings is unknown, the research suggests a potential role for amylin in weight loss.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7819850/"
        },
        {
          "title": "Combined Amylin/GLP-1 pharmacotherapy to promote and sustain ...",
          "author": "Claudia G Liberini, University of Pennsylvania, 19104, Philadelphia, PA, USA, Kieran  Koch-Laskowski, University of Pennsylvania, 19104, Philadelphia, PA, USA, Evan  Shaulson, University of Pennsylvania, 19104, Philadelphia, PA, USA, Lauren E Mcgrath, University of Pennsylvania, 19104, Philadelphia, PA, USA, Rachele K Lipsky, University of Pennsylvania, 19104, Philadelphia, PA, USA, Rinzin  Lhamo, University of Pennsylvania, 19104, Philadelphia, PA, USA, Misgana  Ghidewon, University of Pennsylvania, 19104, Philadelphia, PA, USA, Tyler  Ling, University of Pennsylvania, 19104, Philadelphia, PA, USA, Lauren M Stein, University of Pennsylvania, 19104, Philadelphia, PA, USA, Matthew R Hayes, University of Pennsylvania, 19104, Philadelphia, PA, USA",
          "published_date": "2023-11-09T20:26:12.407000+00:00",
          "summary": "Yes, research using rats has shown that amylin, combined with GLP-1, leads to significantly greater weight loss than either treatment alone.  This effect was observed both in lean and obese rats over both short and long-term treatment. The combination therapy resulted in reduced food intake and increased weight loss compared to monotherapy, suggesting a synergistic effect.\n",
          "url": "https://www.nature.com/articles/s41598-019-44591-8"
        },
        {
          "title": "Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet-Induced ...",
          "author": "Jonathan D Roth, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Heather  Hughes, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Eric  Kendall, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Alain D Baron, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Christen M Anderson, Amylin Pharmaceuticals, Inc, 92121, San Diego, California",
          "published_date": "2023-11-09T20:13:16.011000+00:00",
          "summary": "Yes, studies in diet-induced obese rats show that amylin (300 \u00b5g/kg daily for 22 days) significantly reduces food intake and weight gain, resulting in approximately 10% weight loss, similar to pair-feeding.  Importantly, amylin's effect on weight loss was associated with a greater reduction in body fat compared to pair-feeding, while preserving lean tissue mass.  These effects appear to be mediated by both appetite suppression and metabolic changes.\n",
          "url": "https://academic.oup.com/endo/article/147/12/5855/2501043"
        },
        {
          "title": "The dual amylin and calcitonin receptor agonist KBP-089 and the ...",
          "author": "Anna Thors\u00f8 Larsen, Sofie  Gydesen, Nina  Sonne, Morten Asser Karsdal, Kim  Henriksen",
          "published_date": "2023-11-09T20:33:28.234000+00:00",
          "summary": "Yes.  A study using rats fed a high-fat diet showed that the dual amylin and calcitonin receptor agonist KBP-089 caused a 15% reduction in body weight.  When combined with the GLP-1 receptor agonist liraglutide, the weight loss increased to 21%.  This suggests that amylin agonists may enhance weight loss, particularly when used in combination with other therapies.\n",
          "url": "https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-00678-2"
        },
        {
          "title": "Comparing the efficacies of the dual amylin and calcitonin receptor ...",
          "author": "M. Bl\u00fcher",
          "published_date": "2022-12-01T00:00:00+00:00",
          "summary": "Yes, studies show that cagrilintide, a long-acting amylin receptor agonist, induces potent weight loss.  A study comparing cagrilintide to KBP-336 (another dual amylin and calcitonin receptor agonist) in obese rats found both caused dose-dependent weight loss, with KBP-336 showing superior results at the highest dose.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0753332222012318"
        },
        {
          "title": "Leptin responsiveness restored by amylin agonism in diet-induced ...",
          "author": "Jonathan D Roth; Barbara L Roland; Rebecca L Cole; James L Trevaskis; Christian Weyer; Joy E Koda; Christen M Anderson; David G Parkes; Alain D Baron; Roth; Jonathan D; Roland; Barbara L; Cole; Rebecca L; Trevaskis; James L; Weyer; Christian; Koda; Joy E; Anderson; Christen M; Parkes; David G; Baron; Alain D",
          "published_date": "2023-02-22T20:44:40.478000+00:00",
          "summary": "Yes.  Studies in both diet-induced obese rats and overweight/obese humans showed that amylin (specifically, the amylin analog pramlintide) significantly increased weight loss.  In rats, combining amylin and leptin led to synergistic weight loss, exceeding the effect of either treatment alone.  A 24-week human clinical trial showed that co-administration of leptin and pramlintide resulted in a 12.7% mean weight loss, significantly more than either treatment individually.  The mechanism appears to involve restoring leptin responsiveness in obese individuals.\n",
          "url": "https://www.pnas.org/doi/10.1073/pnas.0706473105"
        },
        {
          "title": "Experimental Oral Drug Shows 'Remarkable' Weight Loss, Novo ...",
          "author": "By Claire Bugos Published on September 23, 2024 Fact checked by Nick Blackmer",
          "published_date": "2024-09-23T13:59:25+00:00",
          "summary": "Yes.  Novo Nordisk's experimental oral drug, amycretin, which targets both GLP-1 receptors and amylin, showed remarkable weight loss in a Phase 1 trial. Participants taking the highest dose lost up to 13% of their body weight in three months, compared to 1.2% in the placebo group.  Researchers believe amylin's action in the brain, affecting appetite, contributes to this weight loss.\n",
          "url": "https://www.verywellhealth.com/amycretin-novo-nordisk-obesity-drug-8714295"
        }
      ],
      "full_explanation": "Multiple studies have demonstrated that amylin increases weight loss in both animal models and humans. The paper \"Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression\" (https://academic.oup.com/endo/article/147/12/5855/2501043) showed that in diet-induced obese rats, amylin treatment resulted in reduced food intake and weight gain, with greater fat loss and preservation of lean tissue.  Similarly, the paper \"Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet-Induced ...\" (https://academic.oup.com/endo/article/147/12/5855/2501043) also shows that amylin causes weight loss in rats with a reduction of fat mass. The study \"Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies\" (https://www.pnas.org/doi/10.1073/pnas.0706473105) and the study with the same name and URL (https://www.pnas.org/doi/full/10.1073/pnas.0706473105) demonstrated synergistic weight loss in rats when amylin was combined with leptin. Furthermore, the paper with this title also confirms that the amylin analogue, pramlintide, increases weight loss in humans. The paper \"Combined Amylin/GLP-1 pharmacotherapy to promote and sustain ...\" (https://www.nature.com/articles/s41598-019-44591-8) shows that the combination of amylin with GLP-1 leads to greater weight loss in rats than either treatment alone. Additionally, \"The dual amylin and calcitonin receptor agonist KBP-089 and the ...\" (https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-00678-2) shows that the dual amylin and calcitonin receptor agonist KBP-089 caused weight loss in rats and that this was enhanced when combined with a GLP-1 agonist. Moreover, the paper \"Comparing the efficacies of the dual amylin and calcitonin receptor ...\" (https://www.sciencedirect.com/science/article/pii/S0753332222012318) demonstrates that the amylin receptor agonist cagrilintide induced significant weight loss in obese rats. Finally, the article \"Experimental Oral Drug Shows 'Remarkable' Weight Loss, Novo ...\" (https://www.verywellhealth.com/amycretin-novo-nordisk-obesity-drug-8714295) reports that a novel oral drug, amycretin, which targets both GLP-1 receptors and amylin, resulted in significant weight loss in a phase 1 trial, demonstrating the effect of amylin in humans. Taken together, these studies provide strong evidence that amylin, either alone or in combination with other therapies, increases weight loss."
    },
    {
      "question": "Has anyone designed neural networks that compute with protein or DNA?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Simple and rewireable biomolecular building blocks for DNA machine-learning algorithms",
          "author": "Ryan C. Lee, Ariel Corsano, Chung Yi Tseng, Leo Y. T. Chou",
          "published_date": "2023-07-23T00:00:00+00:00",
          "summary": "Yes. This bioRxiv preprint describes a new design for DNA-based neural networks that addresses scalability limitations of previous designs.  The authors improved the design by using enzymatic synthesis for high-purity neurons, spatial patterning of neuron clusters, and encoding neuron connectivity on a single-stranded DNA backbone.  This allows for faster activation, higher signal-to-background ratio, and implementation of basic neural network motifs.  The modular design aims to scale DNA-based neural networks for applications like portable diagnostics and lab-on-a-chip systems.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1"
        },
        {
          "title": "DNA-based programmable gate arrays for general-purpose DNA computing",
          "author": "Lv; Hui; Xie; Nuli; Li; Mingqiang; Dong; Mingkai; Sun; Chenyun; Zhang; Qian; Zhao; Lei; Jiang; Zuo; Xiaolei; Chen; Haibo; Wang; Fei; Fan; Chunhai",
          "published_date": "2023-12-04T03:09:05.243000+00:00",
          "summary": "This Nature paper describes the design of DNA-based programmable gate arrays for general-purpose DNA computing.  While not explicitly neural networks, the research explores programmable computing using DNA, addressing a part of the search query.  The authors provide source code (available on GitHub) and data related to their work.\n",
          "url": "https://www.nature.com/articles/s41586-023-06484-9"
        },
        {
          "title": "Neural network execution using nicked DNA and microfluidics",
          "author": "Arnav Solanki,Zak Griffin,Purab Ranjan Sutradhar,A. Ganguly,Marc D. Riedel",
          "published_date": "2023-10-26T19:31:04.476000+00:00",
          "summary": "Yes.  This paper describes a microfluidic device that performs artificial neural network (ANN) computations using nicked DNA.  The computation happens entirely within the molecular domain, modifying DNA strands using enzymes (nickases) without converting data to electrical form.  Data is represented stochastically via the concentration of nicked DNA molecules.  The authors report benchmarks on the neural network's performance.\n",
          "url": "https://arxiv.org/pdf/2307.00686.pdf"
        },
        {
          "title": "Computational Protein Design with Deep Learning Neural ...",
          "author": "Qi, Yifei",
          "published_date": "2018-04-20T00:00:00+00:00",
          "summary": "This paper discusses computational protein design, using methods that include, but are not limited to, physics-based scoring functions (van der Waals and electrostatic energy) and knowledge-based terms (rotamer and backbone dihedral preference).  While it mentions the increasing use of computation in protein design, including the design of novel folds, enzymes, vaccines, and antibodies, it does *not* describe the use of neural networks to directly compute with protein or DNA sequences.  The focus is on using computational methods *to design* proteins, not using proteins or DNA as computational elements themselves.\n",
          "url": "https://www.nature.com/articles/s41598-018-24760-x"
        },
        {
          "title": "Neural networks to learn protein sequence\u2013function ...",
          "author": "Anthony Gitter",
          "published_date": "2021-11-23T00:00:00+00:00",
          "summary": "Yes, this PNAS paper describes neural networks trained on deep mutational scanning data to predict protein function from sequence.  The researchers tested various architectures, including a graph convolutional network incorporating protein structure, and showed that these networks outperform physics-based and unsupervised methods.  The trained models were even used to design a protein with enhanced binding affinity, demonstrating their ability to navigate sequence space and create novel proteins.  While the focus is on proteins, the methodology could potentially be adapted for DNA sequences.\n",
          "url": "https://www.pnas.org/doi/10.1073/pnas.2104878118"
        },
        {
          "title": "An Efficient Deep Learning Approach for DNA-Binding ...",
          "author": "Musa, Mohamed Elhafiz M.",
          "published_date": "2024-04-11T00:00:00+00:00",
          "summary": "Yes. This paper describes a CNN-BiLG neural network model that classifies DNA-binding proteins based on their amino acid sequences.  The model outperforms other machine learning and deep learning approaches, achieving 94% accuracy on a validation set.  The authors state that existing methods don't fully utilize contextual information within amino acid sequences, while their model addresses this limitation.\n",
          "url": "https://link.springer.com/article/10.1007/s44196-024-00462-3"
        },
        {
          "title": "Cracking the genetic code with neural networks",
          "author": "Marc Joiret1*",
          "published_date": "2023-04-06T00:00:00+00:00",
          "summary": "This article discusses using deep learning (a type of neural network) to analyze omics data (genomics, transcriptomics, proteomics). While it doesn't describe neural networks that directly *compute* using protein or DNA as components, it highlights the application of neural networks to analyze data derived from these biological molecules to predict things like gene function, molecular structures, phenotypes, and disease outcomes.  The authors acknowledge challenges in interpreting the results due to the \"black box\" nature of deep learning models.\n",
          "url": "https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2023.1128153/full"
        },
        {
          "title": "Cracking the genetic code with neural networks - PMC",
          "author": "",
          "published_date": "2023-04-06T00:00:00+00:00",
          "summary": "Yes, this study used neural networks to decipher the genetic code (mapping codons to amino acids).  The researchers trained different deep learning architectures on transcriptomic data to determine the codon-amino acid pairings.  The results showed that a large training dataset (4-22 million codon-amino acid pairs) was needed to achieve 100% accuracy, including deciphering rare codons.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10117997/"
        },
        {
          "title": "Modeling in-vivo protein-DNA binding by combining ...",
          "author": "Qinhu  Zhang, tongji University, 201804, Shanghai, P.R. China, Zhen  Shen, tongji University, 201804, Shanghai, P.R. China, De-Shuang  Huang",
          "published_date": "2023-11-09T20:26:13.773000+00:00",
          "summary": "Yes. This paper presents a hybrid deep neural network that models in-vivo protein-DNA binding.  The network uses k-mer encoding of DNA sequences as input and combines convolutional and recurrent neural networks to predict binding.  It employs a weakly supervised multiple-instance learning framework to handle the complexity of multiple binding sites within a DNA sequence.\n",
          "url": "https://www.nature.com/articles/s41598-019-44966-x"
        },
        {
          "title": "ENNGene: an Easy Neural Network model building tool for ...",
          "author": "Eli\u0161ka Chalupov\u00e1,Ond\u0159ej Vacul\u00edk,Jakub Pol\u00e1cek,Filip Jozefov,Tom\u00e1s Majtner,P. Alexiou",
          "published_date": "2023-10-26T19:29:42.755000+00:00",
          "summary": "Yes.  The ENNGene tool facilitates the creation and training of custom convolutional neural networks (CNNs) and hybrid CNN-RNN models for genomic data analysis.  It accepts various input types, including sequence, evolutionary conservation scores, and secondary structure, and provides tools for interpreting the results.  The authors demonstrate its use by training models on the RBP24 dataset, achieving state-of-the-art results and improving performance for over half the proteins by incorporating evolutionary conservation scores.\n",
          "url": "https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-022-08414-x"
        }
      ],
      "full_explanation": "Several papers demonstrate that neural networks have been designed to compute with protein or DNA. Specifically, the following papers directly address the research question:\n\n*   **Simple and rewireable biomolecular building blocks for DNA machine-learning algorithms**: This paper describes the design of DNA-based neural networks. The researchers improved upon previous designs to make them scalable for applications like portable diagnostics and lab-on-a-chip systems. (URL: https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1)\n\n*   **Neural network execution using nicked DNA and microfluidics**: This paper describes a system that uses a microfluidic device to perform artificial neural network (ANN) computations using nicked DNA. The computation occurs directly in the molecular domain, using enzymes, and does not convert data into electrical form. (URL: https://arxiv.org/pdf/2307.00686.pdf)\n\n*   **Modeling in-vivo protein-DNA binding by combining ...**: This paper details a hybrid deep neural network model that predicts in-vivo protein-DNA binding using k-mer encoded DNA sequences. This demonstrates neural networks being used to directly process information derived from DNA and protein. (URL: https://www.nature.com/articles/s41598-019-44966-x)\n\nThese papers showcase various approaches to utilizing DNA and proteins to perform computations within neural networks, therefore answering the research question in the affirmative.\n\nOther papers in the list, such as \"Computational Protein Design with Deep Learning Neural ...\", \"Neural networks to learn protein sequence\u2013function ...\", \"An Efficient Deep Learning Approach for DNA-Binding ...\", \"Cracking the genetic code with neural networks,\" \"Cracking the genetic code with neural networks - PMC\", and \"ENNGene: an Easy Neural Network model building tool for ...\", describe using neural networks to *analyze* protein and DNA data or to design proteins, but don't directly use DNA or protein to implement the neural network computations themselves. While these papers are related to the broad topic, they don't directly address the specific research question."
    },
    {
      "question": "Has anyone evolved AAV capsids to target pancreatic beta cells in vivo?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset - Nature Neuroscience",
          "author": "Goertsen; David; Flytzanis; Nicholas C; Goeden; Nick; Chuapoco; Miguel R; Cummins; Alexander; Chen; Yijing; Fan; Yingying; Zhang; Qiangge; Sharma; Jitendra; Duan; Yangyang; Wang; Liping; Feng; Guoping; Yu; Ip; Nancy Y; Pickel; James; Gradinaru; Viviana",
          "published_date": "2023-02-07T20:46:57.937000+00:00",
          "summary": "This research focused on evolving AAV capsids for improved brain-wide gene expression after intravenous delivery in mice and marmosets, reducing off-target effects in the liver.  The study did *not* investigate AAV capsid evolution for pancreatic beta cell targeting.\n",
          "url": "https://www.nature.com/articles/s41593-021-00969-4"
        },
        {
          "title": "A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism | Proceedings of the National Academy of Sciences",
          "author": "Marcus Davidsson; Gang Wang; Patrick Aldrin-Kirk; Tiago Cardoso; Sara Nolbrant; Morgan Hartnor; Janitha Mudannayake; Malin Parmar; Tomas Bj\u00f6rklund; Davidsson; Marcus; Wang; Gang; Aldrin-Kirk; Patrick; Cardoso; Tiago; Nolbrant; Sara; Hartnor; Morgan; Mudannayake; Janitha; Parmar; Malin; Bj\u00f6rklund; Tomas",
          "published_date": "2023-02-23T02:48:47.406000+00:00",
          "summary": "This PNAS paper describes a new method (BRAVE) for evolving AAV capsids with tailored tropism.  While the study successfully targeted dopaminergic neurons in rodents and humans, it does not mention any work on targeting pancreatic beta cells.  The research focuses on improving the efficiency and understanding of AAV capsid engineering, rather than targeting a specific cell type like pancreatic beta cells.\n",
          "url": "https://www.pnas.org/doi/10.1073/pnas.1910061116"
        },
        {
          "title": "Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression",
          "author": "Zengel; James; Wang; Yu Xin; Seo; Jai Woong; Ning; Ke; Hamilton; Wu; Bo; Raie; Marina; Holbrook; Colin; Su; Shiqi; Clements; Derek R; Pillay; Sirika; Puschnik; Andreas S; Winslow; Monte M; Idoyaga; Juliana; Nagamine; Claude M; Yang; Mahajan; Vinit B; Ferrara; Katherine W; Blau; Helen M; Carette; Jan E",
          "published_date": "2023-12-04T01:57:33.451000+00:00",
          "summary": "This research doesn't directly address the evolution of AAV capsids for targeting pancreatic beta cells *in vivo*.  However, the study describes a new system for achieving tissue-specific AAV transduction in mice by controlling the expression of the AAV receptor (AAVR).  This method offers potential for targeting specific cell types, including potentially pancreatic beta cells, through breeding with Cre mouse lines that express Cre recombinase in those cells.  The system's broad compatibility with AAV variants offers flexibility in choosing a capsid suitable for pancreatic beta cell transduction.\n",
          "url": "https://www.nature.com/articles/s41592-023-01896-x?utm_source=twitter&utm_medium=social&utm_campaign=nmeth"
        },
        {
          "title": "In vivo genetic engineering of murine pancreatic beta cells ...",
          "author": "V Jimenez 1 ,",
          "published_date": "2023-02-01T00:00:00+00:00",
          "summary": "This study did not evolve AAV capsids but compared the in vivo transduction efficiency of three pre-existing serotypes (AAV6, AAV8, and AAV9) in murine pancreatic beta cells using intraductal and systemic administration.  AAV6 and AAV8 showed the highest transduction efficiency of beta cells, while alpha cells were poorly transduced.  The study demonstrated the feasibility of using these AAV serotypes for pancreatic beta cell gene therapy, as shown by improved outcomes in a type 1 diabetes mouse model following intraductal delivery of AAV9 encoding hepatocyte growth factor (HGF).\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21311856/"
        },
        {
          "title": "Various AAV Serotypes and Their Applications in Gene ...",
          "author": "",
          "published_date": "2023-03-01T00:00:00+00:00",
          "summary": "This article reviews adeno-associated virus (AAV) serotypes and their applications in gene therapy, focusing on FDA-approved treatments for hemophilia A and B, spinal muscular atrophy, and retinal dystrophy.  While it details various AAV serotypes and their tropism (tissue targeting), it does not address the evolution of AAV capsids for in vivo targeting of pancreatic beta cells.  Therefore, the answer to your query is not found within this document.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10000783/"
        },
        {
          "title": "AAV vector-mediated in vivo reprogramming into pluripotency",
          "author": "Sen\u00eds; Elena; Mosteiro; Lluc; Wilkening; Stefan; Wiedtke; Ellen; Nowrouzi; Ali; Afzal; Saira; Fronza; Raffaele; Landerer; Henrik; Abad; Maria; Niopek; Dominik; Schmidt; Manfred; Serrano; Manuel; Grimm; Dirk",
          "published_date": "2023-02-06T15:36:40.008000+00:00",
          "summary": "This article does not discuss the evolution of AAV capsids to target pancreatic beta cells.  The research focuses on using AAV vectors to deliver reprogramming factors (OKSM) in vivo in mice, exploring the effects on aging, tissue regeneration, and cancer development.  While it mentions studies involving pancreatic cancer, it does not address the specific question of AAV capsid engineering for beta cell targeting.\n",
          "url": "https://www.nature.com/articles/s41467-018-05059-x"
        },
        {
          "title": "Evolving AAV-delivered therapeutics towards ultimate cures",
          "author": "Xiangjun  He, The Chinese University of Hong Kong, Hong Kong SAR, China, Brian Anugerah Urip, Zhenjie  Zhang, The Chinese University of Hong Kong, Hong Kong SAR, China, Chun Christopher Ngan, The Chinese University of Hong Kong, Hong Kong SAR, China, Bo  Feng, The Chinese University of Hong Kong, Hong Kong SAR, China, fengbo@cuhk.edu.hk",
          "published_date": "2023-11-09T20:32:13.877000+00:00",
          "summary": "This article reviews the progress of AAV gene therapies, including those using CRISPR. While it details clinical updates and safety concerns of AAV delivery, it does *not* address the specific question of whether AAV capsids have been evolved to target pancreatic beta cells *in vivo*.  The article focuses on broader applications of AAV in gene therapy.\n",
          "url": "https://link.springer.com/article/10.1007/s00109-020-02034-2"
        },
        {
          "title": "Novel recombinant adeno-associated virus capsids with ...",
          "author": "",
          "published_date": "2019-03-29T00:00:00+00:00",
          "summary": "This patent (US20200024616A1) describes novel recombinant adeno-associated virus (AAV) capsids with enhanced tropism for human pancreatic cells.  While the patent doesn't explicitly state *beta cell* targeting *in vivo*,  the enhanced pancreatic tropism suggests it may be relevant to your query.  The inventors are Katja Pekrun and Mark A. Kay of Leland Stanford Junior University.  The patent application was filed in 2019 and granted in 2023.  Further investigation of the patent's details would be necessary to determine the precise level of beta-cell specificity and in vivo efficacy.\n",
          "url": "https://patents.google.com/patent/US20200024616A1/en"
        },
        {
          "title": "Pancreatic endocrine cells are transduced by adeno ...",
          "author": "Vishal Ahuja, Sanjeev Jeyabalan, View ORCID ProfileEmmanuel S. Tzanakakis",
          "published_date": "2024-08-23T00:00:00+00:00",
          "summary": "This study does not describe the *in vivo* evolution of AAV capsids to target pancreatic beta cells.  It compares the transduction efficiency of AAV serotypes 2, 6, and 9 in murine pancreatic alpha and beta cells *in vitro*.  AAV2 showed better transduction than AAV9, while AAV6 was cytotoxic.  The study also investigated the role of heparin and neuraminidase in transduction.  While AAV8 is mentioned as commonly used *in vivo*, this research focuses on alternative serotypes.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2024.08.22.609291v1.full-text"
        },
        {
          "title": "Pancreatic islet cell-specific rAAV vectors for more efficient ...",
          "author": "",
          "published_date": "2019-01-01T00:00:00+00:00",
          "summary": "Yes, researchers at Stanford University have developed novel AAV vectors with significantly improved (10x) transduction efficiency in pancreatic alpha- and beta-cells compared to previous gold standards.  This was achieved through directed molecular evolution and has been demonstrated *in vitro* (human, mouse, monkey, rat, and hamster cells) and *in vivo* (mouse liver transduction).  A separate lab achieved >90% transduction of beta-cells and 99% of alpha-cells using these vectors in intact human islets.  These findings are supported by a publication in the *Journal of Clinical Investigation Insight* (2019) and associated patents.\n",
          "url": "https://techfinder.stanford.edu/technology/pancreatic-islet-cell-specific-raav-vectors-more-efficient-gene-therapy-or-research"
        }
      ],
      "full_explanation": "Based on the provided papers, the research question has been addressed previously. While several papers explore AAV delivery to the pancreas or discuss general AAV tropism, a few specifically address the evolution of AAV capsids for targeting pancreatic cells.\nSpecifically, the patent US20200024616A1 (https://patents.google.com/patent/US20200024616A1/en) from Leland Stanford Junior University describes \"novel recombinant adeno-associated virus (AAV) capsids with enhanced tropism for human pancreatic cells.\u201d Although it doesn't explicitly specify *beta cell* targeting *in vivo*, the enhanced pancreatic tropism is highly relevant, suggesting that this work aimed to target and transduce pancreatic cells more efficiently using novel AAV capsids.\nFurthermore, the Stanford University techfinder page (https://techfinder.stanford.edu/technology/pancreatic-islet-cell-specific-raav-vectors-more-efficient-gene-therapy-or-research) reports the development of novel AAV vectors with \"significantly improved (10x) transduction efficiency in pancreatic alpha- and beta-cells\" achieved through directed molecular evolution. These vectors have shown high transduction rates in both *in vitro* and *in vivo* (mouse liver) experiments, confirming that the research question has been addressed by directed molecular evolution of AAV capsids. This research, published in the *Journal of Clinical Investigation Insight* (2019) and associated patents further supports the fact that AAV capsids have been evolved to target pancreatic beta cells.\nWhile other papers, such as the one by Jimenez et al. (https://pubmed.ncbi.nlm.nih.gov/21311856/), explore the transduction efficiency of *existing* AAV serotypes in pancreatic beta cells and Zengel et al. (https://www.nature.com/articles/s41592-023-01896-x?utm_source=twitter&utm_medium=social&utm_campaign=nmeth) offers a method for achieving tissue-specific AAV transduction using receptor expression which could potentially be applied to beta-cells, these do not explore the specific in vivo evolution of capsids for beta-cell targeting. However, the two references mentioned above confirm that AAV capsids have been engineered to target pancreatic cells, answering the research question."
    },
    {
      "question": "Has anyone studied the receptors of adropin as drug targets for reducing anxiety?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Modulation of depression-related behaviors by adiponectin AdipoR1 receptors in 5-HT neurons",
          "author": "Chen Li,Fantao Meng,J. Garza,Jing Liu,Y. Lei,S. Kirov,M. Guo,Xin-Yun Lu",
          "published_date": "2023-10-26T19:28:00.740000+00:00",
          "summary": "This research focuses on adiponectin, not adropin, and its role in depression, not anxiety.  The study found that adiponectin, acting through its receptor AdipoR1 on serotonin (5-HT) neurons, influences depression-related behaviors in a sex-dependent manner.  Deleting AdipoR1 in 5-HT neurons led to depression-like symptoms in mice.  While the study explores the mechanism of adiponectin's action, it does not investigate its potential as a drug target or address adropin receptors.\n",
          "url": "https://www.nature.com/articles/s41380-020-0649-0.pdf"
        },
        {
          "title": "The role of adenosine receptors in mood and anxiety disorders",
          "author": "Dietrich  Van Calker, University of Freiburg, dietrich.calker@uniklinik-freiburg.de, Knut  Biber, Katharina  Domschke, University of Freiburg, Tsvetan  Serchov, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany",
          "published_date": "2023-11-09T20:26:37.970000+00:00",
          "summary": "This article focuses on the role of adenosine receptors, not adropin receptors, in mood and anxiety disorders.  While it mentions that adenosine receptor antagonists like caffeine have anxiogenic effects (increase anxiety), and that A2A receptors may be important in anxiety disorders, it does not discuss adropin receptors or their potential as drug targets for anxiety reduction.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1111/jnc.14841"
        },
        {
          "title": "Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice",
          "author": "S. Klein",
          "published_date": "2021-12-01T00:00:00+00:00",
          "summary": "This study does not investigate adropin receptors as drug targets for anxiety reduction.  The research focuses on whether adropin improves cognitive function in obese mice with metabolic dysregulation, finding that adropin transgenesis improved recognition memory in this model.  While the study mentions adropin's role in memory and its potential connection to neurodegenerative diseases, it doesn't explore its potential as an anxiolytic via receptor interaction.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0196978121001868"
        },
        {
          "title": "Adropin correlates with aging-related neuropathology in ...",
          "author": "Subhashis  Banerjee, Saint Louis University School of Medicine, St. Louis, MO, USA, Sarbani  Ghoshal, Saint Louis University School of Medicine, St. Louis, MO, USA, Clemence  Girardet, Saint Louis University School of Medicine, St. Louis, MO, USA, Kelly M Demars, University of Florida, Gainesville, FL, USA, Changjun  Yang, University of Florida, Gainesville, FL, USA, Michael L Niehoff, Saint Louis University School of Medicine, St. Louis, MO, USA, Andrew D Nguyen, Saint Louis University School of Medicine, St. Louis, MO, USA, Prerana  Jayanth, Saint Louis University, St. Louis, MO, USA, Brittany A Hoelscher, Saint Louis University School of Medicine, St. Louis, MO, USA, Fenglian  Xu, Saint Louis University School of Medicine, St. Louis, MO, USA, William A Banks, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA, Kim M Hansen, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA, Jinsong  Zhang, Saint Louis University School of Medicine, St. Louis, MO, USA, Eduardo  Candelario-Jalil, University of Florida, Gainesville, FL, USA, Susan A Farr, Saint Louis University School of Medicine, St. Louis, MO, USA, susan.farr@health.slu.edu, Andrew A Butler, Saint Louis University School of Medicine, St. Louis, MO, USA, andrew.butler@health.slu.edu",
          "published_date": "2023-11-09T20:33:10.142000+00:00",
          "summary": "This study investigated adropin's role in age-related cognitive decline, not anxiety.  While it found adropin improved cognitive function in aging mice and correlated with neural processes relevant to neurodegeneration,  it did not examine adropin receptors as drug targets for anxiety reduction.  The research focused on adropin's effects on cognitive function and its correlation with aging-related neuropathology, not its potential anxiolytic properties or receptor interactions.\n",
          "url": "https://www.nature.com/articles/s41514-021-00076-5"
        },
        {
          "title": "The Neuroscience of Drug Reward and Addiction - PMC",
          "author": "",
          "published_date": "2019-09-11T00:00:00+00:00",
          "summary": "This article focuses on the neuroscience of drug reward and addiction, primarily exploring the roles of dopamine and glutamate in the brain's reward circuitry and the neuroadaptations leading to compulsive drug seeking.  It does not address adropin or its receptors as potential drug targets for anxiety reduction.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6890985/"
        },
        {
          "title": "A Review of Adropin as the Medium of Dialogue between ...",
          "author": "",
          "published_date": "2020-03-04T00:00:00+00:00",
          "summary": "This review article focuses on adropin's role in energy and immune regulation, not its potential as an anxiolytic drug targeting specific receptors.  While the article details adropin's metabolic functions and interactions (e.g., with GPR19), it does not discuss its receptors in the context of anxiety reduction or research into such applications.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7073478/"
        },
        {
          "title": "Increased Dopamine Receptor Activity in the Nucleus ...",
          "author": "Anna K Radke, Graduate Program in Neuroscience, Minneapolis, MN, USA, Jonathan C Gewirtz, Graduate Program in Neuroscience, Minneapolis, MN, USA, jgewirtz@umn.edu",
          "published_date": "2023-11-09T20:00:56.396000+00:00",
          "summary": "This study investigated the role of dopamine receptors, not adropin receptors, in reducing anxiety during drug withdrawal.  Researchers found that activating dopamine receptors in the nucleus accumbens shell (using apomorphine) lessened anxiety-like behaviors in morphine and nicotine withdrawal.  The study does not address adropin's role in anxiety reduction.\n",
          "url": "https://www.nature.com/articles/npp201297"
        },
        {
          "title": "The role of serotonin within the microbiota-gut-brain axis in ...",
          "author": "S. Afshar, S. Shahidi, A.H. Rohani, A. Komaki, S.S. Asl",
          "published_date": "2022-03-01T00:00:00+00:00",
          "summary": "This review article focuses on the role of serotonin within the gut-brain axis in the development of Alzheimer's disease (AD), and does not discuss adropin or its receptors as drug targets for anxiety reduction.  The text details the neurochemical changes in AD, including the decline of serotonergic neuronal functioning, but doesn't mention adropin.  Therefore, the answer to your query based on this article is no.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S1568163721003032"
        },
        {
          "title": "Unveiling the multifaceted role of adropin in various ...",
          "author": "",
          "published_date": "2024-10-01T00:00:00+00:00",
          "summary": "This review article on adropin does not discuss its role in anxiety or its receptors as potential drug targets for anxiety reduction.  The article focuses on adropin's involvement in metabolic diseases (e.g., diabetes, obesity, NAFLD) and its effects on glucose and lipid metabolism. While adropin's mechanisms of action are explored (mentioning pathways like PI3K/AKT and ERK1/2),  no research on its interaction with anxiety-related receptors is mentioned.\n",
          "url": "https://www.spandidos-publications.com/10.3892/ijmm.2024.5414"
        },
        {
          "title": "Attention-enhancing effects of propranolol and synergistic ...",
          "author": "Britta  Hahn, Maryland Psychiatric Research Center, bhahn@som.umaryland.edu, Cory K Olmstead, Maryland Psychiatric Research Center, Marie B Yuille, Maryland Psychiatric Research Center, Joshua J Chiappelli, Maryland Psychiatric Research Center, Ashleigh K Wells, Maryland Psychiatric Research Center",
          "published_date": "2023-11-09T20:29:30.656000+00:00",
          "summary": "This study investigated the interaction between nicotine and propranolol on attention, not adropin's role in anxiety.  While it examined the effects of \u03b2-adrenoceptor antagonism (via propranolol) on cognitive performance, it did not explore adropin receptors or their potential as anxiety treatments.  The research focused on how propranolol counteracted some of nicotine's effects on attention, suggesting that \u03b2-adrenoceptor activation may negatively impact cognitive performance in humans.\n",
          "url": "https://link.springer.com/article/10.3758/s13415-020-00794-5"
        }
      ],
      "full_explanation": "Based on the provided papers, there is no evidence that the specific research question of studying adropin receptors as drug targets for reducing anxiety has been previously investigated.\n\nWhile several papers discuss adropin and its functions, none of them directly explore its receptors in the context of anxiety reduction. \n\nSpecifically:\n\n*   **Paper: \"Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice\"** focuses on the impact of adropin on memory, not anxiety. While it does mention the potential link between adropin and neurodegenerative diseases, it does not investigate its potential anxiolytic effects via receptor interaction. URL: https://www.sciencedirect.com/science/article/abs/pii/S0196978121001868\n\n*   **Paper: \"Adropin correlates with aging-related neuropathology in ...\"** investigates adropin's role in age-related cognitive decline, not anxiety. The study does not explore the potential of adropin receptors as drug targets for anxiety reduction. URL: https://www.nature.com/articles/s41514-021-00076-5\n\n*   **Paper: \"A Review of Adropin as the Medium of Dialogue between ...\"** reviews the role of adropin in energy and immune regulation but does not discuss its potential as an anxiolytic drug targeting specific receptors. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7073478/\n\n*   **Paper: \"Unveiling the multifaceted role of adropin in various ...\"** This review focuses on the metabolic functions of adropin and while it mentions some pathways, it does not discuss its potential link to anxiety or its receptors as potential targets for reducing anxiety. URL: https://www.spandidos-publications.com/10.3892/ijmm.2024.5414\n\nThe other papers provided focus on different receptors (adenosine, dopamine), different proteins (adiponectin), or different disorders (depression, addiction), and do not address adropin receptors and anxiety. Therefore, based on the information provided, the proposed research question appears novel."
    },
    {
      "question": "Has anyone designed neural networks that compute with proteins or DNA?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Simple and rewireable biomolecular building blocks for DNA machine-learning algorithms",
          "author": "Ryan C. Lee, Ariel Corsano, Chung Yi Tseng, Leo Y. T. Chou",
          "published_date": "2023-07-23T00:00:00+00:00",
          "summary": "Yes, this bioRxiv preprint describes a new design for DNA-based neural networks.  The authors address the scalability limitations of previous DNA computing approaches by using enzymatic synthesis for high-purity neurons, spatial patterning of neuron clusters, and encoding connectivity on a single-stranded DNA backbone.  This improved design enables faster activation, higher signal-to-noise ratios, and the implementation of basic neural network motifs, paving the way for more complex and scalable DNA-based computation.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1"
        },
        {
          "title": "Neural network execution using nicked DNA and microfluidics",
          "author": "Arnav Solanki,Zak Griffin,Purab Ranjan Sutradhar,A. Ganguly,Marc D. Riedel",
          "published_date": "2023-10-26T19:31:04.476000+00:00",
          "summary": "Yes. This paper details a microfluidic device that executes artificial neural networks (ANNs) using nicked DNA.  The computation happens entirely within the molecular domain, modifying DNA strands via enzymes (nickases), without converting data to electrical form.  The system uses a stochastic representation of data via DNA molecule concentrations and shows promising benchmark results for neural network computation.\n",
          "url": "https://arxiv.org/pdf/2307.00686.pdf"
        },
        {
          "title": "DNA-based programmable gate arrays for general-purpose DNA computing",
          "author": "Lv; Hui; Xie; Nuli; Li; Mingqiang; Dong; Mingkai; Sun; Chenyun; Zhang; Qian; Zhao; Lei; Jiang; Zuo; Xiaolei; Chen; Haibo; Wang; Fei; Fan; Chunhai",
          "published_date": "2023-12-04T03:09:05.243000+00:00",
          "summary": "This Nature paper details the design of DNA-based programmable gate arrays for general-purpose DNA computing.  While not explicitly neural networks, this research demonstrates a significant advance in biomolecular computing, using DNA as a computational substrate.  The authors provide source code on GitHub (https://github.com/FeiWANG-SJTU/DPGA).  The paper cites prior work on nucleic acid computation, suggesting this approach builds upon previous efforts to create programmable molecular circuitry using DNA.\n",
          "url": "https://www.nature.com/articles/s41586-023-06484-9"
        },
        {
          "title": "Computational Protein Design with Deep Learning Neural ...",
          "author": "Qi, Yifei",
          "published_date": "2018-04-20T00:00:00+00:00",
          "summary": "This article discusses computational protein design using deep learning neural networks. While it doesn't explicitly detail neural networks *computing* with proteins or DNA, it focuses on using neural networks to *design* proteins.  The process involves using computational methods, including scoring functions based on physics and knowledge-based terms, to generate protein sequences likely to fold into a desired structure.  The authors note a gap between current methods and fully automated design, suggesting that while neural networks are a tool in the design process, they aren't currently used for computation *within* the protein or DNA molecules themselves.\n",
          "url": "https://www.nature.com/articles/s41598-018-24760-x"
        },
        {
          "title": "An Efficient Deep Learning Approach for DNA-Binding ...",
          "author": "Musa, Mohamed Elhafiz M.",
          "published_date": "2024-04-11T00:00:00+00:00",
          "summary": "Yes, this paper describes a neural network (CNN-BiLG) designed to classify DNA-binding proteins based on their amino acid sequences.  The model integrates convolutional neural networks (CNNs) with bidirectional long short-term memory (LSTMs) and gated recurrent units (GRUs) to improve accuracy by considering contextual information within the sequences.  The authors report a validation accuracy of 94%, outperforming other machine learning and deep learning methods.\n",
          "url": "https://link.springer.com/article/10.1007/s44196-024-00462-3"
        },
        {
          "title": "Neural networks to learn protein sequence\u2013function ...",
          "author": "",
          "published_date": "2021-11-23T00:00:00+00:00",
          "summary": "Yes, this paper describes neural networks trained on deep mutational scanning data to predict protein function from sequence.  The researchers tested various architectures, including a graph convolutional network incorporating protein structure, achieving superior performance to physics-based and unsupervised methods.  The trained models were used to design new proteins with enhanced properties, such as a GB1 domain variant with significantly higher affinity for immunoglobulin G than the wild type.  The study demonstrates the potential of neural networks to learn complex sequence-function relationships in proteins.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8640744/"
        },
        {
          "title": "DeepDBP: Deep neural networks for identification of DNA- ...",
          "author": "Shadman  Shadab, United International University, Plot-2, Madani Avenue, Dhaka-1212, United City, Badda, Bangladesh, Md Tawab Alam Khan, Nazia Afrin Neezi, United International University, Plot-2, Madani Avenue, Dhaka-1212, United City, Badda, Bangladesh, Sheikh  Adilina, Swakkhar  Shatabda, United International University, Plot-2, Madani Avenue, Dhaka-1212, United City, Badda, Bangladesh",
          "published_date": "2023-11-09T20:29:03.608000+00:00",
          "summary": "Yes.  The paper \"DeepDBP: Deep Neural Networks for Identification of DNA-binding Proteins\" presents two deep learning methods (DeepDBP-ANN and DeepDBP-CNN) that identify DNA-binding proteins from their sequences.  DeepDBP-ANN uses a traditional neural network, while DeepDBP-CNN employs a convolutional neural network with pre-learned embeddings. Both achieved state-of-the-art results on benchmark datasets.  The code is publicly available.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2352914819304307"
        },
        {
          "title": "Cracking the genetic code with neural networks",
          "author": "Marc Joiret1*",
          "published_date": "2023-04-06T00:00:00+00:00",
          "summary": "Yes, the paper discusses the application of deep learning (a subset of artificial intelligence using neural networks) to analyze omics data, including genomics, transcriptomics, and proteomics.  This involves using neural networks to learn complex relationships within this data, such as those between gene expression profiles and disease outcomes.  While the paper focuses on the challenges of interpreting these \"black box\" models, it confirms that neural networks are being actively used for computation involving protein and DNA data.\n",
          "url": "https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2023.1128153/full"
        },
        {
          "title": "Modeling in-vivo protein-DNA binding by combining ...",
          "author": "Qinhu  Zhang, tongji University, 201804, Shanghai, P.R. China, Zhen  Shen, tongji University, 201804, Shanghai, P.R. China, De-Shuang  Huang",
          "published_date": "2023-11-09T20:26:13.773000+00:00",
          "summary": "Yes.  This paper describes a hybrid deep neural network that models in-vivo protein-DNA binding.  The network uses k-mer encoding to represent DNA sequences and incorporates both convolutional and recurrent neural networks to analyze these sequences, achieving superior performance compared to other methods.  The approach utilizes a weakly supervised multiple-instance learning framework to account for the complexity of protein-DNA interactions.\n",
          "url": "https://www.nature.com/articles/s41598-019-44966-x"
        },
        {
          "title": "a deep neural network for predicting essential genes in ...",
          "author": "Lonardi, Stefano",
          "published_date": "2020-09-30T00:00:00+00:00",
          "summary": "Yes.  The paper describes DeeplyEssential, a deep neural network that predicts essential genes in microbes using only the gene's primary sequence and the corresponding protein sequence as input.  This work demonstrates the use of neural networks to analyze protein sequences for biological function prediction.\n",
          "url": "https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-020-03688-y"
        }
      ],
      "full_explanation": "Several papers describe the design and implementation of neural networks that directly compute using DNA or proteins as the computational substrate, thereby directly addressing the research question. \n\n*   **Lee et al. (2023)** describe a novel design for DNA-based neural networks using enzymatic synthesis for high-purity neurons, spatial patterning, and encoding connectivity on a single-stranded DNA backbone. This directly demonstrates neural network computation using DNA. [URL: https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1]\n\n*   **Solanki et al. (2023)** details a microfluidic device that executes artificial neural networks (ANNs) using nicked DNA. Here the computation happens within the molecular domain, with data represented by DNA strand concentrations, confirming that proteins (enzymes) and DNA are used as a computational substrate to perform neural network computations.  [URL: https://arxiv.org/pdf/2307.00686.pdf]\n\n*  **Lv et al. (2023)** designed DNA-based programmable gate arrays for general-purpose DNA computing. This paper doesn't explicitly mention neural networks, but it does describe DNA as a computational substrate. As such, it's a relevant development towards the research question.  [URL: https://www.nature.com/articles/s41586-023-06484-9]\n  \nThe other papers use neural networks to process protein and DNA data, or to design proteins, rather than using the proteins and DNA themselves as a computational medium for the neural network. While these are useful for training or using networks on protein/DNA data, they do not directly answer the proposed research question of a neural network _computing with_ proteins or DNA."
    },
    {
      "question": "Has anyone found a small molecule that maintains healthy ovarian reserve?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy",
          "author": "Robert J. Schneider",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "Yes, this study found that inhibiting the mTOR pathway with the small molecule everolimus (approved for breast cancer) or the experimental drug INK128 preserves ovarian reserve and fertility in mice undergoing chemotherapy.  Both drugs prevented the chemotherapy-induced loss of primordial follicles, maintaining normal fertility.  Even a modest reduction (2-4 fold) in mTOR activity was sufficient to protect ovarian function.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.1617233114"
        },
        {
          "title": "Postnatal oogenesis leads to an exceptionally large ovarian reserve in naked mole-rats - Nature Communications",
          "author": "Brie\u00f1o-Enr\u00edquez; Miguel Angel; Faykoo-Martinez; Mariela; Goben; Meagan; Grenier; Jennifer K; McGrath; Ashley; Prado; Alexandra M; Sinopoli; Jacob; Wagner; Kate; Walsh; Patrick T; Lopa; Samia H; Laird; Diana J; Cohen; Paula E; Wilson; Michael D; Holmes; Melissa M; Place; Ned J",
          "published_date": "2023-04-13T14:55:44.672000+00:00",
          "summary": "This research article focuses on the exceptionally large ovarian reserve in naked mole-rats, a species with exceptional longevity and reproductive lifespan.  The study investigates the mechanisms behind this, finding that unlike most mammals where the ovarian reserve is established before or shortly after birth, naked mole-rats exhibit postnatal oogenesis, meaning they continue to produce oocytes after birth. The research does *not* identify any small molecules responsible for maintaining a healthy ovarian reserve, but rather explores the unique biological mechanisms contributing to the remarkable reproductive capacity of this species.\n",
          "url": "https://www.nature.com/articles/s41467-023-36284-8"
        },
        {
          "title": "Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice - PubMed",
          "author": "Username",
          "published_date": "2023-02-27T02:00:16.084000+00:00",
          "summary": "Yes, this study found that rapamycin, an mTOR inhibitor, maintains ovarian follicle reserve in mice and human ovarian tissue grafted into mice.  Three weeks of rapamycin treatment suppressed primordial follicle development, preserving the follicle pool without harming oocyte developmental potential.  The effect on follicle recruitment was also reversible.  The researchers suggest this supports further investigation into using mTOR inhibitors to preserve ovarian reserve in women undergoing cancer treatments or facing age-related decline.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31887337/"
        },
        {
          "title": "Can ovarian aging be delayed by pharmacological ...",
          "author": "",
          "published_date": "2019-01-23T00:00:00+00:00",
          "summary": "This article reviews pharmacological strategies to delay ovarian aging, but it does not identify any specific small molecules proven to maintain healthy ovarian reserve.  The paper discusses potential approaches like calorie restriction mimetics, antioxidants, and autophagy inducers, but these are areas of ongoing research, not established treatments.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6366956/"
        },
        {
          "title": "Recent progress in the treatment of women with diminished ...",
          "author": "J. Cohen, N. Chabbert-Buffet, E. Darai",
          "published_date": "2021-12-01T00:00:00+00:00",
          "summary": "This article reviews treatments for diminished ovarian reserve (DOR), a condition characterized by reduced egg quantity and/or quality. While research explores stem cell therapies to improve ovarian function, the text doesn't mention the discovery of a small molecule specifically designed to maintain healthy ovarian reserve.  The focus is on improving outcomes using assisted reproductive technologies (ART) and identifying medications to enhance ovarian function, but no specific small molecule is highlighted as successfully achieving this.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S266716462100052X"
        },
        {
          "title": "Examining Use of Small-molecule Inhibitors in Preserving ...",
          "author": "medweb",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "Northwestern Medicine researchers found that a clinically available small-molecule mTOR inhibitor, when used alongside chemotherapy in mice, preserved ovarian function and fertility.  While total follicle counts were still lower than in untreated mice, the combination therapy significantly improved follicle counts compared to chemotherapy alone, maintaining normal birth rates.  The study suggests that a small reduction in mTOR activity is sufficient to protect ovarian reserve, but further research is needed to optimize dosage and address potential effects on tumor growth.\n",
          "url": "https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/"
        },
        {
          "title": "Ovarian Reserve Disorders, Can We Prevent Them? A ...",
          "author": "",
          "published_date": "2022-12-06T00:00:00+00:00",
          "summary": "This review article on ovarian reserve disorders discusses prevention and mitigation of ovarian damage, but does not identify any small molecules shown to maintain healthy ovarian reserve.  The article focuses on primary prevention (avoiding damage before it occurs), secondary prevention (screening in high-risk individuals), and tertiary prevention (managing disease after diagnosis).  While various factors contributing to ovarian reserve decline are explored, no specific small molecule interventions are highlighted as successful in maintaining ovarian reserve.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9737352/"
        },
        {
          "title": "Protein phosphatase 4 maintains the survival of primordial ...",
          "author": "Sun, Qing-Yuan",
          "published_date": "2024-09-08T00:00:00+00:00",
          "summary": "This research does not identify a specific small molecule maintaining ovarian reserve.  However, the study finds that protein phosphatase 4 (PP4) regulates autophagy in oocytes, impacting primordial follicle survival.  Autophagy's role in maintaining ovarian reserve is highlighted, suggesting that manipulating this pathway (though not via a named small molecule) could potentially influence ovarian health and fertility.  The study focuses on the mechanisms of primordial follicle loss and survival, but doesn't report on the discovery or testing of any small molecules.\n",
          "url": "https://www.nature.com/articles/s41419-024-07051-4"
        },
        {
          "title": "Genetic determination of the ovarian reserve: a literature review",
          "author": "Sinelnikov, Mikhail Y.",
          "published_date": "2021-08-06T00:00:00+00:00",
          "summary": "This literature review on the genetic determination of ovarian reserve does not discuss small molecules that maintain healthy ovarian reserve.  The focus is on identifying genetic factors (e.g., FMR1, EIF4ENIF1, BRCA1/2, and others) associated with ovarian reserve, and how genetic testing can be used to assess and manage related infertility issues.  The review does not address the use of small molecules for this purpose.\n",
          "url": "https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-021-00850-9"
        },
        {
          "title": "NADase CD38 is a key determinant of ovarian aging",
          "author": "Yang; Qingling; Chen; Wenhui; Cong; Luping; Wang; Mengchen; Li; Hui; Huan; Luo; Xiaoyan; Zhu; Jing; Zeng; Xinxin; Zhenye; Xu; Yining; Lei; Min; Zhao; Yanqing; Wei; Sun; Yingpu",
          "published_date": "2023-12-21T00:00:00+00:00",
          "summary": "This research article focuses on the role of NADase CD38 in ovarian aging, but does not identify any small molecules that maintain healthy ovarian reserve.  The study explores the mechanisms of ovarian aging, highlighting the impact of oxidative stress and inflammation, but it doesn't present findings related to small molecule interventions.\n",
          "url": "https://www.nature.com/articles/s43587-023-00532-9"
        }
      ],
      "full_explanation": "Several studies have identified small molecules that can maintain healthy ovarian reserve, primarily by inhibiting the mTOR pathway. The paper \"mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy\" (URL: https://www.pnas.org/doi/full/10.1073/pnas.1617233114) demonstrates that the small molecules everolimus and INK128, both mTOR inhibitors, preserved ovarian reserve in mice undergoing chemotherapy by preventing the loss of primordial follicles. Similarly, the paper \"Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice\" (URL: https://pubmed.ncbi.nlm.nih.gov/31887337/) showed that rapamycin, another mTOR inhibitor, maintained ovarian follicle reserve in mice and in human ovarian tissue. This study also showed that the effect was reversible. Finally, the article \"Examining Use of Small-molecule Inhibitors in Preserving...\" (URL: https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/) also shows that the use of an mTOR inhibitor preserved ovarian reserve in mice undergoing chemotherapy. These studies collectively provide strong evidence that small molecules, specifically mTOR inhibitors, can maintain healthy ovarian reserve."
    },
    {
      "question": "Has anyone done large scale conversion of CO2 to propene?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Combining CO2 reduction with propane oxidative dehydrogenation over bimetallic catalysts",
          "author": "Elaine  Gomez, Columbia University, 10027, New York, NY, USA, Shyam  Kattel, Brookhaven National Laboratory, Upton, 11973, NY, USA, Binhang  Yan, Brookhaven National Laboratory, Upton, 11973, NY, USA, Siyu  Yao, Brookhaven National Laboratory, Upton, 11973, NY, USA, Ping  Liu, Brookhaven National Laboratory, Upton, 11973, NY, USA, Jingguang G Chen, Columbia University, 10027, New York, NY, USA, jgchen@columbia.edu",
          "published_date": "2023-11-09T20:21:59.438000+00:00",
          "summary": "No, the research described focuses on lab-scale investigations of CO\u2082-ODHP (oxidative dehydrogenation of propane by CO\u2082) using FeNi and NiPt catalysts supported on CeO\u2082.  While promising results were obtained at 823 K in flow reactors, the study doesn't address large-scale conversion of CO\u2082 to propene.\n",
          "url": "https://www.nature.com/articles/s41467-018-03793-w"
        },
        {
          "title": "Multifunctional Catalyst Combination for the Direct Conversion of CO2 to Propane",
          "author": "A. Ram\u00edrez,P. Ticali,D. Salusso,T. Cordero-Lanzac,S. Ould-Chikh,Christian Ahoba-Sam,A. Bugaev,E. Borfecchia,S. Morandi,M. Signorile,S. Bordiga,J. Gasc\u00f3n,U. Olsbye",
          "published_date": "2023-10-26T19:28:01.184000+00:00",
          "summary": "This research focuses on converting CO2 to propane, not propene.  The study describes a highly active and selective catalyst (PdZn/ZrO2 + SAPO-34) achieving over 50% selectivity to propane with ~40% CO2 conversion under specific conditions (350\u00b0C, 50 bar, 1500 mL g\u207b\u00b9 h\u207b\u00b9).  While the scale isn't explicitly stated as \"large-scale,\" the researchers highlight the significant market demand for propane (projected to reach 350 million metric tons annually by 2025) and the potential of their catalyst to contribute to its production from CO2.  Therefore, although not directly addressing propene, the work represents a significant step towards large-scale CO2 conversion to a related hydrocarbon.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34723275"
        },
        {
          "title": "Selective conversion of CO2 to isobutane-enriched C4 alkanes over InZrOx-Beta composite catalyst - Nature Communications",
          "author": "Wang; Han; Fan; Sheng; Guo; Shujia; Sen; Qin; Zhangfeng; Dong; Mei; Zhu; Huaqing; Weibin; Jianguo",
          "published_date": "2023-05-16T16:55:45.446000+00:00",
          "summary": "This research focuses on converting CO2 to isobutane-enriched C4 alkanes, not propene.  While the paper mentions significant progress in converting CO2 to C2-C3 alkenes/alkanes, achieving high selectivity to a specific, longer-chain hydrocarbon like butane is challenging.  High selectivity to propene (around 65% along with butene) has been reported, but large-scale production isn't discussed.\n",
          "url": "https://www.nature.com/articles/s41467-023-38336-5"
        },
        {
          "title": "Electrochemical synthesis of propylene from carbon ...",
          "author": "Gr\u00e4tzel, Michael",
          "published_date": "2023-04-06T00:00:00+00:00",
          "summary": "No large-scale conversion of CO2 to propene has been achieved.  While researchers have demonstrated electrochemical CO2 reduction to propene using copper nanocrystals, the production rate remains very low (72 \u03bcA cm\u207b\u00b2 with a Faradaic efficiency of only 0.9%).  The challenges include the complex reaction pathway requiring multiple C-C coupling steps and the easy desorption of an intermediate which favors other products.  Therefore, despite its potential as a sustainable propene source, this technology is currently not commercially viable at scale.\n",
          "url": "https://www.nature.com/articles/s41557-023-01163-8"
        },
        {
          "title": "Direct and selective hydrogenation of CO2 to ethylene and ...",
          "author": "Bin Liu",
          "published_date": "2017-11-27T00:00:00+00:00",
          "summary": "This study demonstrates a method for selectively converting CO2 to light olefins, including propene, using a bifunctional catalyst.  While not explicitly stated as large-scale, the researchers achieved a propene selectivity of 80-90% within hydrocarbons at 20% CO2 conversion under tested conditions (15 bar, 400\u00b0C).  This selectivity is significantly higher than that achieved by conventional methods.  The catalyst also exhibited good stability over 50 hours of continuous operation.\n",
          "url": "https://pubs.rsc.org/en/content/articlelanding/2017/cy/c7cy01549f"
        },
        {
          "title": "Combining CO2 reduction with propane oxidative ...",
          "author": "Elaine  Gomez, Columbia University, 10027, New York, NY, USA, Shyam  Kattel, Brookhaven National Laboratory, Upton, 11973, NY, USA, Binhang  Yan, Brookhaven National Laboratory, Upton, 11973, NY, USA, Siyu  Yao, Brookhaven National Laboratory, Upton, 11973, NY, USA, Ping  Liu, Brookhaven National Laboratory, Upton, 11973, NY, USA, Jingguang G Chen, Columbia University, 10027, New York, NY, USA, jgchen@columbia.edu",
          "published_date": "2023-11-09T20:21:59.438000+00:00",
          "summary": "No, the research described focuses on using CO2 in the oxidative dehydrogenation of propane to produce propene, but it's conducted using flow reactors, not at a large scale.  The study investigates the catalytic properties of FeNi and NiPt catalysts supported on CeO2,  examining reaction pathways and metal oxidation states via X-ray absorption spectroscopy and DFT calculations. While promising results were obtained at 823K, the research doesn't address large-scale implementation.\n",
          "url": "https://www.nature.com/articles/s41467-018-03793-w"
        },
        {
          "title": "Toward the Development and Deployment of Large-Scale ...",
          "author": "Zhihong  Yuan, Mario R Eden, Rafiqul  Gani",
          "published_date": "2023-11-09T20:13:41.012000+00:00",
          "summary": "The provided text focuses on the challenges of large-scale CO2 capture and conversion generally, mentioning various conversion routes (thermochemical, electrochemical, photochemical, and biochemical).  However, it does *not* provide specific information on whether large-scale CO2 conversion to propene has been achieved.  The article discusses the need for and challenges in scaling up CO2 conversion technologies, but doesn't offer data on the success of any specific conversion to propene.\n",
          "url": "https://pubs.acs.org/doi/10.1021/acs.iecr.5b03277"
        },
        {
          "title": "The enhancing effect of Co2+ on propane non-oxidative ...",
          "author": "S.M. Sadrameli",
          "published_date": "2024-04-01T00:00:00+00:00",
          "summary": "This research paper does not address the large-scale conversion of CO2 to propene.  It focuses on propane dehydrogenation (PDH), a process to convert propane (C3H8) to propene (C3H6), investigating the use of Co/ZrO2 catalysts as a more environmentally friendly and cost-effective alternative to current Cr- or Pt-based catalysts.  The study shows that Co/ZrO2 catalysts, particularly those with single Co\u00b2\u207a ions, are highly effective in this process.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0021951724001532"
        },
        {
          "title": "Reshaping the Role of CO 2 in Propane Dehydrogenation",
          "author": "",
          "published_date": "2022-07-18T00:00:00+00:00",
          "summary": "This research paper investigates using CO2 in propane dehydrogenation (PDH), a process crucial for propylene production.  While it doesn't report large-scale CO2-to-propene conversion, it explores the potential for significantly reducing greenhouse gas emissions by coupling CO2 reduction with PDH.  The study screens various catalytic materials under industrial conditions to optimize the process, focusing on reaction kinetics and catalyst deactivation.  The researchers found that oxygen mobility is key to efficient reoxidation with CO2, influencing the overall balance of active sites.  Although not at a large scale, the work demonstrates a promising pathway for integrating CO2 into propylene production.\n",
          "url": "https://www.researchgate.net/publication/362089758_Reshaping_the_Role_of_CO_2_in_Propane_Dehydrogenation_From_Waste_Gas_to_Platform_Chemical"
        },
        {
          "title": "Heterogeneous Catalysis for CO2 Conversion into ...",
          "author": "Cai, Rui",
          "published_date": "2022-08-09T00:00:00+00:00",
          "summary": "This research review focuses on heterogeneous catalysis for CO2 conversion into various chemicals and fuels, including methanol, methane, ethanol, and propanol, but it does not discuss large-scale conversion of CO2 specifically to propene.  The paper details progress made by the Dalian Institute of Chemical Physics, covering thermal, electrocatalytic, and photo(electro)catalytic methods, but doesn't address the scalability of any specific CO2-to-propene process.\n",
          "url": "https://link.springer.com/article/10.1007/s12209-022-00326-x"
        }
      ],
      "full_explanation": "While several papers explore aspects related to CO2 conversion and propene production, none directly describe large-scale conversion of CO2 to propene. The research primarily focuses on lab-scale investigations or alternative pathways involving CO2.\n\nSpecifically, the following papers, although relevant, do not demonstrate large-scale CO2 conversion to propene:\n\n*   **Combining CO2 reduction with propane oxidative dehydrogenation over bimetallic catalysts** ([https://www.nature.com/articles/s41467-018-03793-w](https://www.nature.com/articles/s41467-018-03793-w)): This paper investigates the oxidative dehydrogenation of propane using CO2 to produce propene at the lab-scale using flow reactors, but does not address large-scale implementation. It explores the catalytic properties of FeNi and NiPt catalysts supported on CeO2.\n*   **Electrochemical synthesis of propylene from carbon ...** ([https://www.nature.com/articles/s41557-023-01163-8](https://www.nature.com/articles/s41557-023-01163-8)): This study showcases the electrochemical reduction of CO2 to propene, but the production rate is very low, and it is not commercially viable at scale. The process faces challenges such as complex reaction pathways and the desorption of key intermediates.\n*   **Direct and selective hydrogenation of CO2 to ethylene and ...** ([https://pubs.rsc.org/en/content/articlelanding/2017/cy/c7cy01549f](https://pubs.rsc.org/en/content/articlelanding/2017/cy/c7cy01549f)):  This paper demonstrates high propene selectivity during CO2 hydrogenation using a bifunctional catalyst, but does not explicitly state a large-scale production of propene was achieved. The study is done at the lab scale (15 bar, 400\u00b0C).\n*   **Reshaping the Role of CO 2 in Propane Dehydrogenation** ([https://www.researchgate.net/publication/362089758_Reshaping_the_Role_of_CO_2_in_Propane_Dehydrogenation_From_Waste_Gas_to_Platform_Chemical](https://www.researchgate.net/publication/362089758_Reshaping_the_Role_of_CO_2_in_Propane_Dehydrogenation_From_Waste_Gas_to_Platform_Chemical)): This paper explores the use of CO2 in propane dehydrogenation, a process for propene production, but not the direct conversion of CO2 to propene.\n\nWhile there is ongoing research into CO2 conversion to propene, large-scale implementation of such a process has not been demonstrated in the provided literature."
    },
    {
      "question": "Has anyone discovered how proteins contribute to the mechanical properties of cells and tissues?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "The laminin\u2013keratin link shields the nucleus from mechanical deformation and signalling",
          "author": "Kechagia; Zanetta; S\u00e1ez; Pablo; G\u00f3mez-Gonz\u00e1lez; Manuel; Canales; Brenda; Viswanadha; Srivatsava; Zamarbide; Mart\u00edn; Andreu; Ion; Koorman; Thijs; Beedle; Amy E M; Elosegui-Artola; Alberto; Derksen; Patrick W B; Trepat; Xavier; Arroyo; Marino; Roca-Cusachs; Pere",
          "published_date": "2023-12-04T03:54:56.396000+00:00",
          "summary": "This study investigates how laminin-111, a protein in the extracellular matrix (ECM), affects how cells respond to changes in tissue stiffness.  The researchers found that laminin-111 hinders the typical cellular response to increased rigidity, impacting mechanotransduction (the process by which cells sense and respond to mechanical forces).  While the study focuses on a specific protein and cell type, it contributes to the broader understanding of how ECM proteins influence cellular mechanical properties and responses, impacting processes like cancer metastasis.  The study highlights the complex interplay between ECM proteins, cell signaling, and tissue mechanics.\n",
          "url": "https://www.nature.com/articles/s41563-023-01657-3"
        },
        {
          "title": "The vimentin cytoskeleton: when polymer physics meets cell biology",
          "author": "A. Patteson,Robert J. Carroll,Daniel V. Iwamoto,P. Janmey",
          "published_date": "2023-10-26T19:28:33.989000+00:00",
          "summary": "This review article discusses the role of vimentin, an intermediate filament protein, in contributing to the mechanical properties of cells and tissues.  Vimentin's unique structure and polymerization process (unlike actin and microtubules) give it exceptional extensibility, flexibility, and toughness.  Mutations in vimentin genes lead to diseases with observable mechanical defects, highlighting its importance in cellular mechanics.  The article focuses on how vimentin, and intermediate filaments in general, act as links transferring forces between the cell surface and nucleus, enabling cells and tissues to withstand stress.  In short, yes, the research described shows a clear contribution of proteins (specifically vimentin) to the mechanical properties of cells and tissues.\n",
          "url": "https://arxiv.org/pdf/2008.10563.pdf"
        },
        {
          "title": "The mechanical cell \u2013 the role of force dependencies in synchronising protein interaction networks",
          "author": "Benjamin T. Goult",
          "published_date": "2022-11-15T00:00:00+00:00",
          "summary": "This review article discusses the role of force-dependent protein interactions in synchronizing cellular processes.  It explores how mechanical forces influence protein networks, contributing to the mechanical properties of cells.  The authors investigate how these force dependencies impact cellular behavior and tissue mechanics.  While not explicitly stating a single \"discovery,\" the article comprehensively reviews the current understanding of how proteins contribute to cell and tissue mechanics through force-dependent interactions.\n",
          "url": "https://journals.biologists.com/jcs/article/135/22/jcs259769/283155/The-mechanical-cell-the-role-of-force-dependencies"
        },
        {
          "title": "Mechanical Players\u2014The Role of Intermediate Filaments ...",
          "author": "",
          "published_date": "2013-10-15T00:00:00+00:00",
          "summary": "Yes.  Research indicates that the cytoskeleton, a complex protein composite of actin, microtubules, and intermediate filaments, significantly contributes to cell mechanics.  While actin and microtubules are well-studied, intermediate filaments, despite their abundance, are less understood.  However, studies show they are crucial for cell geometry and mechanical properties, acting as a protective element enhancing cell integrity against severe deformation due to their unique mechanical compliance.  Recent work by Weitz et al. has shed light on the mechanisms by which vimentin intermediate filaments (a type of intermediate filament) control cell stiffness.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3797571/"
        },
        {
          "title": "Cell mechanics and the cytoskeleton - PMC - PubMed Central",
          "author": "",
          "published_date": "2010-01-28T00:00:00+00:00",
          "summary": "Yes, research indicates that the cytoskeleton, a network of filamentous polymers and proteins, significantly contributes to a cell's mechanical properties.  This network enables cells to resist deformation, transport internal cargo, and change shape during movement.  The interplay of internal and external forces acting through the cytoskeleton affects both local mechanical properties and cellular behavior.  While many cytoskeletal proteins have been identified and their individual functions studied, understanding how they collectively contribute to the mechanical properties of cells and tissues remains an active area of research.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2851742/"
        },
        {
          "title": "How to define and study structural proteins as biopolymer ...",
          "author": "Keiji  Numata, Kyoto University, Kyoto-Daigaku-Katsura, Nishikyo-ku, 615-8510, Kyoto, Japan, keiji.numata@riken.jp",
          "published_date": "2023-11-09T20:29:43.698000+00:00",
          "summary": "This Nature article reviews structural proteins, like silk fibroins, and their role in cell, tissue, and organism structure.  The authors discuss how these proteins, with their unique repeating amino acid sequences, are being studied for their contributions to the mechanical properties of biomaterials.  The review focuses on characterization methods and potential applications, implicitly highlighting the importance of structural proteins in determining the mechanical properties of cells and tissues.\n",
          "url": "https://www.nature.com/articles/s41428-020-0362-5"
        },
        {
          "title": "Mechanical Properties of Living Cells and Tissues Related ...",
          "author": "Written By Miroslav Hole\u010dek, Petra Kochov\u00e1 and Zbyn\u011bk Tonar",
          "published_date": "2011-11-25T00:00:00+00:00",
          "summary": "This review article discusses the mechanical properties of living cells and tissues from a physics perspective, acknowledging the challenges of applying traditional physics concepts to complex biological systems.  While the article doesn't directly address the specific contribution of proteins to cellular mechanics in detail, it highlights the use of macromolecular chemistry and polymer physics to describe the molecular structure of cells.  This implies that protein structure and interactions, as components of the cellular macromolecular structure, are implicitly relevant to the discussion of mechanical properties, but  a precise answer to the role of proteins is not explicitly provided.\n",
          "url": "https://www.intechopen.com/chapters/22184"
        },
        {
          "title": "Review Fibrous proteins and tissue engineering",
          "author": "Xianyan  Wang, Tufts University, 02155, Medford, MA, USA, Joo  Kim, Tufts University, 02155, Medford, MA, USA, Cheryl  Wong, Tufts University, 02155, Medford, MA, USA, Charu  Vepari, Tufts University, 02155, Medford, MA, USA, Akira  Matsumoto, Tufts University, 02155, Medford, MA, USA, David L Kaplan, Tufts University, 02155, Medford, MA, USA, david.kaplan@tufts.edu",
          "published_date": "2023-11-09T19:55:09.836000+00:00",
          "summary": "Research shows fibrous proteins significantly impact the mechanical properties of cells and tissues.  Their unique properties, stemming from understood structure-function relationships, are being exploited in biomaterial and tissue engineering.  Current research focuses on controlling the structure, chemistry, and morphology of these proteins to direct cell and tissue outcomes both in vitro and in vivo.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S1369702106717424"
        },
        {
          "title": "The mechanical properties of individual cell spheroids",
          "author": "Blumlein; Alice; Williams; Noel; McManus; Jennifer J",
          "published_date": "2023-02-07T23:09:00.608000+00:00",
          "summary": "This Scientific Reports article investigates the mechanical properties of cell spheroids, focusing on interfacial tension between cells as a key contributor.  While it doesn't directly address the role of *specific proteins*, the authors highlight that the biophysical properties of the cytoskeleton (which is composed of proteins) and cell membrane influence individual cell mechanics.  Further, the interplay between cell adhesion molecules (proteins) and the extracellular matrix contributes to the mechanical properties of multicellular tissues.  The study uses cavitation rheology to measure these properties in HEK cell spheroids, but doesn't detail the specific protein contributions.\n",
          "url": "https://www.nature.com/articles/s41598-017-07813-5"
        },
        {
          "title": "Molecular assembly and mechanical properties of the ...",
          "author": "J. Gosline, M. Lillie, E. Carrington, P. Guerette, C. Ortlepp, K. Savage",
          "published_date": "2013-07-01T00:00:00+00:00",
          "summary": "Yes.  This article focuses on the contribution of collagen and elastin proteins to the mechanical properties of tissues.  Collagen provides tensile strength, resisting deformation and rupture, while elastin allows for extensibility and recoil, enabling tissues to withstand repetitive stress.  The article details the molecular assembly of these proteins and how their structure contributes to these mechanical properties.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0925443912002839"
        }
      ],
      "full_explanation": "The research question, \"Has anyone discovered how proteins contribute to the mechanical properties of cells and tissues?\", has been addressed in numerous studies. Several papers demonstrate that the role of specific proteins and protein networks in determining cell and tissue mechanical properties has been extensively investigated.\n\nSpecifically, the paper titled \"The vimentin cytoskeleton: when polymer physics meets cell biology\" (URL: https://arxiv.org/pdf/2008.10563.pdf) directly discusses how vimentin, an intermediate filament protein, contributes to cell and tissue mechanical properties, highlighting its unique extensibility, flexibility, and toughness. This paper clearly indicates a discovery of a protein's role in this mechanical property. \n\nAdditionally, the review article \"Mechanical Players\u2014The Role of Intermediate Filaments...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3797571/) confirms that the cytoskeleton, a protein composite, contributes to cell mechanics. It further points out that intermediate filaments such as vimentin are crucial for cell geometry and mechanical properties, thereby stating discovery of the role of specific proteins. This paper explicitly mentions research showing how vimentin controls cell stiffness.\n\nSimilarly, \"Cell mechanics and the cytoskeleton\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2851742/) also states that the cytoskeleton, a network of proteins, contributes to a cell's mechanical properties. It describes how the cytoskeleton enables cells to resist deformation and thus shows how the protein networks contribute to mechanical properties.\n\nThe paper \"Molecular assembly and mechanical properties of the ...\" (URL: https://www.sciencedirect.com/science/article/pii/S0925443912002839) details the contributions of collagen and elastin to tissue mechanical properties, showcasing how specific proteins provide tensile strength and extensibility to tissues, again a clear case of how a protein influences mechanical properties.\n\nFurthermore, \"Fibrous proteins and tissue engineering\" (URL: https://www.sciencedirect.com/science/article/pii/S1369702106717424) shows that fibrous proteins have a significant impact on cell and tissue mechanical properties, again supporting that research has shown protein contributions. Finally, \"The mechanical cell \u2013 the role of force dependencies in synchronising protein interaction networks\" (URL: https://journals.biologists.com/jcs/article/135/22/jcs259769/283155/The-mechanical-cell-the-role-of-force-dependencies) reviews how mechanical forces influence protein networks, contributing to the mechanical properties of cells. This is again clear research into how proteins impact mechanical properties. While the paper from 2023 \"The laminin\u2013keratin link shields the nucleus from mechanical deformation and signalling\" (URL: https://www.nature.com/articles/s41563-023-01657-3) investigates a specific protein (laminin-111) and its impact on cell responses to stiffness, it also fits into this broader research question of how proteins impact cellular mechanics. In summary, multiple papers demonstrate that this research question has indeed been explored, and the roles of various proteins in cell and tissue mechanical properties have been discovered."
    },
    {
      "question": "Has anyone made an entire cell with D amino acids?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Consecutive Elongation of D-Amino Acids in Translation",
          "author": "Search for articles by this author",
          "published_date": "2017-01-19T00:00:00+00:00",
          "summary": "No, this research does not describe the creation of an entire cell using D-amino acids.  The study focuses on developing a method to incorporate up to ten consecutive D-serine residues into a peptide chain during ribosomal translation *in vitro*, using engineered tRNAs and optimized translation factors.  It also details the creation of macrocyclic D-peptides.  The work is limited to peptide synthesis, not whole-cell construction.\n",
          "url": "https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(16)30435-4"
        },
        {
          "title": "D-amino acid doping peptide hydrogel for the production of a cell colony",
          "author": "Caiwen  Ou, Zhujiang Hospital of Southern Medical University, 510280, Guangzhou, P. R. China, Jianwu  Zhang, Zhujiang Hospital of Southern Medical University, 510280, Guangzhou, P. R. China, Yang  Shi, Nankai University, 300071, Tianjin, P. R. China, yangzm@nankai.edu.cn, Zhongyan  Wang, Nankai University, 300071, Tianjin, P. R. China, Ling  Wang, Zhimou  Yang, Nankai University, 300071, Tianjin, P. R. China, Minsheng  Chen, Zhujiang Hospital of Southern Medical University, 510280, Guangzhou, P. R. China, gzminsheng@vip.163.com",
          "published_date": "2023-11-09T20:04:57.198000+00:00",
          "summary": "No, this research used D-amino acids to create a peptide hydrogel for growing a *colony* of HeLa cells, not to construct an entire cell from D-amino acids.  The study focuses on using the hydrogel as a scaffold for cell growth, not on building cells from D-amino acids themselves.\n",
          "url": "https://pubs.rsc.org/en/content/articlelanding/2014/RA/c3ra46847j"
        },
        {
          "title": "Adding \u03b1,\u03b1-disubstituted and \u03b2-linked monomers to the genetic code of an organism",
          "author": "Dunkelmann; Daniel L; Piedrafita; Carlos; Dickson; Alexandre; Liu; Kim C; Elliott; Thomas S; Fiedler; Marc; Bellini; Dom; Zhou; Andrew; Cervettini; Daniele; Chin; Jason W",
          "published_date": "2024-01-10T00:00:00+00:00",
          "summary": "This research expands the genetic code of cells to incorporate non-canonical amino acids (ncAAs) into proteins,  including \u03b1,\u03b1-disubstituted and \u03b2-linked monomers.  While the study significantly advances the ability to incorporate a wider range of monomers into proteins, it does not address the creation of a cell composed entirely of D-amino acids.  The focus is on site-specific incorporation of ncAAs during cellular translation, not complete replacement of all amino acids.\n",
          "url": "https://www.nature.com/articles/s41586-023-06897-6"
        },
        {
          "title": "Production of D-amino acid using whole cells ...",
          "author": "J H Park 1 , G J Kim, H S Kim",
          "published_date": "2014-07-18T00:00:00+00:00",
          "summary": "This research used recombinant *Escherichia coli* cells expressing D-hydantoinase and N-carbamoylase to produce D-amino acids from 5'-monosubstituted hydantoin.  While the study doesn't create cells *entirely* composed of D-amino acids, it demonstrates a method for producing D-amino acids *within* and using whole *E. coli* cells.  The co-expression of the two enzymes yielded significantly higher (98%) D-hydroxyphenylglycine production than separate expression (71%).\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/10933829/"
        },
        {
          "title": "Highly selective synthesis of d-amino acids via ...",
          "author": "Dan-Ping  Zhang, Xiao-Ran  Jing, Lun-Jie  Wu, An-Wen  Fan, Yao  Nie, ynie@jiangnan.edu.cn, Yan  Xu",
          "published_date": "2023-11-09T20:33:38.692000+00:00",
          "summary": "No, this research does not describe a cell made entirely of D-amino acids.  Instead, it details the creation of a genetically modified *E. coli* cell factory that efficiently converts L-amino acids into D-amino acids through a three-enzyme cascade.  This process achieves high yields (over 99% enantiomeric excess) for various aromatic and aliphatic amino acids.\n",
          "url": "https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-020-01506-x"
        },
        {
          "title": "The Role of D-Amino Acids in Humans",
          "author": "Sponsored Content by PittconMar 4 2021",
          "published_date": "2024-02-01T10:56:00+00:00",
          "summary": "The provided text focuses on the roles of D-amino acids in human health and disease, particularly in cancer and neurological disorders.  It does *not* address whether a cell has been created entirely from D-amino acids.  The research discussed uses techniques like HPLC and mass spectrometry to analyze D-amino acid levels in various contexts, but this is analytical work, not synthetic cell creation.\n",
          "url": "https://www.news-medical.net/news/20210304/The-Role-of-D-Amino-Acids-in-Humans.aspx"
        },
        {
          "title": "d-amino Acids in Health and Disease: A Focus on Cancer",
          "author": "",
          "published_date": "2019-09-12T00:00:00+00:00",
          "summary": "This article focuses on the roles of D-amino acids in human health and disease, particularly cancer.  While it discusses the sources and functions of D-amino acids in various organisms, including their presence in human tissues and bodily fluids, it does *not* address the creation of an entire cell using only D-amino acids.  The paper does not mention any such research.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6770864/"
        },
        {
          "title": "Emerging knowledge of regulatory roles of d-amino acids ...",
          "author": "Cava; Felipe; Lam; Hubert; De Pedro; Miguel A; Waldor; Matthew K",
          "published_date": "2023-12-04T02:14:09.379000+00:00",
          "summary": "This article focuses on the regulatory roles of D-amino acids in bacteria, not on the creation of cells entirely composed of D-amino acids.  While the article notes that D-amino acids are found in bacterial cell walls and influence processes like cell wall remodeling and biofilm dispersal, it does not address the feasibility or any attempts to construct a complete cell using only D-amino acids.\n",
          "url": "https://link.springer.com/article/10.1007/s00018-010-0571-8"
        },
        {
          "title": "d-amino acids signal a stress-dependent run-away ...",
          "author": "Irazoki; Oihane; Ter Beek; Josy; Alvarez; Laura; Mateus; Andr\u00e9; Colin; Remy; Typas; Athanasios; Savitski; Mikhail M; Sourjik; Victor; Berntsson; Ronnie P -A; Cava; Felipe",
          "published_date": "2023-12-04T02:09:55.764000+00:00",
          "summary": "This research does not address the creation of an entire cell using D-amino acids.  The study focuses on the role of D-amino acids (DAAs) as environmental signals in *Vibrio cholerae*, specifically how their release and detection impact bacterial motility and chemotaxis.  The authors find that *V. cholerae* releases high concentrations of DAAs, which are sensed by the bacteria, influencing their behavior.  No mention is made of constructing a cell from DAAs.\n",
          "url": "https://www.nature.com/articles/s41564-023-01419-6"
        },
        {
          "title": "Stepwise engineering of a Pichia pastoris D-amino acid ...",
          "author": "Sandra  Abad, Jozef  Nahalka, Gabriele  Bergler, Alison  Arnold, Ingenza Ltd, Roslin BioCentre, EH25 9PP, Wallace Building, Roslin, UK, Robert  Speight, Ingenza Ltd, Roslin BioCentre, EH25 9PP, Wallace Building, Roslin, UK, Ian  Fotheringham, Ingenza Ltd, Roslin BioCentre, EH25 9PP, Wallace Building, Roslin, UK, Bernd  Nidetzky, Anton  Glieder, anton.glieder@acib.at",
          "published_date": "2023-11-09T20:00:16.477000+00:00",
          "summary": "This research did not create a whole cell *composed* of D-amino acids.  Instead, it engineered a *Pichia pastoris* yeast cell to highly express a D-amino acid oxidase (Tv DAO) enzyme, resulting in a significantly improved whole-cell biocatalyst for D-amino acid conversion.  The improvements involved codon optimization, subcellular targeting, multi-copy integration, and optimized fed-batch cultivation.  The resulting biocatalyst showed a seven-fold increase in activity compared to the native host.\n",
          "url": "https://microbialcellfactories.biomedcentral.com/articles/10.1186/1475-2859-9-24"
        }
      ],
      "full_explanation": "None of the provided papers describe the creation of an entire cell constructed from D-amino acids. While several papers explore the use, production, and effects of D-amino acids, they do not achieve the complete substitution of L-amino acids with D-amino acids in a functional cell.\n\n*   **Consecutive Elongation of D-Amino Acids in Translation** (URL: https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(16)30435-4): This paper focuses on *in vitro* peptide synthesis using D-amino acids. It details the incorporation of up to ten consecutive D-serine residues into a peptide chain. While it demonstrates the capability of using D-amino acids in peptide synthesis, it does not construct an entire cell from them.\n\n*   **D-amino acid doping peptide hydrogel for the production of a cell colony** (URL: https://pubs.rsc.org/en/content/articlelanding/2014/RA/c3ra46847j): This paper describes the creation of a hydrogel from D-amino acids which is then used as a scaffold to grow colonies of HeLa cells. The D-amino acids here are not used to construct the cell but rather to create a suitable environment for cell growth.\n\n*   **Production of D-amino acid using whole cells ...** (URL: https://pubmed.ncbi.nlm.nih.gov/10933829/): This study focuses on producing D-amino acids within *E. coli* cells by expressing specific enzymes. While the research uses whole cells, it does *not* construct a cell entirely from D-amino acids but instead uses them to produce D-amino acids.\n\n*   **Highly selective synthesis of d-amino acids via ...** (URL: https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-020-01506-x): This paper also uses *E. coli* to produce D-amino acids by converting them from L-amino acids via a multi-enzyme system. Again, the goal is D-amino acid production, not construction of a cell solely from D-amino acids.\n\n*   **Stepwise engineering of a Pichia pastoris D-amino acid ...** (URL: https://microbialcellfactories.biomedcentral.com/articles/10.1186/1475-2859-9-24): This paper describes engineered yeast cells for the high production of D-amino acid oxidase. The work uses yeast cells and produces an enzyme that is useful for working with D-amino acids but does not create a cell made of D-amino acids.\n\nIn summary, while the literature contains significant research on the synthesis, production, and use of D-amino acids, none of the reviewed papers describe the creation of a complete cell composed entirely of D-amino acids. The research question, therefore, appears to be novel."
    },
    {
      "question": "Has anyone identified how many copies of p53 whales have?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity - PubMed",
          "author": "Martin Bartas 1 ,",
          "published_date": "2021-07-08T00:00:00+00:00",
          "summary": "This study doesn't specify the p53 gene copy number in whales.  However, it uses whales (specifically, bowhead whales) as an example of a long-lived species and investigates correlations between specific amino acid changes in the p53 protein and longevity across various animal species.  The research focuses on p53 protein sequence variations, not gene copy number.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34445220/"
        },
        {
          "title": "The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity",
          "author": "Martin Bartas; V\u00e1clav Br\u00e1zda; Adriana Voln\u00e1; Ji\u0159\u00ed \u010cerve\u0148; Petr Pe\u010dinka; Joanna E Zawacka-Pankau",
          "published_date": "2023-02-06T18:48:01.083000+00:00",
          "summary": "This research article does not contain information on the number of p53 gene copies in whales.  The study focuses on the correlation between p53 amino acid sequence variations and lifespan across different species, using examples such as humans (one copy of TP53) and African elephants (20 copies, including 19 retrogenes).\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395165/"
        },
        {
          "title": "Nucleotide sequence of the p53 cDNA of beluga whale (Delphinapterus leucas).",
          "author": "Ning  Xu, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Japan, Takashi  Shiraki, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Japan, Tadasu  Yamada, National Science Museum, 3-23-1, Hyakunin-cho, Shinjuku-ku, 169-0073, Tokyo, Japan, Masayuki  Nakajima, Hakkeijima Sea Paradise Aquarium, Kanazawa-ku, 236-0006, Hakkeijima, Yokohama, Japan, Julie M Gauthier, University of Que \u00b4bec, Montre \u00b4al, Que \u00b4bec, Canada, Carl J Pfeiffer, Virginia Polytechnic Institute and State University, 24061-0442, Blacksburg, VA, USA, Shigeaki  Sato, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Japan, sato@kobe-u.ac.jp",
          "published_date": "2023-11-09T19:58:42.557000+00:00",
          "summary": "This study sequenced the beluga whale p53 gene cDNA, finding it to be 2150 nucleotides long and encoding a 387-amino acid protein.  The research doesn't specify the copy number of the p53 gene in whales; it only focuses on the sequence of a single copy obtained from blood and liver samples.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0378111902004729"
        },
        {
          "title": "Evolution of p53 pathway-related genes provides insights ...",
          "author": "",
          "published_date": "2023-09-18T00:00:00+00:00",
          "summary": "This study doesn't specify the copy number of the p53 gene itself in whales.  However, it examines 73 genes in the p53 pathway in cetaceans and finds that several positively selected tumor suppressor genes (not specified as p53) had high copy numbers correlated with body size in long-lived whale lineages.  This supports Peto's paradox, which suggests that cancer incidence isn't simply linked to body size or longevity.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10559092/"
        },
        {
          "title": "How Do Whales Fight Off Cancer? Scholar in Duke's ...",
          "author": "By Lindsay Key",
          "published_date": "2019-08-14T00:00:00+00:00",
          "summary": "This article discusses the surprisingly low cancer rates in whales despite their large size (Peto's Paradox).  While it mentions research into potential mechanisms of whale cancer resistance, including the p53 protein, it does *not* state the number of p53 copies found in whales.  The research described focuses on exploring *why* whales have low cancer rates, not on the specific gene copy number of p53.\n",
          "url": "https://medschool.duke.edu/stories/how-do-whales-fight-cancer-scholar-dukes-marine-medicine-program-breaks-new-ground"
        },
        {
          "title": "Peto's Paradox: how has evolution solved the problem of ...",
          "author": "Tollis; Marc; Boddy; Amy M; Maley; Carlo C",
          "published_date": "2023-02-06T08:47:05.871000+00:00",
          "summary": "This article does not contain information about the number of p53 copies in whales.  The article discusses Peto's Paradox, which observes that larger, longer-lived animals don't get cancer at a rate proportional to their size and lifespan.  While it explores the evolutionary mechanisms that might explain this, it doesn't delve into the specifics of p53 gene copies in any particular species.\n",
          "url": "https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-017-0401-7"
        },
        {
          "title": "TP53 copy number expansion is associated with the ...",
          "author": "",
          "published_date": "2016-09-19T00:00:00+00:00",
          "summary": "This study examined the number of *TP53* (p53) gene copies in 61 animals of varying sizes, including Minke whales.  While the exact number of p53 copies in Minke whales isn't explicitly stated, the research found that African elephants had the most, with 19 copies,  and that an increase in *TP53* copy number correlated with larger body size across species.  The study suggests that extra *TP53* copies may help large animals combat cancer, but doesn't provide the specific p53 copy number for Minke whales.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5061548/"
        },
        {
          "title": "The changes in the p53 protein across the animal kingdom ...",
          "author": "View ORCID ProfileMartin Bartas",
          "published_date": "2021-07-12T00:00:00+00:00",
          "summary": "This study does not contain information on the number of p53 copies in whales.  The research focuses on the correlation between p53 amino acid sequence variations and lifespan across different species, noting that African elephants, with their many p53 copies, have extended lifespans and cancer resistance.  The study does not provide data on whale p53 copy numbers.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2020.05.06.080200.full"
        },
        {
          "title": "DNA repair and anti-cancer mechanisms in the longest ...",
          "author": "View ORCID ProfileDenis Firsanov",
          "published_date": "2023-05-08T00:00:00+00:00",
          "summary": "This study does not address the copy number of the p53 gene in bowhead whales.  While it mentions that research on elephants has shown p53 gene expansion as a potential explanation for Peto's Paradox (the lack of increased cancer risk in larger animals), the authors found that bowhead whales' exceptional longevity and cancer resistance are instead linked to highly efficient and accurate DNA repair mechanisms, involving proteins like CIRBP and RPA2.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.05.07.539748v1.full"
        },
        {
          "title": "The Elephant in the Room: Gene Copy Number and Cancer",
          "author": "SITNFlash",
          "published_date": "2015-11-23T15:00:03+00:00",
          "summary": "This article discusses gene copy number and its role in cancer, explaining how the typical human cell has two copies of each gene.  It gives examples of gene duplication and its impact on health, but does not contain information about the number of p53 gene copies in whales.\n",
          "url": "https://sitn.hms.harvard.edu/flash/2015/the-elephant-in-the-room-gene-copy-number-and-cancer/"
        }
      ],
      "full_explanation": "The research question, \"Has anyone identified how many copies of p53 whales have?\", has been partially addressed in the provided literature. Specifically, the paper titled \"TP53 copy number expansion is associated with the evolution of increased body size and decreased cancer risk in mammals\" directly investigates the copy number of the *TP53* (p53) gene across multiple species, including Minke whales. The summary states that the study \"examined the number of *TP53* (p53) gene copies in 61 animals of varying sizes, including Minke whales\" and found a correlation between increased copy number and larger body size, although it does not give a precise copy number for Minke Whales. While the other papers discuss p53 and cancer resistance in whales, they do not specifically explore the copy number of p53 in whales. These papers include: \"The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity\" (https://pubmed.ncbi.nlm.nih.gov/34445220/), \"The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395165/), \"Nucleotide sequence of the p53 cDNA of beluga whale (Delphinapterus leucas).\" (https://www.sciencedirect.com/science/article/pii/S0378111902004729), \"Evolution of p53 pathway-related genes provides insights ...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC10559092/), \"How Do Whales Fight Off Cancer? Scholar in Duke's ...\" (https://medschool.duke.edu/stories/how-do-whales-fight-cancer-scholar-dukes-marine-medicine-program-breaks-new-ground), \"Peto's Paradox: how has evolution solved the problem of ...\" (https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-017-0401-7), \"The changes in the p53 protein across the animal kingdom ...\" (https://www.biorxiv.org/content/10.1101/2020.05.06.080200.full), \"DNA repair and anti-cancer mechanisms in the longest ...\" (https://www.biorxiv.org/content/10.1101/2023.05.07.539748v1.full), and \"The Elephant in the Room: Gene Copy Number and Cancer\" (https://sitn.hms.harvard.edu/flash/2015/the-elephant-in-the-room-gene-copy-number-and-cancer/). However, the paper \"TP53 copy number expansion is associated with the evolution of increased body size and decreased cancer risk in mammals\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC5061548/) directly addresses the question, although it doesn't provide a specific copy number for minke whales."
    },
    {
      "question": "Has anyone successfully identified the precise mechanisms by which prion proteins propagate their misfolded conformations across different species?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "A structural basis for prion strain diversity - Nature Chemical Biology",
          "author": "Manka; Szymon W; Wenborn; Adam; Betts; Jemma; Joiner; Susan; Saibil; Helen R; Collinge; John; Wadsworth; Jonathan D F",
          "published_date": "2023-04-13T18:51:23.128000+00:00",
          "summary": "This Nature Chemical Biology article explores the structural basis of prion strain diversity, focusing on how prions propagate their misfolded conformations.  While it details the challenges of cross-species transmission (species barrier effects linked to structural compatibility with host PrP<sup>C</sup>) and the role of PrP polymorphisms in generating novel strains, it doesn't describe a *precisely* identified mechanism for the propagation of misfolded conformations across species.  The research highlights the importance of understanding this mechanism to assess zoonotic risks from emerging animal prion strains, but doesn't yet provide a definitive answer to the query.\n",
          "url": "https://www.nature.com/articles/s41589-022-01229-7"
        },
        {
          "title": "Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations - Nature Communications",
          "author": "Farag; Mina; Cohen; Samuel R; Borcherds; Wade M; Bremer; Anne; Mittag; Tanja; Pappu; Rohit V",
          "published_date": "2023-04-13T16:49:39.982000+00:00",
          "summary": "This research article focuses on the structure and formation of biomolecular condensates driven by prion-like low-complexity domains (PLCDs), not on interspecies prion propagation.  The study investigates the network structures and interfaces of these condensates,  finding that they exhibit small-world network characteristics and interfaces defined by expanded conformations.  The article does not address the mechanism of prion misfolding propagation across species.\n",
          "url": "https://www.nature.com/articles/s41467-022-35370-7"
        },
        {
          "title": "Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein",
          "author": "David  Westaway",
          "published_date": "2022-12-27T00:00:00+00:00",
          "summary": "This research identifies dipeptidyl peptidase-4 (DPP4) and fibroblast activation protein (FAP) as proteins that cleave the cellular prion protein (PrPC), a process implicated in prion disease.  While the study focuses on the cleavage mechanism itself and its role in disease pathogenesis, it does not address interspecies propagation of misfolded prion conformations.  The paper's findings relate to the processing of PrPC, not the mechanism of prion propagation between species.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.2209815120"
        },
        {
          "title": "Prion disease: experimental models and reality - PMC",
          "author": "",
          "published_date": "2017-01-13T00:00:00+00:00",
          "summary": "The paper reviews prion disease models, highlighting the challenges in fully recapitulating human disease in model systems. While in vitro and in vivo studies have significantly advanced understanding of prion transmission, replication, and toxicity, the precise mechanisms of misfolded prion protein propagation across species remain unclear.  The concept of a \"species barrier\" is discussed, indicating that cross-species infection is less efficient, with longer incubation periods and lower infection rates.  The paper does not offer a definitive answer to the specific question of the precise mechanisms of cross-species propagation.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5250673/"
        },
        {
          "title": "Prion Diseases and Their Biochemical Mechanisms - PMC",
          "author": "",
          "published_date": "2009-03-31T00:00:00+00:00",
          "summary": "The provided text focuses on the biochemical mechanisms of prion diseases and the conformational conversion of PrP<sup>C</sup> to PrP<sup>Sc</sup>,  but it doesn't detail the precise mechanisms of interspecies prion propagation. While the review mentions the existence of prion strains and their relation to interspecies transmissibility barriers, it does not offer a conclusive answer on the successful identification of the precise mechanisms involved.  More research is indicated to fully elucidate this complex process.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2805067/"
        },
        {
          "title": "Understanding the key features of the spontaneous formation ...",
          "author": "Castilla, Joaqu\u00edn",
          "published_date": "2023-09-07T00:00:00+00:00",
          "summary": "This research article describes a novel methodology for rapidly and consistently generating bona fide prions.  The study focuses on the spontaneous misfolding of cellular PrP into its pathogenic isoform, relevant to sporadic prion diseases like Creutzfeldt-Jakob disease. However, the abstract provided does not address interspecies prion propagation mechanisms.  Therefore, the question of whether anyone has successfully identified the precise mechanisms of cross-species misfolded prion propagation is not answered in this paper.\n",
          "url": "https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-023-01640-8"
        },
        {
          "title": "What is the evidence that tau pathology spreads through prion ...",
          "author": "Amrit  Mudher, University of Southampton, SO17 1BJ, Southampton, UK, a.mudher@soton.ac.uk, Morvane  Colin, Simon  Dujardin, Univ. Lille, Inserm, Miguel  Medina, Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), CIEN Foundation, Madrid, Queen, Spain, Ilse  Dewachter, Dementia Research Group, Hasselt University, 3500, Hasselt, Belgium, Seyedeh Maryam Alavi Naini, Eva-Maria  Mandelkow, Eckhard  Mandelkow, Luc  Bu\u00e9e, Univ. Lille, Inserm, Michel  Goedert, MRC Laboratory of Molecular Biology, Francis Crick Avenue, CB2 0QH, Cambridge, UK, Jean-Pierre  Brion, Laboratory of Histology, ULB Neuroscience Institute (UNI, 808, route de Lennik 1070, Brussels, Belgium, jpbrion@ulb.ac.be",
          "published_date": "2023-11-09T20:22:13.702000+00:00",
          "summary": "This article focuses on the prion-like propagation of tau pathology, not prion proteins themselves.  While it discusses the mechanisms proposed for tau's spread (cellular uptake, seeding, secretion, intercellular transfer), it doesn't address cross-species propagation of prion proteins, which is the focus of your query.  The article notes that tau propagation hasn't been shown to exhibit all the characteristics of bona fide prion propagation, such as transmission between organisms.  Therefore, it does not provide an answer to your question.\n",
          "url": "https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-017-0488-7"
        },
        {
          "title": "Artificial strain of human prions created in vitro",
          "author": "Chae  Kim, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Xiangzhu  Xiao, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Shugui  Chen, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Tracy  Haldiman, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Vitautas  Smirnovas, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Diane  Kofskey, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Miriam  Warren, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Krystyna  Surewicz, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Nicholas R Maurer, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Qingzhong  Kong, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Witold  Surewicz, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, Jiri G Safar, Case Western Reserve University, 2085 Adelbert Rd, 44106, Cleveland, OH, USA, jiri.safar@case.edu",
          "published_date": "2023-11-09T20:22:46.640000+00:00",
          "summary": "This study did not identify the precise mechanisms of prion misfolding propagation across species. However, researchers successfully created a new, infectious human prion strain *in vitro* using recombinant human prion protein, sCJD MM1 prions, and ganglioside GM1.  The resulting prions exhibited distinct biological and structural characteristics, suggesting that subtle structural changes, potentially linked to post-translational modifications, influence infectivity, host range, and neurotoxicity in mice.  While this advances understanding of human prion infectivity, it doesn't address interspecies propagation mechanisms directly.\n",
          "url": "https://www.nature.com/articles/s41467-018-04584-z"
        },
        {
          "title": "Pathogenesis of prion diseases: a progress report",
          "author": "A  Aguzzi, University Hospital Zurich, Schmelzbergstrasse. 12, CH-8091, Zurich, Switzerland, F L Heppner, University Hospital Zurich, Schmelzbergstrasse. 12, CH-8091, Zurich, Switzerland",
          "published_date": "2023-11-09T19:35:39.256000+00:00",
          "summary": "The provided text focuses on the broader progress in understanding prion diseases, not the specific interspecies transmission mechanisms of misfolded prion proteins.  While it notes advances in human genetics, mouse transgenetics, and biophysics, it doesn't offer an answer to whether the precise mechanisms of cross-species propagation have been identified.  The article concludes that the \"prion principle\" is better understood in yeast than mammals, implying a lack of complete understanding in mammals, let alone across species.\n",
          "url": "https://www.nature.com/articles/4400737"
        },
        {
          "title": "Invited Review: The role of prion\u2010like mechanisms in ...",
          "author": "Zane  Jaunmuktane, University College London NHS Foundation Trust, Queen Square, WC1N 3BG, London, UK, z.jaunmuktane@ucl.ac.uk, Sebastian  Brandner, University College London NHS Foundation Trust, Queen Square, WC1N 3BG, London, UK, s.brandner@ucl.ac.uk",
          "published_date": "2023-11-09T20:27:41.733000+00:00",
          "summary": "This review article discusses the prion-like properties of proteins implicated in various neurodegenerative diseases, including Alzheimer's, Parkinson's, and frontotemporal dementia. While it details mechanisms of misfolded protein propagation within a species,  it does *not* address interspecies transmission of prion protein misfolded conformations, nor does it report on successful identification of the precise mechanisms for such cross-species propagation.  The focus is on the similarities between prion diseases and other neurodegenerative diseases regarding protein misfolding and propagation, not on cross-species transmission.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1111/nan.12592"
        }
      ],
      "full_explanation": "Based on the provided papers, there is no evidence that anyone has successfully identified the *precise* mechanisms by which prion proteins propagate their misfolded conformations across different species. While many papers touch on the topic of prion propagation and the species barrier, none offer a complete and detailed explanation of the *precise* mechanism for interspecies transmission. \n\nThe paper \"A structural basis for prion strain diversity\" (https://www.nature.com/articles/s41589-022-01229-7) discusses the challenges of cross-species transmission and the role of structural compatibility, but it does not identify the specific *mechanisms* of cross-species propagation. It highlights the importance of understanding this mechanism but does not offer a definitive answer. Similarly, the review paper \"Prion disease: experimental models and reality\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC5250673/) discusses the \"species barrier,\" which indicates that cross-species infection is less efficient but does not detail how that happens. The paper \"Prion Diseases and Their Biochemical Mechanisms\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC2805067/) focuses on the conformational conversion of PrP<sup>C</sup> to PrP<sup>Sc</sup> but does not delve into the specifics of interspecies prion propagation, also stating that more research is needed to understand the complex process. Finally, \"Pathogenesis of prion diseases: a progress report\" (https://www.nature.com/articles/4400737) notes a lack of complete understanding of the prion principle in mammals and fails to describe precise mechanisms for cross-species propagation. Although the paper \"Artificial strain of human prions created in vitro\" (https://www.nature.com/articles/s41467-018-04584-z) successfully created a new human prion strain *in vitro*, it does not identify the mechanisms of propagation across species. While each of these papers discusses elements *related* to the research question, they do not provide a clear answer regarding *precise* cross-species propagation mechanisms, suggesting that this is still an open area of research."
    },
    {
      "question": "Has anyone found a way to transfer memories between organisms?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "A sperm peptide enhances long-term memory in female Drosophila",
          "author": "T. Preat",
          "published_date": "2019-11-01T00:00:00+00:00",
          "summary": "This study in *Drosophila* shows that a peptide in male sperm enhances long-term memory in females.  While not memory transfer between organisms, the research demonstrates that a substance from one organism can alter the memory capacity of another.  The peptide acts on specific brain neurons, affecting the cAMP/protein kinase A pathway.  The study focuses on the effects of mating and associated hormonal changes on memory, not on direct memory transfer.\n",
          "url": "https://www.science.org/doi/10.1126/sciadv.aax3432?cookieSet=1"
        },
        {
          "title": "Inheritance of associative memories and acquired cellular changes in C. elegans",
          "author": "Deshe; Noa; Eliezer; Yifat; Hoch; Lihi; Itskovits; Eyal; Bokman; Eduard; Ben-Ezra; Shachaf; Zaslaver; Alon",
          "published_date": "2023-07-15T00:00:00+00:00",
          "summary": "Studies in mice have shown that associative memories (linking a cue to an aversive experience) can be passed down to offspring for multiple generations, suggesting a transgenerational inheritance mechanism.  Similar findings in *C. elegans* show inherited avoidance behaviors passed through multiple generations, even those induced by bacterial RNA. While not a direct transfer of memory between distinct organisms, these findings demonstrate the inheritance of learned behaviors across generations.\n",
          "url": "https://www.nature.com/articles/s41467-023-39804-8"
        },
        {
          "title": "Direct transfer of learned behaviour via cell fusion in non-neural organisms | Proceedings of the Royal Society B: Biological Sciences",
          "author": "David Vogel; Audrey Dussutour",
          "published_date": "2023-04-13T17:12:19.410000+00:00",
          "summary": "Research using the slime mold *Physarum polycephalum* shows that learned behavior (a form of memory) can be transferred between individuals through cell fusion.  The study demonstrates that when a slime mold habituates to a repellent, this learned avoidance can be passed on to another slime mold after they fuse.  This represents a novel finding regarding the transfer of learned behavior, though not explicitly memories, between organisms.\n",
          "url": "https://royalsocietypublishing.org/doi/10.1098/rspb.2016.2382"
        },
        {
          "title": "The memory-transfer episode",
          "author": "Stern, Larry",
          "published_date": "2024-06-01T00:00:00+00:00",
          "summary": "Research in the 1960s attempted to transfer memories between organisms, particularly using planarians (flatworms).  James McConnell conditioned planarians, then chopped them up and fed them to untrained planarians, observing if the learned behavior transferred.  While initially promising, with many research teams and significant funding involved, these experiments ultimately failed to produce consistently replicable results and the findings were not widely accepted within the scientific community.  Therefore, currently, no reliable method exists for transferring memories between organisms.\n",
          "url": "https://www.apa.org/monitor/2010/06/memory-transfer"
        },
        {
          "title": "Scientists successfully transfer memory of one animal to ...",
          "author": "By Dr. Ananya Mandal, MDMay 16 2018",
          "published_date": "2019-06-24T08:47:00+00:00",
          "summary": "Yes.  Researchers at UCLA have successfully transferred memory from one sea slug ( *Aplysia californica*) to another by injecting RNA extracted from the nervous system of slugs that had received electric shocks.  The recipient slugs then exhibited the same learned behavior (longer siphon withdrawal) as the shocked slugs. While the study's authors suggest this could have implications for understanding memory in higher organisms, including humans, experts remain skeptical due to the simpler nervous system of sea slugs compared to humans.\n",
          "url": "https://www.news-medical.net/news/20180516/Scientists-successfully-transfer-memory-of-one-animal-to-another.aspx"
        },
        {
          "title": "Can we transfer memories from one living being to another?",
          "author": "",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "Yes, researchers at UCLA have reported transferring a form of memory between sea snails.  They trained sea snails to exhibit a defensive reflex, then extracted RNA from their nervous systems. Injecting this RNA into untrained snails caused them to display a similar defensive reflex, suggesting the RNA carried a memory trace.  While this research is preliminary and uses a simple organism, it raises the possibility of using RNA to treat memory disorders like Alzheimer's in the future.\n",
          "url": "https://www.happy-neuron.com/scientific-news/can-we-transfer-memories-from-one-living-being-to-another"
        },
        {
          "title": "Memory Transferred between Snails, Challenging ...",
          "author": "Usha Lee McFarling; STAT",
          "published_date": "2023-02-23T04:13:49.365000+00:00",
          "summary": "Yes, researchers at UCLA have reported transferring a memory from one sea snail to another by injecting RNA extracted from the nervous system of a trained snail into an untrained one.  The untrained snail then exhibited the same learned behavior (longer siphon withdrawal after a touch) as the trained snail.  This challenges the established theory that memories are stored solely through changes in synaptic connections between neurons. While the study has been met with skepticism and needs further replication in more complex organisms, it suggests a potential new understanding of memory storage involving RNA and epigenetic changes within the neuron's nucleus.\n",
          "url": "https://www.scientificamerican.com/article/memory-transferred-between-snails-challenging-standard-theory-of-how-the-brain-remembers/"
        },
        {
          "title": "Memory Consolidation - PMC",
          "author": "",
          "published_date": "2015-01-01T00:00:00+00:00",
          "summary": "This article discusses memory consolidation, the process by which memories become stable and independent of the hippocampus, moving to distributed regions of the neocortex.  It does *not* address the transfer of memories between organisms.  The research focuses on the mechanisms within a single organism's brain.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4526749/"
        },
        {
          "title": "Amazing breakthrough shows transfer of memories is ...",
          "author": "Colm Gorey",
          "published_date": "2018-05-15T10:07:49+00:00",
          "summary": "Yes, scientists have transferred a simple defensive reflex memory between California sea snails by injecting RNA from a trained snail into an untrained one.  The untrained snails then exhibited the same reflex.  However, this is a very specific type of memory, not complex personal memories like birthdays or historical facts.  While some researchers are optimistic, others remain skeptical about whether this constitutes true memory transfer.\n",
          "url": "https://www.siliconrepublic.com/innovation/transfer-memories-possible-rna"
        },
        {
          "title": "(PDF) Reckoning the Unresolved Scientific Question on ...",
          "author": "Authors:",
          "published_date": "2020-08-14T00:00:00+00:00",
          "summary": "Research suggests memory transfer between organisms may be possible.  A study using sea snails demonstrated that memory can be genetically transferred (potentially via RNA).  However, this is a relatively new finding and the field remains largely unresolved, with many open questions.  Anecdotal reports of memory transfer in organ transplant patients also exist but lack robust scientific confirmation.\n",
          "url": "https://www.researchgate.net/publication/345333033_Reckoning_the_Unresolved_Scientific_Question_on_Memory_Transfer"
        }
      ],
      "full_explanation": "The research question, \"Has anyone found a way to transfer memories between organisms?\" has been explored, although the extent and mechanisms are still under investigation. Several papers demonstrate attempts and successes in transferring learned behaviors, which can be considered a form of memory, between organisms.\n\nSpecifically, several papers highlight the work done with sea slugs (*Aplysia californica*). The research group at UCLA is prominently featured. They successfully transferred a simple defensive reflex memory from one sea slug to another by extracting RNA from the nervous system of trained slugs and injecting it into untrained slugs. The untrained slugs then displayed the same learned behavior. This is detailed in several articles: \"Scientists successfully transfer memory of one animal to...\" (https://www.news-medical.net/news/20180516/Scientists-successfully-transfer-memory-of-one-animal-to-another.aspx), \"Can we transfer memories from one living being to another?\" (https://www.happy-neuron.com/scientific-news/can-we-transfer-memories-from-one-living-being-to-another), \"Memory Transferred between Snails, Challenging...\" (https://www.scientificamerican.com/article/memory-transferred-between-snails-challenging-standard-theory-of-how-the-brain-remembers/), and \"Amazing breakthrough shows transfer of memories is...\" (https://www.siliconrepublic.com/innovation/transfer-memories-possible-rna). These papers consistently show that RNA seems to be a key component in this transfer process. The paper \"(PDF) Reckoning the Unresolved Scientific Question on...\" (https://www.researchgate.net/publication/345333033_Reckoning_the_Unresolved_Scientific_Question_on_Memory_Transfer) also references this research using sea snails and the potential of RNA transfer.\n\nAdditionally, the paper \"Direct transfer of learned behaviour via cell fusion in non-neural organisms\" (https://royalsocietypublishing.org/doi/10.1098/rspb.2016.2382) shows that learned behavior (a form of memory) can be transferred between individuals of the slime mold *Physarum polycephalum* through cell fusion, where a habituation to a repellent was transferred to another slime mold after fusion.\n\nWhile there has been successful transfer of simple memories using RNA in sea slugs and learned behaviors through cell fusion in slime mold, the field is still in its early stages. Research using planarians (flatworms) in the 1960s also attempted memory transfer, but these experiments were ultimately not replicable (described in \"The memory-transfer episode\" https://www.apa.org/monitor/2010/06/memory-transfer).\n\nTherefore, it is clear that there have been attempts, and some successes, in transferring memories and learned behaviors between organisms. The methods and the complexity of the memories that can be transferred are still under investigation, but the answer is YES, research has been done on transferring memories between organisms."
    },
    {
      "question": "Has anyone discovered all the protein conformations that exist in different cellular environments?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Protein Allostery at Atomic Resolution",
          "author": "Dr Dean Strotz",
          "published_date": "2023-02-22T20:50:09.660000+00:00",
          "summary": "This research article focuses on allostery in proteins at an atomic level, investigating conformational changes.  It does not address the question of whether all protein conformations across different cellular environments have been discovered.  The research is highly specific to the methodologies and findings related to atomic-level protein allostery, not a comprehensive survey of all possible protein conformations.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/anie.202008734"
        },
        {
          "title": "Effect of micro-environment on protein conformation studied by fluorescence-based techniques",
          "author": "Sabera  Millan, National Institute of Technology (NIT), Rourkela, Odisha, India, Bikash Chandra Swain, Umakanta  Tripathy, Indian Institute of Technology (Indian School of Mines), Dhanbad, Jharkhand, India, Padmaja P Mishra, Saha Institute of Nuclear Physics, 1/AF Bidhannagar, Kolkata, West Bengal, India, Harekrushna  Sahoo, National Institute of Technology (NIT), Rourkela, Odisha, India, sahooh@nitrkl.ac.in",
          "published_date": "2023-11-09T20:31:08.294000+00:00",
          "summary": "No, the provided research article does not claim to have discovered all protein conformations in different cellular environments.  It investigates the impact of specific anions (sulfate, phosphate, and chloride) on the conformation of one specific protein (CRABP I) using fluorescence-based techniques. The study highlights conformational changes in CRABP I depending on its ionic environment, suggesting the influence of cellular conditions on protein folding. However, this is a limited investigation and doesn't address the vast complexity of all protein conformations across diverse cellular environments.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0167732220344779"
        },
        {
          "title": "Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations - Nature Communications",
          "author": "Farag; Mina; Cohen; Samuel R; Borcherds; Wade M; Bremer; Anne; Mittag; Tanja; Pappu; Rohit V",
          "published_date": "2023-04-13T16:49:39.982000+00:00",
          "summary": "This research article focuses on prion-like low-complexity domains (PLCDs) within proteins and their role in forming biomolecular condensates in cells.  The study does *not* address the complete catalog of protein conformations across all cellular environments.  Instead, it investigates the relationship between the sequence of PLCDs and their resulting condensate structures, finding that these condensates exhibit small-world network structures and interfaces defined by expanded conformations.  The research centers on understanding the physical principles governing the phase transitions of PLCDs, not on a comprehensive identification of all protein conformations.\n",
          "url": "https://www.nature.com/articles/s41467-022-35370-7"
        },
        {
          "title": "Protein interaction patterns in different cellular ...",
          "author": "Letizia Barbieri 1 2 ,",
          "published_date": "2015-09-24T00:00:00+00:00",
          "summary": "No, this study does not identify all protein conformations in different cellular environments.  Researchers used in-cell NMR to study the human protein profilin 1 in human and bacterial cells. They found that the protein's NMR signals were affected by both specific and non-specific interactions with the cellular environment, and that these interactions differed between the two cell types.  By introducing mutations, they were able to recover NMR signals and assess the relative contribution of each interaction type.  This improved the ability to study soluble proteins using in-cell NMR, but it did not comprehensively map all protein conformations across all cellular environments.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26399546/"
        },
        {
          "title": "Spatially resolved profiling of protein conformation and ...",
          "author": "Zhao, Qun",
          "published_date": "2024-09-27T00:00:00+00:00",
          "summary": "No, a complete catalog of all protein conformations across various cellular environments has not been achieved.  While techniques like cryo-electron tomography and in-cell NMR offer insights into protein structure and interactions, they don't provide proteome-wide characterization.  Although chemical cross-linking mass spectrometry (CXMS) shows promise in identifying intra- and inter-protein cross-linked sites, providing information on conformation and interactions, it's not yet capable of comprehensively mapping all protein conformations in all cellular contexts.\n",
          "url": "https://www.nature.com/articles/s41467-024-52558-1"
        },
        {
          "title": "Uncovering protein structure - PMC",
          "author": "",
          "published_date": "2020-09-25T00:00:00+00:00",
          "summary": "No, the article does not claim that all protein conformations in different cellular environments have been discovered.  It discusses the challenges in determining protein structure, highlighting that proteins exist in a range of conformations and that while significant progress has been made in understanding protein structure and dynamics using various techniques, a complete catalog of all conformations across diverse cellular environments remains elusive.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7545034/"
        },
        {
          "title": "Structure prediction of alternative protein conformations",
          "author": "No\u00e9, Frank",
          "published_date": "2024-08-26T00:00:00+00:00",
          "summary": "No, the paper does not claim that all protein conformations in different cellular environments have been discovered.  It focuses on the computational prediction of alternative protein conformations, highlighting the limitations of current methods.  While techniques exist to predict some alternative conformations, the number of known structures with significantly different conformations is limited (only 38 initially identified, expanded to 244 in a created dataset), and existing methods are not evaluated on a comprehensive set representing all possible conformations.  The study points to the considerable challenge of predicting all possible protein conformations, especially those influenced by cellular environments.\n",
          "url": "https://www.nature.com/articles/s41467-024-51507-2"
        },
        {
          "title": "Protein assembly systems in natural and synthetic biology",
          "author": "Chiesa; Giulio; Kiriakov; Szilvia; Khalil; Ahmad S",
          "published_date": "2023-02-06T09:26:29.943000+00:00",
          "summary": "No, the paper does not claim that all protein conformations in different cellular environments have been discovered.  It discusses how proteins assemble into higher-order complexes, often involving intrinsically disordered regions (IDRs) that allow for flexibility and multiple interactions.  The focus is on the role of protein aggregation in both disease and beneficial biological functions, and how this understanding can be leveraged in synthetic biology.  The paper highlights the diverse range of assembly phenomena but doesn't suggest a complete catalog of all possible conformations is known.\n",
          "url": "https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-020-0751-4"
        },
        {
          "title": "Principles of protein folding in the cellular environment",
          "author": "D Thieffry",
          "published_date": "1999-02-01T00:00:00+00:00",
          "summary": "No, a complete catalog of all protein conformations across diverse cellular environments has not been achieved.  While research demonstrates that a protein's primary structure dictates its folding (at least in simplified environments), the cellular environment's complexity significantly influences the folding process.  Factors like molecular chaperones and co-translational folding play roles, making complete characterization a significant challenge.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0959440X9980013X"
        },
        {
          "title": "The Dynamic Lives of Intrinsically Disordered Proteins",
          "author": "Danielle Gerhard; PhD",
          "published_date": "2024-09-13T00:00:00+00:00",
          "summary": "No, scientists have not discovered all protein conformations across different cellular environments.  The article focuses on intrinsically disordered proteins (IDPs), which lack a single stable 3D structure and exist in many conformations.  While research is ongoing using computational and experimental methods, a complete catalog of IDP conformations remains elusive, highlighting the complexity of studying these dynamic proteins.\n",
          "url": "https://www.the-scientist.com/the-dynamic-lives-of-intrinsically-disordered-proteins-72125"
        }
      ],
      "full_explanation": "Based on the provided research papers, it is clear that a comprehensive catalog of all protein conformations across different cellular environments has not been discovered. Several papers directly state that this has not been achieved.\n\n*   The paper titled \"Protein Allostery at Atomic Resolution\" (URL: https://onlinelibrary.wiley.com/doi/10.1002/anie.202008734) focuses on the mechanisms of allostery at an atomic level. While it explores conformational changes, it does not attempt to identify all conformations across all environments, and its scope is specific to the investigation of allosteric changes.\n*   The study \"Effect of micro-environment on protein conformation studied by fluorescence-based techniques\" (URL: https://www.sciencedirect.com/science/article/pii/S0167732220344779) specifically investigates the impact of certain anions on one protein's conformation and admits that its limited scope means it \"doesn't address the vast complexity of all protein conformations across diverse cellular environments\".\n*   Similarly, \"Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations - Nature Communications\" (URL: https://www.nature.com/articles/s41467-022-35370-7) focuses on a specific class of proteins (PLCDs) and their condensate formation, and does not attempt to catalog all conformations in any environment.\n*  The study \"Protein interaction patterns in different cellular ...\" (URL: https://pubmed.ncbi.nlm.nih.gov/26399546/) uses in-cell NMR to study one protein in two cell types, showing that protein-environment interactions differ, but does not attempt to provide a comprehensive mapping.\n*  The paper \"Spatially resolved profiling of protein conformation and ...\" (URL: https://www.nature.com/articles/s41467-024-52558-1) also notes that techniques such as cryo-electron tomography and in-cell NMR do not currently provide \"proteome-wide characterization\" and that while new methods like CXMS show promise, a full mapping of protein conformations remains elusive.\n*   The article \"Uncovering protein structure - PMC\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7545034/) directly states that \"a complete catalog of all conformations across diverse cellular environments remains elusive.\"\n*   The study \"Structure prediction of alternative protein conformations\" (URL: https://www.nature.com/articles/s41467-024-51507-2) addresses the challenges of predicting alternative conformations of proteins, highlighting the limitations of current methods, and stating that \"the number of known structures with significantly different conformations is limited\" and that they are not evaluated on all conformations.\n*   The paper \"Principles of protein folding in the cellular environment\" (URL: https://www.sciencedirect.com/science/article/abs/pii/S0959440X9980013X) highlights the complexities of protein folding within the cellular environment itself, noting that it makes \"complete characterization a significant challenge\".\n*   Finally, \"The Dynamic Lives of Intrinsically Disordered Proteins\" (URL: https://www.the-scientist.com/the-dynamic-lives-of-intrinsically-disordered-proteins-72125) points out that scientists have not discovered all the conformations for intrinsically disordered proteins (IDPs), and highlights the complexity of their dynamic natures as the reason why.\n\nAll the research papers provided acknowledge that the complete cataloging of all protein conformations within diverse cellular environments is an unsolved challenge. The studies focus on particular aspects of protein structure and interactions but do not claim to have achieved a comprehensive inventory of all possible conformations in different cellular contexts."
    },
    {
      "question": "Has anyone shown that  GLP-1 increases weight loss?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice",
          "author": "I. Grattagliano",
          "published_date": "2021-02-01T00:00:00+00:00",
          "summary": "Yes, research indicates GLP-1 analogs can increase weight loss.  Studies show that GLP-1, and specifically the analog EGLP-1, reduces body weight in obese mice. This effect is achieved through two mechanisms: decreasing food intake and increasing basal energy expenditure.  While Exendin-4, another GLP-1 receptor agonist, reduces appetite, it lacks the components of GLP-1 responsible for the increase in energy expenditure.  Therefore, EGLP-1 appears more effective for weight loss than Exendin-4.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0014482720307072"
        },
        {
          "title": "Effects of GLP-1 on appetite and weight",
          "author": "Shah; Meera; Vella; Adrian",
          "published_date": "2023-12-04T03:32:42.371000+00:00",
          "summary": "This webpage lists several research articles on glucagon-like peptide-1 (GLP-1) and its effects on appetite and weight, but doesn't directly state whether GLP-1 *increases* weight loss.  The articles explore GLP-1's role in regulating feeding behavior and its secretion patterns, suggesting a potential connection to weight management.  However, the provided text lacks conclusive evidence explicitly demonstrating GLP-1's causal role in weight loss.  To find that information, you'll need to review the full research papers linked.\n",
          "url": "https://link.springer.com/article/10.1007/s11154-014-9289-5"
        },
        {
          "title": "GLP-1 and weight loss: unraveling the diverse neural circuitry",
          "author": "Scott E Kanoski; Matthew R Hayes; Karolina P Skibicka",
          "published_date": "2023-04-13T10:23:06.278000+00:00",
          "summary": "Yes, research shows that GLP-1 analogs, like liraglutide (Saxenda), effectively reduce food intake and body weight in both human clinical trials and animal models.  This is because GLP-1 acts on multiple brain areas, influencing appetite and reward pathways, to decrease caloric intake.  However, the review also highlights the complexity of the neural systems involved and the challenges in developing effective treatments without side effects.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888559/"
        },
        {
          "title": "Real-world weight loss effectiveness of GLP-1 agonists ...",
          "author": "",
          "published_date": "2023-01-09T00:00:00+00:00",
          "summary": "Yes.  Multiple studies, including a retrospective cohort study of over 2,400 patients with type 2 diabetes and obesity, show that GLP-1 agonists lead to weight loss.  While the amount varies depending on the dose and study design (ranging from modest weight loss at standard doses to more significant weight loss with higher doses used in weight-loss trials),  the effect is consistently observed.  One study showed a mean weight loss of 2.2% after 72 weeks at standard doses, with one-third of patients losing \u22655% of their body weight.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9877131/"
        },
        {
          "title": "Research shows GLP-1 drugs are effective but complex",
          "author": "Grace Niewijk",
          "published_date": "2024-05-30T00:00:00+00:00",
          "summary": "Yes, research shows GLP-1 receptor agonist (GLP-1RA) drugs, such as Ozempic, Wegovy, and Mounjaro, are highly effective for weight loss.  Multiple studies, including one comparing 15 GLP-1RAs, demonstrate significant weight loss in patients.  Another study using statistical modeling showed GLP-1RAs were superior to other diabetes medications in reducing cardiovascular risk and overall mortality, indicating weight loss benefits extend beyond just blood sugar control.  However, experts caution against overuse and emphasize the need for nuanced patient-specific decisions regarding drug selection and dosage.\n",
          "url": "https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/2024/may/research-on-glp-1-drugs"
        },
        {
          "title": "Emerging Role of GLP-1 Agonists in Obesity",
          "author": "",
          "published_date": "2023-06-21T00:00:00+00:00",
          "summary": "Yes, numerous studies reviewed in this article show GLP-1 agonists are effective for weight loss in both preclinical and clinical settings.  The review summarizes findings from trials on several GLP-1 agonists (liraglutide, semaglutide, tirzepatide, lixisenatide, and exenatide), highlighting the maximum weight loss achievable with each.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10341852/"
        },
        {
          "title": "Reflections on the discovery GLP-1 as a satiety hormone",
          "author": "Astrup; Arne",
          "published_date": "2024-06-18T00:00:00+00:00",
          "summary": "This article traces the discovery of GLP-1 as a satiety hormone. While it details the development of a methodology to measure appetite and food intake, focusing on the validation of visual analogue scales (VAS) for assessing hunger and satiety,  it does not directly address whether GLP-1 *increases* weight loss.  The research described focuses on establishing the methodology for studying GLP-1's effects on appetite and food intake, laying the groundwork for future studies on its potential impact on weight.  The article mentions the development of long-acting GLP-1 analogues (liraglutide and semaglutide) but doesn't present data on their efficacy in weight loss.\n",
          "url": "https://www.nature.com/articles/s41430-024-01460-6"
        },
        {
          "title": "GLP-1 receptor agonists for weight reduction in people ...",
          "author": "Search for articles by this author",
          "published_date": "2024-07-01T00:00:00+00:00",
          "summary": "Yes.  A study of 8847 participants found that GLP-1 receptor agonists (GLP-1 RAs) led to significant weight loss.  Over two years, 375 out of 1000 treated individuals achieved a 10% weight loss compared to placebo.  While some side effects were more common in the GLP-1 RA group (e.g., abdominal pain, nausea), the benefits of achieving a 10% weight loss outweighed these harms in the majority of cases.  However, the net benefit was lower for a 5% weight loss goal and depended on individual tolerance for side effects.\n",
          "url": "https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00240-2/fulltext"
        },
        {
          "title": "GLP-1 medications and weight loss: Helping patients ...",
          "author": "John M Moorman; PharmD; BCPS",
          "published_date": "2024-07-19T00:00:00+00:00",
          "summary": "Yes, clinical observations and studies show GLP-1 medications are effective for weight loss.  Initially used for type 2 diabetes, clinicians noted weight loss benefits in patients, leading to approval of many GLP-1s for weight loss as a primary indication.  A recent poll shows 22% of overweight or obese adults are now taking these medications.\n",
          "url": "https://www.wolterskluwer.com/en/expert-insights/glp-1-medications-and-weight-loss-help-patients-navigate-beyond-trends?utm_source=twitter&utm_medium=social&utm_campaign=health-ce-glp-1"
        },
        {
          "title": "GLP-1 physiology informs the pharmacotherapy of obesity",
          "author": "Author links open overlay panel Daniel J Drucker",
          "published_date": "2023-02-22T08:04:16.495000+00:00",
          "summary": "Yes, research shows GLP-1 receptor agonists (GLP-1RAs) like liraglutide and semaglutide cause weight loss in both animals and humans.  These medications reduce food intake and may even rival bariatric surgery as obesity treatments.  The article highlights that GLP-1's effects are achieved through a single G protein-coupled receptor and are well-conserved across different populations.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2212877821001988"
        }
      ],
      "full_explanation": "Multiple studies and reviews confirm that GLP-1 increases weight loss. The paper titled \"EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice\" (https://www.sciencedirect.com/science/article/abs/pii/S0014482720307072) shows that GLP-1 analogs, specifically EGLP-1, reduce body weight in obese mice by decreasing food intake and increasing energy expenditure. Similarly, the paper \"GLP-1 and weight loss: unraveling the diverse neural circuitry\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888559/) states that GLP-1 analogs like liraglutide effectively reduce food intake and body weight in both human and animal models. The article titled \"Real-world weight loss effectiveness of GLP-1 agonists ...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC9877131/) shows that GLP-1 agonists lead to weight loss in patients with type 2 diabetes and obesity. A study reviewed in the \"Emerging Role of GLP-1 Agonists in Obesity\" article (https://pmc.ncbi.nlm.nih.gov/articles/PMC10341852/) also shows that GLP-1 agonists are effective for weight loss in both preclinical and clinical settings. Furthermore, the paper \"Research shows GLP-1 drugs are effective but complex\" (https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/2024/may/research-on-glp-1-drugs) highlights that GLP-1 receptor agonist drugs are effective for weight loss. The study highlighted in the paper \"GLP-1 receptor agonists for weight reduction in people ...\" (https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00240-2/fulltext) found that GLP-1 receptor agonists led to significant weight loss in participants. Additionally, the article \"GLP-1 medications and weight loss: Helping patients ...\" (https://www.wolterskluwer.com/en/expert-insights/glp-1-medications-and-weight-loss-help-patients-navigate-beyond-trends?utm_source=twitter&utm_medium=social&utm_campaign=health-ce-glp-1) notes that clinical observations and studies show GLP-1 medications are effective for weight loss. Finally, the article \"GLP-1 physiology informs the pharmacotherapy of obesity\" (https://www.sciencedirect.com/science/article/pii/S2212877821001988) confirms that GLP-1 receptor agonists cause weight loss in both animals and humans."
    },
    {
      "question": "Has anyone used machine learning based exchange functionals in protein molecular dynamics simulations?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "NNP/MM: Accelerating Molecular Dynamics Simulations with Machine Learning Potentials and Molecular Mechanics.",
          "author": "Raimondas Galvelis,Alejandro Varela-Rial,Stefan Doerr,R. Fino,P. Eastman,T. Markland,J. Chodera,G. de Fabritiis",
          "published_date": "2023-10-26T19:27:47.995000+00:00",
          "summary": "This paper introduces NNP/MM, a hybrid method combining neural network potentials (NNPs) and molecular mechanics (MM) for accelerating molecular dynamics (MD) simulations.  While it doesn't explicitly use machine learning-based exchange functionals, it employs NNPs to model parts of the system (e.g., small molecules), improving accuracy over traditional MM for molecules where accurate parameters are hard to obtain.  The authors demonstrate a 5x speedup in MD and metadynamics simulations of protein-ligand complexes.  The focus is on improving efficiency and accuracy of the force field, not on replacing exchange functionals within density functional theory.\n",
          "url": "https://arxiv.org/pdf/2201.08110.pdf"
        },
        {
          "title": "Machine Learning with and for Molecular Dynamics Simulations.",
          "author": "Sereina S Riniker, sriniker@ethz.ch, Shuzhe  Wang, Patrick  Bleiziffer, Lennard  B\u00f6selt, Carmen  Esposito",
          "published_date": "2023-11-09T20:28:24.520000+00:00",
          "summary": "This article discusses using machine learning (ML) with molecular dynamics (MD) simulations, but doesn't address the use of ML-based exchange functionals specifically in protein MD simulations.  The article covers two applications: using MD data to train ML models for understanding molecular systems, and using ML to improve MD simulations themselves (setup, interpretation, accuracy).  It does not mention exchange functionals.\n",
          "url": "https://www.chimia.ch/chimia/article/view/2019_1024"
        },
        {
          "title": "On-line Optimization of Hamiltonian Replica Exchange Simulations",
          "author": "Justin L. MacCallum, Mir Ishruna Muniyat, Kari Gaalswyk",
          "published_date": "2017-12-03T00:00:00+00:00",
          "summary": "This bioRxiv preprint describes a machine learning-based algorithm for optimizing Hamiltonian replica exchange in molecular simulations, including protein folding.  The algorithm optimizes an objective function reflecting simulation efficiency, requiring no pre-simulation and adapting to multiple control parameters.  While not explicitly stated as \"exchange functionals,\" the method uses machine learning techniques within the context of replica exchange, a common approach in protein molecular dynamics.  The authors demonstrate its effectiveness on a protein folding simulation.\n",
          "url": "https://www.biorxiv.org/content/10.1101/228262v1"
        },
        {
          "title": "Protein Function Analysis through Machine Learning - PMC",
          "author": "",
          "published_date": "2022-09-06T00:00:00+00:00",
          "summary": "This review article discusses the application of machine learning (ML) in various aspects of computational biology related to protein function, including structure prediction, engineering, molecular docking, and protein-protein interactions.  While it broadly covers ML applications in protein research, it does *not* specifically address the use of ML-based exchange functionals within protein molecular dynamics simulations.  Therefore, the answer to your query is not directly addressed within this paper.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9496392/"
        },
        {
          "title": "Machine learning/molecular dynamic protein structure ...",
          "author": "Ulander, Johan",
          "published_date": "2022-06-15T00:00:00+00:00",
          "summary": "This research uses machine learning to predict protein conformations, combining deep learning with molecular dynamics (MD) simulations.  While it doesn't employ machine learning-based exchange functionals *within* the MD simulations themselves, it uses machine learning to predict residue-residue distances, which are then used to generate and refine protein structure models that are subsequently compared to MD simulations.  Therefore, the answer to your query is no, not directly.  The study uses ML for prediction prior to the MD simulation step, not as part of the MD simulation's force field.\n",
          "url": "https://www.nature.com/articles/s41598-022-13714-z"
        },
        {
          "title": "Machine learning in the analysis of biomolecular simulations",
          "author": "Shreyas Kaptan; Ilpo Vattulainen",
          "published_date": "2023-02-07T20:39:24.679000+00:00",
          "summary": "This article discusses the application of machine learning (ML) to analyze biomolecular simulation data, particularly molecular dynamics (MD) simulations.  While it details the benefits of ML in analyzing the vast datasets generated by MD simulations (e.g., identifying physiological processes and unveiling functions), it does *not* address the use of ML-based exchange functionals within the MD simulations themselves.  The article focuses on post-simulation analysis using ML, not on integrating ML directly into the simulation's force field.\n",
          "url": "https://www.tandfonline.com/doi/full/10.1080/23746149.2021.2006080"
        },
        {
          "title": "Machine learning heralding a new development phase in ...",
          "author": "Bori\u0161ek, Jure",
          "published_date": "2024-03-29T00:00:00+00:00",
          "summary": "This review discusses the use of artificial intelligence (AI), including machine learning, in molecular dynamics (MD) simulations. While it doesn't specifically address machine learning-based exchange functionals in *protein* MD simulations, it highlights AI's role in improving simulation speed, data extraction from trajectories, and prediction of complex systems' behavior.  The article notes challenges remain, such as the need for large datasets and the relatively slower speed of neural network potentials compared to classical force fields.  To find information on the specific use of machine learning exchange functionals in protein MD simulations, further research using more targeted keywords is recommended.\n",
          "url": "https://link.springer.com/article/10.1007/s10462-024-10731-4"
        },
        {
          "title": "Simulations meet machine learning in structural biology",
          "author": "Author links open overlay panel Adri\u00e0 P\u00e9rez 1; Gerard Mart\u00ednez-Rosell 1; Gianni De Fabritiis",
          "published_date": "2023-02-22T11:20:07.405000+00:00",
          "summary": "This article discusses the increasing use of machine learning (ML) alongside classical molecular dynamics (MD) simulations in structural biology.  While it highlights the potential of ML to improve both the accuracy and speed of predictions in MD simulations, it doesn't specifically mention the use of ML-based exchange functionals within those simulations.  The text focuses on the general application of ML to analyze and improve the results of existing MD simulations, not on modifying the fundamental physics engines of the simulations themselves.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0959440X17301069"
        },
        {
          "title": "Machine learning coarse-grained potentials of protein ...",
          "author": "De Fabritiis, Gianni",
          "published_date": "2023-09-15T00:00:00+00:00",
          "summary": "This paper explores machine learning (ML) to create coarse-grained potentials for protein thermodynamics, aiming to improve the efficiency of molecular dynamics (MD) simulations. While the paper doesn't directly address the use of ML-based exchange functionals in MD simulations, it focuses on developing ML-based potentials to accurately capture protein conformational states and their probabilities.  The authors highlight limitations of traditional MD simulations for studying complex protein dynamics and long timescales, motivating the need for improved methods like the ML approach presented.  Therefore, the answer to your query is not explicitly addressed in this research.\n",
          "url": "https://www.nature.com/articles/s41467-023-41343-1"
        },
        {
          "title": "Machine learning in the analysis of biomolecular simulations",
          "author": "Authors:",
          "published_date": "2022-12-31T00:00:00+00:00",
          "summary": "This research review discusses the application of machine learning (ML) in biomolecular simulations, focusing on dimensionality reduction, clustering, regression, and classification for tasks like enhanced sampling, coordinate discovery, and structure prediction.  While the paper doesn't specifically address the use of ML-based exchange functionals in protein molecular dynamics simulations, it highlights the use of ML for identifying slow system dynamics crucial for accurate free energy profile calculations in membrane permeation studies.  The review mentions various ML techniques, including time-lagged independent component analysis (tICA), used to find slow collective degrees of freedom.  The provided text does not offer an answer to whether ML-based exchange functionals have been used in protein MD simulations.\n",
          "url": "https://www.researchgate.net/publication/357741405_Machine_learning_in_the_analysis_of_biomolecular_simulations"
        }
      ],
      "full_explanation": "The provided papers primarily focus on using machine learning (ML) to enhance various aspects of molecular dynamics (MD) simulations, but none of them directly address the core question of using machine learning-based exchange functionals *within* protein MD simulations.\n\n*   **NNP/MM: Accelerating Molecular Dynamics Simulations with Machine Learning Potentials and Molecular Mechanics** (https://arxiv.org/pdf/2201.08110.pdf) This paper utilizes neural network potentials (NNPs) to model parts of the system but does not employ ML for the exchange-correlation functional. While this enhances force field accuracy, it does not answer the question.\n\n*   **On-line Optimization of Hamiltonian Replica Exchange Simulations** (https://www.biorxiv.org/content/10.1101/228262v1) This paper uses machine learning to optimize replica exchange, which is used in protein folding simulations, but it does not address the application of machine learning to exchange functionals. While it uses ML within the context of MD, it's not within the actual potential/force calculation\n\n*   **Machine learning/molecular dynamic protein structure...** (https://www.nature.com/articles/s41598-022-13714-z) This paper uses ML to predict protein conformations, but only *before* the MD simulation. The ML model generates input parameters for the MD, it does not modify the MD force field itself. Therefore it is not relevant.\n\nThe other listed papers primarily use ML for analysis of MD results or use of ML for other parameters that are not related to the exchange functional. These papers do not address the question.\n\nTherefore, based on the provided papers, there is no evidence that machine learning-based exchange functionals have been used in protein molecular dynamics simulations."
    },
    {
      "question": "Has anyone figured out the mechanism of cellular aging?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Molecular damage in aging - Nature Aging",
          "author": "Gladyshev; Vadim N; Kritchevsky; Stephen B; Clarke; Steven G; Cuervo; Ana Maria; Fiehn; Oliver; De Magalh\u00e3es; Jo\u00e3o Pedro; Mau; Theresa; Maes; Michal; Moritz; Robert L; Niedernhofer; Laura J; Van Schaftingen; Emile; Tranah; Gregory J; Walsh; Kenneth; Yura; Yoshimitsu; Zhang; Bohan; Cummings; Steven R",
          "published_date": "2023-02-06T09:44:51.648000+00:00",
          "summary": "The mechanism of cellular aging is not fully understood, but research points to several contributing factors.  Studies highlight the roles of protein oxidation (Stadtman, 1992),  and accumulating damaging mutations (Kinzina et al., 2019).  Furthermore, the \"hallmarks of aging\" (Lopez-Otin et al., 2013) provide a framework encompassing various processes involved, though the precise interplay remains an area of active investigation.  While several theories exist (Kirkwood & Austad, 2000; Rando & Wyss-Coray, 2021), a complete, unified mechanism hasn't been elucidated.\n",
          "url": "https://www.nature.com/articles/s43587-021-00150-3"
        },
        {
          "title": "Nucleophagy delays aging and preserves germline immortality - Nature Aging",
          "author": "Papandreou; Margarita-Elena; Konstantinidis; Georgios; Tavernarakis; Nektarios",
          "published_date": "2023-04-13T21:21:49.056000+00:00",
          "summary": "This study in *Nature Aging* investigates the role of nucleophagy (autophagy of the nucleus) in aging.  Researchers found that nucleophagy is crucial for germline immortality and delaying somatic aging.  Reduced nucleophagy leads to nuclear abnormalities, increased nucleolar size, and reduced resistance to stress.  Specifically, the proteins ANC-1/nesprin-2, degraded via autophagy, regulate nucleolar size.  Their loss causes infertility and tumor formation, highlighting nucleophagy's importance in maintaining nuclear health and preventing aging.  While not a complete explanation of cellular aging, the study identifies a key mechanism involving the regulated removal of nuclear components through autophagy.\n",
          "url": "https://www.nature.com/articles/s43587-022-00327-4"
        },
        {
          "title": "Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration - Nature",
          "author": "Moiseeva; Victoria; Cisneros; Andr\u00e9s; Sica; Valentina; Deryagin; Oleg; Lai; Yiwei; Jung; Sascha; Eva; An; Juan; Segal\u00e9s; Jessica; Ortet; Laura; Lukesova; Vera; Volpe; Giacomo; Benguria; Alberto; Dopazo; Benitah; Salvador Aznar; Urano; Yasuteru; Del Sol; Esteban; Miguel A; Ohkawa; Yasuyuki; Serrano; Perdiguero; Eusebio; Mu\u00f1oz-C\u00e1noves; Pura",
          "published_date": "2023-04-13T10:10:00.109000+00:00",
          "summary": "This Nature article investigates the role of senescent cells (cells that have stopped dividing but remain metabolically active) in the aging process and impaired muscle regeneration.  While not fully elucidating the mechanism of cellular aging itself, the study identifies senescent cells as a key component of an age-related inflamed niche that hinders muscle repair.  The researchers created a comprehensive atlas of senescent cells in regenerating muscle using single-cell transcriptomics, revealing that these cells accumulate after injury and suppress regeneration throughout life.  The exact mechanisms by which these senescent cells impair regeneration are still under investigation, but this research points to a significant contribution of these cells to the age-related decline in regenerative capacity.\n",
          "url": "https://www.nature.com/articles/s41586-022-05535-x"
        },
        {
          "title": "The cell biology of aging - PMC",
          "author": "",
          "published_date": "2015-12-15T00:00:00+00:00",
          "summary": "Current research suggests aging is not solely due to random cellular degradation, but is at least partly genetically regulated.  Studies using model organisms like *C. elegans* have identified mutations extending lifespan, highlighting the role of genetics in controlling cellular aging processes.  While the precise mechanism remains unclear, research focuses on how dysregulation of processes like autophagy and proteostasis contributes to age-related diseases and cellular decline.  These processes, along with others such as protein translation quality control, organelle recycling, and extracellular matrix maintenance, are intricately interconnected and influence cellular health throughout the aging process.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4678010/"
        },
        {
          "title": "Molecular mechanisms of aging and anti-aging strategies",
          "author": "Wu, Xin",
          "published_date": "2024-05-24T00:00:00+00:00",
          "summary": "This review article summarizes current understanding of cellular aging mechanisms.  While a complete mechanism hasn't been definitively established,  research points to several key factors: telomere attrition, DNA damage, mitochondrial dysfunction, reduced NAD+ levels, impaired autophagy, stem cell exhaustion, inflammation, protein imbalance, disrupted nutrient sensing, altered intercellular communication, and dysbiosis.  The article also explores potential anti-aging strategies including calorie restriction, improved sleep, increased physical activity, and targeting longevity genes.\n",
          "url": "https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01663-1"
        },
        {
          "title": "Aging and aging-related diseases: from molecular ...",
          "author": "Guo; Jun; Huang; Xiuqing; Dou; Lin; Yan; Mingjing; Shen; Tao; Tang; Weiqing; Li; Jian",
          "published_date": "2023-04-13T11:35:49.645000+00:00",
          "summary": "The provided text is a list of research articles on aging and age-related diseases, not a summary of the mechanisms of cellular aging.  Therefore, it does not directly answer your question.  The articles cover various aspects of aging research, from the effects of light intensity on lifespan in Drosophila (1925) to more recent studies on caloric restriction and the relationship between aging and diseases like Alzheimer's.  While the articles collectively contribute to the understanding of aging,  a concise explanation of the cellular mechanisms is not present in this bibliography.\n",
          "url": "https://www.nature.com/articles/s41392-022-01251-0"
        },
        {
          "title": "A synopsis on aging\u2014Theories, mechanisms and future ...",
          "author": "",
          "published_date": "2016-06-25T00:00:00+00:00",
          "summary": "This article reviews various theories of aging, focusing on the biochemical processes involved.  While it doesn't present a single, conclusive mechanism for cellular aging, it highlights the complexity of the process and the lack of a complete understanding.  The authors emphasize the need for an integrative approach, combining aging research with systems biology, to unravel the mysteries of aging.  Several theories and associated changes at different biological levels are discussed but a unified mechanism remains elusive.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5991498/"
        },
        {
          "title": "Principles of the Molecular and Cellular Mechanisms ...",
          "author": "J. Alcedo, C. Kenyon",
          "published_date": "2021-04-01T00:00:00+00:00",
          "summary": "No single mechanism fully explains cellular aging, but research points to several key factors.  Accumulation of cellular damage (DNA lesions, misfolded proteins, shortened telomeres) due to normal metabolism and environmental factors is a major contributor.  This damage triggers processes like DNA damage response, potentially leading to cellular senescence.  Studies of premature aging syndromes, often caused by mutations in DNA repair genes, further support the role of genomic damage accumulation in aging.  While much is understood about these processes, a complete mechanistic understanding of cellular aging remains elusive.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022202X20323642"
        },
        {
          "title": "Aging, Cell Division | Learn Science at Scitable",
          "author": "Share; Cancel",
          "published_date": "2023-04-13T16:53:32.160000+00:00",
          "summary": "Research into cellular aging began in 1961 with the discovery of the Hayflick limit, showing that human cells in culture divide a limited number of times before entering senescence (dormancy).  Key pathways involved are controlled by tumor suppressors p53 and Rb.  These pathways, triggered by DNA damage or insufficient telomere replication, can lead to either apoptosis (cell death) or senescence.  Failure of these pathways results in tumor formation. While a complete mechanism isn't fully elucidated, the connection between aging and cancer is strong, with slowed aging processes also delaying cancer onset.\n",
          "url": "https://www.nature.com/scitable/topicpage/aging-and-cell-division-14230076/"
        },
        {
          "title": "Aging of the cells: Insight into cellular senescence and ...",
          "author": "P.D. Adams",
          "published_date": "2020-08-01T00:00:00+00:00",
          "summary": "No single mechanism fully explains cellular aging.  The article discusses several contributing factors, including the accumulation of unrepaired molecular damage (DNA, proteins, lipids, organelles) from both intrinsic (e.g., reactive oxygen species) and extrinsic (e.g., UV light) sources.  Cellular senescence, a state of irreversible cell cycle arrest, is also highlighted as a significant consequence of stress, impacting the aging process.  While research focuses on these cellular mechanisms to understand overall body aging, a complete understanding remains elusive.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0171933520300479"
        }
      ],
      "full_explanation": "While extensive research has been conducted into the mechanisms of cellular aging, no single study has definitively \"figured out\" the complete mechanism. The provided papers consistently point to a complex interplay of factors, and a unified theory remains elusive. Here's a breakdown of why the answer is NO, citing relevant papers:\n\n*   **Multiple Contributing Factors:** Several papers emphasize that cellular aging is not due to one single cause but rather an accumulation of multiple factors. \"Molecular damage in aging - Nature Aging\" (https://www.nature.com/articles/s43587-021-00150-3) states that \"the mechanism of cellular aging is not fully understood,\" and discusses the roles of protein oxidation and accumulating mutations.  Similarly, \"Molecular mechanisms of aging and anti-aging strategies\" (https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01663-1) lists telomere attrition, DNA damage, mitochondrial dysfunction, impaired autophagy, and other factors as being involved, without suggesting a single unifying mechanism. The paper \"Principles of the Molecular and Cellular Mechanisms ...\" (https://www.sciencedirect.com/science/article/pii/S0022202X20323642) also points to accumulation of cellular damage (DNA lesions, misfolded proteins, shortened telomeres).\n\n*   **Complex Interplay:** The papers indicate that these factors don't work in isolation.  \"The cell biology of aging - PMC\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC4678010/) highlights how processes like autophagy and proteostasis are interconnected. \"A synopsis on aging\u2014Theories, mechanisms and future ...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC5991498/) emphasizes the need for an integrative approach to study this complex interplay. \n\n*   **Focus on Specific Mechanisms or Pathways:** While some papers focus on specific mechanisms, they don't claim to explain the entire process of cellular aging.  For example, \"Nucleophagy delays aging and preserves germline immortality - Nature Aging\" (https://www.nature.com/articles/s43587-022-00327-4) identifies nucleophagy as a key mechanism in aging and germline immortality but doesn't propose it as the sole mechanism of cellular aging.  Similarly, \"Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration - Nature\" (https://www.nature.com/articles/s41586-022-05535-x) focuses on the role of senescent cells in muscle regeneration decline, not on the complete mechanism of aging. \"Aging of the cells: Insight into cellular senescence and ...\" (https://www.sciencedirect.com/science/article/abs/pii/S0171933520300479) discusses cellular senescence but doesn't suggest a unified mechanism for overall cellular aging.\n\n*   **Lack of a Complete Understanding:** The consistent theme across many of the relevant papers is that a complete mechanistic understanding is lacking. Both \"Principles of the Molecular and Cellular Mechanisms ...\" (https://www.sciencedirect.com/science/article/pii/S0022202X20323642) and \"Aging of the cells: Insight into cellular senescence and ...\" (https://www.sciencedirect.com/science/article/abs/pii/S0171933520300479) explicitly state that no single mechanism fully explains cellular aging.\n\nIn conclusion, while significant progress has been made in understanding different aspects of cellular aging, no single study has elucidated the entire mechanism. Therefore, the answer is NO."
    },
    {
      "question": "Has anyone been able to impute previously unknown relationships from a knowledge graph? ",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Data Imputation with Iterative Graph Reconstruction",
          "author": "J. Zhong,Weiwei Ye,Ning Gui",
          "published_date": "2023-10-26T19:29:50.600000+00:00",
          "summary": "This paper introduces a novel Iterative Graph Generation and Reconstruction framework (IGRM) for data imputation.  Unlike previous methods that treat all data samples equally, IGRM utilizes \"friend networks\" to represent relationships between samples, improving imputation accuracy. While the paper focuses on improving imputation using learned relationships *within* the data itself (rather than incorporating a pre-existing knowledge graph), it does learn relationships between samples, which could be considered a form of relationship imputation.  The method doesn't explicitly impute relationships from a *pre-existing* knowledge graph, however.\n",
          "url": "https://arxiv.org/pdf/2212.02810.pdf"
        },
        {
          "title": "Contextual Parameter Generation for Knowledge Graph Link Prediction",
          "author": "George  Stoica, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, Otilia  Stretcu, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, ostretcu@cs.cmu.edu, Emmanouil Antonios Platanios, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, e.a.platanios@cs.cmu.edu, Tom M Mitchell, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, tom.mitchell@cs.cmu.edu, Barnab\u00e1s  P\u00f3czos, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, bapoczos@cs.cmu.edu",
          "published_date": "2023-11-09T20:30:54.758000+00:00",
          "summary": "Yes.  This paper introduces a method for knowledge graph link prediction, which effectively imputes previously unknown relationships.  The authors improve upon existing methods by using contextual parameter generation, allowing the model to learn more complex interactions between entities and relations, resulting in significant performance gains and faster convergence.  This leads to better prediction of missing links within the knowledge graph.\n",
          "url": "https://ojs.aaai.org/index.php/AAAI/article/view/5693"
        },
        {
          "title": "Robust Knowledge Graph Completion with Stacked Convolutions and a Student Re-Ranking Network",
          "author": "Justin  Lovelace, Carnegie Mellon University, USA, jlovelac@cs.cmu.edu, Denis  Newman-Griffis, University of Pittsburgh, USA, dnewmangriffis@pitt.edu, Shikhar  Vashishth, t-svashishth@microsoft.com, Jill  Fain Lehman, Carnegie Mellon University, USA, Carolyn Penstein Ros\u00e9, Carnegie Mellon University, USA",
          "published_date": "2023-11-16T01:35:14.593000+00:00",
          "summary": "This paper introduces a new knowledge graph completion (KGC) method that outperforms existing methods, particularly on sparsely connected graphs which are more representative of real-world scenarios.  The method uses a deep convolutional network with textual entity representations to learn robust entity embeddings, even with limited data.  A student re-ranking network further improves performance.  While not explicitly stated as \"imputing previously unknown relationships,\" the core goal and demonstrated success of the model is precisely to predict missing links (relationships) within a knowledge graph, effectively inferring them from existing data and textual information.\n",
          "url": "https://arxiv.org/pdf/2106.06555.pdf"
        },
        {
          "title": "Knowledge graph revision in the context of unknown ...",
          "author": "",
          "published_date": "2024-07-05T00:00:00+00:00",
          "summary": "This paper investigates updating knowledge graphs when initial knowledge is unknown, a situation analogous to imputing previously unknown relationships.  The authors prove that finding the optimal solution is strongly NP-complete and propose two algorithms, Flaccid_search and Tight_search, to address this challenge.  While the paper doesn't explicitly state successful imputation of unknown relationships, it presents methods for revising a knowledge graph in the absence of prior knowledge, which is a step towards achieving this goal.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226096/"
        },
        {
          "title": "Toxicology knowledge graph for structural birth defects",
          "author": "Ma\u2019ayan, Avi",
          "published_date": "2023-07-17T00:00:00+00:00",
          "summary": "This article discusses the development of a toxicology knowledge graph to understand structural birth defects.  While the article focuses on building the knowledge graph itself and doesn't directly address imputation of *previously unknown* relationships, it highlights the potential for such a system to reveal new insights by integrating data from multiple sources.  The authors suggest that combining information in this way could uncover previously unknown connections between genetic factors, drug interactions, and infections as causes of birth defects.  However, the paper does not present results demonstrating the actual imputation of new relationships.\n",
          "url": "https://www.nature.com/articles/s43856-023-00329-2"
        },
        {
          "title": "Knowledge Graph Imputation - UWSpace",
          "author": "AuthorsNiknamian, Mohammadali",
          "published_date": "2021-05-27T00:00:00+00:00",
          "summary": "The provided text is empty.  Therefore, I cannot provide a summary regarding knowledge graph imputation or whether previously unknown relationships have been imputed.  To answer your query, I need the actual content of the webpage.\n",
          "url": "https://uwspace.uwaterloo.ca/items/189c536b-a75a-4101-8601-86637b8152cf"
        },
        {
          "title": "Building product graphs automatically",
          "author": "Xin Luna Dong",
          "published_date": "2020-08-13T13:00:26+00:00",
          "summary": "Amazon's AutoKnow system, presented at the KDD conference, automatically builds product knowledge graphs.  It successfully imputed previously unknown relationships in Amazon's consumables product graph (grocery, beauty, baby, health), increasing the number of facts by almost 200%.  The system extracts information from structured data and free-form text sources like product descriptions and reviews to identify new product types and attributes, and correct errors.\n",
          "url": "https://www.amazon.science/blog/building-product-graphs-automatically"
        },
        {
          "title": "Knowledge Graphs in Practice: Characterizing their Users ...",
          "author": "\\authororcidHarry Li0000-0002-2288-6039",
          "published_date": "2023-03-24T00:00:00+00:00",
          "summary": "This research paper focuses on the challenges and opportunities in knowledge graph (KG) visualization, based on interviews with 19 KG practitioners.  While the study doesn't directly address imputation of unknown relationships, it highlights that KG analysts need customizable query builders providing interim results. This suggests a need for improved tools to explore and analyze KGs, which could potentially facilitate the discovery of new relationships, but the paper doesn't present any findings on whether this is currently achievable.\n",
          "url": "https://arxiv.org/html/2304.01311"
        },
        {
          "title": "Exploiting Semantic Patterns over Biomedical Knowledge ...",
          "author": "",
          "published_date": "2018-05-12T00:00:00+00:00",
          "summary": "This research used semantic graph patterns from the SemMedDB knowledge graph to predict previously unknown \"treats\" and \"causes\" relationships between biomedical entities.  Logistic regression and decision tree models achieved high F-scores (99% and 90%, respectively).  The researchers were able to predict plausible new relationships, some of which were validated by physician co-authors.  The study demonstrates the successful imputation of previously unknown relationships from a knowledge graph.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6070294/"
        },
        {
          "title": "(PDF) Knowledge graph revision in the context of unknown ...",
          "author": "",
          "published_date": "2024-07-05T00:00:00+00:00",
          "summary": "This research paper investigates updating knowledge graphs when initial knowledge is unknown,  a scenario exemplified by lacking access to a software's full code.  The authors prove that finding the optimal solution is strongly NP-complete and propose two algorithms (Flaccid_search and Tight_search) to address this challenge.  While the paper doesn't directly address imputation of *previously unknown relationships*, it tackles the related problem of updating a graph when foundational knowledge is missing, suggesting a potential pathway for future research in relationship imputation.\n",
          "url": "https://www.researchgate.net/publication/382023067_Knowledge_graph_revision_in_the_context_of_unknown_knowledge"
        }
      ],
      "full_explanation": "Several papers demonstrate the successful imputation of previously unknown relationships from a knowledge graph. Specifically:\n\n*   **\"Contextual Parameter Generation for Knowledge Graph Link Prediction\"** directly addresses the research question by presenting a method for link prediction, which effectively imputes previously unknown relationships within a knowledge graph. The method improves on previous approaches, leading to better predictions of missing links. URL: https://ojs.aaai.org/index.php/AAAI/article/view/5693\n*   **\"Robust Knowledge Graph Completion with Stacked Convolutions and a Student Re-Ranking Network\"** describes a knowledge graph completion method that predicts missing links, effectively imputing previously unknown relationships. Although not explicitly described as such, the paper demonstrates the prediction of new links within the knowledge graph using a novel approach. URL: https://arxiv.org/pdf/2106.06555.pdf\n*   **\"Building product graphs automatically\"** presents Amazon's AutoKnow system, which automatically builds product knowledge graphs and successfully imputed previously unknown relationships in Amazon's consumables product graph. The system increased the number of known facts by almost 200%, demonstrating significant imputation capability. URL: https://www.amazon.science/blog/building-product-graphs-automatically\n*  **\"Exploiting Semantic Patterns over Biomedical Knowledge ...\"** shows the successful imputation of previously unknown \"treats\" and \"causes\" relationships within the SemMedDB knowledge graph. High F-scores were achieved in predicting these relationships, with some validated by experts. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6070294/\nThese papers provide clear evidence that the research question has indeed been explored and successfully demonstrated by various researchers."
    },
    {
      "question": "Has anyone tried to have an LLM prompt set-up where one LLM pretends to be the user and the other the assistant and they accomplish a complex task via chatting? I think the paper had a camel in it or something",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Thinking Assistants: LLM-Based Conversational Assistants that Help Users Think By Asking rather than Answering",
          "author": "[Submitted on 10 Dec 2023 (v1), last revised 29 Feb 2024 (this version, v2)]",
          "published_date": "2023-12-10T00:00:00+00:00",
          "summary": "This paper introduces \"thinking assistants,\" LLMs designed to help users think critically by prompting reflection rather than directly answering questions.  The authors built Gradschool.chat, a thinking assistant for prospective graduate students applying to HCI programs.  While the paper doesn't describe an LLM prompting setup where one LLM acts as the user and the other as the assistant to accomplish a complex task (there's no mention of camels), it does detail a system where an LLM interacts with users to help them brainstorm and refine their research ideas.  A study of 223 conversations showed positive user feedback in about 65% of instances, with users brainstorming research ideas engaging for significantly longer periods.\n",
          "url": "https://arxiv.org/abs/2312.06024"
        },
        {
          "title": "Chatbots in Knowledge-Intensive Contexts: Comparing Intent and LLM-Based Systems",
          "author": "Freire; Samuel Kernan; Wang; Chaofan; Niforatos; Evangelos",
          "published_date": "2024-02-07T00:00:00+00:00",
          "summary": "This paper compares intent-based and large language model (LLM)-based cognitive assistants (chatbots) in knowledge-intensive tasks.  A user study found that the LLM-based system performed better in terms of user experience, task completion rate, usability, and perceived performance.  The paper does *not* describe a setup where two LLMs interact to complete a task; there is no mention of camels.\n",
          "url": "https://arxiv.org/abs/2402.04955"
        },
        {
          "title": "CAMEL: Communicative Agents for \"Mind\" Exploration of Large Language Model Society https://www.camel-ai.org",
          "author": "Guohao  Li, King Abdullah University of Science and Technology (KAUST), *  Hasan, King Abdullah University of Science and Technology (KAUST), Abed  Al, King Abdullah University of Science and Technology (KAUST), Kader  Hammoud, King Abdullah University of Science and Technology (KAUST), Hani  Itani, King Abdullah University of Science and Technology (KAUST), Dmitrii  Khizbullin, King Abdullah University of Science and Technology (KAUST), Bernard  Ghanem, King Abdullah University of Science and Technology (KAUST), Human  User, King Abdullah University of Science and Technology (KAUST), Stock  Trader, King Abdullah University of Science and Technology (KAUST)",
          "published_date": "2023-11-16T01:36:20.238000+00:00",
          "summary": "Yes, the CAMEL framework described in this paper uses multiple LLMs in a role-playing setup to accomplish complex tasks.  One LLM simulates a user providing instructions, while another acts as the assistant carrying out the task.  This approach aims to reduce reliance on human prompting and explore autonomous cooperation between language models.  The researchers use inception prompting to guide the agents and generate data for studying multi-agent collaboration.\n",
          "url": "https://arxiv.org/pdf/2303.17760.pdf"
        },
        {
          "title": "An example of LLM prompting for programming",
          "author": null,
          "published_date": "2023-05-16T16:35:36.764000+00:00",
          "summary": "This Hacker News thread discusses using LLMs for programming, specifically the limitations of iteratively prompting a single LLM to complete a complex task.  Users found that after a few steps, the LLM loses context and begins hallucinating, requiring a new chat session for each subsequent task.  While helpful for initial brainstorming, generating boilerplate code, and overcoming initial hurdles, the approach is ultimately limited by token constraints and the LLM's tendency to get \"stuck\" in loops.  The idea of using two LLMs, one simulating a user and the other an assistant, to tackle a complex task is not discussed in this thread.  There is no mention of a camel in the paper.\n",
          "url": "https://news.ycombinator.com/item?id=35612494"
        },
        {
          "title": "The LLM wants to talk. Large language model prompt and\u2026",
          "author": "Chris Ismael",
          "published_date": "2023-08-06T09:35:04+00:00",
          "summary": "This Medium post explains various LLM concepts like system prompts, hallucinations, and reasoning methods.  While it doesn't directly address your question about two LLMs collaborating on a complex task (like the one you describe with a camel), it does discuss how system prompts define the LLM's persona and initial instructions, which is a fundamental element of such a setup.  The article uses numerous examples to illustrate its points, focusing on practical applications rather than technical details.\n",
          "url": "https://chrispogeek.medium.com/the-llm-wants-to-talk-e1514043ae9c"
        },
        {
          "title": "Need help deciding what to put in System vs User prompt ...",
          "author": "",
          "published_date": "2024-08-02T11:51:43+00:00",
          "summary": "Summary:  The provided webpage text is only \"Loading,\" so I cannot answer your question about using two LLMs to collaboratively complete a complex task, simulating a user and assistant interaction (even if a paper mentioning camels was involved).  The webpage likely contains a forum discussion, but no content is currently available.\n",
          "url": "https://community.openai.com/t/need-help-deciding-what-to-put-in-system-vs-user-prompt-for-dialogue-generation/891133"
        },
        {
          "title": "Prompt Patterns: What They Are and 16 You Should Know",
          "author": "Dan Cleary",
          "published_date": "2024-10-30T04:00:00+00:00",
          "summary": "This article discusses \"prompt patterns,\" reusable methods for improving Large Language Model (LLM) outputs.  While it doesn't directly address your query about two LLMs collaborating on a complex task (like a user and assistant), it does explore various prompt engineering techniques that *could* be applied to such a setup. The article categorizes 16 prompt patterns across six categories (Input Semantics, Output Customization, Error Identification, Prompt Improvement, Interaction, and Context Control), offering a framework for creating more effective prompts.  The mention of a camel in your search query isn't found in the provided text.\n",
          "url": "https://www.prompthub.us/blog/prompt-patterns-what-they-are-and-16-you-should-know"
        },
        {
          "title": "Protecting LLMs from prompt injections and jailbreaks",
          "author": "",
          "published_date": "2024-04-25T16:43:20+00:00",
          "summary": "The provided text only contains \"Loading,\" so I cannot summarize the OpenAI paper regarding LLM prompt injections and jailbreaks, nor can I answer your question about using two LLMs to collaboratively complete a complex task.  The mention of a camel in your query is not helpful without further context from the actual paper content.\n",
          "url": "https://community.openai.com/t/protecting-llms-from-prompt-injections-and-jailbreaks-new-openai-paper/727636"
        },
        {
          "title": "How to get exact message sent to LLM using LangChain's ...",
          "author": "cserpellcserpell 90422 gold badges1010 silver badges2020 bronze badges",
          "published_date": "2023-07-07T19:01:00+00:00",
          "summary": "This Stack Overflow question asks how to retrieve the exact prompt sent to an LLM using LangChain's `LLMChain` in Python.  The provided solutions suggest using `LLMChain(..., verbose=True)` (though output is to stdout),  `LLMChain(prompt=prompt,llm=llm).prompt.format_prompt(your_prompt_variables_here).to_string()`, or the `.format()` method of `ChatPromptTemplate` for retrieving the formatted prompt string.  The question is unrelated to your search query about using two LLMs to collaboratively perform a complex task.\n",
          "url": "https://stackoverflow.com/questions/76639580/how-to-get-exact-message-sent-to-llm-using-langchains-llmchain-python"
        },
        {
          "title": "LLM prompter with local models issues",
          "author": "",
          "published_date": "2024-02-02T08:30:57+00:00",
          "summary": "The provided text is just a \"Loading\" message and offers no information regarding using two LLMs to simulate a user and assistant completing a complex task, or any mention of a paper with a camel.  Therefore, no summary can be provided to answer the user's query.\n",
          "url": "https://forum.knime.com/t/llm-prompter-with-local-models-issues/77007"
        }
      ],
      "full_explanation": "The research question, specifically whether anyone has explored a setup where one LLM pretends to be the user and another the assistant to accomplish a complex task via chatting, has indeed been investigated. The paper titled \"CAMEL: Communicative Agents for \"Mind\" Exploration of Large Language Model Society\" directly addresses this concept. As stated in the summary, the CAMEL framework \"uses multiple LLMs in a role-playing setup to accomplish complex tasks. One LLM simulates a user providing instructions, while another acts as the assistant carrying out the task.\" The summary also highlights that this was done to reduce human prompting, and to study multi-agent collaboration. This matches the core idea in the research question, especially the part concerning the usage of LLMs as user and assistant. The paper's URL is: https://arxiv.org/pdf/2303.17760.pdf. The fact that the summary mentions a camel further solidifies this paper's relevance."
    },
    {
      "question": "Has anyone investigated osteocalcin as a drug for weight loss?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Osteocalcin differentially regulates \u03b2 cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice",
          "author": "Mathieu Ferron; Eiichi Hinoi; Gerard Karsenty; Patricia Ducy",
          "published_date": "2023-02-06T07:31:06.171000+00:00",
          "summary": "This study investigated osteocalcin's role in regulating glucose metabolism and fat mass in wild-type mice.  Researchers found that administering osteocalcin to these mice lessened the negative effects of high-fat diets and induced hyperphagia on body mass and glucose metabolism.  While not explicitly framed as a weight-loss drug trial, the results suggest osteocalcin's potential therapeutic value in treating metabolic diseases, including obesity.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278202/"
        },
        {
          "title": "Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway.",
          "author": "Bo  Zhou, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Huixia  Li, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Lin  Xu, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Weijin  Zang, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Shufang  Wu, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Hongzhi  Sun, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China",
          "published_date": "2023-11-09T20:04:47.632000+00:00",
          "summary": "Yes, research suggests osteocalcin may have weight-loss potential.  Studies in mice fed a high-fat diet showed that osteocalcin reduced weight gain, fat accumulation, and improved insulin sensitivity.  These effects were linked to its ability to reduce endoplasmic reticulum stress and improve insulin signaling through the NF-\u03baB pathway.  While this research is pre-clinical (in mice and cell cultures), it indicates osteocalcin warrants further investigation as a potential drug for weight loss and related metabolic disorders.\n",
          "url": "https://academic.oup.com/endo/article/154/3/1055/2423406?login=false"
        },
        {
          "title": "Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway - PubMed",
          "author": "Bo Zhou 1 , Huixia Li, Lin Xu, Weijin Zang, Shufang Wu, Hongzhi Sun",
          "published_date": "2021-12-01T00:00:00+00:00",
          "summary": "Yes, research suggests osteocalcin may aid weight loss.  Studies in mice with diet-induced obesity showed that osteocalcin reduced body weight gain, fat pad accumulation, and improved insulin sensitivity.  These effects appear to be mediated through the NF-\u03baB signaling pathway, impacting endoplasmic reticulum stress and improving mitochondrial function.  While this research is pre-clinical (in mice), it indicates a potential therapeutic role for osteocalcin in treating obesity and related conditions.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23407450/"
        },
        {
          "title": "Effect of Weight Loss on Serum Osteocalcin and Its ...",
          "author": "",
          "published_date": "2015-02-15T00:00:00+00:00",
          "summary": "This study investigated the effect of weight loss on serum osteocalcin levels in obese men, not osteocalcin *as a treatment* for weight loss.  While the study found that undercarboxylated osteocalcin (uOC) levels increased after weight loss, it concluded that this increase wasn't related to changes in adipokine levels.  The research does not explore osteocalcin's potential as a weight-loss drug.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345075/"
        },
        {
          "title": "Osteocalcin has a muscle-protective effect during weight ...",
          "author": "",
          "published_date": "2023-11-29T00:00:00+00:00",
          "summary": "This study investigated the relationship between osteocalcin (OC) and muscle mass during weight loss in overweight or obese men without metabolic syndrome.  While the study did not investigate osteocalcin *as a drug*,  it found a positive correlation between OC levels and preservation of muscle mass during a high-protein, energy-restricted diet.  The researchers concluded that OC has a protective effect on muscle loss in men during weight reduction, but did not explore its use as a pharmaceutical intervention for weight loss.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10716436/"
        },
        {
          "title": "The role of osteocalcin in the endocrine cross-talk between ...",
          "author": "Ducy; P",
          "published_date": "2023-02-06T13:58:51.872000+00:00",
          "summary": "This article discusses osteocalcin's role in regulating glucose metabolism, not its potential as a weight-loss drug. While studies show osteocalcin improves insulin sensitivity and glucose tolerance in mice, and increases insulin levels,  the text doesn't explore its effects on weight or fat mass reduction as a therapeutic target.  The focus is on its function in bone remodeling and its influence on energy homeostasis.\n",
          "url": "https://link.springer.com/article/10.1007/s00125-011-2155-z"
        },
        {
          "title": "Inverse relationship between serum osteocalcin levels and ...",
          "author": "Yu-Qi  Luo, Xiao-Jing  Ma, Ya-Ping  Hao, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Xiao-Ping  Pan, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Yi-Ting  Xu, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Qin  Xiong, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Yu-Qian  Bao, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Wei-Ping  Jia, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China",
          "published_date": "2023-11-09T20:13:30.649000+00:00",
          "summary": "This study did not investigate osteocalcin as a weight-loss drug.  Instead, it found an inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease (NAFLD) in postmenopausal Chinese women with normal blood glucose.  Lower osteocalcin levels were associated with a higher likelihood of NAFLD.  The study suggests osteocalcin may play a role in liver health, but doesn't explore its potential as a weight-loss medication.\n",
          "url": "https://www.nature.com/articles/aps201581"
        },
        {
          "title": "Relationships between serum osteocalcin, leptin and the ...",
          "author": "N.K. Lee",
          "published_date": "2013-03-15T00:00:00+00:00",
          "summary": "This study investigated the relationship between osteocalcin (OC) levels and weight loss in obese Korean adults undergoing pharmacological treatment.  While the study did not investigate osteocalcin *as a drug* for weight loss, it found that serum OC levels increased significantly after three months of weight loss treatment. This increase was significantly associated with decreases in BMI, visceral fat mass, HOMA (a measure of insulin resistance), and leptin levels.  The researchers suggest a relationship between bone and adipose tissue, but the study does not support the use of osteocalcin as a weight-loss drug.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0009898112005712"
        },
        {
          "title": "Circulating osteocalcin is associated with time in range and ...",
          "author": "Shao, Jiaqing",
          "published_date": "2022-08-04T00:00:00+00:00",
          "summary": "This study investigated the relationship between osteocalcin levels and glucose control in type 2 diabetes patients using continuous glucose monitoring (CGM).  The research did *not* investigate osteocalcin as a weight-loss drug.  Higher osteocalcin levels were associated with better time in range (TIR) on CGM, indicating improved glucose control.  However, the study focused on the correlation between osteocalcin and glucose metabolism markers, not its potential use for weight loss.\n",
          "url": "https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-022-00863-4"
        },
        {
          "title": "Pronounced Elevation of Undercarboxylated Osteocalcin in ...",
          "author": "Marieke  Van Summeren, Lavienja  Braam, Florence  Noirt, Wietse  Kuis, Cees  Vermeer, c.vermeer@bioch.unimaas.nl",
          "published_date": "2023-11-09T20:12:59.781000+00:00",
          "summary": "This research article investigates osteocalcin levels in children, finding significantly higher levels of undercarboxylated osteocalcin (ucOC), indicating low vitamin K status.  The study does *not* explore osteocalcin's use as a weight-loss drug.  The focus is on its role in bone metabolism and the relationship between vitamin K intake and bone health in children.\n",
          "url": "https://www.nature.com/articles/pr200772"
        }
      ],
      "full_explanation": "Based on the provided papers, there is evidence to suggest that osteocalcin has been investigated, in pre-clinical settings, for its potential as a weight loss intervention. While not directly framed as a drug trial in humans, several papers demonstrate that osteocalcin administration in mice leads to reduced weight gain and fat accumulation.\n\nSpecifically:\n\n*   The paper titled \"Osteocalcin differentially regulates \u03b2 cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278202/) found that administering osteocalcin to mice lessened the negative effects of high-fat diets on body mass. This suggests a potential therapeutic use in treating metabolic diseases such as obesity.\n\n*   The paper \"Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway.\" (https://academic.oup.com/endo/article/154/3/1055/2423406?login=false) explicitly states that studies in mice fed a high-fat diet showed that osteocalcin reduced weight gain and fat accumulation. This supports the idea of osteocalcin having weight-loss potential.\n\n*   The paper \"Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway - PubMed\" (https://pubmed.ncbi.nlm.nih.gov/23407450/)  also corroborates this finding, stating that osteocalcin administration in mice with diet-induced obesity reduced body weight gain and fat pad accumulation.\n\nThese three papers demonstrate that the idea of using osteocalcin for weight loss has been investigated in animal models, indicating the research has indeed been done, although not yet in a full clinical setting as a pharmaceutical drug trial in humans."
    },
    {
      "question": "Has anyone beaten stockfish as a human",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "[2402.04494] Grandmaster-Level Chess Without Search",
          "author": null,
          "published_date": null,
          "summary": "No human has beaten Stockfish 16, currently the strongest publicly available chess engine.  This paper describes a 270M parameter transformer model that achieves a Lichess blitz Elo of 2895 (comparable to grandmasters) without using search algorithms like Stockfish.  While it doesn't explicitly state a victory *over* Stockfish, its performance suggests a significant advance in AI chess capabilities.\n",
          "url": "https://arxiv.org/pdf/2402.04494.pdf"
        },
        {
          "title": "[2402.04494] Grandmaster-Level Chess Without Search",
          "author": null,
          "published_date": null,
          "summary": "No human has beaten Stockfish 16, currently the world's strongest publicly available chess engine.  This paper describes a 270M parameter transformer model that achieves a Lichess blitz Elo of 2895 (against humans) without using search algorithms, outperforming AlphaZero's policy and value networks (without MCTS) and GPT-3.5-turbo-instruct.  While impressive, this doesn't represent a human beating Stockfish.\n",
          "url": "https://arxiv.org/pdf/2402.04494.pdf"
        },
        {
          "title": "Bridging the Human-AI Knowledge Gap: Concept Discovery and Transfer in AlphaZero",
          "author": "Lisa  Schut, University of Oxford, Nenad  Toma\u0161ev, Tom  Mcgrath, Demis  Hassabis, Ulrich  Paquet, Been  Kim",
          "published_date": "2023-11-16T01:36:45.223000+00:00",
          "summary": "This paper does not address whether any human has beaten Stockfish.  It focuses on extracting knowledge from AlphaZero, a different chess AI, to improve human chess understanding.  The research shows that AlphaZero possesses chess concepts beyond current human knowledge, which top grandmasters were able to learn and use to improve their game.  The study's aim is to bridge the knowledge gap between humans and AI, not to compare human players against Stockfish.\n",
          "url": "https://arxiv.org/pdf/2310.16410.pdf"
        },
        {
          "title": "Finally!! A actual human who manages to beat Stockfish!!",
          "author": "",
          "published_date": "2020-09-14T00:00:00+00:00",
          "summary": "A YouTube video claims a human, Jonathan Schrantz, defeated Stockfish using the Urusov Gambit.  However, forum users are skeptical, suggesting the Stockfish version used was weaker than the full-strength engine and that Schrantz likely exploited the engine's limitations by preparing a specific line of play.  Some believe it's a clickbait video.  While defeating a weaker version of Stockfish is still a noteworthy achievement, it's not considered a defeat of the strongest Stockfish engine.\n",
          "url": "https://www.chess.com/forum/view/general/finally-a-actual-human-who-manages-to-beat-stockfish"
        },
        {
          "title": "Is it possible for any titled player to beat a chess engine?",
          "author": "LynobLynob 5,78455 gold badges4242 silver badges8080 bronze badges",
          "published_date": "2022-06-04T12:12:00+00:00",
          "summary": "No human has beaten Stockfish in a fair, standard chess game.  A series of games between Hikaru Nakamura and Stockfish saw Nakamura win one game (with assistance), but lose the other two.  The possibility of a human winning by exploiting Stockfish's time constraints or rules like threefold repetition is discussed, but no such victory has been documented.\n",
          "url": "https://chess.stackexchange.com/questions/6184/is-it-possible-for-any-titled-player-to-beat-a-chess-engine"
        },
        {
          "title": "Is it really possible to beat a stockfish level 8 computer in ...",
          "author": "David NiDavid Ni 28711 gold badge33 silver badges1212 bronze badges",
          "published_date": "2018-03-03T09:28:00+00:00",
          "summary": "No verifiable wins by humans against Stockfish level 8 in blitz games (3+0 to 15+0) have been found.  While theoretically possible due to Stockfish's occasional miscalculations in complex positions, it's highly improbable.  Even strong grandmasters would struggle immensely.  The likelihood increases if Stockfish is running on a weaker, mobile device, and the human is a very strong player (near 2300 ELO).\n",
          "url": "https://chess.stackexchange.com/questions/20036/is-it-really-possible-to-beat-a-stockfish-level-8-computer-in-any-time-that-is-b"
        },
        {
          "title": "Has any human ever beaten a computer at chess?",
          "author": "",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "No human has ever beaten the top chess engines like Stockfish or LC0, and it's highly unlikely to ever happen.  While humans beat computers in the past (before the 1990s), current top engines are far superior.\n",
          "url": "https://chessforbeginners.quora.com/Has-any-human-ever-beaten-a-computer-at-chess?top_ans=3542080"
        },
        {
          "title": "Chess engine sacrifices mastery to mimic human play",
          "author": "By Melanie Lefkowitz",
          "published_date": "2021-01-25T00:00:00+00:00",
          "summary": "No human has beaten a computer in a chess tournament for 15 years.  While the article doesn't specifically mention Stockfish, it highlights the general superiority of chess engines over human players.\n",
          "url": "https://news.cornell.edu/stories/2021/01/chess-engine-sacrifices-mastery-mimic-human-play"
        },
        {
          "title": "Can human beat stockfish in classical time format?",
          "author": "FootballGirl",
          "published_date": "2018-04-04T11:13:02+00:00",
          "summary": "No human has beaten Stockfish in a classical time format.  While a top human player might achieve a draw with white, a win is considered extremely unlikely due to Stockfish's superior calculation and rating (estimated at 3300-3400, significantly higher than the highest-rated human player).  The consensus is that humans are at a considerable disadvantage against such strong chess engines.\n",
          "url": "https://lichess.org/forum/game-analysis/can-human-beat-stockfish-in-classical-time-format"
        }
      ],
      "full_explanation": "Multiple sources confirm that no human has verifiably beaten the strongest versions of Stockfish in a standard, fair chess game. The paper \"[2402.04494] Grandmaster-Level Chess Without Search\" (https://arxiv.org/pdf/2402.04494.pdf), explicitly states, \"No human has beaten Stockfish 16, currently the world's strongest publicly available chess engine\". This is further supported by the chess forum post titled \"Is it possible for any titled player to beat a chess engine?\" (https://chess.stackexchange.com/questions/6184/is-it-possible-for-any-titled-player-to-beat-a-chess-engine), which states, \"No human has beaten Stockfish in a fair, standard chess game.\" The Quora post \"Has any human ever beaten a computer at chess?\" (https://chessforbeginners.quora.com/Has-any-human-ever-beaten-a-computer-at-chess?top_ans=3542080) also corroborates this, saying, \"No human has ever beaten the top chess engines like Stockfish or LC0, and it's highly unlikely to ever happen.\" The Lichess forum post \"Can human beat stockfish in classical time format?\" (https://lichess.org/forum/game-analysis/can-human-beat-stockfish-in-classical-time-format) reinforces this point, specifically for classical time controls, saying \"No human has beaten Stockfish in a classical time format\". While there are claims of humans beating weaker versions of Stockfish, such as the youtube video referenced in the chess.com forum post \"Finally!! A actual human who manages to beat Stockfish!!\" (https://www.chess.com/forum/view/general/finally-a-actual-human-who-manages-to-beat-stockfish) this is not considered a true defeat of the strongest version of the engine. In addition, the chess stack exchange post \"Is it really possible to beat a stockfish level 8 computer in...\" (https://chess.stackexchange.com/questions/20036/is-it-really-possible-to-beat-a-stockfish-level-8-computer-in-any-time-that-is-b) concludes that no verifiable human wins against even Stockfish level 8 have been found."
    }
  ]
}